




Analysis Type:	PANTHER Overrepresentation Test (Released 20190711)
Annotation Version and Release Date:	GO Ontology database  Released 2019-12-09
Analyzed List:	cluster5.txt (Danio rerio)
Reference List:	backgroundlist_35562genes.txt (Danio rerio)
Test Type:	FISHER
Correction:	FDR
GO biological process complete	backgroundlist_35562genes.txt - REFLIST (23232)	cluster5.txt (452)	cluster5.txt (expected)	cluster5.txt (over/under)	cluster5.txt (fold Enrichment)	cluster5.txt (raw P-value)	cluster5.txt (FDR)
regulation of cellular metabolic process (GO:0031323)	2815	150	54.77	+	2.74	6.89E-31	2.96E-27
regulation of macromolecule metabolic process (GO:0060255)	2781	149	54.11	+	2.75	6.73E-31	5.79E-27
regulation of metabolic process (GO:0019222)	2992	154	58.21	+	2.65	3.17E-30	9.07E-27
chromosome organization (GO:0051276)	468	61	9.11	+	6.70	6.43E-30	1.38E-26
regulation of primary metabolic process (GO:0080090)	2703	143	52.59	+	2.72	6.28E-29	1.08E-25
regulation of nitrogen compound metabolic process (GO:0051171)	2656	141	51.67	+	2.73	1.29E-28	1.85E-25
regulation of nucleobase-containing compound metabolic process (GO:0019219)	1964	119	38.21	+	3.11	1.73E-28	2.12E-25
regulation of RNA metabolic process (GO:0051252)	1905	114	37.06	+	3.08	9.29E-27	9.98E-24
regulation of gene expression (GO:0010468)	2107	119	40.99	+	2.90	6.46E-26	6.17E-23
regulation of cellular macromolecule biosynthetic process (GO:2000112)	1910	109	37.16	+	2.93	6.33E-24	5.44E-21
regulation of cellular biosynthetic process (GO:0031326)	1944	110	37.82	+	2.91	7.09E-24	5.54E-21
regulation of macromolecule biosynthetic process (GO:0010556)	1918	109	37.32	+	2.92	8.69E-24	6.22E-21
regulation of biosynthetic process (GO:0009889)	1962	110	38.17	+	2.88	1.43E-23	9.46E-21
regulation of RNA biosynthetic process (GO:2001141)	1757	97	34.18	+	2.84	3.29E-20	1.77E-17
regulation of nucleic acid-templated transcription (GO:1903506)	1756	97	34.16	+	2.84	3.17E-20	1.81E-17
regulation of transcription, DNA-templated (GO:0006355)	1755	97	34.15	+	2.84	3.05E-20	1.87E-17
regulation of cellular process (GO:0050794)	7076	231	137.67	+	1.68	1.60E-19	8.08E-17
chromatin organization (GO:0006325)	316	40	6.15	+	6.51	1.83E-19	8.74E-17
regulation of biological process (GO:0050789)	7515	238	146.21	+	1.63	1.53E-18	6.92E-16
cell cycle (GO:0007049)	494	47	9.61	+	4.89	4.26E-18	1.83E-15
organelle organization (GO:0006996)	1837	94	35.74	+	2.63	1.71E-17	6.98E-15
cell cycle process (GO:0022402)	378	40	7.35	+	5.44	5.45E-17	2.13E-14
anatomical structure development (GO:0048856)	3624	143	70.51	+	2.03	5.85E-17	2.19E-14
biological regulation (GO:0065007)	8169	246	158.94	+	1.55	1.68E-16	6.01E-14
multicellular organism development (GO:0007275)	3357	134	65.31	+	2.05	3.49E-16	1.20E-13
developmental process (GO:0032502)	3778	144	73.50	+	1.96	6.49E-16	2.15E-13
mitotic cell cycle (GO:0000278)	281	33	5.47	+	6.04	2.15E-15	6.83E-13
cellular component organization (GO:0016043)	2957	121	57.53	+	2.10	3.21E-15	9.86E-13
mitotic cell cycle process (GO:1903047)	220	29	4.28	+	6.78	7.68E-15	2.28E-12
cellular component organization or biogenesis (GO:0071840)	3080	123	59.92	+	2.05	1.02E-14	2.91E-12
sister chromatid segregation (GO:0000819)	63	18	1.23	+	14.69	1.22E-14	3.38E-12
nervous system development (GO:0007399)	1392	73	27.08	+	2.70	4.12E-14	1.11E-11
system development (GO:0048731)	2957	117	57.53	+	2.03	1.07E-13	2.80E-11
nuclear chromosome segregation (GO:0098813)	100	19	1.95	+	9.77	1.26E-12	3.18E-10
multicellular organismal process (GO:0032501)	4046	141	78.72	+	1.79	1.60E-12	3.94E-10
DNA conformation change (GO:0071103)	105	19	2.04	+	9.30	2.69E-12	6.41E-10
animal organ development (GO:0048513)	2094	90	40.74	+	2.21	2.81E-12	6.53E-10
tissue development (GO:0009888)	1238	64	24.09	+	2.66	3.47E-12	7.46E-10
negative regulation of biological process (GO:0048519)	1796	81	34.94	+	2.32	3.31E-12	7.49E-10
DNA packaging (GO:0006323)	79	17	1.54	+	11.06	3.43E-12	7.55E-10
cell differentiation (GO:0030154)	1895	83	36.87	+	2.25	6.91E-12	1.45E-09
chromosome segregation (GO:0007059)	128	20	2.49	+	8.03	7.81E-12	1.60E-09
nuclear division (GO:0000280)	116	19	2.26	+	8.42	1.26E-11	2.52E-09
regulation of cell cycle process (GO:0010564)	149	21	2.90	+	7.24	1.35E-11	2.63E-09
mitotic nuclear division (GO:0140014)	62	15	1.21	+	12.44	1.54E-11	2.94E-09
cellular developmental process (GO:0048869)	1936	83	37.67	+	2.20	2.06E-11	3.85E-09
negative regulation of cellular process (GO:0048523)	1652	75	32.14	+	2.33	2.42E-11	4.42E-09
regulation of chromosome organization (GO:0033044)	123	19	2.39	+	7.94	3.12E-11	5.59E-09
mitotic sister chromatid segregation (GO:0000070)	43	13	.84	+	15.54	3.37E-11	5.90E-09
chordate embryonic development (GO:0043009)	419	33	8.15	+	4.05	5.51E-11	9.29E-09
positive regulation of macromolecule metabolic process (GO:0010604)	1131	58	22.00	+	2.64	5.48E-11	9.41E-09
regulation of gene expression, epigenetic (GO:0040029)	97	17	1.89	+	9.01	5.97E-11	9.87E-09
embryo development ending in birth or egg hatching (GO:0009792)	421	33	8.19	+	4.03	6.19E-11	1.00E-08
head development (GO:0060322)	403	32	7.84	+	4.08	8.98E-11	1.43E-08
chromosome condensation (GO:0030261)	37	12	.72	+	16.67	9.83E-11	1.54E-08
positive regulation of metabolic process (GO:0009893)	1220	60	23.74	+	2.53	1.30E-10	1.99E-08
brain development (GO:0007420)	386	31	7.51	+	4.13	1.37E-10	2.07E-08
regulation of chromatin silencing (GO:0031935)	30	11	.58	+	18.85	2.05E-10	3.03E-08
central nervous system development (GO:0007417)	548	37	10.66	+	3.47	2.23E-10	3.25E-08
positive regulation of biological process (GO:0048518)	2081	84	40.49	+	2.07	2.97E-10	4.26E-08
organelle fission (GO:0048285)	143	19	2.78	+	6.83	3.16E-10	4.45E-08
positive regulation of cellular process (GO:0048522)	1802	76	35.06	+	2.17	3.46E-10	4.80E-08
regulation of cellular component organization (GO:0051128)	758	44	14.75	+	2.98	3.94E-10	5.38E-08
positive regulation of cellular metabolic process (GO:0031325)	1160	57	22.57	+	2.53	4.16E-10	5.58E-08
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	650	40	12.65	+	3.16	5.31E-10	7.02E-08
chromatin assembly or disassembly (GO:0006333)	70	14	1.36	+	10.28	6.54E-10	8.52E-08
embryo development (GO:0009790)	928	49	18.06	+	2.71	7.84E-10	1.01E-07
pattern specification process (GO:0007389)	471	33	9.16	+	3.60	9.15E-10	1.16E-07
positive regulation of gene expression (GO:0010628)	671	40	13.05	+	3.06	1.26E-09	1.57E-07
regulation of chromatin organization (GO:1902275)	75	14	1.46	+	9.59	1.44E-09	1.77E-07
positive regulation of RNA metabolic process (GO:0051254)	625	38	12.16	+	3.13	2.01E-09	2.43E-07
regulation of gene silencing (GO:0060968)	39	11	.76	+	14.50	2.07E-09	2.47E-07
epithelium development (GO:0060429)	718	41	13.97	+	2.93	2.54E-09	2.99E-07
nucleosome organization (GO:0034728)	79	14	1.54	+	9.11	2.61E-09	3.04E-07
sister chromatid cohesion (GO:0007062)	30	10	.58	+	17.13	2.95E-09	3.38E-07
positive regulation of macromolecule biosynthetic process (GO:0010557)	637	38	12.39	+	3.07	3.28E-09	3.71E-07
positive regulation of nitrogen compound metabolic process (GO:0051173)	1100	53	21.40	+	2.48	3.33E-09	3.72E-07
generation of neurons (GO:0048699)	853	45	16.60	+	2.71	4.17E-09	4.59E-07
positive regulation of cellular biosynthetic process (GO:0031328)	651	38	12.67	+	3.00	5.73E-09	6.23E-07
positive regulation of biosynthetic process (GO:0009891)	655	38	12.74	+	2.98	6.70E-09	7.20E-07
negative regulation of chromatin silencing (GO:0031936)	25	9	.49	+	18.50	1.07E-08	1.13E-06
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	473	31	9.20	+	3.37	1.30E-08	1.35E-06
regulation of transcription by RNA polymerase II (GO:0006357)	1048	50	20.39	+	2.45	1.30E-08	1.36E-06
negative regulation of gene silencing (GO:0060969)	26	9	.51	+	17.79	1.41E-08	1.44E-06
chromatin assembly (GO:0031497)	62	12	1.21	+	9.95	1.52E-08	1.54E-06
regulation of cell cycle (GO:0051726)	589	35	11.46	+	3.05	1.54E-08	1.54E-06
neurogenesis (GO:0022008)	925	46	18.00	+	2.56	2.05E-08	2.03E-06
positive regulation of transcription, DNA-templated (GO:0045893)	598	35	11.63	+	3.01	2.20E-08	2.13E-06
positive regulation of nucleic acid-templated transcription (GO:1903508)	599	35	11.65	+	3.00	2.29E-08	2.14E-06
negative regulation of cellular component organization (GO:0051129)	169	18	3.29	+	5.47	2.19E-08	2.14E-06
negative regulation of macromolecule metabolic process (GO:0010605)	748	40	14.55	+	2.75	2.25E-08	2.15E-06
positive regulation of RNA biosynthetic process (GO:1902680)	599	35	11.65	+	3.00	2.29E-08	2.16E-06
neural tube development (GO:0021915)	80	13	1.56	+	8.35	2.44E-08	2.25E-06
negative regulation of metabolic process (GO:0009892)	784	41	15.25	+	2.69	2.68E-08	2.45E-06
positive regulation of gene expression, epigenetic (GO:0045815)	30	9	.58	+	15.42	3.96E-08	3.58E-06
anatomical structure morphogenesis (GO:0009653)	1699	67	33.06	+	2.03	6.08E-08	5.44E-06
negative regulation of chromatin organization (GO:1905268)	32	9	.62	+	14.46	6.32E-08	5.60E-06
negative regulation of cellular metabolic process (GO:0031324)	690	37	13.42	+	2.76	7.27E-08	6.31E-06
protein-DNA complex subunit organization (GO:0071824)	124	15	2.41	+	6.22	7.25E-08	6.36E-06
cell division (GO:0051301)	144	16	2.80	+	5.71	7.82E-08	6.72E-06
anterior/posterior pattern specification (GO:0009952)	186	18	3.62	+	4.97	8.39E-08	7.14E-06
nucleosome positioning (GO:0016584)	24	8	.47	+	17.13	1.16E-07	9.81E-06
regulation of organelle organization (GO:0033043)	472	29	9.18	+	3.16	1.41E-07	1.18E-05
regulation of cell development (GO:0060284)	287	22	5.58	+	3.94	1.46E-07	1.20E-05
negative regulation of chromosome organization (GO:2001251)	49	10	.95	+	10.49	1.58E-07	1.29E-05
regulation of neurogenesis (GO:0050767)	265	21	5.16	+	4.07	1.67E-07	1.36E-05
animal organ morphogenesis (GO:0009887)	685	36	13.33	+	2.70	1.75E-07	1.41E-05
negative regulation of organelle organization (GO:0010639)	115	14	2.24	+	6.26	1.84E-07	1.47E-05
nucleic acid metabolic process (GO:0090304)	1108	49	21.56	+	2.27	2.01E-07	1.58E-05
regulation of nervous system development (GO:0051960)	299	22	5.82	+	3.78	2.81E-07	2.20E-05
negative regulation of cell cycle (GO:0045786)	120	14	2.33	+	6.00	2.96E-07	2.29E-05
cell development (GO:0048468)	1052	47	20.47	+	2.30	3.31E-07	2.54E-05
mesenchyme development (GO:0060485)	184	17	3.58	+	4.75	3.52E-07	2.68E-05
nucleosome assembly (GO:0006334)	57	10	1.11	+	9.02	5.45E-07	4.11E-05
cranial skeletal system development (GO:1904888)	191	17	3.72	+	4.57	5.71E-07	4.27E-05
regulation of DNA metabolic process (GO:0051052)	90	12	1.75	+	6.85	5.78E-07	4.28E-05
negative regulation of nitrogen compound metabolic process (GO:0051172)	660	34	12.84	+	2.65	6.00E-07	4.41E-05
embryonic morphogenesis (GO:0048598)	600	32	11.67	+	2.74	6.38E-07	4.65E-05
mitotic sister chromatid cohesion (GO:0007064)	12	6	.23	+	25.70	7.14E-07	5.16E-05
negative regulation of DNA recombination (GO:0045910)	32	8	.62	+	12.85	7.45E-07	5.33E-05
stem cell differentiation (GO:0048863)	173	16	3.37	+	4.75	7.67E-07	5.45E-05
macromolecule metabolic process (GO:0043170)	4044	121	78.68	+	1.54	9.68E-07	6.82E-05
cellular process (GO:0009987)	11027	267	214.54	+	1.24	1.13E-06	7.87E-05
mesenchymal cell differentiation (GO:0048762)	139	14	2.70	+	5.18	1.49E-06	1.03E-04
covalent chromatin modification (GO:0016569)	139	14	2.70	+	5.18	1.49E-06	1.03E-04
tube development (GO:0035295)	595	31	11.58	+	2.68	1.52E-06	1.04E-04
regionalization (GO:0003002)	310	21	6.03	+	3.48	1.82E-06	1.23E-04
hindbrain development (GO:0030902)	103	12	2.00	+	5.99	2.11E-06	1.42E-04
regulation of cell differentiation (GO:0045595)	425	25	8.27	+	3.02	2.17E-06	1.44E-04
neural crest cell differentiation (GO:0014033)	123	13	2.39	+	5.43	2.16E-06	1.44E-04
regulation of DNA recombination (GO:0000018)	38	8	.74	+	10.82	2.29E-06	1.50E-04
mRNA cis splicing, via spliceosome (GO:0045292)	26	7	.51	+	13.84	2.45E-06	1.59E-04
biological_process (GO:0008150)	15802	353	307.44	+	1.15	3.18E-06	2.04E-04
Unclassified (UNCLASSIFIED)	7430	99	144.56	-	.68	3.18E-06	2.05E-04
embryonic organ development (GO:0048568)	495	27	9.63	+	2.80	3.28E-06	2.09E-04
negative regulation of DNA metabolic process (GO:0051053)	41	8	.80	+	10.03	3.76E-06	2.37E-04
DNA metabolic process (GO:0006259)	356	22	6.93	+	3.18	4.23E-06	2.65E-04
negative regulation of cell cycle process (GO:0010948)	43	8	.84	+	9.56	5.13E-06	3.20E-04
histone modification (GO:0016570)	135	13	2.63	+	4.95	5.54E-06	3.43E-04
regulation of cell cycle phase transition (GO:1901987)	76	10	1.48	+	6.76	5.63E-06	3.46E-04
regulation of multicellular organismal development (GO:2000026)	605	30	11.77	+	2.55	5.73E-06	3.50E-04
epithelial tube morphogenesis (GO:0060562)	206	16	4.01	+	3.99	6.27E-06	3.80E-04
determination of left/right symmetry (GO:0007368)	208	16	4.05	+	3.95	7.03E-06	4.22E-04
RNA splicing, via transesterification reactions (GO:0000375)	139	13	2.70	+	4.81	7.43E-06	4.37E-04
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	139	13	2.70	+	4.81	7.43E-06	4.40E-04
mRNA splicing, via spliceosome (GO:0000398)	139	13	2.70	+	4.81	7.43E-06	4.43E-04
embryonic organ morphogenesis (GO:0048562)	346	21	6.73	+	3.12	9.04E-06	5.28E-04
neuron development (GO:0048666)	557	28	10.84	+	2.58	9.27E-06	5.35E-04
negative regulation of gene expression (GO:0010629)	557	28	10.84	+	2.58	9.27E-06	5.38E-04
protein-DNA complex assembly (GO:0065004)	101	11	1.97	+	5.60	1.01E-05	5.77E-04
spindle organization (GO:0007051)	64	9	1.25	+	7.23	1.02E-05	5.81E-04
forebrain development (GO:0030900)	123	12	2.39	+	5.01	1.12E-05	6.35E-04
regulation of developmental process (GO:0050793)	752	34	14.63	+	2.32	1.25E-05	7.02E-04
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	474	25	9.22	+	2.71	1.30E-05	7.09E-04
negative regulation of nervous system development (GO:0051961)	66	9	1.28	+	7.01	1.28E-05	7.13E-04
negative regulation of macromolecule biosynthetic process (GO:0010558)	474	25	9.22	+	2.71	1.30E-05	7.14E-04
mRNA processing (GO:0006397)	245	17	4.77	+	3.57	1.30E-05	7.16E-04
embryonic cranial skeleton morphogenesis (GO:0048701)	147	13	2.86	+	4.55	1.30E-05	7.18E-04
morphogenesis of an epithelium (GO:0002009)	389	22	7.57	+	2.91	1.57E-05	8.51E-04
regulation of neuron differentiation (GO:0045664)	199	15	3.87	+	3.87	1.69E-05	9.04E-04
heart morphogenesis (GO:0003007)	199	15	3.87	+	3.87	1.69E-05	9.10E-04
negative regulation of cellular biosynthetic process (GO:0031327)	485	25	9.44	+	2.65	1.88E-05	9.97E-04
regulation of signal transduction (GO:0009966)	1047	42	20.37	+	2.06	1.90E-05	1.00E-03
digestive system development (GO:0055123)	109	11	2.12	+	5.19	1.94E-05	1.02E-03
meiotic cell cycle process (GO:1903046)	70	9	1.36	+	6.61	1.96E-05	1.02E-03
meiotic cell cycle (GO:0051321)	89	10	1.73	+	5.78	1.99E-05	1.03E-03
negative regulation of biosynthetic process (GO:0009890)	487	25	9.48	+	2.64	2.01E-05	1.03E-03
nucleobase-containing compound metabolic process (GO:0006139)	1429	52	27.80	+	1.87	2.05E-05	1.05E-03
mRNA metabolic process (GO:0016071)	310	19	6.03	+	3.15	2.11E-05	1.08E-03
neural tube patterning (GO:0021532)	38	7	.74	+	9.47	2.13E-05	1.08E-03
RNA splicing (GO:0008380)	179	14	3.48	+	4.02	2.20E-05	1.11E-03
transport (GO:0006810)	2539	23	49.40	-	.47	2.27E-05	1.12E-03
specification of symmetry (GO:0009799)	230	16	4.47	+	3.58	2.26E-05	1.12E-03
determination of bilateral symmetry (GO:0009855)	230	16	4.47	+	3.58	2.26E-05	1.13E-03
ventral midline development (GO:0007418)	14	5	.27	+	18.36	2.31E-05	1.13E-03
tissue morphogenesis (GO:0048729)	492	25	9.57	+	2.61	2.36E-05	1.15E-03
stem cell development (GO:0048864)	112	11	2.18	+	5.05	2.45E-05	1.18E-03
embryonic skeletal system morphogenesis (GO:0048704)	157	13	3.05	+	4.26	2.47E-05	1.18E-03
mesenchymal cell development (GO:0014031)	112	11	2.18	+	5.05	2.45E-05	1.18E-03
neural crest cell development (GO:0014032)	112	11	2.18	+	5.05	2.45E-05	1.19E-03
negative regulation of RNA metabolic process (GO:0051253)	433	23	8.42	+	2.73	2.60E-05	1.23E-03
neuron differentiation (GO:0030182)	683	31	13.29	+	2.33	3.42E-05	1.61E-03
regulation of mRNA metabolic process (GO:1903311)	117	11	2.28	+	4.83	3.56E-05	1.67E-03
digestive tract development (GO:0048565)	77	9	1.50	+	6.01	3.89E-05	1.81E-03
floor plate development (GO:0033504)	16	5	.31	+	16.06	3.91E-05	1.81E-03
negative regulation of mitotic cell cycle (GO:0045930)	77	9	1.50	+	6.01	3.89E-05	1.82E-03
embryonic heart tube development (GO:0035050)	144	12	2.80	+	4.28	4.76E-05	2.17E-03
midbrain-hindbrain boundary development (GO:0030917)	29	6	.56	+	10.63	4.74E-05	2.17E-03
somite development (GO:0061053)	121	11	2.35	+	4.67	4.73E-05	2.17E-03
heterocycle metabolic process (GO:0046483)	1519	53	29.55	+	1.79	5.29E-05	2.39E-03
embryonic heart tube morphogenesis (GO:0003143)	123	11	2.39	+	4.60	5.43E-05	2.44E-03
mitotic cell cycle checkpoint (GO:0007093)	45	7	.88	+	8.00	5.61E-05	2.47E-03
negative regulation of mitotic cell cycle phase transition (GO:1901991)	30	6	.58	+	10.28	5.60E-05	2.48E-03
negative regulation of neurogenesis (GO:0050768)	62	8	1.21	+	6.63	5.54E-05	2.48E-03
somitogenesis (GO:0001756)	81	9	1.58	+	5.71	5.59E-05	2.49E-03
cellular macromolecule metabolic process (GO:0044260)	3175	93	61.77	+	1.51	6.06E-05	2.66E-03
determination of heart left/right asymmetry (GO:0061371)	149	12	2.90	+	4.14	6.47E-05	2.82E-03
cellular response to DNA damage stimulus (GO:0006974)	339	19	6.60	+	2.88	6.64E-05	2.88E-03
neuron projection development (GO:0031175)	433	22	8.42	+	2.61	7.23E-05	3.12E-03
embryonic skeletal system development (GO:0048706)	176	13	3.42	+	3.80	7.43E-05	3.19E-03
cranial nerve development (GO:0021545)	48	7	.93	+	7.50	8.10E-05	3.45E-03
mitotic G2/M transition checkpoint (GO:0044818)	9	4	.18	+	22.84	8.16E-05	3.46E-03
cellular aromatic compound metabolic process (GO:0006725)	1531	53	29.79	+	1.78	8.09E-05	3.46E-03
heart development (GO:0007507)	439	22	8.54	+	2.58	8.75E-05	3.68E-03
negative regulation of cell cycle phase transition (GO:1901988)	33	6	.64	+	9.35	8.94E-05	3.75E-03
negative regulation of developmental process (GO:0051093)	155	12	3.02	+	3.98	9.21E-05	3.84E-03
regulation of RNA splicing (GO:0043484)	87	9	1.69	+	5.32	9.27E-05	3.85E-03
negative regulation of nucleic acid-templated transcription (GO:1903507)	411	21	8.00	+	2.63	9.75E-05	3.99E-03
negative regulation of transcription, DNA-templated (GO:0045892)	411	21	8.00	+	2.63	9.75E-05	4.01E-03
negative regulation of RNA biosynthetic process (GO:1902679)	411	21	8.00	+	2.63	9.75E-05	4.03E-03
axon guidance (GO:0007411)	208	14	4.05	+	3.46	1.01E-04	4.12E-03
rostrocaudal neural tube patterning (GO:0021903)	34	6	.66	+	9.07	1.04E-04	4.18E-03
mitotic spindle organization (GO:0007052)	34	6	.66	+	9.07	1.04E-04	4.20E-03
movement of cell or subcellular component (GO:0006928)	883	35	17.18	+	2.04	1.08E-04	4.33E-03
segmentation (GO:0035282)	89	9	1.73	+	5.20	1.09E-04	4.35E-03
gland development (GO:0048732)	211	14	4.11	+	3.41	1.16E-04	4.63E-03
neuron projection guidance (GO:0097485)	212	14	4.12	+	3.39	1.22E-04	4.70E-03
plasma membrane bounded cell projection morphogenesis (GO:0120039)	356	19	6.93	+	2.74	1.22E-04	4.72E-03
negative regulation of cell development (GO:0010721)	70	8	1.36	+	5.87	1.21E-04	4.73E-03
microtubule cytoskeleton organization (GO:0000226)	267	16	5.19	+	3.08	1.20E-04	4.74E-03
neuron projection morphogenesis (GO:0048812)	356	19	6.93	+	2.74	1.22E-04	4.74E-03
sensory organ morphogenesis (GO:0090596)	239	15	4.65	+	3.23	1.20E-04	4.74E-03
cell projection morphogenesis (GO:0048858)	356	19	6.93	+	2.74	1.22E-04	4.76E-03
protein acetylation (GO:0006473)	52	7	1.01	+	6.92	1.28E-04	4.85E-03
pectoral fin development (GO:0033339)	52	7	1.01	+	6.92	1.28E-04	4.87E-03
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	52	7	1.01	+	6.92	1.28E-04	4.89E-03
morphogenesis of embryonic epithelium (GO:0016331)	53	7	1.03	+	6.79	1.42E-04	5.38E-03
regulation of response to stimulus (GO:0048583)	1414	49	27.51	+	1.78	1.50E-04	5.65E-03
G protein-coupled receptor signaling pathway (GO:0007186)	1022	5	19.88	-	.25	1.51E-04	5.66E-03
mitotic chromosome condensation (GO:0007076)	11	4	.21	+	18.69	1.51E-04	5.67E-03
cell part morphogenesis (GO:0032990)	363	19	7.06	+	2.69	1.55E-04	5.75E-03
gene silencing (GO:0016458)	73	8	1.42	+	5.63	1.57E-04	5.81E-03
axon development (GO:0061564)	333	18	6.48	+	2.78	1.57E-04	5.83E-03
regulation of multicellular organismal process (GO:0051239)	823	33	16.01	+	2.06	1.67E-04	6.14E-03
mitotic DNA integrity checkpoint (GO:0044774)	23	5	.45	+	11.17	1.69E-04	6.19E-03
embryonic viscerocranium morphogenesis (GO:0048703)	95	9	1.85	+	4.87	1.72E-04	6.26E-03
transmembrane transport (GO:0055085)	905	4	17.61	-	.23	1.77E-04	6.41E-03
organic cyclic compound metabolic process (GO:1901360)	1617	54	31.46	+	1.72	1.80E-04	6.48E-03
cell morphogenesis involved in differentiation (GO:0000904)	399	20	7.76	+	2.58	1.81E-04	6.48E-03
small molecule metabolic process (GO:0044281)	916	4	17.82	-	.22	1.80E-04	6.50E-03
ear development (GO:0043583)	143	11	2.78	+	3.95	1.89E-04	6.70E-03
inner ear development (GO:0048839)	143	11	2.78	+	3.95	1.89E-04	6.73E-03
epithelial cell differentiation (GO:0030855)	196	13	3.81	+	3.41	2.03E-04	7.18E-03
negative regulation of multicellular organismal process (GO:0051241)	170	12	3.31	+	3.63	2.07E-04	7.29E-03
neuron fate commitment (GO:0048663)	40	6	.78	+	7.71	2.29E-04	8.05E-03
axonogenesis (GO:0007409)	314	17	6.11	+	2.78	2.34E-04	8.17E-03
chromatin remodeling (GO:0006338)	78	8	1.52	+	5.27	2.39E-04	8.28E-03
locomotion (GO:0040011)	741	30	14.42	+	2.08	2.39E-04	8.31E-03
pigmentation (GO:0043473)	123	10	2.39	+	4.18	2.42E-04	8.37E-03
floor plate formation (GO:0021508)	13	4	.25	+	15.81	2.56E-04	8.76E-03
floor plate morphogenesis (GO:0033505)	13	4	.25	+	15.81	2.56E-04	8.79E-03
regulation of axonogenesis (GO:0050770)	101	9	1.97	+	4.58	2.63E-04	8.96E-03
skeletal system morphogenesis (GO:0048705)	202	13	3.93	+	3.31	2.68E-04	9.09E-03
regulation of cell cycle G2/M phase transition (GO:1902749)	26	5	.51	+	9.88	2.79E-04	9.41E-03
midbrain development (GO:0030901)	26	5	.51	+	9.88	2.79E-04	9.45E-03
cell morphogenesis (GO:0000902)	471	22	9.16	+	2.40	2.94E-04	9.84E-03
regulation of neuron projection development (GO:0010975)	151	11	2.94	+	3.74	2.93E-04	9.84E-03
cellular response to stress (GO:0033554)	649	27	12.63	+	2.14	3.04E-04	1.01E-02
skeletal system development (GO:0001501)	323	17	6.28	+	2.71	3.19E-04	1.06E-02
neural crest formation (GO:0014029)	14	4	.27	+	14.69	3.24E-04	1.07E-02
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	14	4	.27	+	14.69	3.24E-04	1.07E-02
macromolecule modification (GO:0043412)	2070	64	40.27	+	1.59	3.29E-04	1.08E-02
cell projection organization (GO:0030030)	671	28	13.05	+	2.14	3.35E-04	1.09E-02
nerve development (GO:0021675)	62	7	1.21	+	5.80	3.43E-04	1.12E-02
neural crest cell migration (GO:0001755)	83	8	1.61	+	4.95	3.52E-04	1.14E-02
mitotic G2 DNA damage checkpoint (GO:0007095)	5	3	.10	+	30.84	3.60E-04	1.16E-02
negative regulation of cell differentiation (GO:0045596)	106	9	2.06	+	4.36	3.66E-04	1.17E-02
regulation of cell communication (GO:0010646)	1196	42	23.27	+	1.80	3.65E-04	1.18E-02
cell cycle checkpoint (GO:0000075)	63	7	1.23	+	5.71	3.74E-04	1.20E-02
digestive tract morphogenesis (GO:0048546)	28	5	.54	+	9.18	3.78E-04	1.20E-02
regulation of signaling (GO:0023051)	1202	42	23.39	+	1.80	3.80E-04	1.20E-02
neuron fate specification (GO:0048665)	28	5	.54	+	9.18	3.78E-04	1.20E-02
regulation of Wnt signaling pathway (GO:0030111)	131	10	2.55	+	3.92	3.88E-04	1.22E-02
cell morphogenesis involved in neuron differentiation (GO:0048667)	329	17	6.40	+	2.66	3.90E-04	1.22E-02
ion transport (GO:0006811)	947	5	18.42	-	.27	3.92E-04	1.22E-02
eye morphogenesis (GO:0048592)	184	12	3.58	+	3.35	4.08E-04	1.27E-02
positive regulation of molecular function (GO:0044093)	448	21	8.72	+	2.41	4.07E-04	1.27E-02
nitrogen compound metabolic process (GO:0006807)	4606	121	89.61	+	1.35	4.37E-04	1.35E-02
RNA processing (GO:0006396)	491	22	9.55	+	2.30	4.36E-04	1.35E-02
heart looping (GO:0001947)	109	9	2.12	+	4.24	4.43E-04	1.36E-02
spinal cord development (GO:0021510)	65	7	1.26	+	5.54	4.45E-04	1.36E-02
cellular protein modification process (GO:0006464)	1966	61	38.25	+	1.59	4.56E-04	1.39E-02
protein modification process (GO:0036211)	1966	61	38.25	+	1.59	4.56E-04	1.39E-02
regulation of mRNA processing (GO:0050684)	87	8	1.69	+	4.73	4.72E-04	1.43E-02
plasma membrane bounded cell projection organization (GO:0120036)	654	27	12.72	+	2.12	4.88E-04	1.47E-02
cellular component morphogenesis (GO:0032989)	551	24	10.72	+	2.24	4.87E-04	1.47E-02
negative regulation of cell cycle G2/M phase transition (GO:1902750)	16	4	.31	+	12.85	4.98E-04	1.49E-02
regulation of cytokinesis (GO:0032465)	30	5	.58	+	8.57	5.01E-04	1.50E-02
developmental growth (GO:0048589)	246	14	4.79	+	2.93	5.11E-04	1.52E-02
growth (GO:0040007)	246	14	4.79	+	2.93	5.11E-04	1.52E-02
regulation of mitotic cell cycle phase transition (GO:1901990)	67	7	1.30	+	5.37	5.27E-04	1.56E-02
cellular component assembly (GO:0022607)	1112	39	21.63	+	1.80	5.42E-04	1.59E-02
negative regulation of neuron differentiation (GO:0045665)	48	6	.93	+	6.42	5.56E-04	1.62E-02
ameboidal-type cell migration (GO:0001667)	191	12	3.72	+	3.23	5.58E-04	1.62E-02
regulation of cell division (GO:0051302)	48	6	.93	+	6.42	5.56E-04	1.63E-02
tube morphogenesis (GO:0035239)	465	21	9.05	+	2.32	5.55E-04	1.63E-02
DNA repair (GO:0006281)	249	14	4.84	+	2.89	5.73E-04	1.66E-02
establishment of localization (GO:0051234)	2578	28	50.16	-	.56	5.98E-04	1.73E-02
chromosome separation (GO:0051304)	17	4	.33	+	12.09	6.05E-04	1.74E-02
definitive hemopoiesis (GO:0060216)	49	6	.95	+	6.29	6.14E-04	1.76E-02
DNA recombination (GO:0006310)	116	9	2.26	+	3.99	6.74E-04	1.92E-02
regulation of cell morphogenesis involved in differentiation (GO:0010769)	117	9	2.28	+	3.95	7.14E-04	2.03E-02
regulation of DNA replication (GO:0006275)	18	4	.35	+	11.42	7.29E-04	2.05E-02
diencephalon development (GO:0021536)	71	7	1.38	+	5.07	7.24E-04	2.05E-02
protein monoubiquitination (GO:0006513)	18	4	.35	+	11.42	7.29E-04	2.06E-02
negative regulation of gene expression, epigenetic (GO:0045814)	33	5	.64	+	7.79	7.40E-04	2.06E-02
chromatin silencing (GO:0006342)	33	5	.64	+	7.79	7.40E-04	2.07E-02
chromatin organization involved in negative regulation of transcription (GO:0097549)	33	5	.64	+	7.79	7.40E-04	2.08E-02
regulation of plasma membrane bounded cell projection organization (GO:0120035)	198	12	3.85	+	3.12	7.53E-04	2.09E-02
regulation of cell projection organization (GO:0031344)	200	12	3.89	+	3.08	8.18E-04	2.27E-02
microtubule-based process (GO:0007017)	408	19	7.94	+	2.39	8.64E-04	2.39E-02
reproductive process (GO:0022414)	231	13	4.49	+	2.89	8.84E-04	2.43E-02
retina development in camera-type eye (GO:0060041)	202	12	3.93	+	3.05	8.88E-04	2.44E-02
circulatory system development (GO:0072359)	769	29	14.96	+	1.94	9.00E-04	2.46E-02
regulation of mRNA splicing, via spliceosome (GO:0048024)	74	7	1.44	+	4.86	9.08E-04	2.48E-02
cell fate commitment (GO:0045165)	148	10	2.88	+	3.47	9.43E-04	2.57E-02
hematopoietic progenitor cell differentiation (GO:0002244)	75	7	1.46	+	4.80	9.77E-04	2.65E-02
primitive erythrocyte differentiation (GO:0060319)	20	4	.39	+	10.28	1.03E-03	2.77E-02
reproduction (GO:0000003)	235	13	4.57	+	2.84	1.03E-03	2.77E-02
regulation of cell morphogenesis (GO:0022604)	206	12	4.01	+	2.99	1.04E-03	2.80E-02
autonomic nervous system development (GO:0048483)	36	5	.70	+	7.14	1.05E-03	2.81E-02
retinal ganglion cell axon guidance (GO:0031290)	36	5	.70	+	7.14	1.05E-03	2.82E-02
anatomical structure formation involved in morphogenesis (GO:0048646)	625	25	12.16	+	2.06	1.09E-03	2.91E-02
gliogenesis (GO:0042063)	77	7	1.50	+	4.67	1.13E-03	2.99E-02
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	56	6	1.09	+	5.51	1.16E-03	3.08E-02
chromatin organization involved in regulation of transcription (GO:0034401)	37	5	.72	+	6.95	1.18E-03	3.09E-02
regulation of chromosome segregation (GO:0051983)	37	5	.72	+	6.95	1.18E-03	3.10E-02
fin development (GO:0033333)	78	7	1.52	+	4.61	1.21E-03	3.15E-02
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	21	4	.41	+	9.79	1.20E-03	3.16E-02
Wnt signaling pathway (GO:0016055)	128	9	2.49	+	3.61	1.29E-03	3.37E-02
axis elongation (GO:0003401)	38	5	.74	+	6.76	1.31E-03	3.41E-02
double-strand break repair (GO:0006302)	103	8	2.00	+	3.99	1.32E-03	3.41E-02
regulation of centrosome duplication (GO:0010824)	9	3	.18	+	17.13	1.34E-03	3.45E-02
cell-cell signaling by wnt (GO:0198738)	129	9	2.51	+	3.59	1.36E-03	3.49E-02
positive regulation of catalytic activity (GO:0043085)	393	18	7.65	+	2.35	1.36E-03	3.49E-02
regulation of binding (GO:0051098)	22	4	.43	+	9.35	1.40E-03	3.56E-02
neural precursor cell proliferation (GO:0061351)	22	4	.43	+	9.35	1.40E-03	3.57E-02
neural nucleus development (GO:0048857)	22	4	.43	+	9.35	1.40E-03	3.58E-02
ventricular system development (GO:0021591)	22	4	.43	+	9.35	1.40E-03	3.59E-02
histone acetylation (GO:0016573)	39	5	.76	+	6.59	1.46E-03	3.68E-02
protein-containing complex subunit organization (GO:0043933)	601	24	11.69	+	2.05	1.48E-03	3.72E-02
regulation of microtubule-based process (GO:0032886)	81	7	1.58	+	4.44	1.48E-03	3.72E-02
sensory system development (GO:0048880)	493	21	9.59	+	2.19	1.48E-03	3.72E-02
cellular component biogenesis (GO:0044085)	1244	41	24.20	+	1.69	1.50E-03	3.74E-02
posttranscriptional regulation of gene expression (GO:0010608)	158	10	3.07	+	3.25	1.50E-03	3.74E-02
embryonic pectoral fin morphogenesis (GO:0035118)	23	4	.45	+	8.94	1.62E-03	3.99E-02
double-strand break repair via homologous recombination (GO:0000724)	60	6	1.17	+	5.14	1.62E-03	4.00E-02
pharyngeal system development (GO:0060037)	23	4	.45	+	8.94	1.62E-03	4.01E-02
recombinational repair (GO:0000725)	60	6	1.17	+	5.14	1.62E-03	4.01E-02
protein localization to chromosome (GO:0034502)	10	3	.19	+	15.42	1.71E-03	4.12E-02
regulation of centrosome cycle (GO:0046605)	10	3	.19	+	15.42	1.71E-03	4.13E-02
appendage development (GO:0048736)	83	7	1.61	+	4.33	1.69E-03	4.14E-02
chemotaxis (GO:0006935)	361	17	7.02	+	2.42	1.69E-03	4.14E-02
cytokinetic process (GO:0032506)	10	3	.19	+	15.42	1.71E-03	4.15E-02
regulation of nucleocytoplasmic transport (GO:0046822)	10	3	.19	+	15.42	1.71E-03	4.16E-02
spinal cord patterning (GO:0021511)	10	3	.19	+	15.42	1.71E-03	4.17E-02
spinal cord dorsal/ventral patterning (GO:0021513)	10	3	.19	+	15.42	1.71E-03	4.18E-02
DNA integrity checkpoint (GO:0031570)	41	5	.80	+	6.27	1.78E-03	4.23E-02
positive regulation of cell cycle process (GO:0090068)	41	5	.80	+	6.27	1.78E-03	4.24E-02
internal peptidyl-lysine acetylation (GO:0018393)	41	5	.80	+	6.27	1.78E-03	4.26E-02
peptidyl-lysine acetylation (GO:0018394)	41	5	.80	+	6.27	1.78E-03	4.27E-02
internal protein amino acid acetylation (GO:0006475)	41	5	.80	+	6.27	1.78E-03	4.28E-02
regulation of anatomical structure morphogenesis (GO:0022603)	371	17	7.22	+	2.36	1.92E-03	4.54E-02
otic vesicle development (GO:0071599)	42	5	.82	+	6.12	1.96E-03	4.64E-02
developmental growth involved in morphogenesis (GO:0060560)	86	7	1.67	+	4.18	2.04E-03	4.75E-02
cell fate specification (GO:0001708)	86	7	1.67	+	4.18	2.04E-03	4.77E-02
taxis (GO:0042330)	375	17	7.30	+	2.33	2.03E-03	4.78E-02
muscle cell differentiation (GO:0042692)	194	11	3.77	+	2.91	2.03E-03	4.79E-02
cohesin loading (GO:0071921)	2	2	.04	+	51.40	2.13E-03	4.79E-02
positive regulation of sister chromatid cohesion (GO:0045876)	2	2	.04	+	51.40	2.13E-03	4.81E-02
positive regulation of protein localization to chromatin (GO:0120187)	2	2	.04	+	51.40	2.13E-03	4.82E-02
rDNA condensation (GO:0070550)	2	2	.04	+	51.40	2.13E-03	4.83E-02
formation of anatomical boundary (GO:0048859)	11	3	.21	+	14.02	2.15E-03	4.83E-02
positive regulation of nuclear cell cycle DNA replication (GO:0010571)	2	2	.04	+	51.40	2.13E-03	4.85E-02
gene looping (GO:0090202)	2	2	.04	+	51.40	2.13E-03	4.86E-02
corpora quadrigemina development (GO:0061378)	2	2	.04	+	51.40	2.13E-03	4.87E-02
dsDNA loop formation (GO:0090579)	2	2	.04	+	51.40	2.13E-03	4.88E-02
positive regulation of cohesin loading (GO:1905309)	2	2	.04	+	51.40	2.13E-03	4.90E-02
regulation of nuclear cell cycle DNA replication (GO:0033262)	2	2	.04	+	51.40	2.13E-03	4.91E-02
regulation of mitotic cohesin loading (GO:1905405)	2	2	.04	+	51.40	2.13E-03	4.92E-02
positive regulation of mitotic cohesin loading (GO:1905406)	2	2	.04	+	51.40	2.13E-03	4.94E-02
transcriptional activation by promoter-enhancer looping (GO:0071733)	2	2	.04	+	51.40	2.13E-03	4.95E-02
protein acylation (GO:0043543)	88	7	1.71	+	4.09	2.30E-03	5.16E-02
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	140	9	2.72	+	3.30	2.31E-03	5.16E-02
RNA metabolic process (GO:0016070)	779	28	15.16	+	1.85	2.35E-03	5.25E-02
regulation of cellular response to growth factor stimulus (GO:0090287)	114	8	2.22	+	3.61	2.40E-03	5.34E-02
enteric nervous system development (GO:0048484)	26	4	.51	+	7.91	2.42E-03	5.35E-02
regulation of mitotic sister chromatid segregation (GO:0033047)	26	4	.51	+	7.91	2.42E-03	5.36E-02
epithelial to mesenchymal transition (GO:0001837)	26	4	.51	+	7.91	2.42E-03	5.38E-02
cellular protein-containing complex assembly (GO:0034622)	387	17	7.53	+	2.26	2.51E-03	5.52E-02
negative regulation of Wnt signaling pathway (GO:0030178)	66	6	1.28	+	4.67	2.52E-03	5.53E-02
regulation of axon extension (GO:0030516)	66	6	1.28	+	4.67	2.52E-03	5.55E-02
G2 DNA damage checkpoint (GO:0031572)	12	3	.23	+	12.85	2.65E-03	5.76E-02
endocardium development (GO:0003157)	12	3	.23	+	12.85	2.65E-03	5.78E-02
anterior/posterior axon guidance (GO:0033564)	12	3	.23	+	12.85	2.65E-03	5.79E-02
glial cell differentiation (GO:0010001)	67	6	1.30	+	4.60	2.71E-03	5.88E-02
regulation of canonical Wnt signaling pathway (GO:0060828)	91	7	1.77	+	3.95	2.74E-03	5.91E-02
convergent extension involved in axis elongation (GO:0060028)	27	4	.53	+	7.61	2.74E-03	5.91E-02
neuron migration (GO:0001764)	27	4	.53	+	7.61	2.74E-03	5.93E-02
dorsal/ventral pattern formation (GO:0009953)	117	8	2.28	+	3.51	2.79E-03	5.99E-02
posterior lateral line system development (GO:0048915)	68	6	1.32	+	4.54	2.90E-03	6.21E-02
cellular amide metabolic process (GO:0043603)	466	1	9.07	-	.11	2.91E-03	6.22E-02
regulation of growth (GO:0040008)	119	8	2.32	+	3.46	3.07E-03	6.56E-02
pectoral fin morphogenesis (GO:0035138)	28	4	.54	+	7.34	3.08E-03	6.56E-02
convergent extension involved in gastrulation (GO:0060027)	69	6	1.34	+	4.47	3.10E-03	6.58E-02
positive regulation of transcription by RNA polymerase II (GO:0045944)	457	19	8.89	+	2.14	3.16E-03	6.68E-02
dorsal convergence (GO:0060030)	13	3	.25	+	11.86	3.21E-03	6.77E-02
rhombomere development (GO:0021546)	13	3	.25	+	11.86	3.21E-03	6.79E-02
regulation of developmental growth (GO:0048638)	94	7	1.83	+	3.83	3.25E-03	6.82E-02
positive regulation of cell cycle (GO:0045787)	48	5	.93	+	5.35	3.35E-03	7.02E-02
anion transport (GO:0006820)	318	0	6.19	-	 < 0.01	3.36E-03	7.03E-02
establishment of protein localization to chromosome (GO:0070199)	3	2	.06	+	34.27	3.50E-03	7.06E-02
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	3	2	.06	+	34.27	3.50E-03	7.07E-02
tongue development (GO:0043586)	3	2	.06	+	34.27	3.50E-03	7.09E-02
tongue morphogenesis (GO:0043587)	3	2	.06	+	34.27	3.50E-03	7.11E-02
mechanosensory lateral line system development (GO:0048881)	71	6	1.38	+	4.34	3.54E-03	7.12E-02
regulation of chromatin silencing at rDNA (GO:0061187)	3	2	.06	+	34.27	3.50E-03	7.12E-02
taste bud development (GO:0061193)	3	2	.06	+	34.27	3.50E-03	7.14E-02
taste bud morphogenesis (GO:0061194)	3	2	.06	+	34.27	3.50E-03	7.16E-02
taste bud formation (GO:0061195)	3	2	.06	+	34.27	3.50E-03	7.17E-02
protein localization to chromatin (GO:0071168)	3	2	.06	+	34.27	3.50E-03	7.19E-02
embryonic appendage morphogenesis (GO:0035113)	29	4	.56	+	7.09	3.46E-03	7.19E-02
establishment of protein localization to chromatin (GO:0071169)	3	2	.06	+	34.27	3.50E-03	7.21E-02
microtubule polymerization or depolymerization (GO:0031109)	29	4	.56	+	7.09	3.46E-03	7.21E-02
meiotic spindle organization (GO:0000212)	3	2	.06	+	34.27	3.50E-03	7.23E-02
meiotic chromosome condensation (GO:0010032)	3	2	.06	+	34.27	3.50E-03	7.24E-02
establishment of mitotic sister chromatid cohesion (GO:0034087)	3	2	.06	+	34.27	3.50E-03	7.26E-02
visual system development (GO:0150063)	406	17	7.90	+	2.15	3.65E-03	7.32E-02
eye development (GO:0001654)	406	17	7.90	+	2.15	3.65E-03	7.34E-02
regulation of molecular function (GO:0065009)	795	28	15.47	+	1.81	3.83E-03	7.66E-02
adenohypophysis development (GO:0021984)	14	3	.27	+	11.01	3.85E-03	7.67E-02
regulation of response to wounding (GO:1903034)	30	4	.58	+	6.85	3.86E-03	7.68E-02
fin morphogenesis (GO:0033334)	50	5	.97	+	5.14	3.93E-03	7.77E-02
primitive hemopoiesis (GO:0060215)	50	5	.97	+	5.14	3.93E-03	7.79E-02
cellular nitrogen compound metabolic process (GO:0034641)	1864	54	36.27	+	1.49	3.93E-03	7.80E-02
regulation of microtubule cytoskeleton organization (GO:0070507)	73	6	1.42	+	4.22	4.02E-03	7.92E-02
eye photoreceptor cell differentiation (GO:0001754)	51	5	.99	+	5.04	4.25E-03	8.37E-02
regulation of extent of cell growth (GO:0061387)	74	6	1.44	+	4.17	4.28E-03	8.39E-02
regulation of sister chromatid segregation (GO:0033045)	31	4	.60	+	6.63	4.29E-03	8.40E-02
cytoskeleton organization (GO:0007010)	737	26	14.34	+	1.81	4.35E-03	8.49E-02
sensory organ development (GO:0007423)	548	21	10.66	+	1.97	4.45E-03	8.68E-02
DNA replication (GO:0006260)	100	7	1.95	+	3.60	4.47E-03	8.69E-02
pons development (GO:0021548)	15	3	.29	+	10.28	4.55E-03	8.81E-02
photoreceptor cell differentiation (GO:0046530)	75	6	1.46	+	4.11	4.55E-03	8.82E-02
heart jogging (GO:0003146)	32	4	.62	+	6.42	4.76E-03	9.17E-02
muscle structure development (GO:0061061)	283	13	5.51	+	2.36	4.77E-03	9.17E-02
regulation of intracellular transport (GO:0032386)	32	4	.62	+	6.42	4.76E-03	9.19E-02
appendage morphogenesis (GO:0035107)	53	5	1.03	+	4.85	4.95E-03	9.49E-02
axon target recognition (GO:0007412)	4	2	.08	+	25.70	5.18E-03	9.64E-02
positive regulation of DNA-dependent DNA replication (GO:2000105)	4	2	.08	+	25.70	5.18E-03	9.66E-02
camera-type eye development (GO:0043010)	345	15	6.71	+	2.23	5.05E-03	9.67E-02
positive regulation of nucleobase-containing compound transport (GO:0032241)	4	2	.08	+	25.70	5.18E-03	9.68E-02
negative regulation of centrosome cycle (GO:0046606)	4	2	.08	+	25.70	5.18E-03	9.70E-02
positive regulation of ubiquitin protein ligase activity (GO:1904668)	4	2	.08	+	25.70	5.18E-03	9.72E-02
negative regulation of centrosome duplication (GO:0010826)	4	2	.08	+	25.70	5.18E-03	9.74E-02
positive regulation of nucleocytoplasmic transport (GO:0046824)	4	2	.08	+	25.70	5.18E-03	9.76E-02
positive regulation of RNA export from nucleus (GO:0046833)	4	2	.08	+	25.70	5.18E-03	9.79E-02
histone H3-K27 demethylation (GO:0071557)	4	2	.08	+	25.70	5.18E-03	9.81E-02
muscle cell fate specification (GO:0042694)	4	2	.08	+	25.70	5.18E-03	9.83E-02
neuroepithelial cell differentiation (GO:0060563)	16	3	.31	+	9.64	5.33E-03	9.83E-02
thymus development (GO:0048538)	16	3	.31	+	9.64	5.33E-03	9.85E-02
cardioblast differentiation (GO:0010002)	4	2	.08	+	25.70	5.18E-03	9.85E-02
pituitary gland development (GO:0021983)	16	3	.31	+	9.64	5.33E-03	9.87E-02
positive regulation of DNA binding (GO:0043388)	4	2	.08	+	25.70	5.18E-03	9.87E-02
cardiocyte differentiation (GO:0035051)	54	5	1.05	+	4.76	5.32E-03	9.88E-02
establishment of sister chromatid cohesion (GO:0034085)	4	2	.08	+	25.70	5.18E-03	9.89E-02
primary metabolic process (GO:0044238)	5024	123	97.75	+	1.26	5.63E-03	1.04E-01
neural retina development (GO:0003407)	79	6	1.54	+	3.90	5.75E-03	1.06E-01
centrosome cycle (GO:0007098)	34	4	.66	+	6.05	5.79E-03	1.06E-01
nucleic acid transport (GO:0050657)	56	5	1.09	+	4.59	6.13E-03	1.11E-01
regulation of catalytic activity (GO:0050790)	645	23	12.55	+	1.83	6.08E-03	1.11E-01
urogenital system development (GO:0001655)	164	9	3.19	+	2.82	6.16E-03	1.11E-01
RNA transport (GO:0050658)	56	5	1.09	+	4.59	6.13E-03	1.11E-01
notochord cell differentiation (GO:0060034)	17	3	.33	+	9.07	6.18E-03	1.12E-01
establishment of RNA localization (GO:0051236)	56	5	1.09	+	4.59	6.13E-03	1.12E-01
glomerulus development (GO:0032835)	56	5	1.09	+	4.59	6.13E-03	1.12E-01
cellular metabolic process (GO:0044237)	5018	122	97.63	+	1.25	6.76E-03	1.22E-01
positive regulation of binding (GO:0051099)	5	2	.10	+	20.56	7.16E-03	1.23E-01
regulation of cohesin loading (GO:0071922)	5	2	.10	+	20.56	7.16E-03	1.23E-01
positive regulation of DNA replication (GO:0045740)	5	2	.10	+	20.56	7.16E-03	1.24E-01
regulation of nucleobase-containing compound transport (GO:0032239)	5	2	.10	+	20.56	7.16E-03	1.24E-01
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253)	5	2	.10	+	20.56	7.16E-03	1.24E-01
hematopoietic or lymphoid organ development (GO:0048534)	362	15	7.04	+	2.13	6.92E-03	1.24E-01
endocrine system development (GO:0035270)	109	7	2.12	+	3.30	6.91E-03	1.24E-01
regulation of histone H3-K9 methylation (GO:0051570)	5	2	.10	+	20.56	7.16E-03	1.24E-01
'de novo' IMP biosynthetic process (GO:0006189)	5	2	.10	+	20.56	7.16E-03	1.25E-01
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	5	2	.10	+	20.56	7.16E-03	1.25E-01
actomyosin contractile ring assembly (GO:0000915)	5	2	.10	+	20.56	7.16E-03	1.25E-01
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	5	2	.10	+	20.56	7.16E-03	1.25E-01
meiotic nuclear division (GO:0140013)	58	5	1.13	+	4.43	7.02E-03	1.26E-01
regulation of ubiquitin protein ligase activity (GO:1904666)	5	2	.10	+	20.56	7.16E-03	1.26E-01
posterior lateral line development (GO:0048916)	58	5	1.13	+	4.43	7.02E-03	1.26E-01
regulation of glycogen metabolic process (GO:0070873)	5	2	.10	+	20.56	7.16E-03	1.26E-01
regulation of RNA export from nucleus (GO:0046831)	5	2	.10	+	20.56	7.16E-03	1.26E-01
actomyosin contractile ring organization (GO:0044837)	5	2	.10	+	20.56	7.16E-03	1.26E-01
regulation of sister chromatid cohesion (GO:0007063)	5	2	.10	+	20.56	7.16E-03	1.27E-01
mitotic DNA damage checkpoint (GO:0044773)	18	3	.35	+	8.57	7.11E-03	1.27E-01
mitotic DNA replication checkpoint (GO:0033314)	5	2	.10	+	20.56	7.16E-03	1.27E-01
regulation of protein localization to chromatin (GO:1905634)	5	2	.10	+	20.56	7.16E-03	1.27E-01
organic acid metabolic process (GO:0006082)	491	2	9.55	-	.21	7.15E-03	1.27E-01
regulation of cellular localization (GO:0060341)	84	6	1.63	+	3.67	7.56E-03	1.30E-01
smoothened signaling pathway (GO:0007224)	37	4	.72	+	5.56	7.59E-03	1.30E-01
immune system development (GO:0002520)	368	15	7.16	+	2.10	7.78E-03	1.33E-01
organelle assembly (GO:0070925)	434	17	8.44	+	2.01	7.89E-03	1.35E-01
nucleocytoplasmic transport (GO:0006913)	85	6	1.65	+	3.63	7.97E-03	1.35E-01
nuclear transport (GO:0051169)	85	6	1.65	+	3.63	7.97E-03	1.35E-01
epithelial cell development (GO:0002064)	85	6	1.65	+	3.63	7.97E-03	1.36E-01
demethylation (GO:0070988)	19	3	.37	+	8.12	8.12E-03	1.37E-01
optic cup morphogenesis involved in camera-type eye development (GO:0002072)	19	3	.37	+	8.12	8.12E-03	1.37E-01
peptidyl-lysine modification (GO:0018205)	113	7	2.20	+	3.18	8.27E-03	1.39E-01
negative regulation of neuron projection development (GO:0010977)	38	4	.74	+	5.41	8.27E-03	1.39E-01
microtubule organizing center organization (GO:0031023)	38	4	.74	+	5.41	8.27E-03	1.39E-01
striated muscle cell differentiation (GO:0051146)	173	9	3.37	+	2.67	8.47E-03	1.42E-01
notochord development (GO:0030903)	61	5	1.19	+	4.21	8.53E-03	1.43E-01
oxidation-reduction process (GO:0055114)	654	4	12.72	-	.31	8.63E-03	1.44E-01
negative regulation of cell projection organization (GO:0031345)	39	4	.76	+	5.27	8.98E-03	1.50E-01
facial nucleus development (GO:0021754)	6	2	.12	+	17.13	9.43E-03	1.55E-01
cell fate specification involved in pattern specification (GO:0060573)	6	2	.12	+	17.13	9.43E-03	1.55E-01
intestinal epithelial cell differentiation (GO:0060575)	6	2	.12	+	17.13	9.43E-03	1.55E-01
centromeric sister chromatid cohesion (GO:0070601)	6	2	.12	+	17.13	9.43E-03	1.56E-01
membrane disruption in other organism (GO:0051673)	6	2	.12	+	17.13	9.43E-03	1.56E-01
organic substance metabolic process (GO:0071704)	5351	128	104.11	+	1.23	9.54E-03	1.56E-01
regulation of polysaccharide metabolic process (GO:0032881)	6	2	.12	+	17.13	9.43E-03	1.56E-01
neural plate morphogenesis (GO:0001839)	6	2	.12	+	17.13	9.43E-03	1.56E-01
ventral spinal cord interneuron specification (GO:0021521)	6	2	.12	+	17.13	9.43E-03	1.57E-01
embryonic pattern specification (GO:0009880)	40	4	.78	+	5.14	9.73E-03	1.59E-01
RNA export from nucleus (GO:0006405)	40	4	.78	+	5.14	9.73E-03	1.59E-01
cell migration (GO:0016477)	520	19	10.12	+	1.88	9.98E-03	1.63E-01
positive regulation of hydrolase activity (GO:0051345)	178	9	3.46	+	2.60	1.00E-02	1.63E-01
regulation of cell growth (GO:0001558)	90	6	1.75	+	3.43	1.02E-02	1.66E-01
RNA localization (GO:0006403)	64	5	1.25	+	4.02	1.02E-02	1.66E-01
DNA replication initiation (GO:0006270)	21	3	.41	+	7.34	1.04E-02	1.67E-01
camera-type eye morphogenesis (GO:0048593)	148	8	2.88	+	2.78	1.04E-02	1.67E-01
meiotic chromosome segregation (GO:0045132)	42	4	.82	+	4.90	1.14E-02	1.82E-01
cardiac muscle cell differentiation (GO:0055007)	42	4	.82	+	4.90	1.14E-02	1.82E-01
embryonic eye morphogenesis (GO:0048048)	42	4	.82	+	4.90	1.14E-02	1.83E-01
developmental pigmentation (GO:0048066)	66	5	1.28	+	3.89	1.15E-02	1.84E-01
glomerular epithelial cell development (GO:0072310)	22	3	.43	+	7.01	1.16E-02	1.85E-01
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036)	22	3	.43	+	7.01	1.16E-02	1.85E-01
posterior lateral line neuromast primordium migration (GO:0048920)	22	3	.43	+	7.01	1.16E-02	1.85E-01
glomerular visceral epithelial cell development (GO:0072015)	22	3	.43	+	7.01	1.16E-02	1.86E-01
ventral spinal cord interneuron fate commitment (GO:0060579)	7	2	.14	+	14.69	1.20E-02	1.88E-01
animal organ maturation (GO:0048799)	7	2	.14	+	14.69	1.20E-02	1.88E-01
cell surface receptor signaling pathway (GO:0007166)	1042	32	20.27	+	1.58	1.19E-02	1.88E-01
muscle cell fate commitment (GO:0042693)	7	2	.14	+	14.69	1.20E-02	1.88E-01
commissural neuron axon guidance (GO:0071679)	7	2	.14	+	14.69	1.20E-02	1.89E-01
histone demethylation (GO:0016577)	7	2	.14	+	14.69	1.20E-02	1.89E-01
histone lysine demethylation (GO:0070076)	7	2	.14	+	14.69	1.20E-02	1.89E-01
spindle assembly (GO:0051225)	43	4	.84	+	4.78	1.22E-02	1.91E-01
embryonic camera-type eye development (GO:0031076)	43	4	.84	+	4.78	1.22E-02	1.91E-01
regulation of mitotic cell cycle (GO:0007346)	423	16	8.23	+	1.94	1.27E-02	1.97E-01
negative regulation of response to stimulus (GO:0048585)	374	15	7.28	+	2.06	1.28E-02	1.99E-01
neuromast primordium migration (GO:0048883)	23	3	.45	+	6.70	1.30E-02	2.01E-01
regulation of cell size (GO:0008361)	95	6	1.85	+	3.25	1.29E-02	2.01E-01
regulation of mitotic nuclear division (GO:0007088)	44	4	.86	+	4.67	1.31E-02	2.04E-01
renal system development (GO:0072001)	155	8	3.02	+	2.65	1.32E-02	2.04E-01
kidney development (GO:0001822)	155	8	3.02	+	2.65	1.32E-02	2.05E-01
gene expression (GO:0010467)	995	31	19.36	+	1.60	1.35E-02	2.08E-01
cellular protein metabolic process (GO:0044267)	2463	65	47.92	+	1.36	1.36E-02	2.09E-01
oxoacid metabolic process (GO:0043436)	450	2	8.76	-	.23	1.41E-02	2.16E-01
organic substance transport (GO:0071702)	1119	11	21.77	-	.51	1.41E-02	2.16E-01
anatomical structure homeostasis (GO:0060249)	97	6	1.89	+	3.18	1.42E-02	2.16E-01
telencephalon development (GO:0021537)	24	3	.47	+	6.42	1.44E-02	2.19E-01
rhombomere boundary formation (GO:0021654)	8	2	.16	+	12.85	1.48E-02	2.23E-01
cell fate commitment involved in pattern specification (GO:0060581)	8	2	.16	+	12.85	1.48E-02	2.23E-01
histone monoubiquitination (GO:0010390)	8	2	.16	+	12.85	1.48E-02	2.24E-01
neural plate anterior/posterior regionalization (GO:0021999)	8	2	.16	+	12.85	1.48E-02	2.24E-01
motor neuron migration (GO:0097475)	8	2	.16	+	12.85	1.48E-02	2.24E-01
neural plate development (GO:0001840)	8	2	.16	+	12.85	1.48E-02	2.25E-01
midbrain-hindbrain boundary morphogenesis (GO:0021555)	8	2	.16	+	12.85	1.48E-02	2.25E-01
regulation of nuclear division (GO:0051783)	46	4	.89	+	4.47	1.51E-02	2.27E-01
muscle cell development (GO:0055001)	159	8	3.09	+	2.59	1.51E-02	2.27E-01
ventral spinal cord development (GO:0021517)	46	4	.89	+	4.47	1.51E-02	2.27E-01
central nervous system neuron differentiation (GO:0021953)	99	6	1.93	+	3.12	1.54E-02	2.31E-01
nephron development (GO:0072006)	72	5	1.40	+	3.57	1.59E-02	2.36E-01
regulation of cellular protein metabolic process (GO:0032268)	760	25	14.79	+	1.69	1.58E-02	2.36E-01
regulation of chromosome separation (GO:1905818)	25	3	.49	+	6.17	1.59E-02	2.36E-01
lipid metabolic process (GO:0006629)	612	4	11.91	-	.34	1.59E-02	2.36E-01
embryonic camera-type eye formation (GO:0060900)	25	3	.49	+	6.17	1.59E-02	2.37E-01
gene silencing by miRNA (GO:0035195)	25	3	.49	+	6.17	1.59E-02	2.37E-01
response to stress (GO:0006950)	1265	37	24.61	+	1.50	1.60E-02	2.37E-01
regulation of small molecule metabolic process (GO:0062012)	47	4	.91	+	4.37	1.61E-02	2.38E-01
metencephalon development (GO:0022037)	47	4	.91	+	4.37	1.61E-02	2.38E-01
DNA-dependent DNA replication (GO:0006261)	73	5	1.42	+	3.52	1.68E-02	2.46E-01
nucleobase-containing compound transport (GO:0015931)	73	5	1.42	+	3.52	1.68E-02	2.47E-01
nuclear export (GO:0051168)	48	4	.93	+	4.28	1.72E-02	2.53E-01
regulation of BMP signaling pathway involved in heart jogging (GO:2000223)	9	2	.18	+	11.42	1.78E-02	2.57E-01
protein dealkylation (GO:0008214)	9	2	.18	+	11.42	1.78E-02	2.58E-01
neural plate regionalization (GO:0060897)	9	2	.18	+	11.42	1.78E-02	2.58E-01
DNA replication-independent nucleosome organization (GO:0034724)	9	2	.18	+	11.42	1.78E-02	2.58E-01
negative regulation of phosphatase activity (GO:0010923)	9	2	.18	+	11.42	1.78E-02	2.59E-01
protein demethylation (GO:0006482)	9	2	.18	+	11.42	1.78E-02	2.59E-01
regulation of cell-matrix adhesion (GO:0001952)	9	2	.18	+	11.42	1.78E-02	2.60E-01
regulation of protein binding (GO:0043393)	9	2	.18	+	11.42	1.78E-02	2.60E-01
cell motility (GO:0048870)	545	19	10.60	+	1.79	1.78E-02	2.60E-01
localization of cell (GO:0051674)	545	19	10.60	+	1.79	1.78E-02	2.61E-01
regulation of cellular protein localization (GO:1903827)	49	4	.95	+	4.20	1.84E-02	2.64E-01
cell differentiation in spinal cord (GO:0021515)	49	4	.95	+	4.20	1.84E-02	2.64E-01
regulation of cell migration (GO:0030334)	198	9	3.85	+	2.34	1.84E-02	2.64E-01
negative regulation of cell population proliferation (GO:0008285)	75	5	1.46	+	3.43	1.85E-02	2.65E-01
glomerular epithelial cell differentiation (GO:0072311)	27	3	.53	+	5.71	1.91E-02	2.71E-01
renal filtration cell differentiation (GO:0061318)	27	3	.53	+	5.71	1.91E-02	2.72E-01
base-excision repair (GO:0006284)	27	3	.53	+	5.71	1.91E-02	2.72E-01
regulation of histone methylation (GO:0031060)	27	3	.53	+	5.71	1.91E-02	2.73E-01
glomerular epithelium development (GO:0072010)	27	3	.53	+	5.71	1.91E-02	2.73E-01
glomerular visceral epithelial cell differentiation (GO:0072112)	27	3	.53	+	5.71	1.91E-02	2.74E-01
embryonic hemopoiesis (GO:0035162)	76	5	1.48	+	3.38	1.94E-02	2.75E-01
regulation of small GTPase mediated signal transduction (GO:0051056)	200	9	3.89	+	2.31	1.94E-02	2.75E-01
positive regulation of Wnt signaling pathway (GO:0030177)	50	4	.97	+	4.11	1.96E-02	2.76E-01
carboxylic acid metabolic process (GO:0019752)	435	2	8.46	-	.24	1.99E-02	2.80E-01
lateral line system development (GO:0048925)	106	6	2.06	+	2.91	2.06E-02	2.89E-01
retina morphogenesis in camera-type eye (GO:0060042)	106	6	2.06	+	2.91	2.06E-02	2.89E-01
modification of morphology or physiology of other organism (GO:0035821)	10	2	.19	+	10.28	2.11E-02	2.91E-01
chromosome organization involved in meiotic cell cycle (GO:0070192)	28	3	.54	+	5.51	2.09E-02	2.91E-01
regulation of retinoic acid receptor signaling pathway (GO:0048385)	10	2	.19	+	10.28	2.11E-02	2.91E-01
positive regulation of mitotic cell cycle (GO:0045931)	28	3	.54	+	5.51	2.09E-02	2.92E-01
positive regulation of ubiquitin-protein transferase activity (GO:0051443)	10	2	.19	+	10.28	2.11E-02	2.92E-01
brain morphogenesis (GO:0048854)	28	3	.54	+	5.51	2.09E-02	2.92E-01
neural plate pattern specification (GO:0060896)	10	2	.19	+	10.28	2.11E-02	2.92E-01
regulation of dephosphorylation (GO:0035303)	28	3	.54	+	5.51	2.09E-02	2.92E-01
regulation of DNA-dependent DNA replication (GO:0090329)	10	2	.19	+	10.28	2.11E-02	2.92E-01
positive regulation of protein ubiquitination (GO:0031398)	28	3	.54	+	5.51	2.09E-02	2.93E-01
DNA replication checkpoint (GO:0000076)	10	2	.19	+	10.28	2.11E-02	2.93E-01
regulation of cell population proliferation (GO:0042127)	262	11	5.10	+	2.16	2.14E-02	2.93E-01
spinal cord motor neuron cell fate specification (GO:0021520)	10	2	.19	+	10.28	2.11E-02	2.93E-01
rhombomere formation (GO:0021594)	10	2	.19	+	10.28	2.11E-02	2.94E-01
positive regulation of transferase activity (GO:0051347)	204	9	3.97	+	2.27	2.16E-02	2.96E-01
cytokinesis (GO:0000910)	52	4	1.01	+	3.95	2.20E-02	3.01E-01
columnar/cuboidal epithelial cell differentiation (GO:0002065)	52	4	1.01	+	3.95	2.20E-02	3.01E-01
epithelial tube formation (GO:0072175)	52	4	1.01	+	3.95	2.20E-02	3.02E-01
muscle tissue development (GO:0060537)	172	8	3.35	+	2.39	2.26E-02	3.08E-01
spinal cord motor neuron differentiation (GO:0021522)	29	3	.56	+	5.32	2.27E-02	3.09E-01
mitotic cell cycle phase transition (GO:0044772)	53	4	1.03	+	3.88	2.34E-02	3.17E-01
kidney epithelium development (GO:0072073)	53	4	1.03	+	3.88	2.34E-02	3.17E-01
regulation of Rho protein signal transduction (GO:0035023)	141	7	2.74	+	2.55	2.38E-02	3.21E-01
peptide metabolic process (GO:0006518)	328	1	6.38	-	.16	2.37E-02	3.21E-01
pronephros development (GO:0048793)	110	6	2.14	+	2.80	2.40E-02	3.23E-01
regulation of axon regeneration (GO:0048679)	11	2	.21	+	9.35	2.47E-02	3.25E-01
cell cycle phase transition (GO:0044770)	54	4	1.05	+	3.81	2.47E-02	3.25E-01
regulation of neuron projection regeneration (GO:0070570)	11	2	.21	+	9.35	2.47E-02	3.26E-01
regulation of ubiquitin-protein transferase activity (GO:0051438)	11	2	.21	+	9.35	2.47E-02	3.26E-01
lateral line nerve development (GO:0048892)	11	2	.21	+	9.35	2.47E-02	3.27E-01
DNA unwinding involved in DNA replication (GO:0006268)	11	2	.21	+	9.35	2.47E-02	3.27E-01
organic anion transport (GO:0015711)	224	0	4.36	-	 < 0.01	2.43E-02	3.27E-01
positive regulation of RNA splicing (GO:0033120)	11	2	.21	+	9.35	2.47E-02	3.28E-01
regulation of gliogenesis (GO:0014013)	11	2	.21	+	9.35	2.47E-02	3.28E-01
purine nucleobase biosynthetic process (GO:0009113)	11	2	.21	+	9.35	2.47E-02	3.29E-01
microtubule depolymerization (GO:0007019)	11	2	.21	+	9.35	2.47E-02	3.29E-01
rhombomere morphogenesis (GO:0021593)	11	2	.21	+	9.35	2.47E-02	3.30E-01
posttranscriptional gene silencing by RNA (GO:0035194)	30	3	.58	+	5.14	2.47E-02	3.30E-01
posttranscriptional gene silencing (GO:0016441)	30	3	.58	+	5.14	2.47E-02	3.31E-01
embryonic epithelial tube formation (GO:0001838)	30	3	.58	+	5.14	2.47E-02	3.31E-01
neural tube formation (GO:0001841)	30	3	.58	+	5.14	2.47E-02	3.32E-01
regulation of ion transport (GO:0043269)	235	0	4.57	-	 < 0.01	2.58E-02	3.39E-01
tube formation (GO:0035148)	55	4	1.07	+	3.74	2.61E-02	3.43E-01
cellular response to fibroblast growth factor stimulus (GO:0044344)	31	3	.60	+	4.97	2.67E-02	3.47E-01
enzyme linked receptor protein signaling pathway (GO:0007167)	337	13	6.56	+	1.98	2.65E-02	3.47E-01
fibroblast growth factor receptor signaling pathway (GO:0008543)	31	3	.60	+	4.97	2.67E-02	3.47E-01
positive regulation of chromosome organization (GO:2001252)	31	3	.60	+	4.97	2.67E-02	3.48E-01
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	31	3	.60	+	4.97	2.67E-02	3.48E-01
regulation of protein metabolic process (GO:0051246)	806	25	15.68	+	1.59	2.69E-02	3.49E-01
response to fibroblast growth factor (GO:0071774)	31	3	.60	+	4.97	2.67E-02	3.49E-01
Kupffer's vesicle development (GO:0070121)	56	4	1.09	+	3.67	2.76E-02	3.58E-01
cellular response to growth factor stimulus (GO:0071363)	146	7	2.84	+	2.46	2.78E-02	3.60E-01
double-strand break repair via break-induced replication (GO:0000727)	12	2	.23	+	8.57	2.84E-02	3.65E-01
production of miRNAs involved in gene silencing by miRNA (GO:0035196)	12	2	.23	+	8.57	2.84E-02	3.65E-01
positive regulation of mitotic sister chromatid segregation (GO:0062033)	12	2	.23	+	8.57	2.84E-02	3.66E-01
thyroid gland development (GO:0030878)	12	2	.23	+	8.57	2.84E-02	3.66E-01
negative regulation of chemotaxis (GO:0050922)	32	3	.62	+	4.82	2.88E-02	3.66E-01
regulation of Ras protein signal transduction (GO:0046578)	180	8	3.50	+	2.28	2.84E-02	3.66E-01
neuron cellular homeostasis (GO:0070050)	12	2	.23	+	8.57	2.84E-02	3.67E-01
regulation of smoothened signaling pathway (GO:0008589)	32	3	.62	+	4.82	2.88E-02	3.67E-01
response to growth factor (GO:0070848)	147	7	2.86	+	2.45	2.87E-02	3.67E-01
inner ear receptor cell differentiation (GO:0060113)	32	3	.62	+	4.82	2.88E-02	3.67E-01
mitotic cytokinesis (GO:0000281)	32	3	.62	+	4.82	2.88E-02	3.68E-01
negative regulation of cytoskeleton organization (GO:0051494)	57	4	1.11	+	3.61	2.91E-02	3.70E-01
hemopoiesis (GO:0030097)	350	13	6.81	+	1.91	3.01E-02	3.82E-01
striated muscle cell development (GO:0055002)	149	7	2.90	+	2.41	3.05E-02	3.86E-01
negative regulation of response to external stimulus (GO:0032102)	58	4	1.13	+	3.54	3.07E-02	3.87E-01
organonitrogen compound biosynthetic process (GO:1901566)	865	8	16.83	-	.48	3.07E-02	3.88E-01
photoreceptor cell development (GO:0042461)	58	4	1.13	+	3.54	3.07E-02	3.88E-01
positive regulation of axonogenesis (GO:0050772)	33	3	.64	+	4.67	3.10E-02	3.90E-01
regulation of microtubule polymerization or depolymerization (GO:0031110)	33	3	.64	+	4.67	3.10E-02	3.90E-01
regeneration (GO:0031099)	150	7	2.92	+	2.40	3.14E-02	3.94E-01
positive regulation of signal transduction (GO:0009967)	424	15	8.25	+	1.82	3.16E-02	3.96E-01
regulation of DNA binding (GO:0051101)	13	2	.25	+	7.91	3.24E-02	4.03E-01
posterior lateral line neuromast hair cell differentiation (GO:0048923)	13	2	.25	+	7.91	3.24E-02	4.04E-01
positive regulation of neuron projection development (GO:0010976)	59	4	1.15	+	3.48	3.23E-02	4.04E-01
positive regulation of chromosome segregation (GO:0051984)	13	2	.25	+	7.91	3.24E-02	4.05E-01
histone ubiquitination (GO:0016574)	13	2	.25	+	7.91	3.24E-02	4.05E-01
localization (GO:0051179)	3226	47	62.76	-	.75	3.28E-02	4.08E-01
regulation of translation (GO:0006417)	119	6	2.32	+	2.59	3.29E-02	4.09E-01
epithelial cell differentiation involved in kidney development (GO:0035850)	34	3	.66	+	4.54	3.32E-02	4.10E-01
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535)	1	1	.02	+	51.40	3.78E-02	4.10E-01
cell differentiation involved in kidney development (GO:0061005)	34	3	.66	+	4.54	3.32E-02	4.10E-01
positive regulation of cell morphogenesis involved in differentiation (GO:0010770)	36	3	.70	+	4.28	3.80E-02	4.10E-01
axial mesodermal cell differentiation (GO:0048321)	1	1	.02	+	51.40	3.78E-02	4.11E-01
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	34	3	.66	+	4.54	3.32E-02	4.11E-01
negative regulation of cell morphogenesis involved in differentiation (GO:0010771)	36	3	.70	+	4.28	3.80E-02	4.11E-01
axial mesodermal cell fate commitment (GO:0048322)	1	1	.02	+	51.40	3.78E-02	4.11E-01
regulation of morphogenesis of an epithelium (GO:1905330)	34	3	.66	+	4.54	3.32E-02	4.12E-01
eye photoreceptor cell development (GO:0042462)	36	3	.70	+	4.28	3.80E-02	4.12E-01
axial mesodermal cell fate specification (GO:0048327)	1	1	.02	+	51.40	3.78E-02	4.12E-01
regulation of protein ubiquitination (GO:0031396)	36	3	.70	+	4.28	3.80E-02	4.12E-01
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	34	3	.66	+	4.54	3.32E-02	4.12E-01
axial mesoderm structural organization (GO:0048331)	1	1	.02	+	51.40	3.78E-02	4.12E-01
mesoderm structural organization (GO:0048338)	1	1	.02	+	51.40	3.78E-02	4.13E-01
regulation of homocysteine metabolic process (GO:0050666)	1	1	.02	+	51.40	3.78E-02	4.13E-01
ventral aorta development (GO:0035908)	1	1	.02	+	51.40	3.78E-02	4.14E-01
forebrain anterior/posterior pattern specification (GO:0021797)	1	1	.02	+	51.40	3.78E-02	4.14E-01
ventriculo bulbo valve development (GO:0003173)	1	1	.02	+	51.40	3.78E-02	4.15E-01
ion transmembrane transport (GO:0034220)	542	4	10.55	-	.38	3.85E-02	4.15E-01
cation transport (GO:0006812)	544	4	10.58	-	.38	3.86E-02	4.15E-01
ventriculo bulbo valve morphogenesis (GO:0003187)	1	1	.02	+	51.40	3.78E-02	4.15E-01
intestinal motility (GO:0120054)	1	1	.02	+	51.40	3.78E-02	4.16E-01
positive regulation of Wnt signaling pathway, calcium modulating pathway (GO:0045813)	1	1	.02	+	51.40	3.78E-02	4.17E-01
bone regeneration (GO:1990523)	1	1	.02	+	51.40	3.78E-02	4.17E-01
regulation of somitomeric trunk muscle development (GO:0014708)	1	1	.02	+	51.40	3.78E-02	4.18E-01
positive regulation of somitomeric trunk muscle development (GO:0014709)	1	1	.02	+	51.40	3.78E-02	4.18E-01
positive regulation of synaptic growth at neuromuscular junction (GO:0045887)	1	1	.02	+	51.40	3.78E-02	4.19E-01
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914)	1	1	.02	+	51.40	3.78E-02	4.19E-01
regulation of oligodendrocyte progenitor proliferation (GO:0070445)	1	1	.02	+	51.40	3.78E-02	4.20E-01
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)	1	1	.02	+	51.40	3.78E-02	4.20E-01
axon regeneration at neuromuscular junction (GO:0014814)	1	1	.02	+	51.40	3.78E-02	4.21E-01
regulation of BMP signaling pathway (GO:0030510)	63	4	1.23	+	3.26	3.92E-02	4.21E-01
apical constriction (GO:0003383)	1	1	.02	+	51.40	3.78E-02	4.21E-01
anterograde trans-synaptic signaling (GO:0098916)	312	1	6.07	-	.16	3.43E-02	4.22E-01
optic cup formation involved in camera-type eye development (GO:0003408)	1	1	.02	+	51.40	3.78E-02	4.22E-01
chemical synaptic transmission (GO:0007268)	312	1	6.07	-	.16	3.43E-02	4.22E-01
lymphatic endothelial cell differentiation (GO:0060836)	1	1	.02	+	51.40	3.78E-02	4.23E-01
amide biosynthetic process (GO:0043604)	313	1	6.09	-	.16	3.44E-02	4.23E-01
cellular lipid metabolic process (GO:0044255)	469	3	9.12	-	.33	3.93E-02	4.23E-01
lymphatic endothelial cell fate commitment (GO:0060838)	1	1	.02	+	51.40	3.78E-02	4.23E-01
venous endothelial cell differentiation (GO:0060843)	1	1	.02	+	51.40	3.78E-02	4.24E-01
venous endothelial cell fate commitment (GO:0060845)	1	1	.02	+	51.40	3.78E-02	4.24E-01
regulation of transcription involved in venous endothelial cell fate commitment (GO:0060852)	1	1	.02	+	51.40	3.78E-02	4.25E-01
positive regulation of Rac protein signal transduction (GO:0035022)	1	1	.02	+	51.40	3.78E-02	4.25E-01
trans-synaptic signaling (GO:0099537)	315	1	6.13	-	.16	3.47E-02	4.25E-01
lateral semicircular canal development (GO:0060875)	1	1	.02	+	51.40	3.78E-02	4.26E-01
positive regulation of spindle checkpoint (GO:0090232)	1	1	.02	+	51.40	3.78E-02	4.26E-01
fibroblast growth factor receptor signaling pathway involved in somitogenesis (GO:0090243)	1	1	.02	+	51.40	3.78E-02	4.27E-01
Wnt signaling pathway involved in somitogenesis (GO:0090244)	1	1	.02	+	51.40	3.78E-02	4.28E-01
associative learning (GO:0008306)	1	1	.02	+	51.40	3.78E-02	4.28E-01
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)	1	1	.02	+	51.40	3.78E-02	4.29E-01
protein-containing complex assembly (GO:0065003)	512	17	9.96	+	1.71	3.50E-02	4.29E-01
mammillary axonal complex development (GO:0061373)	1	1	.02	+	51.40	3.78E-02	4.29E-01
negative regulation of transcription by RNA polymerase II (GO:0000122)	259	10	5.04	+	1.98	4.00E-02	4.30E-01
mammillothalamic axonal tract development (GO:0061374)	1	1	.02	+	51.40	3.78E-02	4.30E-01
synaptic signaling (GO:0099536)	318	1	6.19	-	.16	3.52E-02	4.30E-01
positive regulation of GTPase activity (GO:0043547)	121	6	2.35	+	2.55	3.52E-02	4.30E-01
inferior colliculus development (GO:0061379)	1	1	.02	+	51.40	3.78E-02	4.30E-01
ear morphogenesis (GO:0042471)	61	4	1.19	+	3.37	3.56E-02	4.30E-01
regulation of generation of precursor metabolites and energy (GO:0043467)	15	2	.29	+	6.85	4.09E-02	4.31E-01
superior colliculus development (GO:0061380)	1	1	.02	+	51.40	3.78E-02	4.31E-01
inner ear morphogenesis (GO:0042472)	61	4	1.19	+	3.37	3.56E-02	4.31E-01
macroautophagy (GO:0016236)	64	4	1.25	+	3.21	4.10E-02	4.31E-01
negative regulation of axonogenesis (GO:0050771)	35	3	.68	+	4.41	3.56E-02	4.31E-01
positive regulation of mitotic nuclear division (GO:0045840)	15	2	.29	+	6.85	4.09E-02	4.31E-01
cell migration in diencephalon (GO:0061381)	1	1	.02	+	51.40	3.78E-02	4.31E-01
embryonic camera-type eye morphogenesis (GO:0048596)	35	3	.68	+	4.41	3.56E-02	4.32E-01
centrosome duplication (GO:0051298)	15	2	.29	+	6.85	4.09E-02	4.32E-01
regulation of alkaline phosphatase activity (GO:0010692)	1	1	.02	+	51.40	3.78E-02	4.32E-01
regulation of ion transmembrane transport (GO:0034765)	199	0	3.87	-	 < 0.01	3.58E-02	4.32E-01
positive regulation of intracellular transport (GO:0032388)	15	2	.29	+	6.85	4.09E-02	4.32E-01
negative regulation of axon extension (GO:0030517)	35	3	.68	+	4.41	3.56E-02	4.33E-01
negative regulation of alkaline phosphatase activity (GO:0010693)	1	1	.02	+	51.40	3.78E-02	4.33E-01
negative regulation of developmental growth (GO:0048640)	37	3	.72	+	4.17	4.05E-02	4.33E-01
positive regulation of nuclear division (GO:0051785)	15	2	.29	+	6.85	4.09E-02	4.33E-01
DNA damage checkpoint (GO:0000077)	35	3	.68	+	4.41	3.56E-02	4.33E-01
regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000431)	1	1	.02	+	51.40	3.78E-02	4.33E-01
positive regulation of endopeptidase activity (GO:0010950)	37	3	.72	+	4.17	4.05E-02	4.33E-01
lateral line development (GO:0048882)	94	5	1.83	+	2.73	4.12E-02	4.33E-01
chromosome localization (GO:0050000)	15	2	.29	+	6.85	4.09E-02	4.34E-01
endothelial cell differentiation (GO:0045446)	35	3	.68	+	4.41	3.56E-02	4.34E-01
positive regulation of cell cycle checkpoint (GO:1901978)	1	1	.02	+	51.40	3.78E-02	4.34E-01
positive regulation of peptidase activity (GO:0010952)	37	3	.72	+	4.17	4.05E-02	4.34E-01
meiotic chromosome separation (GO:0051307)	14	2	.27	+	7.34	3.66E-02	4.34E-01
inner ear auditory receptor cell differentiation (GO:0042491)	15	2	.29	+	6.85	4.09E-02	4.34E-01
interstitial cell of Cajal differentiation (GO:0061453)	1	1	.02	+	51.40	3.78E-02	4.34E-01
ATP-dependent chromatin remodeling (GO:0043044)	37	3	.72	+	4.17	4.05E-02	4.34E-01
regulation of signal transduction by p53 class mediator (GO:1901796)	14	2	.27	+	7.34	3.66E-02	4.34E-01
regulation of transmembrane transport (GO:0034762)	203	0	3.95	-	 < 0.01	3.61E-02	4.35E-01
negative regulation of dephosphorylation (GO:0035305)	15	2	.29	+	6.85	4.09E-02	4.35E-01
regulation of action potential firing pattern (GO:0099608)	1	1	.02	+	51.40	3.78E-02	4.35E-01
IMP biosynthetic process (GO:0006188)	14	2	.27	+	7.34	3.66E-02	4.35E-01
activin receptor signaling pathway (GO:0032924)	15	2	.29	+	6.85	4.09E-02	4.35E-01
visual learning (GO:0008542)	1	1	.02	+	51.40	3.78E-02	4.36E-01
DNA strand elongation involved in DNA replication (GO:0006271)	14	2	.27	+	7.34	3.66E-02	4.36E-01
epithelial cell fate commitment (GO:0072148)	15	2	.29	+	6.85	4.09E-02	4.36E-01
response to wounding (GO:0009611)	213	9	4.14	+	2.17	4.09E-02	4.36E-01
targeting of mRNA for destruction involved in RNA interference (GO:0030423)	1	1	.02	+	51.40	3.78E-02	4.36E-01
production of small RNA involved in gene silencing by RNA (GO:0070918)	14	2	.27	+	7.34	3.66E-02	4.36E-01
regulation of synaptic growth at neuromuscular junction (GO:0008582)	1	1	.02	+	51.40	3.78E-02	4.37E-01
regulation of glucose metabolic process (GO:0010906)	14	2	.27	+	7.34	3.66E-02	4.37E-01
regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0062025)	1	1	.02	+	51.40	3.78E-02	4.37E-01
dsRNA processing (GO:0031050)	14	2	.27	+	7.34	3.66E-02	4.37E-01
negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process (GO:0062026)	1	1	.02	+	51.40	3.78E-02	4.38E-01
cell cycle G1/S phase transition (GO:0044843)	14	2	.27	+	7.34	3.66E-02	4.38E-01
regulation of cell motility (GO:2000145)	215	9	4.18	+	2.15	4.18E-02	4.38E-01
regulation of glycogen catabolic process (GO:0005981)	1	1	.02	+	51.40	3.78E-02	4.38E-01
G1/S transition of mitotic cell cycle (GO:0000082)	14	2	.27	+	7.34	3.66E-02	4.39E-01
regulation of cellular amine metabolic process (GO:0033238)	1	1	.02	+	51.40	3.78E-02	4.39E-01
neuromast hair cell development (GO:0035675)	14	2	.27	+	7.34	3.66E-02	4.39E-01
regulation of cellular amino acid metabolic process (GO:0006521)	1	1	.02	+	51.40	3.78E-02	4.40E-01
myelination in peripheral nervous system (GO:0022011)	14	2	.27	+	7.34	3.66E-02	4.40E-01
de novo centriole assembly (GO:0097742)	1	1	.02	+	51.40	3.78E-02	4.40E-01
histone H4-K20 demethylation (GO:0035574)	1	1	.02	+	51.40	3.78E-02	4.41E-01
polyuridylation-dependent mRNA catabolic process (GO:1990074)	1	1	.02	+	51.40	3.78E-02	4.41E-01
regulation of cytokinetic process (GO:0032954)	1	1	.02	+	51.40	3.78E-02	4.42E-01
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	216	9	4.20	+	2.14	4.22E-02	4.43E-01
regulation of sulfur metabolic process (GO:0042762)	1	1	.02	+	51.40	3.78E-02	4.43E-01
spinal cord association neuron specification (GO:0021519)	1	1	.02	+	51.40	3.78E-02	4.43E-01
midbrain-hindbrain boundary initiation (GO:0021547)	1	1	.02	+	51.40	3.78E-02	4.44E-01
regulation of cellular amide metabolic process (GO:0034248)	123	6	2.39	+	2.51	3.75E-02	4.44E-01
regulation of sulfur amino acid metabolic process (GO:0031335)	1	1	.02	+	51.40	3.78E-02	4.44E-01
convergent extension (GO:0060026)	123	6	2.39	+	2.51	3.75E-02	4.45E-01
abducens nerve development (GO:0021560)	1	1	.02	+	51.40	3.78E-02	4.45E-01
zona limitans intrathalamica formation (GO:0022006)	1	1	.02	+	51.40	3.78E-02	4.46E-01
maintenance of sister chromatid cohesion (GO:0034086)	1	1	.02	+	51.40	3.78E-02	4.46E-01
maintenance of mitotic sister chromatid cohesion (GO:0034088)	1	1	.02	+	51.40	3.78E-02	4.47E-01
metabolic process (GO:0008152)	5848	133	113.78	+	1.17	4.30E-02	4.50E-01
positive regulation of small GTPase mediated signal transduction (GO:0051057)	38	3	.74	+	4.06	4.31E-02	4.50E-01
positive regulation of Ras protein signal transduction (GO:0046579)	38	3	.74	+	4.06	4.31E-02	4.51E-01
protein-containing complex disassembly (GO:0032984)	66	4	1.28	+	3.12	4.48E-02	4.68E-01
habenula development (GO:0021986)	16	2	.31	+	6.42	4.55E-02	4.70E-01
regulation of GTPase activity (GO:0043087)	163	7	3.17	+	2.21	4.51E-02	4.70E-01
peripheral nervous system axon ensheathment (GO:0032292)	16	2	.31	+	6.42	4.55E-02	4.70E-01
DNA strand elongation (GO:0022616)	16	2	.31	+	6.42	4.55E-02	4.71E-01
regulation of mRNA catabolic process (GO:0061013)	39	3	.76	+	3.95	4.58E-02	4.71E-01
regulation of cellular carbohydrate metabolic process (GO:0010675)	16	2	.31	+	6.42	4.55E-02	4.71E-01
negative regulation of cell growth (GO:0030308)	39	3	.76	+	3.95	4.58E-02	4.72E-01
mitotic spindle assembly (GO:0090307)	16	2	.31	+	6.42	4.55E-02	4.72E-01
regulation of apoptotic signaling pathway (GO:2001233)	39	3	.76	+	3.95	4.58E-02	4.72E-01
microtubule polymerization (GO:0046785)	16	2	.31	+	6.42	4.55E-02	4.72E-01
supramolecular fiber organization (GO:0097435)	337	12	6.56	+	1.83	4.58E-02	4.73E-01
optic nerve development (GO:0021554)	16	2	.31	+	6.42	4.55E-02	4.73E-01
regulation of chemotaxis (GO:0050920)	67	4	1.30	+	3.07	4.68E-02	4.81E-01
regulation of intracellular signal transduction (GO:1902531)	575	18	11.19	+	1.61	4.78E-02	4.90E-01
exocrine system development (GO:0035272)	40	3	.78	+	3.85	4.86E-02	4.96E-01
exocrine pancreas development (GO:0031017)	40	3	.78	+	3.85	4.86E-02	4.96E-01
striated muscle tissue development (GO:0014706)	166	7	3.23	+	2.17	4.87E-02	4.97E-01
negative regulation of cellular component movement (GO:0051271)	68	4	1.32	+	3.02	4.89E-02	4.97E-01
semaphorin-plexin signaling pathway (GO:0071526)	40	3	.78	+	3.85	4.86E-02	4.97E-01
negative regulation of locomotion (GO:0040013)	68	4	1.32	+	3.02	4.89E-02	4.98E-01
regulation of protein modification by small protein conjugation or removal (GO:1903320)	40	3	.78	+	3.85	4.86E-02	4.98E-01
nucleobase biosynthetic process (GO:0046112)	17	2	.33	+	6.05	5.02E-02	5.08E-01
carbohydrate metabolic process (GO:0005975)	298	1	5.80	-	.17	5.03E-02	5.08E-01
closure of optic fissure (GO:0061386)	17	2	.33	+	6.05	5.02E-02	5.09E-01
regulation of phosphatase activity (GO:0010921)	17	2	.33	+	6.05	5.02E-02	5.09E-01
IMP metabolic process (GO:0046040)	17	2	.33	+	6.05	5.02E-02	5.10E-01
protein modification by small protein conjugation or removal (GO:0070647)	421	14	8.19	+	1.71	5.08E-02	5.13E-01
regulation of mitotic spindle checkpoint (GO:1903504)	2	1	.04	+	25.70	5.62E-02	5.15E-01
regulation of cellular carbohydrate catabolic process (GO:0043471)	2	1	.04	+	25.70	5.62E-02	5.16E-01
regulation of tissue remodeling (GO:0034103)	2	1	.04	+	25.70	5.62E-02	5.16E-01
mRNA alternative polyadenylation (GO:0110104)	2	1	.04	+	25.70	5.62E-02	5.17E-01
central nervous system neuron development (GO:0021954)	41	3	.80	+	3.76	5.14E-02	5.17E-01
mitotic sister chromatid cohesion, centromeric (GO:0071962)	2	1	.04	+	25.70	5.62E-02	5.17E-01
oligodendrocyte differentiation (GO:0048709)	41	3	.80	+	3.76	5.14E-02	5.18E-01
axial mesoderm formation (GO:0048320)	2	1	.04	+	25.70	5.62E-02	5.18E-01
regulation of histone modification (GO:0031056)	41	3	.80	+	3.76	5.14E-02	5.18E-01
regulation of respiratory gaseous exchange (GO:0043576)	2	1	.04	+	25.70	5.62E-02	5.19E-01
tissue homeostasis (GO:0001894)	41	3	.80	+	3.76	5.14E-02	5.19E-01
negative regulation of protein binding (GO:0032091)	2	1	.04	+	25.70	5.62E-02	5.19E-01
cell aggregation (GO:0098743)	2	1	.04	+	25.70	5.62E-02	5.20E-01
cardiac atrium morphogenesis (GO:0003209)	2	1	.04	+	25.70	5.62E-02	5.20E-01
regulation of telomere capping (GO:1904353)	2	1	.04	+	25.70	5.62E-02	5.21E-01
positive regulation of telomere capping (GO:1904355)	2	1	.04	+	25.70	5.62E-02	5.21E-01
negative regulation of chromatin silencing at rDNA (GO:0061188)	2	1	.04	+	25.70	5.62E-02	5.22E-01
positive regulation of neuromuscular junction development (GO:1904398)	2	1	.04	+	25.70	5.62E-02	5.22E-01
positive regulation of cell communication (GO:0010647)	454	15	8.83	+	1.70	5.70E-02	5.23E-01
autophagosome organization (GO:1905037)	43	3	.84	+	3.59	5.73E-02	5.23E-01
monocarboxylic acid metabolic process (GO:0032787)	195	0	3.79	-	 < 0.01	5.71E-02	5.23E-01
post-translational protein acetylation (GO:0034421)	2	1	.04	+	25.70	5.62E-02	5.23E-01
hair cell differentiation (GO:0035315)	43	3	.84	+	3.59	5.73E-02	5.23E-01
regulation of xanthophore differentiation (GO:0050938)	2	1	.04	+	25.70	5.62E-02	5.24E-01
autophagosome assembly (GO:0000045)	43	3	.84	+	3.59	5.73E-02	5.24E-01
regulation of cell-cell adhesion involved in gastrulation (GO:0070587)	2	1	.04	+	25.70	5.62E-02	5.24E-01
positive regulation of signaling (GO:0023056)	455	15	8.85	+	1.69	5.73E-02	5.24E-01
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)	2	1	.04	+	25.70	5.62E-02	5.25E-01
miRNA catabolic process (GO:0010587)	2	1	.04	+	25.70	5.62E-02	5.25E-01
negative regulation of intracellular transport (GO:0032387)	2	1	.04	+	25.70	5.62E-02	5.26E-01
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106071)	2	1	.04	+	25.70	5.62E-02	5.26E-01
regulation of spindle checkpoint (GO:0090231)	2	1	.04	+	25.70	5.62E-02	5.27E-01
protein ubiquitination (GO:0016567)	295	11	5.74	+	1.92	5.25E-02	5.27E-01
regulation of hydrolase activity (GO:0051336)	307	11	5.97	+	1.84	5.80E-02	5.27E-01
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)	2	1	.04	+	25.70	5.62E-02	5.28E-01
negative regulation of signal transduction (GO:0009968)	307	11	5.97	+	1.84	5.80E-02	5.28E-01
ossification involved in bone maturation (GO:0043931)	2	1	.04	+	25.70	5.62E-02	5.28E-01
asymmetric cell division (GO:0008356)	2	1	.04	+	25.70	5.62E-02	5.29E-01
embryonic cleavage (GO:0040016)	2	1	.04	+	25.70	5.62E-02	5.29E-01
regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066)	2	1	.04	+	25.70	5.62E-02	5.30E-01
negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067)	2	1	.04	+	25.70	5.62E-02	5.30E-01
negative regulation of intracellular protein transport (GO:0090317)	2	1	.04	+	25.70	5.62E-02	5.31E-01
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	2	1	.04	+	25.70	5.62E-02	5.32E-01
base-excision repair, gap-filling (GO:0006287)	2	1	.04	+	25.70	5.62E-02	5.32E-01
muscle fiber development (GO:0048747)	70	4	1.36	+	2.94	5.31E-02	5.32E-01
regulation of cardiac muscle tissue regeneration (GO:1905178)	2	1	.04	+	25.70	5.62E-02	5.33E-01
small molecule catabolic process (GO:0044282)	178	0	3.46	-	 < 0.01	5.33E-02	5.33E-01
hydrogen sulfide biosynthetic process (GO:0070814)	2	1	.04	+	25.70	5.62E-02	5.33E-01
regulation of transferase activity (GO:0051338)	297	11	5.78	+	1.90	5.33E-02	5.34E-01
DNA replication proofreading (GO:0045004)	2	1	.04	+	25.70	5.62E-02	5.34E-01
protein localization to nuclear envelope (GO:0090435)	2	1	.04	+	25.70	5.62E-02	5.35E-01
cartilage condensation (GO:0001502)	2	1	.04	+	25.70	5.62E-02	5.35E-01
regulation of bone remodeling (GO:0046850)	2	1	.04	+	25.70	5.62E-02	5.36E-01
bone maturation (GO:0070977)	2	1	.04	+	25.70	5.62E-02	5.36E-01
secretion (GO:0046903)	183	0	3.56	-	 < 0.01	5.37E-02	5.36E-01
pharyngeal arch artery morphogenesis (GO:0061626)	2	1	.04	+	25.70	5.62E-02	5.37E-01
lipid transport (GO:0006869)	184	0	3.58	-	 < 0.01	5.38E-02	5.37E-01
hypochord development (GO:0055016)	2	1	.04	+	25.70	5.62E-02	5.38E-01
cysteine biosynthetic process from serine (GO:0006535)	2	1	.04	+	25.70	5.62E-02	5.38E-01
hypothalamus development (GO:0021854)	18	2	.35	+	5.71	5.51E-02	5.38E-01
regulation of animal organ morphogenesis (GO:2000027)	42	3	.82	+	3.67	5.43E-02	5.39E-01
G-quadruplex DNA unwinding (GO:0044806)	2	1	.04	+	25.70	5.62E-02	5.39E-01
cardiac chamber morphogenesis (GO:0003206)	18	2	.35	+	5.71	5.51E-02	5.39E-01
negative regulation of growth (GO:0045926)	42	3	.82	+	3.67	5.43E-02	5.39E-01
auditory receptor cell fate determination (GO:0042668)	2	1	.04	+	25.70	5.62E-02	5.39E-01
notochord morphogenesis (GO:0048570)	18	2	.35	+	5.71	5.51E-02	5.40E-01
lipid localization (GO:0010876)	190	0	3.70	-	 < 0.01	5.53E-02	5.40E-01
chromatin silencing at centromere (GO:0030702)	2	1	.04	+	25.70	5.62E-02	5.40E-01
gene silencing by RNA (GO:0031047)	42	3	.82	+	3.67	5.43E-02	5.40E-01
regulation of carbohydrate metabolic process (GO:0006109)	18	2	.35	+	5.71	5.51E-02	5.40E-01
cleavage furrow formation (GO:0036089)	2	1	.04	+	25.70	5.62E-02	5.41E-01
nephron epithelium development (GO:0072009)	42	3	.82	+	3.67	5.43E-02	5.41E-01
digestive system process (GO:0022600)	18	2	.35	+	5.71	5.51E-02	5.41E-01
regulation of cellular component movement (GO:0051270)	235	9	4.57	+	1.97	5.43E-02	5.41E-01
tissue regeneration (GO:0042246)	102	5	1.98	+	2.52	5.43E-02	5.41E-01
messenger ribonucleoprotein complex assembly (GO:1990120)	2	1	.04	+	25.70	5.62E-02	5.41E-01
regulation of cell-substrate adhesion (GO:0010810)	18	2	.35	+	5.71	5.51E-02	5.41E-01
limbic system development (GO:0021761)	19	2	.37	+	5.41	6.01E-02	5.42E-01
vesicle-mediated transport (GO:0016192)	736	7	14.32	-	.49	5.47E-02	5.42E-01
bone resorption (GO:0045453)	2	1	.04	+	25.70	5.62E-02	5.42E-01
regulation of intracellular protein transport (GO:0033157)	18	2	.35	+	5.71	5.51E-02	5.42E-01
heart valve development (GO:0003170)	19	2	.37	+	5.41	6.01E-02	5.42E-01
protein K27-linked deubiquitination (GO:1990167)	2	1	.04	+	25.70	5.62E-02	5.42E-01
embryonic neurocranium morphogenesis (GO:0048702)	19	2	.37	+	5.41	6.01E-02	5.43E-01
cell cycle arrest (GO:0007050)	18	2	.35	+	5.71	5.51E-02	5.43E-01
toxin biosynthetic process (GO:0009403)	2	1	.04	+	25.70	5.62E-02	5.43E-01
endothelium development (GO:0003158)	44	3	.86	+	3.50	6.04E-02	5.43E-01
DNA duplex unwinding (GO:0032508)	19	2	.37	+	5.41	6.01E-02	5.43E-01
axon regeneration (GO:0031103)	18	2	.35	+	5.71	5.51E-02	5.43E-01
positive regulation of cell-matrix adhesion (GO:0001954)	2	1	.04	+	25.70	5.62E-02	5.44E-01
otolith development (GO:0048840)	44	3	.86	+	3.50	6.04E-02	5.44E-01
odontogenesis (GO:0042476)	19	2	.37	+	5.41	6.01E-02	5.44E-01
ventral spinal cord interneuron differentiation (GO:0021514)	18	2	.35	+	5.71	5.51E-02	5.44E-01
glossopharyngeal nerve development (GO:0021563)	2	1	.04	+	25.70	5.62E-02	5.44E-01
Schwann cell differentiation (GO:0014037)	19	2	.37	+	5.41	6.01E-02	5.44E-01
protein metabolic process (GO:0019538)	2973	72	57.84	+	1.24	5.51E-02	5.45E-01
ubiquitin-dependent endocytosis (GO:0070086)	2	1	.04	+	25.70	5.62E-02	5.45E-01
Schwann cell development (GO:0014044)	19	2	.37	+	5.41	6.01E-02	5.45E-01
regulation of locomotion (GO:0040012)	237	9	4.61	+	1.95	5.59E-02	5.45E-01
cerebellum formation (GO:0021588)	2	1	.04	+	25.70	5.62E-02	5.45E-01
regulation of heart morphogenesis (GO:2000826)	19	2	.37	+	5.41	6.01E-02	5.46E-01
protein localization to nuclear inner membrane (GO:0036228)	2	1	.04	+	25.70	5.62E-02	5.46E-01
epithalamus development (GO:0021538)	19	2	.37	+	5.41	6.01E-02	5.46E-01
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951)	2	1	.04	+	25.70	5.62E-02	5.47E-01
cellular component disassembly (GO:0022411)	103	5	2.00	+	2.50	5.61E-02	5.47E-01
cell population proliferation (GO:0008283)	106	5	2.06	+	2.42	6.17E-02	5.53E-01
protein polyubiquitination (GO:0000209)	106	5	2.06	+	2.42	6.17E-02	5.54E-01
regulation of embryonic development (GO:0045995)	74	4	1.44	+	2.78	6.21E-02	5.56E-01
pigment metabolic process (GO:0042440)	45	3	.88	+	3.43	6.36E-02	5.69E-01
cranial nerve morphogenesis (GO:0021602)	20	2	.39	+	5.14	6.53E-02	5.81E-01
regulation of mitotic metaphase/anaphase transition (GO:0030071)	20	2	.39	+	5.14	6.53E-02	5.82E-01
response to axon injury (GO:0048678)	20	2	.39	+	5.14	6.53E-02	5.82E-01
DNA geometric change (GO:0032392)	20	2	.39	+	5.14	6.53E-02	5.83E-01
cerebellum morphogenesis (GO:0021587)	20	2	.39	+	5.14	6.53E-02	5.83E-01
establishment or maintenance of cytoskeleton polarity (GO:0030952)	20	2	.39	+	5.14	6.53E-02	5.84E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090)	46	3	.89	+	3.35	6.68E-02	5.92E-01
protein import into nucleus (GO:0006606)	46	3	.89	+	3.35	6.68E-02	5.93E-01
anatomical structure maturation (GO:0071695)	46	3	.89	+	3.35	6.68E-02	5.94E-01
negative regulation of signaling (GO:0023057)	322	11	6.26	+	1.76	6.78E-02	6.00E-01
negative regulation of cell communication (GO:0010648)	322	11	6.26	+	1.76	6.78E-02	6.01E-01
regulation of cytokine activity (GO:0060300)	3	1	.06	+	17.13	7.42E-02	6.02E-01
signal transduction involved in cell cycle checkpoint (GO:0072395)	3	1	.06	+	17.13	7.42E-02	6.03E-01
establishment of organelle localization (GO:0051656)	144	6	2.80	+	2.14	6.82E-02	6.03E-01
regulation of carbohydrate catabolic process (GO:0043470)	3	1	.06	+	17.13	7.42E-02	6.03E-01
positive regulation of neuron differentiation (GO:0045666)	79	4	1.54	+	2.60	7.44E-02	6.03E-01
embryonic body morphogenesis (GO:0010172)	3	1	.06	+	17.13	7.42E-02	6.04E-01
protein poly-ADP-ribosylation (GO:0070212)	3	1	.06	+	17.13	7.42E-02	6.04E-01
signal transduction involved in DNA integrity checkpoint (GO:0072401)	3	1	.06	+	17.13	7.42E-02	6.05E-01
signal transduction involved in DNA damage checkpoint (GO:0072422)	3	1	.06	+	17.13	7.42E-02	6.05E-01
trigeminal motor nucleus development (GO:0021731)	3	1	.06	+	17.13	7.42E-02	6.06E-01
signal transduction involved in G2 DNA damage checkpoint (GO:0072425)	3	1	.06	+	17.13	7.42E-02	6.07E-01
abducens nucleus development (GO:0021742)	3	1	.06	+	17.13	7.42E-02	6.07E-01
negative regulation of glycogen biosynthetic process (GO:0045719)	3	1	.06	+	17.13	7.42E-02	6.08E-01
positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	3	1	.06	+	17.13	7.42E-02	6.08E-01
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059)	3	1	.06	+	17.13	7.42E-02	6.09E-01
mesodermal cell fate specification (GO:0007501)	3	1	.06	+	17.13	7.42E-02	6.10E-01
hypothalamus cell migration (GO:0021855)	3	1	.06	+	17.13	7.42E-02	6.10E-01
spindle elongation (GO:0051231)	3	1	.06	+	17.13	7.42E-02	6.11E-01
mitotic spindle midzone assembly (GO:0051256)	3	1	.06	+	17.13	7.42E-02	6.11E-01
endodermal digestive tract morphogenesis (GO:0061031)	3	1	.06	+	17.13	7.42E-02	6.12E-01
regulation of muscle organ development (GO:0048634)	22	2	.43	+	4.67	7.61E-02	6.12E-01
centrosome separation (GO:0051299)	3	1	.06	+	17.13	7.42E-02	6.12E-01
DNA modification (GO:0006304)	22	2	.43	+	4.67	7.61E-02	6.13E-01
telomere localization (GO:0034397)	3	1	.06	+	17.13	7.42E-02	6.13E-01
protein ADP-ribosylation (GO:0006471)	22	2	.43	+	4.67	7.61E-02	6.13E-01
telomere tethering at nuclear periphery (GO:0034398)	3	1	.06	+	17.13	7.42E-02	6.14E-01
regulation of mitotic sister chromatid separation (GO:0010965)	22	2	.43	+	4.67	7.61E-02	6.14E-01
embryonic digestive tract morphogenesis (GO:0048557)	3	1	.06	+	17.13	7.42E-02	6.14E-01
DNA methylation or demethylation (GO:0044728)	22	2	.43	+	4.67	7.61E-02	6.14E-01
regulation of cell adhesion (GO:0030155)	110	5	2.14	+	2.34	6.96E-02	6.15E-01
oligodendrocyte progenitor proliferation (GO:0070444)	3	1	.06	+	17.13	7.42E-02	6.15E-01
purine nucleoside monophosphate biosynthetic process (GO:0009127)	22	2	.43	+	4.67	7.61E-02	6.15E-01
negative regulation of neutrophil chemotaxis (GO:0090024)	3	1	.06	+	17.13	7.42E-02	6.15E-01
purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	22	2	.43	+	4.67	7.61E-02	6.16E-01
anterior commissure morphogenesis (GO:0021960)	3	1	.06	+	17.13	7.42E-02	6.16E-01
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	22	2	.43	+	4.67	7.61E-02	6.16E-01
negative regulation of mitotic recombination (GO:0045950)	3	1	.06	+	17.13	7.42E-02	6.17E-01
neuron projection regeneration (GO:0031102)	22	2	.43	+	4.67	7.61E-02	6.17E-01
regulation of neuromuscular junction development (GO:1904396)	3	1	.06	+	17.13	7.42E-02	6.17E-01
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	3	1	.06	+	17.13	7.42E-02	6.18E-01
cytoskeleton-dependent cytokinesis (GO:0061640)	49	3	.95	+	3.15	7.69E-02	6.18E-01
import into nucleus (GO:0051170)	47	3	.91	+	3.28	7.01E-02	6.18E-01
cardiac muscle tissue development (GO:0048738)	80	4	1.56	+	2.57	7.70E-02	6.18E-01
peripheral nervous system myelin maintenance (GO:0032287)	3	1	.06	+	17.13	7.42E-02	6.18E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	47	3	.91	+	3.28	7.01E-02	6.19E-01
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	21	2	.41	+	4.90	7.07E-02	6.19E-01
post-embryonic foregut morphogenesis (GO:0048618)	3	1	.06	+	17.13	7.42E-02	6.19E-01
auditory receptor cell fate commitment (GO:0009912)	3	1	.06	+	17.13	7.42E-02	6.20E-01
positive regulation of cellular protein localization (GO:1903829)	21	2	.41	+	4.90	7.07E-02	6.20E-01
negative regulation of proteasomal protein catabolic process (GO:1901799)	3	1	.06	+	17.13	7.42E-02	6.20E-01
central nervous system neuron axonogenesis (GO:0021955)	21	2	.41	+	4.90	7.07E-02	6.20E-01
mesenchyme migration (GO:0090131)	3	1	.06	+	17.13	7.42E-02	6.21E-01
protein modification by small protein conjugation (GO:0032446)	326	11	6.34	+	1.73	7.09E-02	6.21E-01
swim bladder development (GO:0048794)	21	2	.41	+	4.90	7.07E-02	6.21E-01
miRNA metabolic process (GO:0010586)	3	1	.06	+	17.13	7.42E-02	6.21E-01
interspecies interaction between organisms (GO:0044419)	21	2	.41	+	4.90	7.07E-02	6.22E-01
regulation of inflammatory response to wounding (GO:0106014)	3	1	.06	+	17.13	7.42E-02	6.22E-01
neuromast hair cell differentiation (GO:0048886)	21	2	.41	+	4.90	7.07E-02	6.22E-01
smooth muscle tissue development (GO:0048745)	3	1	.06	+	17.13	7.42E-02	6.23E-01
regulation of transcription involved in cell fate commitment (GO:0060850)	3	1	.06	+	17.13	7.42E-02	6.23E-01
5-methylcytosine metabolic process (GO:0019857)	3	1	.06	+	17.13	7.42E-02	6.24E-01
regulation of receptor binding (GO:1900120)	3	1	.06	+	17.13	7.42E-02	6.24E-01
regulation of chemokine activity (GO:1900136)	3	1	.06	+	17.13	7.42E-02	6.25E-01
behavioral response to nicotine (GO:0035095)	3	1	.06	+	17.13	7.42E-02	6.26E-01
positive regulation of cAMP-mediated signaling (GO:0043950)	3	1	.06	+	17.13	7.42E-02	6.26E-01
regulation of protein modification process (GO:0031399)	524	16	10.19	+	1.57	7.82E-02	6.27E-01
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	3	1	.06	+	17.13	7.42E-02	6.27E-01
5-methylcytosine catabolic process (GO:0006211)	3	1	.06	+	17.13	7.42E-02	6.28E-01
hydrogen sulfide metabolic process (GO:0070813)	3	1	.06	+	17.13	7.42E-02	6.28E-01
negative regulation of glycogen metabolic process (GO:0070874)	3	1	.06	+	17.13	7.42E-02	6.29E-01
trigeminal ganglion development (GO:0061551)	3	1	.06	+	17.13	7.42E-02	6.29E-01
regulation of Wnt signaling pathway, calcium modulating pathway (GO:0008591)	3	1	.06	+	17.13	7.42E-02	6.30E-01
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051)	3	1	.06	+	17.13	7.42E-02	6.31E-01
regulation of glycogen biosynthetic process (GO:0005979)	3	1	.06	+	17.13	7.42E-02	6.31E-01
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)	3	1	.06	+	17.13	7.42E-02	6.32E-01
regulation of intracellular estrogen receptor signaling pathway (GO:0033146)	3	1	.06	+	17.13	7.42E-02	6.32E-01
negative regulation of neutrophil migration (GO:1902623)	3	1	.06	+	17.13	7.42E-02	6.33E-01
regulation of receptor internalization (GO:0002090)	3	1	.06	+	17.13	7.42E-02	6.34E-01
regulation of glucan biosynthetic process (GO:0010962)	3	1	.06	+	17.13	7.42E-02	6.34E-01
atrial cardiac muscle cell differentiation (GO:0055011)	3	1	.06	+	17.13	7.42E-02	6.35E-01
multi-ciliated epithelial cell differentiation (GO:1903251)	3	1	.06	+	17.13	7.42E-02	6.36E-01
positive regulation of cell death (GO:0010942)	81	4	1.58	+	2.54	7.97E-02	6.36E-01
response to cytokine (GO:0034097)	159	0	3.09	-	 < 0.01	7.95E-02	6.36E-01
single strand break repair (GO:0000012)	3	1	.06	+	17.13	7.42E-02	6.36E-01
positive regulation of apoptotic process (GO:0043065)	81	4	1.58	+	2.54	7.97E-02	6.36E-01
regulation of secretion by cell (GO:1903530)	158	0	3.07	-	 < 0.01	7.95E-02	6.36E-01
activation of immune response (GO:0002253)	162	0	3.15	-	 < 0.01	7.99E-02	6.37E-01
mitotic spindle elongation (GO:0000022)	3	1	.06	+	17.13	7.42E-02	6.37E-01
positive regulation of programmed cell death (GO:0043068)	81	4	1.58	+	2.54	7.97E-02	6.37E-01
ribosomal small subunit export from nucleus (GO:0000056)	3	1	.06	+	17.13	7.42E-02	6.38E-01
regulation of secretion (GO:0051046)	163	0	3.17	-	 < 0.01	8.01E-02	6.38E-01
negative regulation of granulocyte chemotaxis (GO:0071623)	3	1	.06	+	17.13	7.42E-02	6.38E-01
protein alkylation (GO:0008213)	50	3	.97	+	3.08	8.04E-02	6.38E-01
olfactory bulb axon guidance (GO:0071678)	3	1	.06	+	17.13	7.42E-02	6.39E-01
protein localization to nucleus (GO:0034504)	50	3	.97	+	3.08	8.04E-02	6.39E-01
protein methylation (GO:0006479)	50	3	.97	+	3.08	8.04E-02	6.39E-01
mitotic centrosome separation (GO:0007100)	3	1	.06	+	17.13	7.42E-02	6.39E-01
peptidyl-amino acid modification (GO:0018193)	360	12	7.00	+	1.71	8.04E-02	6.40E-01
protein O-linked fucosylation (GO:0036066)	3	1	.06	+	17.13	7.42E-02	6.40E-01
inner ear receptor cell fate commitment (GO:0060120)	3	1	.06	+	17.13	7.42E-02	6.41E-01
regulation of cysteine-type endopeptidase activity (GO:2000116)	48	3	.93	+	3.21	7.35E-02	6.41E-01
nucleosome mobilization (GO:0042766)	3	1	.06	+	17.13	7.42E-02	6.41E-01
pigment cell differentiation (GO:0050931)	48	3	.93	+	3.21	7.35E-02	6.42E-01
myelin maintenance (GO:0043217)	3	1	.06	+	17.13	7.42E-02	6.42E-01
mechanoreceptor differentiation (GO:0042490)	48	3	.93	+	3.21	7.35E-02	6.42E-01
heme oxidation (GO:0006788)	3	1	.06	+	17.13	7.42E-02	6.43E-01
spinal cord association neuron differentiation (GO:0021527)	3	1	.06	+	17.13	7.42E-02	6.43E-01
positive regulation of response to stimulus (GO:0048584)	643	19	12.51	+	1.52	8.12E-02	6.44E-01
trigeminal nerve development (GO:0021559)	3	1	.06	+	17.13	7.42E-02	6.44E-01
facial nerve development (GO:0021561)	3	1	.06	+	17.13	7.42E-02	6.45E-01
vagus nerve development (GO:0021564)	3	1	.06	+	17.13	7.42E-02	6.45E-01
rhombomere 5 development (GO:0021571)	3	1	.06	+	17.13	7.42E-02	6.46E-01
inflammatory response (GO:0006954)	168	0	3.27	-	 < 0.01	8.16E-02	6.46E-01
protein peptidyl-prolyl isomerization (GO:0000413)	23	2	.45	+	4.47	8.17E-02	6.46E-01
rhombomere 6 development (GO:0021572)	3	1	.06	+	17.13	7.42E-02	6.47E-01
defense response to Gram-positive bacterium (GO:0050830)	23	2	.45	+	4.47	8.17E-02	6.47E-01
actomyosin structure organization (GO:0031032)	116	5	2.26	+	2.22	8.24E-02	6.51E-01
secretion by cell (GO:0032940)	171	0	3.33	-	 < 0.01	8.29E-02	6.54E-01
cysteine biosynthetic process via cystathionine (GO:0019343)	4	1	.08	+	12.85	9.19E-02	6.75E-01
cysteine biosynthetic process (GO:0019344)	4	1	.08	+	12.85	9.19E-02	6.76E-01
protein localization to chromosome, telomeric region (GO:0070198)	4	1	.08	+	12.85	9.19E-02	6.76E-01
positive regulation of fat cell differentiation (GO:0045600)	4	1	.08	+	12.85	9.19E-02	6.77E-01
alternative mRNA splicing, via spliceosome (GO:0000380)	4	1	.08	+	12.85	9.19E-02	6.78E-01
axial mesoderm morphogenesis (GO:0048319)	4	1	.08	+	12.85	9.19E-02	6.78E-01
pigment catabolic process (GO:0046149)	4	1	.08	+	12.85	9.19E-02	6.79E-01
foregut morphogenesis (GO:0007440)	4	1	.08	+	12.85	9.19E-02	6.79E-01
trigeminal sensory nucleus development (GO:0021730)	4	1	.08	+	12.85	9.19E-02	6.80E-01
mammillary body development (GO:0021767)	4	1	.08	+	12.85	9.19E-02	6.81E-01
renal absorption (GO:0070293)	4	1	.08	+	12.85	9.19E-02	6.81E-01
meiotic sister chromatid cohesion (GO:0051177)	4	1	.08	+	12.85	9.19E-02	6.82E-01
negative regulation of leukocyte chemotaxis (GO:0002689)	4	1	.08	+	12.85	9.19E-02	6.82E-01
digestion (GO:0007586)	25	2	.49	+	4.11	9.33E-02	6.83E-01
regulation of response to external stimulus (GO:0032101)	178	7	3.46	+	2.02	9.30E-02	6.83E-01
forebrain regionalization (GO:0021871)	4	1	.08	+	12.85	9.19E-02	6.83E-01
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	25	2	.49	+	4.11	9.33E-02	6.83E-01
protein heterotetramerization (GO:0051290)	4	1	.08	+	12.85	9.19E-02	6.83E-01
otic vesicle morphogenesis (GO:0071600)	25	2	.49	+	4.11	9.33E-02	6.84E-01
erythrocyte differentiation (GO:0030218)	86	4	1.67	+	2.39	9.36E-02	6.84E-01
protein heterooligomerization (GO:0051291)	4	1	.08	+	12.85	9.19E-02	6.84E-01
ectodermal placode morphogenesis (GO:0071697)	25	2	.49	+	4.11	9.33E-02	6.84E-01
mRNA cleavage involved in gene silencing (GO:0098795)	4	1	.08	+	12.85	9.19E-02	6.85E-01
positive regulation of mRNA metabolic process (GO:1903313)	25	2	.49	+	4.11	9.33E-02	6.85E-01
septin cytoskeleton organization (GO:0032185)	4	1	.08	+	12.85	9.19E-02	6.85E-01
cardiac atrium development (GO:0003230)	4	1	.08	+	12.85	9.19E-02	6.86E-01
anatomical structure arrangement (GO:0048532)	4	1	.08	+	12.85	9.19E-02	6.86E-01
mechanosensory behavior (GO:0007638)	4	1	.08	+	12.85	9.19E-02	6.87E-01
post-embryonic animal morphogenesis (GO:0009886)	4	1	.08	+	12.85	9.19E-02	6.88E-01
protein localization to cell cortex (GO:0072697)	4	1	.08	+	12.85	9.19E-02	6.88E-01
protein depolymerization (GO:0051261)	24	2	.47	+	4.28	8.75E-02	6.88E-01
response to acidic pH (GO:0010447)	4	1	.08	+	12.85	9.19E-02	6.89E-01
regulation of cellular ketone metabolic process (GO:0010565)	24	2	.47	+	4.28	8.75E-02	6.89E-01
multicellular organismal homeostasis (GO:0048871)	52	3	1.01	+	2.97	8.77E-02	6.89E-01
positive regulation of transcription by RNA polymerase I (GO:0045943)	4	1	.08	+	12.85	9.19E-02	6.89E-01
purine nucleobase metabolic process (GO:0006144)	24	2	.47	+	4.28	8.75E-02	6.90E-01
regulation of Wnt signaling pathway involved in heart development (GO:0003307)	4	1	.08	+	12.85	9.19E-02	6.90E-01
regulation of cellular catabolic process (GO:0031329)	172	7	3.35	+	2.09	8.79E-02	6.90E-01
microtubule anchoring at centrosome (GO:0034454)	4	1	.08	+	12.85	9.19E-02	6.91E-01
positive chemotaxis (GO:0050918)	4	1	.08	+	12.85	9.19E-02	6.91E-01
regulation of pigment cell differentiation (GO:0050932)	4	1	.08	+	12.85	9.19E-02	6.92E-01
xanthophore differentiation (GO:0050936)	4	1	.08	+	12.85	9.19E-02	6.92E-01
wound healing (GO:0042060)	180	7	3.50	+	2.00	9.49E-02	6.93E-01
epithelial cell morphogenesis (GO:0003382)	4	1	.08	+	12.85	9.19E-02	6.93E-01
positive regulation of axon regeneration (GO:0048680)	4	1	.08	+	12.85	9.19E-02	6.94E-01
response to mechanical stimulus (GO:0009612)	54	3	1.05	+	2.86	9.52E-02	6.94E-01
protein localization to cell division site (GO:0072741)	4	1	.08	+	12.85	9.19E-02	6.94E-01
positive regulation of neuron projection regeneration (GO:0070572)	4	1	.08	+	12.85	9.19E-02	6.95E-01
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)	4	1	.08	+	12.85	9.19E-02	6.96E-01
protein localization to mitotic actomyosin contractile ring (GO:1904498)	4	1	.08	+	12.85	9.19E-02	6.96E-01
heme catabolic process (GO:0042167)	4	1	.08	+	12.85	9.19E-02	6.97E-01
regulation of response to stress (GO:0080134)	229	8	4.46	+	1.80	9.56E-02	6.97E-01
cation transmembrane transport (GO:0098655)	392	3	7.63	-	.39	9.57E-02	6.97E-01
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070)	4	1	.08	+	12.85	9.19E-02	6.97E-01
neuronal signal transduction (GO:0023041)	4	1	.08	+	12.85	9.19E-02	6.98E-01
adenohypophysis morphogenesis (GO:0048855)	4	1	.08	+	12.85	9.19E-02	6.99E-01
leading strand elongation (GO:0006272)	4	1	.08	+	12.85	9.19E-02	6.99E-01
nucleotide-excision repair, DNA gap filling (GO:0006297)	4	1	.08	+	12.85	9.19E-02	7.00E-01
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	122	5	2.37	+	2.11	9.64E-02	7.00E-01
erythrocyte homeostasis (GO:0034101)	87	4	1.69	+	2.36	9.65E-02	7.00E-01
tetrapyrrole catabolic process (GO:0033015)	4	1	.08	+	12.85	9.19E-02	7.00E-01
drug metabolic process (GO:0017144)	237	1	4.61	-	.22	9.64E-02	7.01E-01
mRNA cleavage involved in gene silencing by miRNA (GO:0035279)	4	1	.08	+	12.85	9.19E-02	7.01E-01
immune response (GO:0006955)	402	3	7.82	-	.38	9.64E-02	7.01E-01
protein retention in Golgi apparatus (GO:0045053)	4	1	.08	+	12.85	9.19E-02	7.02E-01
translation (GO:0006412)	243	1	4.73	-	.21	9.68E-02	7.02E-01
protein de-ADP-ribosylation (GO:0051725)	4	1	.08	+	12.85	9.19E-02	7.02E-01
methylation-dependent chromatin silencing (GO:0006346)	4	1	.08	+	12.85	9.19E-02	7.03E-01
meiotic sister chromatid cohesion, centromeric (GO:0051754)	4	1	.08	+	12.85	9.19E-02	7.04E-01
CRD-mediated mRNA stabilization (GO:0070934)	4	1	.08	+	12.85	9.19E-02	7.04E-01
actin filament reorganization (GO:0090527)	4	1	.08	+	12.85	9.19E-02	7.05E-01
meiotic sister chromatid segregation (GO:0045144)	4	1	.08	+	12.85	9.19E-02	7.05E-01
protein localization to actin cytoskeleton (GO:1903119)	4	1	.08	+	12.85	9.19E-02	7.06E-01
DNA methylation on cytosine (GO:0032776)	4	1	.08	+	12.85	9.19E-02	7.07E-01
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)	4	1	.08	+	12.85	9.19E-02	7.07E-01
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)	4	1	.08	+	12.85	9.19E-02	7.08E-01
establishment of protein localization to organelle (GO:0072594)	175	7	3.40	+	2.06	9.03E-02	7.08E-01
mesodermal cell fate commitment (GO:0001710)	4	1	.08	+	12.85	9.19E-02	7.09E-01
regulation of polysaccharide biosynthetic process (GO:0032885)	4	1	.08	+	12.85	9.19E-02	7.09E-01
septin ring organization (GO:0031106)	4	1	.08	+	12.85	9.19E-02	7.10E-01
negative regulation of signal transduction in absence of ligand (GO:1901099)	4	1	.08	+	12.85	9.19E-02	7.11E-01
regulation of mitotic recombination (GO:0000019)	4	1	.08	+	12.85	9.19E-02	7.11E-01
positive regulation of cell projection organization (GO:0031346)	85	4	1.65	+	2.42	9.07E-02	7.11E-01
protein K29-linked deubiquitination (GO:0035523)	4	1	.08	+	12.85	9.19E-02	7.12E-01
negative regulation of cellular protein catabolic process (GO:1903363)	4	1	.08	+	12.85	9.19E-02	7.12E-01
protein K33-linked deubiquitination (GO:1990168)	4	1	.08	+	12.85	9.19E-02	7.13E-01
peptide biosynthetic process (GO:0043043)	250	1	4.86	-	.21	9.84E-02	7.13E-01
protein localization to actomyosin contractile ring (GO:1990179)	4	1	.08	+	12.85	9.19E-02	7.14E-01
intein-mediated protein splicing (GO:0016539)	4	1	.08	+	12.85	9.19E-02	7.14E-01
porphyrin-containing compound catabolic process (GO:0006787)	4	1	.08	+	12.85	9.19E-02	7.15E-01
histone dephosphorylation (GO:0016576)	4	1	.08	+	12.85	9.19E-02	7.16E-01
detection of mechanical stimulus (GO:0050982)	26	2	.51	+	3.95	9.93E-02	7.16E-01
dorsal spinal cord development (GO:0021516)	4	1	.08	+	12.85	9.19E-02	7.16E-01
establishment of melanosome localization (GO:0032401)	26	2	.51	+	3.95	9.93E-02	7.16E-01
regulation of response to DNA damage stimulus (GO:2001020)	55	3	1.07	+	2.80	9.90E-02	7.17E-01
inner ear receptor cell development (GO:0060119)	26	2	.51	+	3.95	9.93E-02	7.17E-01
cell proliferation in hindbrain (GO:0021534)	4	1	.08	+	12.85	9.19E-02	7.17E-01
camera-type eye photoreceptor cell differentiation (GO:0060219)	26	2	.51	+	3.95	9.93E-02	7.18E-01
hindbrain formation (GO:0021576)	4	1	.08	+	12.85	9.19E-02	7.18E-01
membrane organization (GO:0061024)	321	2	6.25	-	.32	9.92E-02	7.18E-01
intraciliary transport involved in cilium assembly (GO:0035735)	4	1	.08	+	12.85	9.19E-02	7.18E-01
telencephalon cell migration (GO:0022029)	4	1	.08	+	12.85	9.19E-02	7.19E-01
protein splicing (GO:0030908)	4	1	.08	+	12.85	9.19E-02	7.20E-01
protein localization to organelle (GO:0033365)	250	9	4.86	+	1.85	1.02E-01	7.34E-01
defense response (GO:0006952)	336	2	6.54	-	.31	1.03E-01	7.42E-01
regulation of cellular response to stress (GO:0080135)	125	5	2.43	+	2.06	1.04E-01	7.46E-01
olfactory nerve morphogenesis (GO:0021627)	5	1	.10	+	10.28	1.09E-01	7.50E-01
olfactory nerve formation (GO:0021628)	5	1	.10	+	10.28	1.09E-01	7.50E-01
transsulfuration (GO:0019346)	5	1	.10	+	10.28	1.09E-01	7.51E-01
regulation of mRNA 3'-end processing (GO:0031440)	5	1	.10	+	10.28	1.09E-01	7.51E-01
chromatin disassembly (GO:0031498)	5	1	.10	+	10.28	1.09E-01	7.52E-01
olfactory bulb development (GO:0021772)	5	1	.10	+	10.28	1.09E-01	7.53E-01
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745)	5	1	.10	+	10.28	1.09E-01	7.53E-01
post-embryonic development (GO:0009791)	5	1	.10	+	10.28	1.09E-01	7.54E-01
forebrain cell migration (GO:0021885)	5	1	.10	+	10.28	1.09E-01	7.54E-01
positive regulation of DNA metabolic process (GO:0051054)	27	2	.53	+	3.81	1.05E-01	7.54E-01
spindle midzone assembly (GO:0051255)	5	1	.10	+	10.28	1.09E-01	7.55E-01
purine nucleoside monophosphate metabolic process (GO:0009126)	27	2	.53	+	3.81	1.05E-01	7.55E-01
pineal gland development (GO:0021982)	5	1	.10	+	10.28	1.09E-01	7.56E-01
positive regulation of kinase activity (GO:0033674)	189	7	3.68	+	1.90	1.05E-01	7.56E-01
purine ribonucleoside monophosphate metabolic process (GO:0009167)	27	2	.53	+	3.81	1.05E-01	7.56E-01
olfactory lobe development (GO:0021988)	5	1	.10	+	10.28	1.09E-01	7.56E-01
negative regulation of apoptotic signaling pathway (GO:2001234)	27	2	.53	+	3.81	1.05E-01	7.56E-01
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	5	1	.10	+	10.28	1.09E-01	7.57E-01
positive regulation of telomere maintenance via telomere lengthening (GO:1904358)	5	1	.10	+	10.28	1.09E-01	7.57E-01
positive regulation of telomere maintenance (GO:0032206)	5	1	.10	+	10.28	1.09E-01	7.58E-01
positive regulation of telomere maintenance via telomerase (GO:0032212)	5	1	.10	+	10.28	1.09E-01	7.59E-01
neuron fate determination (GO:0048664)	5	1	.10	+	10.28	1.09E-01	7.59E-01
negative regulation of axon regeneration (GO:0048681)	5	1	.10	+	10.28	1.09E-01	7.60E-01
regulation of RNA stability (GO:0043487)	28	2	.54	+	3.67	1.11E-01	7.60E-01
epidermal cell differentiation (GO:0009913)	58	3	1.13	+	2.66	1.11E-01	7.60E-01
regulation of cell-substrate junction assembly (GO:0090109)	5	1	.10	+	10.28	1.09E-01	7.60E-01
regulation of cell shape (GO:0008360)	92	4	1.79	+	2.23	1.12E-01	7.60E-01
regulation of mRNA stability (GO:0043488)	28	2	.54	+	3.67	1.11E-01	7.60E-01
ossification (GO:0001503)	58	3	1.13	+	2.66	1.11E-01	7.61E-01
regulation of isoprenoid metabolic process (GO:0019747)	5	1	.10	+	10.28	1.09E-01	7.61E-01
negative regulation of TOR signaling (GO:0032007)	28	2	.54	+	3.67	1.11E-01	7.61E-01
negative regulation of neuron projection regeneration (GO:0070571)	5	1	.10	+	10.28	1.09E-01	7.62E-01
melanosome localization (GO:0032400)	28	2	.54	+	3.67	1.11E-01	7.62E-01
regulation of retinoic acid biosynthetic process (GO:1900052)	5	1	.10	+	10.28	1.09E-01	7.62E-01
negative regulation of axon extension involved in axon guidance (GO:0048843)	28	2	.54	+	3.67	1.11E-01	7.62E-01
negative regulation of axon guidance (GO:1902668)	28	2	.54	+	3.67	1.11E-01	7.63E-01
regulation of action potential (GO:0098900)	5	1	.10	+	10.28	1.09E-01	7.63E-01
regulation of protein kinase B signaling (GO:0051896)	28	2	.54	+	3.67	1.11E-01	7.64E-01
swim bladder maturation (GO:0048796)	5	1	.10	+	10.28	1.09E-01	7.64E-01
swim bladder inflation (GO:0048798)	5	1	.10	+	10.28	1.09E-01	7.64E-01
developmental maturation (GO:0021700)	57	3	1.11	+	2.71	1.07E-01	7.65E-01
hypophysis morphogenesis (GO:0048850)	5	1	.10	+	10.28	1.09E-01	7.65E-01
diencephalon morphogenesis (GO:0048852)	5	1	.10	+	10.28	1.09E-01	7.65E-01
caudal fin morphogenesis (GO:0035143)	5	1	.10	+	10.28	1.09E-01	7.66E-01
embryonic limb morphogenesis (GO:0030326)	5	1	.10	+	10.28	1.09E-01	7.67E-01
heterochromatin organization (GO:0070828)	5	1	.10	+	10.28	1.09E-01	7.67E-01
nucleosome disassembly (GO:0006337)	5	1	.10	+	10.28	1.09E-01	7.68E-01
regulation of transcription by RNA polymerase I (GO:0006356)	5	1	.10	+	10.28	1.09E-01	7.69E-01
regulation of mRNA polyadenylation (GO:1900363)	5	1	.10	+	10.28	1.09E-01	7.69E-01
production of siRNA involved in RNA interference (GO:0030422)	5	1	.10	+	10.28	1.09E-01	7.70E-01
regulation of protein export from nucleus (GO:0046825)	5	1	.10	+	10.28	1.09E-01	7.70E-01
bone remodeling (GO:0046849)	5	1	.10	+	10.28	1.09E-01	7.71E-01
homoserine metabolic process (GO:0009092)	5	1	.10	+	10.28	1.09E-01	7.72E-01
apical protein localization (GO:0045176)	5	1	.10	+	10.28	1.09E-01	7.72E-01
regulation of focal adhesion assembly (GO:0051893)	5	1	.10	+	10.28	1.09E-01	7.73E-01
pre-miRNA processing (GO:0031054)	5	1	.10	+	10.28	1.09E-01	7.74E-01
cell proliferation in midbrain (GO:0033278)	5	1	.10	+	10.28	1.09E-01	7.74E-01
ventricular cardiac muscle cell differentiation (GO:0055012)	5	1	.10	+	10.28	1.09E-01	7.75E-01
protein targeting to lysosome (GO:0006622)	5	1	.10	+	10.28	1.09E-01	7.76E-01
positive regulation of locomotion (GO:0040017)	91	4	1.77	+	2.26	1.09E-01	7.76E-01
meiosis II (GO:0007135)	5	1	.10	+	10.28	1.09E-01	7.76E-01
protein-DNA complex disassembly (GO:0032986)	5	1	.10	+	10.28	1.09E-01	7.77E-01
meiosis II cell cycle process (GO:0061983)	5	1	.10	+	10.28	1.09E-01	7.77E-01
regulation of receptor recycling (GO:0001919)	5	1	.10	+	10.28	1.09E-01	7.78E-01
olfactory nerve development (GO:0021553)	5	1	.10	+	10.28	1.09E-01	7.79E-01
intraciliary retrograde transport (GO:0035721)	5	1	.10	+	10.28	1.09E-01	7.79E-01
regulation of fat cell differentiation (GO:0045598)	5	1	.10	+	10.28	1.09E-01	7.80E-01
peripheral nervous system development (GO:0007422)	59	3	1.15	+	2.61	1.15E-01	7.82E-01
positive regulation of response to external stimulus (GO:0032103)	59	3	1.15	+	2.61	1.15E-01	7.82E-01
regulation of cytoskeleton organization (GO:0051493)	269	9	5.23	+	1.72	1.16E-01	7.89E-01
regulation of neuron apoptotic process (GO:0043523)	29	2	.56	+	3.54	1.18E-01	7.99E-01
establishment of pigment granule localization (GO:0051905)	29	2	.56	+	3.54	1.18E-01	7.99E-01
exocytosis (GO:0006887)	138	0	2.68	-	 < 0.01	1.19E-01	8.05E-01
immune response-activating signal transduction (GO:0002757)	139	0	2.70	-	 < 0.01	1.19E-01	8.05E-01
immune response-regulating signaling pathway (GO:0002764)	143	0	2.78	-	 < 0.01	1.20E-01	8.11E-01
alcohol metabolic process (GO:0006066)	144	0	2.80	-	 < 0.01	1.20E-01	8.12E-01
regulation of catabolic process (GO:0009894)	200	7	3.89	+	1.80	1.21E-01	8.17E-01
positive regulation of neurogenesis (GO:0050769)	95	4	1.85	+	2.16	1.21E-01	8.19E-01
plus-end-directed vesicle transport along microtubule (GO:0072383)	6	1	.12	+	8.57	1.26E-01	8.21E-01
plus-end-directed organelle transport along microtubule (GO:0072386)	6	1	.12	+	8.57	1.26E-01	8.22E-01
protein K11-linked deubiquitination (GO:0035871)	6	1	.12	+	8.57	1.26E-01	8.22E-01
cellular component disassembly involved in execution phase of apoptosis (GO:0006921)	6	1	.12	+	8.57	1.26E-01	8.23E-01
regulation of glial cell differentiation (GO:0045685)	6	1	.12	+	8.57	1.26E-01	8.23E-01
axial mesoderm development (GO:0048318)	6	1	.12	+	8.57	1.26E-01	8.24E-01
response to external stimulus (GO:0009605)	844	23	16.42	+	1.40	1.27E-01	8.24E-01
neuroblast proliferation (GO:0007405)	6	1	.12	+	8.57	1.26E-01	8.25E-01
locus ceruleus development (GO:0021703)	6	1	.12	+	8.57	1.26E-01	8.25E-01
regulation of kinase activity (GO:0043549)	279	9	5.43	+	1.66	1.27E-01	8.25E-01
preganglionic parasympathetic fiber development (GO:0021783)	6	1	.12	+	8.57	1.26E-01	8.26E-01
negative regulation of leukocyte migration (GO:0002686)	6	1	.12	+	8.57	1.26E-01	8.27E-01
actin filament organization (GO:0007015)	204	7	3.97	+	1.76	1.27E-01	8.27E-01
endocardium morphogenesis (GO:0003160)	6	1	.12	+	8.57	1.26E-01	8.27E-01
parasympathetic nervous system development (GO:0048486)	6	1	.12	+	8.57	1.26E-01	8.28E-01
embryonic digestive tract development (GO:0048566)	6	1	.12	+	8.57	1.26E-01	8.29E-01
myeloid cell homeostasis (GO:0002262)	97	4	1.89	+	2.12	1.28E-01	8.29E-01
lamellipodium assembly (GO:0030032)	6	1	.12	+	8.57	1.26E-01	8.29E-01
positive regulation of blood pressure by epinephrine-norepinephrine (GO:0003321)	6	1	.12	+	8.57	1.26E-01	8.30E-01
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910)	6	1	.12	+	8.57	1.26E-01	8.30E-01
cardiac endothelial cell differentiation (GO:0003348)	6	1	.12	+	8.57	1.26E-01	8.31E-01
neuron projection extension involved in neuron projection guidance (GO:1902284)	6	1	.12	+	8.57	1.26E-01	8.32E-01
regulation of hormone metabolic process (GO:0032350)	6	1	.12	+	8.57	1.26E-01	8.32E-01
regulation of skeletal muscle fiber development (GO:0048742)	6	1	.12	+	8.57	1.26E-01	8.33E-01
blood vessel endothelial cell fate commitment (GO:0060846)	6	1	.12	+	8.57	1.26E-01	8.34E-01
swim bladder morphogenesis (GO:0048795)	6	1	.12	+	8.57	1.26E-01	8.34E-01
apoptotic nuclear changes (GO:0030262)	6	1	.12	+	8.57	1.26E-01	8.35E-01
axon extension involved in axon guidance (GO:0048846)	6	1	.12	+	8.57	1.26E-01	8.36E-01
ribonucleoprotein complex localization (GO:0071166)	30	2	.58	+	3.43	1.24E-01	8.36E-01
forebrain morphogenesis (GO:0048853)	6	1	.12	+	8.57	1.26E-01	8.36E-01
ribonucleoprotein complex export from nucleus (GO:0071426)	30	2	.58	+	3.43	1.24E-01	8.36E-01
stem cell fate specification (GO:0048866)	6	1	.12	+	8.57	1.26E-01	8.37E-01
cardiac muscle cell development (GO:0055013)	30	2	.58	+	3.43	1.24E-01	8.37E-01
endocardial cell differentiation (GO:0060956)	6	1	.12	+	8.57	1.26E-01	8.37E-01
regulation of cell cycle checkpoint (GO:1901976)	6	1	.12	+	8.57	1.26E-01	8.38E-01
hatching (GO:0035188)	6	1	.12	+	8.57	1.26E-01	8.39E-01
secondary metabolite biosynthetic process (GO:0044550)	6	1	.12	+	8.57	1.26E-01	8.39E-01
apoptotic DNA fragmentation (GO:0006309)	6	1	.12	+	8.57	1.26E-01	8.40E-01
cranial ganglion development (GO:0061550)	6	1	.12	+	8.57	1.26E-01	8.41E-01
positive regulation of dephosphorylation (GO:0035306)	6	1	.12	+	8.57	1.26E-01	8.41E-01
positive regulation of protein dephosphorylation (GO:0035307)	6	1	.12	+	8.57	1.26E-01	8.42E-01
neural crest cell fate commitment (GO:0014034)	6	1	.12	+	8.57	1.26E-01	8.43E-01
neural crest cell fate specification (GO:0014036)	6	1	.12	+	8.57	1.26E-01	8.43E-01
protein polymerization (GO:0051258)	31	2	.60	+	3.32	1.30E-01	8.44E-01
negative regulation of protein kinase B signaling (GO:0051898)	6	1	.12	+	8.57	1.26E-01	8.44E-01
regulation of gastrulation (GO:0010470)	31	2	.60	+	3.32	1.30E-01	8.44E-01
positive regulation of synapse assembly (GO:0051965)	6	1	.12	+	8.57	1.26E-01	8.45E-01
reciprocal meiotic recombination (GO:0007131)	31	2	.60	+	3.32	1.30E-01	8.45E-01
regulation of vitamin metabolic process (GO:0030656)	6	1	.12	+	8.57	1.26E-01	8.45E-01
hindbrain morphogenesis (GO:0021575)	31	2	.60	+	3.32	1.30E-01	8.46E-01
inorganic ion transmembrane transport (GO:0098660)	388	3	7.55	-	.40	1.31E-01	8.46E-01
ribosomal large subunit export from nucleus (GO:0000055)	6	1	.12	+	8.57	1.26E-01	8.46E-01
organism emergence from protective structure (GO:0071684)	6	1	.12	+	8.57	1.26E-01	8.47E-01
olfactory placode morphogenesis (GO:0071699)	6	1	.12	+	8.57	1.26E-01	8.47E-01
regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993)	6	1	.12	+	8.57	1.26E-01	8.48E-01
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994)	6	1	.12	+	8.57	1.26E-01	8.49E-01
stress granule assembly (GO:0034063)	6	1	.12	+	8.57	1.26E-01	8.49E-01
gastrulation (GO:0007369)	207	7	4.03	+	1.74	1.33E-01	8.56E-01
response to oxygen-containing compound (GO:1901700)	301	2	5.86	-	.34	1.36E-01	8.77E-01
homologous recombination (GO:0035825)	32	2	.62	+	3.21	1.37E-01	8.79E-01
renal system process (GO:0003014)	32	2	.62	+	3.21	1.37E-01	8.79E-01
neuron recognition (GO:0008038)	32	2	.62	+	3.21	1.37E-01	8.80E-01
response to hormone (GO:0009725)	221	1	4.30	-	.23	1.37E-01	8.80E-01
pigment granule localization (GO:0051875)	32	2	.62	+	3.21	1.37E-01	8.81E-01
regulation of immune response (GO:0050776)	221	1	4.30	-	.23	1.37E-01	8.81E-01
histone lysine methylation (GO:0034968)	32	2	.62	+	3.21	1.37E-01	8.81E-01
cytoplasmic microtubule organization (GO:0031122)	32	2	.62	+	3.21	1.37E-01	8.82E-01
macromolecule methylation (GO:0043414)	100	4	1.95	+	2.06	1.38E-01	8.83E-01
autophagy (GO:0006914)	100	4	1.95	+	2.06	1.38E-01	8.84E-01
process utilizing autophagic mechanism (GO:0061919)	100	4	1.95	+	2.06	1.38E-01	8.84E-01
cofactor metabolic process (GO:0051186)	228	1	4.44	-	.23	1.39E-01	8.86E-01
peptidyl-lysine methylation (GO:0018022)	33	2	.64	+	3.12	1.44E-01	8.89E-01
homocysteine metabolic process (GO:0050667)	7	1	.14	+	7.34	1.43E-01	8.89E-01
positive regulation of canonical Wnt signaling pathway (GO:0090263)	33	2	.64	+	3.12	1.44E-01	8.89E-01
negative regulation of binding (GO:0051100)	7	1	.14	+	7.34	1.43E-01	8.90E-01
peptidyl-proline modification (GO:0018208)	33	2	.64	+	3.12	1.44E-01	8.90E-01
regulation of DNA methylation (GO:0044030)	7	1	.14	+	7.34	1.43E-01	8.90E-01
posterior lateral line neuromast development (GO:0048919)	33	2	.64	+	3.12	1.44E-01	8.91E-01
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	7	1	.14	+	7.34	1.43E-01	8.91E-01
nucleobase metabolic process (GO:0009112)	33	2	.64	+	3.12	1.44E-01	8.91E-01
positive regulation of immune system process (GO:0002684)	230	1	4.47	-	.22	1.40E-01	8.91E-01
learning (GO:0007612)	7	1	.14	+	7.34	1.43E-01	8.92E-01
ectodermal placode development (GO:0071696)	33	2	.64	+	3.12	1.44E-01	8.92E-01
negative regulation of cellular protein localization (GO:1903828)	7	1	.14	+	7.34	1.43E-01	8.92E-01
regulation of neuron death (GO:1901214)	33	2	.64	+	3.12	1.44E-01	8.93E-01
negative adaptation of signaling pathway (GO:0022401)	7	1	.14	+	7.34	1.43E-01	8.93E-01
negative regulation of DNA replication (GO:0008156)	7	1	.14	+	7.34	1.43E-01	8.94E-01
positive regulation of smooth muscle contraction (GO:0045987)	7	1	.14	+	7.34	1.43E-01	8.94E-01
positive regulation of muscle organ development (GO:0048636)	7	1	.14	+	7.34	1.43E-01	8.95E-01
negative regulation of signal transduction by p53 class mediator (GO:1901797)	7	1	.14	+	7.34	1.43E-01	8.96E-01
cardiac muscle fiber development (GO:0048739)	7	1	.14	+	7.34	1.43E-01	8.96E-01
endothelial cell fate commitment (GO:0060839)	7	1	.14	+	7.34	1.43E-01	8.97E-01
Notch signaling pathway (GO:0007219)	65	3	1.26	+	2.37	1.41E-01	8.97E-01
adaptation of signaling pathway (GO:0023058)	7	1	.14	+	7.34	1.43E-01	8.98E-01
regulation of Rac protein signal transduction (GO:0035020)	7	1	.14	+	7.34	1.43E-01	8.98E-01
myelination of lateral line nerve axons (GO:0048897)	7	1	.14	+	7.34	1.43E-01	8.99E-01
positive regulation of DNA biosynthetic process (GO:2000573)	7	1	.14	+	7.34	1.43E-01	9.00E-01
posterior lateral line nerve glial cell differentiation (GO:0048931)	7	1	.14	+	7.34	1.43E-01	9.00E-01
myelination of posterior lateral line nerve axons (GO:0048932)	7	1	.14	+	7.34	1.43E-01	9.01E-01
lateral line nerve glial cell morphogenesis involved in differentiation (GO:0048938)	7	1	.14	+	7.34	1.43E-01	9.02E-01
posterior lateral line nerve glial cell development (GO:0048941)	7	1	.14	+	7.34	1.43E-01	9.02E-01
posterior lateral line nerve glial cell morphogenesis involved in differentiation (GO:0048942)	7	1	.14	+	7.34	1.43E-01	9.03E-01
filopodium assembly (GO:0046847)	7	1	.14	+	7.34	1.43E-01	9.04E-01
desensitization of G protein-coupled receptor signaling pathway (GO:0002029)	7	1	.14	+	7.34	1.43E-01	9.04E-01
G protein-coupled receptor internalization (GO:0002031)	7	1	.14	+	7.34	1.43E-01	9.05E-01
notochord formation (GO:0014028)	7	1	.14	+	7.34	1.43E-01	9.06E-01
RNA interference (GO:0016246)	7	1	.14	+	7.34	1.43E-01	9.06E-01
cysteine metabolic process (GO:0006534)	7	1	.14	+	7.34	1.43E-01	9.07E-01
negative regulation of endodermal cell differentiation (GO:1903225)	7	1	.14	+	7.34	1.43E-01	9.08E-01
negative regulation of endodermal cell fate specification (GO:0042664)	7	1	.14	+	7.34	1.43E-01	9.08E-01
caudal fin development (GO:0033336)	7	1	.14	+	7.34	1.43E-01	9.09E-01
regulation of stem cell proliferation (GO:0072091)	7	1	.14	+	7.34	1.43E-01	9.10E-01
negative regulation of cell cycle G1/S phase transition (GO:1902807)	7	1	.14	+	7.34	1.43E-01	9.10E-01
cell migration in hindbrain (GO:0021535)	7	1	.14	+	7.34	1.43E-01	9.11E-01
fourth ventricle development (GO:0021592)	7	1	.14	+	7.34	1.43E-01	9.12E-01
cardiac chamber development (GO:0003205)	34	2	.66	+	3.02	1.50E-01	9.24E-01
negative regulation of protein depolymerization (GO:1901880)	34	2	.66	+	3.02	1.50E-01	9.25E-01
regulation of DNA repair (GO:0006282)	34	2	.66	+	3.02	1.50E-01	9.26E-01
ribonucleoside monophosphate biosynthetic process (GO:0009156)	34	2	.66	+	3.02	1.50E-01	9.26E-01
cardiac cell development (GO:0055006)	34	2	.66	+	3.02	1.50E-01	9.27E-01
non-canonical Wnt signaling pathway (GO:0035567)	34	2	.66	+	3.02	1.50E-01	9.28E-01
cerebellum development (GO:0021549)	34	2	.66	+	3.02	1.50E-01	9.28E-01
negative regulation of cellular catabolic process (GO:0031330)	34	2	.66	+	3.02	1.50E-01	9.29E-01
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	104	4	2.02	+	1.98	1.52E-01	9.35E-01
cloaca development (GO:0035844)	8	1	.16	+	6.42	1.59E-01	9.46E-01
centriole assembly (GO:0098534)	8	1	.16	+	6.42	1.59E-01	9.46E-01
paraxial mesoderm development (GO:0048339)	8	1	.16	+	6.42	1.59E-01	9.47E-01
actin-mediated cell contraction (GO:0070252)	8	1	.16	+	6.42	1.59E-01	9.48E-01
positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743)	8	1	.16	+	6.42	1.59E-01	9.48E-01
sex determination (GO:0007530)	8	1	.16	+	6.42	1.59E-01	9.49E-01
positive regulation of cellular protein metabolic process (GO:0032270)	439	13	8.54	+	1.52	1.60E-01	9.49E-01
cardiac muscle tissue regeneration (GO:0061026)	8	1	.16	+	6.42	1.59E-01	9.50E-01
positive regulation of smoothened signaling pathway (GO:0045880)	8	1	.16	+	6.42	1.59E-01	9.50E-01
regulation of neutrophil chemotaxis (GO:0090022)	8	1	.16	+	6.42	1.59E-01	9.51E-01
retinal cone cell development (GO:0046549)	8	1	.16	+	6.42	1.59E-01	9.52E-01
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)	8	1	.16	+	6.42	1.59E-01	9.52E-01
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)	8	1	.16	+	6.42	1.59E-01	9.53E-01
trabecula morphogenesis (GO:0061383)	8	1	.16	+	6.42	1.59E-01	9.54E-01
heart trabecula morphogenesis (GO:0061384)	8	1	.16	+	6.42	1.59E-01	9.54E-01
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037)	8	1	.16	+	6.42	1.59E-01	9.55E-01
positive regulation of cell development (GO:0010720)	105	4	2.04	+	1.96	1.56E-01	9.56E-01
stem cell fate commitment (GO:0048865)	8	1	.16	+	6.42	1.59E-01	9.56E-01
positive regulation of nervous system development (GO:0051962)	105	4	2.04	+	1.96	1.56E-01	9.56E-01
limb morphogenesis (GO:0035108)	8	1	.16	+	6.42	1.59E-01	9.56E-01
lateral line nerve glial cell differentiation (GO:0048895)	8	1	.16	+	6.42	1.59E-01	9.57E-01
anterior lateral line development (GO:0048899)	8	1	.16	+	6.42	1.59E-01	9.58E-01
DNA topological change (GO:0006265)	8	1	.16	+	6.42	1.59E-01	9.58E-01
pointed-end actin filament capping (GO:0051694)	8	1	.16	+	6.42	1.59E-01	9.59E-01
mRNA transport (GO:0051028)	35	2	.68	+	2.94	1.57E-01	9.59E-01
lateral line nerve glial cell development (GO:0048937)	8	1	.16	+	6.42	1.59E-01	9.60E-01
regulation of cyclin-dependent protein kinase activity (GO:1904029)	35	2	.68	+	2.94	1.57E-01	9.60E-01
DNA replication-independent nucleosome assembly (GO:0006336)	8	1	.16	+	6.42	1.59E-01	9.60E-01
pigment biosynthetic process (GO:0046148)	35	2	.68	+	2.94	1.57E-01	9.61E-01
female gonad development (GO:0008585)	8	1	.16	+	6.42	1.59E-01	9.61E-01
regulation of axon extension involved in axon guidance (GO:0048841)	35	2	.68	+	2.94	1.57E-01	9.61E-01
negative regulation of RNA splicing (GO:0033119)	8	1	.16	+	6.42	1.59E-01	9.62E-01
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	35	2	.68	+	2.94	1.57E-01	9.62E-01
peptidyl-tyrosine dephosphorylation (GO:0035335)	8	1	.16	+	6.42	1.59E-01	9.62E-01
cortical actin cytoskeleton organization (GO:0030866)	35	2	.68	+	2.94	1.57E-01	9.63E-01
oxidative demethylation (GO:0070989)	8	1	.16	+	6.42	1.59E-01	9.63E-01
negative regulation of microtubule depolymerization (GO:0007026)	8	1	.16	+	6.42	1.59E-01	9.64E-01
establishment of planar polarity (GO:0001736)	8	1	.16	+	6.42	1.59E-01	9.64E-01
Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	8	1	.16	+	6.42	1.59E-01	9.65E-01
negative regulation of microtubule polymerization or depolymerization (GO:0031111)	8	1	.16	+	6.42	1.59E-01	9.66E-01
protein phosphorylation (GO:0006468)	829	22	16.13	+	1.36	1.58E-01	9.66E-01
centriole replication (GO:0007099)	8	1	.16	+	6.42	1.59E-01	9.66E-01
microtubule-based movement (GO:0007018)	172	6	3.35	+	1.79	1.58E-01	9.67E-01
regulation of granulocyte chemotaxis (GO:0071622)	8	1	.16	+	6.42	1.59E-01	9.67E-01
negative regulation of catabolic process (GO:0009895)	36	2	.70	+	2.86	1.64E-01	9.68E-01
regulation of developmental pigmentation (GO:0048070)	8	1	.16	+	6.42	1.59E-01	9.68E-01
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482)	36	2	.70	+	2.86	1.64E-01	9.68E-01
establishment of tissue polarity (GO:0007164)	8	1	.16	+	6.42	1.59E-01	9.69E-01
positive regulation of Rho protein signal transduction (GO:0035025)	36	2	.70	+	2.86	1.64E-01	9.69E-01
regulation of adherens junction organization (GO:1903391)	8	1	.16	+	6.42	1.59E-01	9.69E-01
melanocyte differentiation (GO:0030318)	36	2	.70	+	2.86	1.64E-01	9.70E-01
posterior lateral line neuromast hair cell development (GO:0035677)	8	1	.16	+	6.42	1.59E-01	9.70E-01
protein export from nucleus (GO:0006611)	36	2	.70	+	2.86	1.64E-01	9.70E-01
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)	8	1	.16	+	6.42	1.59E-01	9.71E-01
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)	8	1	.16	+	6.42	1.59E-01	9.71E-01
toxin metabolic process (GO:0009404)	8	1	.16	+	6.42	1.59E-01	9.72E-01
nitrogen compound transport (GO:0071705)	878	11	17.08	-	.64	1.67E-01	9.90E-01
cell migration involved in gastrulation (GO:0042074)	71	3	1.38	+	2.17	1.68E-01	9.91E-01
microtubule anchoring at microtubule organizing center (GO:0072393)	9	1	.18	+	5.71	1.75E-01	9.98E-01
pre-replicative complex assembly (GO:0036388)	9	1	.18	+	5.71	1.75E-01	9.98E-01
spindle checkpoint (GO:0031577)	9	1	.18	+	5.71	1.75E-01	9.99E-01
ribosome localization (GO:0033750)	9	1	.18	+	5.71	1.75E-01	1.00E00
UMP metabolic process (GO:0046049)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of flagellated sperm motility (GO:1901317)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H2A K63-linked ubiquitination (GO:1901315)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of histone H2A K63-linked ubiquitination (GO:1901314)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	29	1	.56	+	1.77	4.39E-01	1.00E00
oocyte axis specification (GO:0007309)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
ITP metabolic process (GO:0046041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oocyte construction (GO:0007308)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
eggshell chorion assembly (GO:0007306)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
swimming behavior (GO:0036269)	24	1	.47	+	2.14	3.82E-01	1.00E00
chorion-containing eggshell formation (GO:0007304)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
swimming (GO:0036268)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum unfolded protein response (GO:0030968)	38	1	.74	+	1.35	5.29E-01	1.00E00
RNA (guanine-N7)-methylation (GO:0036265)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
RNA capping (GO:0036260)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
alkanesulfonate transport (GO:0042918)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
CENP-A containing nucleosome assembly (GO:0034080)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of G2/MI transition of meiotic cell cycle (GO:0110030)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle prefusion complex stabilization (GO:0048213)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071878)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GTP metabolic process (GO:0046039)	16	1	.31	+	3.21	2.79E-01	1.00E00
Golgi vesicle docking (GO:0048211)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
GMP metabolic process (GO:0046037)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle fusion to target membrane (GO:0048210)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
adrenergic receptor signaling pathway (GO:0071875)	29	1	.56	+	1.77	4.39E-01	1.00E00
CTP metabolic process (GO:0046036)	15	1	.29	+	3.43	2.65E-01	1.00E00
ATP metabolic process (GO:0046034)	97	0	1.89	-	 < 0.01	2.68E-01	1.00E00
AMP metabolic process (GO:0046033)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
response to epinephrine (GO:0071871)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to catecholamine stimulus (GO:0071870)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
ADP metabolic process (GO:0046031)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
astral microtubule organization (GO:0030953)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of actin cytoskeleton polarity (GO:0030950)	18	1	.35	+	2.86	3.07E-01	1.00E00
DNA strand resection involved in replication fork processing (GO:0110025)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle targeting, to, from or within Golgi (GO:0048209)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
COPII vesicle coating (GO:0048208)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle myoblast proliferation (GO:0110023)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xenobiotic transport (GO:0042908)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, rough ER to cis-Golgi (GO:0048207)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle myoblast proliferation (GO:0110022)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac muscle myoblast proliferation (GO:0110021)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
COPI coating of Golgi vesicle (GO:0048205)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of actomyosin structure organization (GO:0110020)	17	1	.33	+	3.02	2.93E-01	1.00E00
response to catecholamine (GO:0071869)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, trans-Golgi to endosome (GO:0048203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to monoamine stimulus (GO:0071868)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
response to monoamine (GO:0071867)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
Golgi transport vesicle coating (GO:0048200)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
arsonoacetate metabolic process (GO:0018872)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)	13	1	.25	+	3.95	2.36E-01	1.00E00
protein localization to Golgi apparatus (GO:0034067)	9	1	.18	+	5.71	1.75E-01	1.00E00
regulation of transcription by glucose (GO:0046015)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic cell cycle arrest (GO:0071850)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
formin-nucleated actin cable organization (GO:0110009)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
granulocyte activation (GO:0036230)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
actin filament debranching (GO:0071846)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
receptor-mediated endocytosis (GO:0006898)	64	2	1.25	+	1.61	3.60E-01	1.00E00
endocytosis (GO:0006897)	221	3	4.30	-	.70	8.04E-01	1.00E00
Golgi to vacuole transport (GO:0006896)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
Golgi to endosome transport (GO:0006895)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine acetylation (GO:0030920)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane transport (GO:0006893)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
post-Golgi vesicle-mediated transport (GO:0006892)	35	1	.68	+	1.47	5.01E-01	1.00E00
intra-Golgi vesicle-mediated transport (GO:0006891)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
intermediate-density lipoprotein particle clearance (GO:0071831)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
triglyceride-rich lipoprotein particle clearance (GO:0071830)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to stem cell factor stimulus (GO:0036216)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
otic vesicle formation (GO:0030916)	19	1	.37	+	2.71	3.20E-01	1.00E00
response to stem cell factor (GO:0036215)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	80	0	1.56	-	 < 0.01	4.10E-01	1.00E00
paranodal junction assembly (GO:0030913)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intracellular protein transport (GO:0006886)	552	9	10.74	-	.84	7.54E-01	1.00E00
regulation of pH (GO:0006885)	48	1	.93	+	1.07	6.11E-01	1.00E00
cell volume homeostasis (GO:0006884)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
olfactory placode formation (GO:0030910)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular sodium ion homeostasis (GO:0006883)	15	1	.29	+	3.43	2.65E-01	1.00E00
purine ribonucleoside bisphosphate metabolic process (GO:0034035)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular zinc ion homeostasis (GO:0006882)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
purine nucleoside bisphosphate catabolic process (GO:0034034)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
purine nucleoside bisphosphate biosynthetic process (GO:0034033)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
intracellular sequestering of iron ion (GO:0006880)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
purine nucleoside bisphosphate metabolic process (GO:0034032)	57	0	1.11	-	 < 0.01	6.30E-01	1.00E00
ribonucleoside bisphosphate catabolic process (GO:0034031)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ribonucleoside bisphosphate biosynthetic process (GO:0034030)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle organization (GO:0071827)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ribonucleoprotein complex subunit organization (GO:0071826)	105	3	2.04	+	1.47	4.64E-01	1.00E00
protein-lipid complex subunit organization (GO:0071825)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular iron ion homeostasis (GO:0006879)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
cellular copper ion homeostasis (GO:0006878)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular metal ion homeostasis (GO:0006875)	275	7	5.35	+	1.31	5.05E-01	1.00E00
cellular calcium ion homeostasis (GO:0006874)	222	6	4.32	+	1.39	4.57E-01	1.00E00
cellular ion homeostasis (GO:0006873)	324	7	6.30	+	1.11	6.86E-01	1.00E00
tail-anchored membrane protein insertion into ER membrane (GO:0071816)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
amino acid transport (GO:0006865)	62	0	1.21	-	 < 0.01	6.34E-01	1.00E00
pyrimidine nucleotide transport (GO:0006864)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
purine nucleobase transport (GO:0006863)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nucleotide transport (GO:0006862)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein transmembrane transport (GO:0071806)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
potassium ion transmembrane transport (GO:0071805)	158	2	3.07	-	.65	7.73E-01	1.00E00
podosome assembly (GO:0071800)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of fat cell differentiation (GO:0045599)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell differentiation (GO:0045597)	144	5	2.80	+	1.78	2.13E-01	1.00E00
mitochondrial RNA modification (GO:1900864)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
extracellular transport (GO:0006858)	24	1	.47	+	2.14	3.82E-01	1.00E00
oligopeptide transport (GO:0006857)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
drug transmembrane transport (GO:0006855)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
mitochondrial calcium ion transmembrane transport (GO:0006851)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
mitochondrial pyruvate transmembrane transport (GO:0006850)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
specification of animal organ identity (GO:0010092)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of regulatory T cell differentiation (GO:0045589)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA localization to chromatin (GO:1990280)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell differentiation (GO:0045582)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell differentiation (GO:0045581)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
pyruvate transport (GO:0006848)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of T cell differentiation (GO:0045580)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
acyl carnitine transport (GO:0006844)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mitochondrial citrate transmembrane transport (GO:0006843)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid transport (GO:0006842)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
specification of animal organ axis polarity (GO:0010084)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen (GO:0002483)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of B cell differentiation (GO:0045577)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mast cell activation (GO:0045576)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
basophil activation (GO:0045575)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial transport (GO:0006839)	89	0	1.73	-	 < 0.01	4.21E-01	1.00E00
serotonin transport (GO:0006837)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neurotransmitter transport (GO:0006836)	93	0	1.81	-	 < 0.01	4.28E-01	1.00E00
dicarboxylic acid transport (GO:0006835)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
water transport (GO:0006833)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA binding (GO:0043392)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial membrane permeability (GO:0035794)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
platelet-derived growth factor receptor-beta signaling pathway (GO:0035791)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
neutrophil migration (GO:1990266)	75	0	1.46	-	 < 0.01	4.08E-01	1.00E00
interkinetic nuclear migration (GO:0022027)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Rac protein signal transduction (GO:0016601)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)	13	1	.25	+	3.95	2.36E-01	1.00E00
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
zinc ion transport (GO:0006829)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
manganese ion transport (GO:0006828)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
iron ion transport (GO:0006826)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
mycotoxin metabolic process (GO:0043385)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
copper ion transport (GO:0006825)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative T cell selection (GO:0043383)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
chloride transport (GO:0006821)	67	0	1.30	-	 < 0.01	6.41E-01	1.00E00
dendritic cell antigen processing and presentation (GO:0002468)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
germinal center formation (GO:0002467)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peripheral tolerance induction (GO:0002465)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone glutamine methylation (GO:1990258)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
tolerance induction dependent upon immune response (GO:0002461)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	50	0	.97	-	 < 0.01	1.00E00	1.00E00
cellular response to leucine starvation (GO:1990253)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
central nervous system myelination (GO:0022010)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
phosphate ion transport (GO:0006817)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
calcium ion transport (GO:0006816)	140	1	2.72	-	.37	5.29E-01	1.00E00
angioblast cell differentiation (GO:0035779)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell differentiation (GO:0043374)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sodium ion transport (GO:0006814)	65	1	1.26	-	.79	1.00E00	1.00E00
pronephric nephron tubule epithelial cell differentiation (GO:0035778)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
potassium ion transport (GO:0006813)	174	2	3.39	-	.59	7.78E-01	1.00E00
pronephric distal tubule development (GO:0035777)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pronephric proximal tubule development (GO:0035776)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
pronephric glomerulus morphogenesis (GO:0035775)	13	1	.25	+	3.95	2.36E-01	1.00E00
regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
insulin secretion involved in cellular response to glucose stimulus (GO:0035773)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
peripheral T cell tolerance induction (GO:0002458)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell mediated immunity (GO:0002456)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	45	0	.88	-	 < 0.01	1.00E00	1.00E00
central nervous system vasculogenesis (GO:0022009)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
polysaccharide catabolic process (GO:0000272)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
polysaccharide biosynthetic process (GO:0000271)	37	0	.72	-	 < 0.01	1.00E00	1.00E00
peptidoglycan metabolic process (GO:0000270)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nitric oxide biosynthetic process (GO:0006809)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive T cell selection (GO:0043368)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell differentiation (GO:0043367)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
xenobiotic metabolic process (GO:0006805)	50	0	.97	-	 < 0.01	1.00E00	1.00E00
nucleate erythrocyte differentiation (GO:0043363)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
endothelial cell chemotaxis (GO:0035767)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
superoxide metabolic process (GO:0006801)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
lymphocyte mediated immunity (GO:0002449)	48	0	.93	-	 < 0.01	1.00E00	1.00E00
response to zinc ion (GO:0010043)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
neutrophil mediated immunity (GO:0002446)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
response to iron(II) ion (GO:0010040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myeloid leukocyte mediated immunity (GO:0002444)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
leukocyte mediated immunity (GO:0002443)	53	0	1.03	-	 < 0.01	6.28E-01	1.00E00
production of molecular mediator of immune response (GO:0002440)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
mitochondrial fission (GO:0000266)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
response to iron ion (GO:0010039)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
B cell chemotaxis (GO:0035754)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to metal ion (GO:0010038)	80	0	1.56	-	 < 0.01	4.10E-01	1.00E00
protein glycosylation in Golgi (GO:0033578)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of lysosomal lumen pH (GO:0035751)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to inorganic substance (GO:0010035)	99	0	1.93	-	 < 0.01	2.69E-01	1.00E00
protein glycosylation in endoplasmic reticulum (GO:0033577)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to organic substance (GO:0010033)	764	11	14.86	-	.74	4.21E-01	1.00E00
response to testosterone (GO:0033574)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
transferrin transport (GO:0033572)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein ubiquitination (GO:0031397)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
complement receptor mediated signaling pathway (GO:0002430)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin biosynthetic process (GO:0031394)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
allantoin catabolic process (GO:0000256)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
allantoin metabolic process (GO:0000255)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of prostaglandin biosynthetic process (GO:0031392)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA replication, Okazaki fragment processing (GO:0033567)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
immune response-activating cell surface receptor signaling pathway (GO:0002429)	109	0	2.12	-	 < 0.01	2.77E-01	1.00E00
gamma-tubulin complex localization (GO:0033566)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of water loss via skin (GO:0033561)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spliceosomal complex assembly (GO:0000245)	28	1	.54	+	1.84	4.28E-01	1.00E00
spliceosomal tri-snRNP complex assembly (GO:0000244)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in compound eye morphogenesis (GO:0035736)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to dsRNA (GO:0043331)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
response to exogenous dsRNA (GO:0043330)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
unsaturated fatty acid metabolic process (GO:0033559)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
multicellular organismal response to stress (GO:0033555)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
response to vitamin B3 (GO:0033552)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pigment metabolic process involved in developmental pigmentation (GO:0043324)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
common myeloid progenitor cell proliferation (GO:0035726)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sodium ion transmembrane transport (GO:0035725)	37	1	.72	+	1.39	5.19E-01	1.00E00
interleukin-15-mediated signaling pathway (GO:0035723)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
siderophore biosynthetic process (GO:0019290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intraciliary anterograde transport (GO:0035720)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dendritic cell chemotaxis (GO:0002407)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
N-terminal protein amino acid modification (GO:0031365)	12	1	.23	+	4.28	2.22E-01	1.00E00
isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glycine betaine biosynthetic process from choline (GO:0019285)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-methionine salvage from S-adenosylmethionine (GO:0019284)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chemokine-mediated signaling pathway (GO:0070098)	53	0	1.03	-	 < 0.01	6.28E-01	1.00E00
CD4-positive, alpha-beta T cell activation (GO:0035710)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial outer membrane translocase complex assembly (GO:0070096)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucagon secretion (GO:0070093)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glucagon secretion (GO:0070092)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell degranulation (GO:0043304)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
rhombomere 4 development (GO:0021570)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte degranulation (GO:0043300)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
S-methylmethionine cycle (GO:0033528)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell migration (GO:0035701)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
glycosylation (GO:0070085)	189	2	3.68	-	.54	5.92E-01	1.00E00
protein initiator methionine removal (GO:0070084)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of defense response (GO:0031349)	41	1	.80	+	1.25	5.55E-01	1.00E00
histone H2A ubiquitination (GO:0033522)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of defense response (GO:0031348)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of defense response (GO:0031347)	88	2	1.71	+	1.17	6.91E-01	1.00E00
positive regulation of cell killing (GO:0031343)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cell killing (GO:0031341)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle fusion (GO:0031340)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glycine biosynthetic process from serine (GO:0019264)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of lysosome organization (GO:1905671)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate catabolic process (GO:0019262)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process to acetyl-CoA via L-pipecolate (GO:0033514)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
clustering of voltage-gated calcium channels (GO:0070073)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
proton-transporting two-sector ATPase complex assembly (GO:0070071)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle fusion (GO:0031338)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
proton-transporting V-type ATPase complex assembly (GO:0070070)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein complex assembly (GO:0031334)	68	0	1.32	-	 < 0.01	6.43E-01	1.00E00
positive regulation of sarcomere organization (GO:0060298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein complex assembly (GO:0031333)	47	1	.91	+	1.09	6.04E-01	1.00E00
regulation of sarcomere organization (GO:0060297)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cilium beat frequency involved in ciliary motility (GO:0060296)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular catabolic process (GO:0031331)	64	1	1.25	-	.80	1.00E00	1.00E00
regulation of cilium movement involved in cell motility (GO:0060295)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cilium movement involved in cell motility (GO:0060294)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
long-term synaptic depression (GO:0060292)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
long-term synaptic potentiation (GO:0060291)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
trochlear nerve development (GO:0021558)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transdifferentiation (GO:0060290)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
oculomotor nerve development (GO:0021557)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
central nervous system formation (GO:0021556)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
central nervous system morphogenesis (GO:0021551)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
carnitine metabolic process, CoA-linked (GO:0019254)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
medulla oblongata development (GO:0021550)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
carbohydrate homeostasis (GO:0033500)	47	1	.91	+	1.09	6.04E-01	1.00E00
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287)	12	1	.23	+	4.28	2.22E-01	1.00E00
cilium-dependent cell motility (GO:0060285)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of oocyte development (GO:0060283)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
female gamete generation (GO:0007292)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
positive regulation of oocyte development (GO:0060282)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by vasopressin (GO:0001992)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of oocyte development (GO:0060281)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by hormone (GO:0001990)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
subpallium development (GO:0021544)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pallium development (GO:0021543)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
methylglyoxal biosynthetic process (GO:0019242)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
citrulline biosynthetic process (GO:0019240)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex III assembly (GO:0017062)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901296)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleoside phosphate biosynthetic process (GO:1901293)	163	3	3.17	-	.95	1.00E00	1.00E00
nucleoside phosphate catabolic process (GO:1901292)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
spermatid nucleus differentiation (GO:0007289)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sperm axoneme assembly (GO:0007288)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
spermatid development (GO:0007286)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
spermatogenesis (GO:0007283)	55	1	1.07	-	.93	1.00E00	1.00E00
embryonic skeletal joint morphogenesis (GO:0060272)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
germ cell development (GO:0007281)	56	1	1.09	-	.92	1.00E00	1.00E00
subthalamus development (GO:0021539)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cilium assembly (GO:0060271)	200	6	3.89	+	1.54	2.96E-01	1.00E00
cell differentiation in hindbrain (GO:0021533)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
response to pheromone (GO:0019236)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
spinal cord radial glial cell differentiation (GO:0021531)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, to, from or within Golgi (GO:0048199)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
spinal cord oligodendrocyte cell fate specification (GO:0021530)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sensory perception of pain (GO:0019233)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle budding (GO:0048194)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle transport (GO:0048193)	152	1	2.96	-	.34	3.77E-01	1.00E00
Okazaki fragment processing involved in mitotic DNA replication (GO:1903461)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
7-methylguanosine RNA capping (GO:0009452)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
RNA modification (GO:0009451)	91	0	1.77	-	 < 0.01	4.24E-01	1.00E00
gamma-aminobutyric acid catabolic process (GO:0009450)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
renal system process involved in regulation of blood volume (GO:0001977)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
gamete generation (GO:0007276)	118	3	2.30	+	1.31	5.04E-01	1.00E00
response to amphetamine (GO:0001975)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuromuscular synaptic transmission (GO:0007274)	24	1	.47	+	2.14	3.82E-01	1.00E00
adenosine receptor signaling pathway (GO:0001973)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ensheathment of neurons (GO:0007272)	51	2	.99	+	2.02	2.68E-01	1.00E00
negative regulation of N-terminal protein palmitoylation (GO:0060262)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, cholinergic (GO:0007271)	25	1	.49	+	2.06	3.94E-01	1.00E00
spinal cord oligodendrocyte cell differentiation (GO:0021529)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
neuron-neuron synaptic transmission (GO:0007270)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of vasoconstriction (GO:0019229)	22	1	.43	+	2.34	3.58E-01	1.00E00
neuronal action potential (GO:0019228)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
somatic motor neuron differentiation (GO:0021523)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
transmission of nerve impulse (GO:0019226)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
lactate catabolic process (GO:1903457)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
arachidonic acid secretion (GO:0050482)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
cytokine-mediated signaling pathway (GO:0019221)	128	0	2.49	-	 < 0.01	1.83E-01	1.00E00
amide transport (GO:0042886)	745	10	14.49	-	.69	2.79E-01	1.00E00
regulation of phosphate metabolic process (GO:0019220)	526	14	10.23	+	1.37	2.61E-01	1.00E00
gamma-aminobutyric acid biosynthetic process (GO:0009449)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid metabolic process (GO:0009448)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process (GO:0009446)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
putrescine metabolic process (GO:0009445)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pyridoxal 5'-phosphate salvage (GO:0009443)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neurotransmitter secretion (GO:0007269)	61	0	1.19	-	 < 0.01	6.33E-01	1.00E00
regulation of feeding behavior (GO:0060259)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
glycolate metabolic process (GO:0009441)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling (GO:0007267)	505	12	9.83	+	1.22	5.12E-01	1.00E00
Rho protein signal transduction (GO:0007266)	79	1	1.54	-	.65	1.00E00	1.00E00
thigmotaxis (GO:0001966)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
Ras protein signal transduction (GO:0007265)	194	1	3.77	-	.26	1.92E-01	1.00E00
small GTPase mediated signal transduction (GO:0007264)	252	2	4.90	-	.41	2.49E-01	1.00E00
regulation of N-terminal protein palmitoylation (GO:0060254)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
startle response (GO:0001964)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
nitric oxide mediated signal transduction (GO:0007263)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell proliferation (GO:0060253)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, dopaminergic (GO:0001963)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell proliferation (GO:0060252)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell proliferation (GO:0060251)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokine-mediated signaling pathway (GO:0001960)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cyclic purine nucleotide metabolic process (GO:0052652)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of steroid metabolic process (GO:0019218)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
monoacylglycerol catabolic process (GO:0052651)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid metabolic process (GO:0019217)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of lipid metabolic process (GO:0019216)	60	1	1.17	-	.86	1.00E00	1.00E00
androst-4-ene-3,17-dione biosynthetic process (GO:1903449)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein import (GO:0017038)	75	3	1.46	+	2.06	1.87E-01	1.00E00
protein transport from ciliary membrane to plasma membrane (GO:1903445)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of short-term neuronal synaptic plasticity (GO:0048172)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to ciliary membrane (GO:1903441)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
methylglyoxal metabolic process (GO:0009438)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
carnitine metabolic process (GO:0009437)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
glyoxylate catabolic process (GO:0009436)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
NAD biosynthetic process (GO:0009435)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
carbohydrate derivative transport (GO:1901264)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
receptor signaling pathway via JAK-STAT (GO:0007259)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of cytokine-mediated signaling pathway (GO:0001959)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
endochondral ossification (GO:0001958)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
activation of JUN kinase activity (GO:0007257)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
intramembranous ossification (GO:0001957)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
blood vessel maturation (GO:0001955)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
JNK cascade (GO:0007254)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-matrix adhesion (GO:0001953)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
I-kappaB phosphorylation (GO:0007252)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
contact inhibition (GO:0060242)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
roof plate formation (GO:0021509)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
alditol phosphate metabolic process (GO:0052646)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
activation of NF-kappaB-inducing kinase activity (GO:0007250)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
prechordal plate formation (GO:0021501)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of neuronal synaptic plasticity (GO:0048168)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
antisense RNA metabolic process (GO:0042868)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic plasticity (GO:0048167)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
pyruvate biosynthetic process (GO:0042866)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of TORC1 signaling (GO:1903432)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell maturation (GO:1903430)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
I-kappaB kinase/NF-kappaB signaling (GO:0007249)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle organization (GO:0060236)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
lymphangiogenesis (GO:0001946)	37	1	.72	+	1.39	5.19E-01	1.00E00
lymph vessel development (GO:0001945)	55	1	1.07	-	.93	1.00E00	1.00E00
neuroblast delamination (GO:0060234)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vasculature development (GO:0001944)	393	9	7.65	+	1.18	5.79E-01	1.00E00
delamination (GO:0060232)	14	1	.27	+	3.67	2.51E-01	1.00E00
mesenchymal to epithelial transition (GO:0060231)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
postsynaptic membrane organization (GO:0001941)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of presynapse assembly (GO:1905606)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of cell maturation (GO:1903429)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of reactive oxygen species biosynthetic process (GO:1903428)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of reactive oxygen species biosynthetic process (GO:1903427)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of reactive oxygen species biosynthetic process (GO:1903426)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	19	1	.37	+	2.71	3.20E-01	1.00E00
regulation of synaptic vesicle recycling (GO:1903421)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to light stimulus (GO:0009416)	125	3	2.43	+	1.23	7.38E-01	1.00E00
response to UV (GO:0009411)	18	1	.35	+	2.86	3.07E-01	1.00E00
positive regulation of endothelial cell proliferation (GO:0001938)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
response to xenobiotic stimulus (GO:0009410)	93	1	1.81	-	.55	1.00E00	1.00E00
negative regulation of endothelial cell proliferation (GO:0001937)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell proliferation (GO:0001936)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
endothelial cell proliferation (GO:0001935)	15	1	.29	+	3.43	2.65E-01	1.00E00
positive regulation of protein phosphorylation (GO:0001934)	301	6	5.86	+	1.02	8.34E-01	1.00E00
negative regulation of protein phosphorylation (GO:0001933)	57	0	1.11	-	 < 0.01	6.30E-01	1.00E00
regulation of protein phosphorylation (GO:0001932)	422	9	8.21	+	1.10	7.21E-01	1.00E00
retinal rod cell differentiation (GO:0060221)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
camera-type eye photoreceptor cell fate commitment (GO:0060220)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
behavioral response to ethanol (GO:0048149)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
behavioral response to cocaine (GO:0048148)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
protein-tetrapyrrole linkage (GO:0017006)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
response to cold (GO:0009409)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
cytochrome complex assembly (GO:0017004)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
response to heat (GO:0009408)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
protein-heme linkage (GO:0017003)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
toxin catabolic process (GO:0009407)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antibiotic catabolic process (GO:0017001)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
antibiotic biosynthetic process (GO:0017000)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of convergent extension involved in axis elongation (GO:1901232)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
integrin-mediated signaling pathway (GO:0007229)	52	1	1.01	-	.99	1.00E00	1.00E00
positive regulation of hh target transcription factor activity (GO:0007228)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell differentiation (GO:0060218)	41	2	.80	+	2.51	1.98E-01	1.00E00
signal transduction downstream of smoothened (GO:0007227)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hemangioblast cell differentiation (GO:0060217)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell proliferation (GO:0030889)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endocardium formation (GO:0060214)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway, calcium modulating pathway (GO:0007223)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of B cell proliferation (GO:0030888)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription of Notch receptor target (GO:0007221)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor recycling (GO:0001921)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Notch receptor processing (GO:0007220)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
amyloid-beta metabolic process (GO:0050435)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
reactive oxygen species biosynthetic process (GO:1903409)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of catecholamine secretion (GO:0050433)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
catecholamine secretion (GO:0050432)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
defense response to protozoan (GO:0042832)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-arginine transmembrane transport (GO:1903400)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of NIK/NF-kappaB signaling (GO:1901224)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of NIK/NF-kappaB signaling (GO:1901222)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
neuropeptide signaling pathway (GO:0007218)	82	0	1.60	-	 < 0.01	4.12E-01	1.00E00
tachykinin receptor signaling pathway (GO:0007217)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
G protein-coupled glutamate receptor signaling pathway (GO:0007216)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
glutamate receptor signaling pathway (GO:0007215)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid signaling pathway (GO:0007214)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
dopamine receptor signaling pathway (GO:0007212)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte mediated cytotoxicity (GO:0001912)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
serotonin receptor signaling pathway (GO:0007210)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte mediated cytotoxicity (GO:0001910)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum tubular network maintenance (GO:0071788)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate biosynthetic process (GO:0042823)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum tubular network formation (GO:0071787)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac chamber morphogenesis (GO:1901219)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate metabolic process (GO:0042822)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum tubular network organization (GO:0071786)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron death (GO:1901216)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron death (GO:1901215)	21	1	.41	+	2.45	3.46E-01	1.00E00
regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
leukocyte mediated cytotoxicity (GO:0001909)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac chamber formation (GO:1901210)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
killing by symbiont of host cells (GO:0001907)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell killing (GO:0001906)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytosolic calcium ion concentration (GO:0007204)	151	4	2.94	+	1.36	5.45E-01	1.00E00
activation of phospholipase C activity (GO:0007202)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	91	3	1.77	+	1.69	2.67E-01	1.00E00
cortical cytoskeleton organization (GO:0030865)	58	2	1.13	+	1.77	3.18E-01	1.00E00
regulation of polarized epithelial cell differentiation (GO:0030860)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vitamin B6 biosynthetic process (GO:0042819)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
vitamin B6 metabolic process (GO:0042816)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of heart looping (GO:1901207)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to BMP stimulus (GO:0071773)	55	2	1.07	+	1.87	2.97E-01	1.00E00
response to BMP (GO:0071772)	55	2	1.07	+	1.87	2.97E-01	1.00E00
positive regulation of extracellular matrix assembly (GO:1901203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix assembly (GO:1901201)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
inner dynein arm assembly (GO:0036159)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
polarized epithelial cell differentiation (GO:0030859)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
outer dynein arm assembly (GO:0036158)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell differentiation (GO:0030858)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell differentiation (GO:0030857)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell differentiation (GO:0030856)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte differentiation (GO:0030854)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulocyte differentiation (GO:0030853)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of granulocyte differentiation (GO:0030852)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
granulocyte differentiation (GO:0030851)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
prostate gland development (GO:0030850)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
somatic stem cell division (GO:0048103)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nuclear membrane organization (GO:0071763)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein arginylation (GO:0016598)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol acyl-chain remodeling (GO:0036149)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
meiosis I cell cycle process (GO:0061982)	52	2	1.01	+	1.98	2.76E-01	1.00E00
positive regulation of intermediate filament depolymerization (GO:0030844)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intermediate filament depolymerization (GO:0030842)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine hydroxylation (GO:0036138)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament polymerization (GO:0030838)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
negative regulation of actin filament polymerization (GO:0030837)	42	1	.82	+	1.22	5.64E-01	1.00E00
positive regulation of actin filament depolymerization (GO:0030836)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
Schwann cell migration (GO:0036135)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane bone morphogenesis (GO:0061973)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin filament depolymerization (GO:0030835)	26	1	.51	+	1.98	4.06E-01	1.00E00
dermal bone morphogenesis (GO:0061972)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament depolymerization (GO:0030834)	28	1	.54	+	1.84	4.28E-01	1.00E00
regulation of actin filament polymerization (GO:0030833)	115	1	2.24	-	.45	7.29E-01	1.00E00
regulation of actin filament length (GO:0030832)	117	1	2.28	-	.44	7.30E-01	1.00E00
protein deubiquitination (GO:0016579)	84	3	1.63	+	1.84	2.31E-01	1.00E00
histone deubiquitination (GO:0016578)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in mitotic DNA replication (GO:1902983)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone deacetylation (GO:0016575)	24	1	.47	+	2.14	3.82E-01	1.00E00
histone phosphorylation (GO:0016572)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histone methylation (GO:0016571)	38	2	.74	+	2.71	1.77E-01	1.00E00
establishment of left/right asymmetry (GO:0061966)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
polyphosphate catabolic process (GO:0006798)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
polyphosphate metabolic process (GO:0006797)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
phosphate-containing compound metabolic process (GO:0006796)	1652	34	32.14	+	1.06	7.12E-01	1.00E00
phosphorus metabolic process (GO:0006793)	1667	34	32.43	+	1.05	7.82E-01	1.00E00
sulfur compound metabolic process (GO:0006790)	154	1	3.00	-	.33	3.77E-01	1.00E00
mitotic DNA replication termination (GO:1902979)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication preinitiation complex assembly (GO:1902977)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication initiation (GO:1902975)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
response to (R)-carnitine (GO:0061959)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, docking (GO:0016560)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to plasma membrane (GO:0061951)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
heme a biosynthetic process (GO:0006784)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide biosynthetic process (GO:0030810)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
heme biosynthetic process (GO:0006783)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
protoporphyrinogen IX biosynthetic process (GO:0006782)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
uroporphyrinogen III biosynthetic process (GO:0006780)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication (GO:1902969)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
peroxisome fission (GO:0016559)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix (GO:0016558)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
mRNA modification (GO:0016556)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cytidine to uridine editing (GO:0016554)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
base conversion or substitution editing (GO:0016553)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide biosynthetic process (GO:0030808)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound biosynthetic process (GO:0006779)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound metabolic process (GO:0006778)	26	1	.51	+	1.98	4.06E-01	1.00E00
Mo-molybdopterin cofactor biosynthetic process (GO:0006777)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
vitamin A metabolic process (GO:0006776)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin metabolic process (GO:0006775)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
thiamine metabolic process (GO:0006772)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
riboflavin metabolic process (GO:0006771)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
icosanoid transport (GO:0071715)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
ER-associated misfolded protein catabolic process (GO:0071712)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
basement membrane organization (GO:0071711)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
protein autoprocessing (GO:0016540)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
water-soluble vitamin metabolic process (GO:0006767)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
vitamin metabolic process (GO:0006766)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound metabolic process (GO:0006760)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
membrane assembly (GO:0071709)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
immunoglobulin heavy chain V-D-J recombination (GO:0071707)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tumor necrosis factor superfamily cytokine production (GO:0071706)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to early endosome (GO:1902946)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell maintenance (GO:0045494)	14	1	.27	+	3.67	2.51E-01	1.00E00
ATP generation from ADP (GO:0006757)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
ATP biosynthetic process (GO:0006754)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
nucleoside phosphate metabolic process (GO:0006753)	256	3	4.98	-	.60	4.96E-01	1.00E00
glutathione catabolic process (GO:0006751)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
glutathione biosynthetic process (GO:0006750)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of angiogenesis (GO:0016525)	22	1	.43	+	2.34	3.58E-01	1.00E00
positive regulation of alcohol biosynthetic process (GO:1902932)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of alcohol biosynthetic process (GO:1902930)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutathione metabolic process (GO:0006749)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
selective autophagy (GO:0061912)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
FAD biosynthetic process (GO:0006747)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
autophagosome-endosome fusion (GO:0061910)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ubiquinone biosynthetic process (GO:0006744)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
ubiquinone metabolic process (GO:0006743)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
NADP catabolic process (GO:0006742)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
NADP biosynthetic process (GO:0006741)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
NADPH regeneration (GO:0006740)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
immunoglobulin production involved in immunoglobulin mediated immune response (GO:0002381)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
autophagosome-lysosome fusion (GO:0061909)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vascular endothelial growth factor signaling pathway (GO:1900746)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
locomotor rhythm (GO:0045475)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of p38MAPK cascade (GO:1900745)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of p38MAPK cascade (GO:1900744)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
stress response to cadmium ion (GO:1990170)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
NADP metabolic process (GO:0006739)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
response to ethanol (GO:0045471)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
apical junction assembly (GO:0043297)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
glial cell activation (GO:0061900)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
NADH regeneration (GO:0006735)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
NADH metabolic process (GO:0006734)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
oxidoreduction coenzyme metabolic process (GO:0006733)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
coenzyme metabolic process (GO:0006732)	134	0	2.61	-	 < 0.01	1.89E-01	1.00E00
mitophagy by induced vacuole formation (GO:0035695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
one-carbon metabolic process (GO:0006730)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
mitochondrial protein catabolic process (GO:0035694)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to drug (GO:0035690)	58	0	1.13	-	 < 0.01	6.31E-01	1.00E00
immunoglobulin production (GO:0002377)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
immune system process (GO:0002376)	912	18	17.74	+	1.01	9.03E-01	1.00E00
negative regulation of protein polyubiquitination (GO:1902915)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of protein polyubiquitination (GO:1902914)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tetrahydrobiopterin biosynthetic process (GO:0006729)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
pharyngeal muscle development (GO:0043282)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
triterpenoid metabolic process (GO:0006722)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
terpenoid metabolic process (GO:0006721)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
isoprenoid metabolic process (GO:0006720)	48	0	.93	-	 < 0.01	1.00E00	1.00E00
leukocyte activation involved in immune response (GO:0002366)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of melanosome transport (GO:1902908)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell lineage commitment (GO:0002363)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of supramolecular fiber organization (GO:1902905)	79	0	1.54	-	 < 0.01	4.09E-01	1.00E00
negative regulation of supramolecular fiber organization (GO:1902904)	53	2	1.03	+	1.94	2.83E-01	1.00E00
inactivation of MAPK activity (GO:0000188)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of supramolecular fiber organization (GO:1902903)	153	2	2.98	-	.67	1.00E00	1.00E00
activation of MAPK activity (GO:0000187)	32	1	.62	+	1.61	4.71E-01	1.00E00
T cell lineage commitment (GO:0002360)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagosome assembly (GO:1902902)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
activation of MAPKK activity (GO:0000186)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
activation of MAPKKK activity (GO:0000185)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	17	1	.33	+	3.02	2.93E-01	1.00E00
chromatin silencing at rDNA (GO:0000183)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cell redox homeostasis (GO:0045454)	53	0	1.03	-	 < 0.01	6.28E-01	1.00E00
response to alkaloid (GO:0043279)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of biological quality (GO:0065008)	1680	37	32.69	+	1.13	4.10E-01	1.00E00
apoptotic cell clearance (GO:0043277)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex assembly (GO:0065005)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
neuromast hair cell morphogenesis (GO:0035678)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intracellular protein transmembrane transport (GO:0065002)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
anterior lateral line neuromast hair cell development (GO:0035676)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of ion transport (GO:0043271)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
specification of axis polarity (GO:0065001)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of ion transport (GO:0043270)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid transmembrane transport (GO:0035674)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
galactose catabolic process via UDP-galactose (GO:0033499)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process via lathosterol (GO:0033490)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myoblast differentiation (GO:0045445)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
fat cell differentiation (GO:0045444)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion transport (GO:0043268)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of potassium ion transport (GO:0043267)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cholesterol catabolic process (GO:0006707)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of potassium ion transport (GO:0043266)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
steroid catabolic process (GO:0006706)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
glucocorticoid biosynthetic process (GO:0006704)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
estrogen biosynthetic process (GO:0006703)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
C21-steroid hormone biosynthetic process (GO:0006700)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process via 24,25-dihydrolanosterol (GO:0033488)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuron projection extension (GO:1990138)	41	2	.80	+	2.51	1.98E-01	1.00E00
MAPK cascade (GO:0000165)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
phosphorelay signal transduction system (GO:0000160)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of carbohydrate biosynthetic process (GO:0043255)	11	1	.21	+	4.67	2.06E-01	1.00E00
regulation of protein complex assembly (GO:0043254)	148	1	2.88	-	.35	5.37E-01	1.00E00
sodium-independent organic anion transport (GO:0043252)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
S-methylmethionine metabolic process (GO:0033477)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
replication fork processing (GO:0031297)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
pre-B cell allelic exclusion (GO:0002331)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell costimulation (GO:0031295)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
retrograde transport, endosome to plasma membrane (GO:1990126)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
lymphocyte costimulation (GO:0031294)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitric oxide biosynthetic process (GO:0045429)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
membrane protein intracellular domain proteolysis (GO:0031293)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of nitric oxide biosynthetic process (GO:0045428)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
rRNA modification (GO:0000154)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
Ran protein signal transduction (GO:0031291)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
erythrocyte maturation (GO:0043249)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
proteasome assembly (GO:0043248)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
telomere maintenance in response to DNA damage (GO:0043247)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein complex disassembly (GO:0043244)	54	2	1.05	+	1.90	2.90E-01	1.00E00
positive regulation of protein complex disassembly (GO:0043243)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein complex disassembly (GO:0043242)	37	2	.72	+	2.78	1.70E-01	1.00E00
pre-B cell differentiation (GO:0002329)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
immature B cell differentiation (GO:0002327)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
actin cortical patch assembly (GO:0000147)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
lymphoid progenitor cell differentiation (GO:0002320)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of guanylate cyclase activity (GO:0031284)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of guanylate cyclase activity (GO:0031282)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclase activity (GO:0031281)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-8 biosynthetic process (GO:0045416)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclase activity (GO:0031280)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-8 biosynthetic process (GO:0045414)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
multicellular organismal signaling (GO:0035637)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
proximal/distal pattern formation involved in pronephric nephron development (GO:0072196)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of permeability of blood-brain barrier (GO:0035633)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cyclase activity (GO:0031279)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
protein linear deubiquitination (GO:1990108)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
B cell activation involved in immune response (GO:0002312)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of pseudopodium assembly (GO:0031274)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of pseudopodium assembly (GO:0031272)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
establishment of mitotic spindle orientation (GO:0000132)	15	1	.29	+	3.43	2.65E-01	1.00E00
ceramide transport (GO:0035627)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of nephron tubule epithelial cell differentiation (GO:0072182)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intrahepatic bile duct development (GO:0035622)	11	1	.21	+	4.67	2.06E-01	1.00E00
ER to Golgi ceramide transport (GO:0035621)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
T cell proliferation involved in immune response (GO:0002309)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell differentiation involved in immune response (GO:0002302)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nephric duct morphogenesis (GO:0072178)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
stress granule disassembly (GO:0035617)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nephric duct development (GO:0072176)	19	1	.37	+	2.71	3.20E-01	1.00E00
nonribosomal peptide biosynthetic process (GO:0019184)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
fibronectin fibril organization (GO:1905590)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to external biotic stimulus (GO:0043207)	327	4	6.36	-	.63	5.39E-01	1.00E00
response to leucine (GO:0043201)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to amino acid (GO:0043200)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
mesonephric tubule development (GO:0072164)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesonephric epithelium development (GO:0072163)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein deacylation (GO:0035601)	31	1	.60	+	1.66	4.60E-01	1.00E00
nephron tubule epithelial cell differentiation (GO:0072160)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
FMN biosynthetic process (GO:0009398)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound catabolic process (GO:0009397)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound biosynthetic process (GO:0009396)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
phospholipid catabolic process (GO:0009395)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
2'-deoxyribonucleotide metabolic process (GO:0009394)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
sulfate assimilation (GO:0000103)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid transport (GO:0000101)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of adherens junction organization (GO:1903393)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of adherens junction organization (GO:1903392)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipase activity (GO:0060193)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipase activity (GO:0060192)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lipase activity (GO:0060191)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
glomerular visceral epithelial cell fate commitment (GO:0072149)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of homophilic cell adhesion (GO:1903385)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
auditory behavior (GO:0031223)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
retina homeostasis (GO:0001895)	19	1	.37	+	2.71	3.20E-01	1.00E00
negative regulation of adenylate cyclase activity (GO:0007194)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
apelin receptor signaling pathway (GO:0060183)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
activation of adenylate cyclase activity (GO:0007190)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
placenta development (GO:0001890)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mesenchyme morphogenesis (GO:0072132)	9	1	.18	+	5.71	1.75E-01	1.00E00
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	114	2	2.22	-	.90	1.00E00	1.00E00
male mating behavior (GO:0060179)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
liver development (GO:0001889)	120	3	2.33	+	1.28	5.10E-01	1.00E00
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	176	2	3.42	-	.58	7.79E-01	1.00E00
biomineral tissue development (GO:0031214)	22	1	.43	+	2.34	3.58E-01	1.00E00
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	225	2	4.38	-	.46	3.34E-01	1.00E00
selenium compound metabolic process (GO:0001887)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endothelial cell morphogenesis (GO:0001886)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endothelial cell development (GO:0001885)	20	1	.39	+	2.57	3.33E-01	1.00E00
limb bud formation (GO:0060174)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
limb development (GO:0060173)	11	1	.21	+	4.67	2.06E-01	1.00E00
receptor recycling (GO:0001881)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
tRNA transcription by RNA polymerase III (GO:0042797)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chromatin-mediated maintenance of transcription (GO:0048096)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
snRNA transcription by RNA polymerase III (GO:0042796)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
snRNA transcription by RNA polymerase II (GO:0042795)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of fear response (GO:1903365)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular protein catabolic process (GO:1903364)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
regulation of cellular protein catabolic process (GO:1903362)	45	1	.88	+	1.14	5.88E-01	1.00E00
5S class rRNA transcription by RNA polymerase III (GO:0042791)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein localization to basolateral plasma membrane (GO:1903361)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of ephrin receptor signaling pathway (GO:1901187)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERBB signaling pathway (GO:1901186)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of ERBB signaling pathway (GO:1901185)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of ERBB signaling pathway (GO:1901184)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta receptor signaling pathway (GO:0007179)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
posttranslational protein targeting to membrane, translocation (GO:0031204)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to yeast (GO:0001878)	23	1	.45	+	2.23	3.70E-01	1.00E00
regulation of epidermal growth factor-activated receptor activity (GO:0007176)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
epidermal growth factor receptor signaling pathway (GO:0007173)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
signal complex assembly (GO:0007172)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pronephros formation (GO:0072116)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mRNA transcription by RNA polymerase II (GO:0042789)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pronephros morphogenesis (GO:0072114)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi organization (GO:1903358)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-ornithine transmembrane transport (GO:1903352)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to dopamine (GO:1903351)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-end processing (GO:0042780)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to dopamine (GO:1903350)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
receptor guanylyl cyclase signaling pathway (GO:0007168)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
complement activation, lectin pathway (GO:0001867)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
signal transduction (GO:0007165)	3369	62	65.55	-	.95	6.86E-01	1.00E00
establishment or maintenance of cell polarity (GO:0007163)	117	3	2.28	+	1.32	5.01E-01	1.00E00
negative regulation of cell adhesion (GO:0007162)	67	2	1.30	+	1.53	3.80E-01	1.00E00
cell-matrix adhesion (GO:0007160)	49	0	.95	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-trailer cleavage (GO:0042779)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
glomerular capillary formation (GO:0072104)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage migration (GO:1905522)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glomerulus vasculature morphogenesis (GO:0072103)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage migration (GO:1905521)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of compound eye pigmentation (GO:0048076)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glomerulus morphogenesis (GO:0072102)	15	1	.29	+	3.43	2.65E-01	1.00E00
mitochondrial ATP synthesis coupled proton transport (GO:0042776)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	41	0	.80	-	 < 0.01	1.00E00	1.00E00
regulation of eye pigmentation (GO:0048073)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ATP synthesis coupled electron transport (GO:0042773)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction resulting in transcription (GO:0042772)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
signal transduction in response to DNA damage (GO:0042770)	11	1	.21	+	4.67	2.06E-01	1.00E00
neural crest cell migration involved in autonomic nervous system development (GO:1901166)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of trophoblast cell migration (GO:1901165)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of trophoblast cell migration (GO:1901163)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of posttranscriptional gene silencing (GO:0060149)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
primary amino compound biosynthetic process (GO:1901162)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
neuron cell-cell adhesion (GO:0007158)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of posttranscriptional gene silencing (GO:0060148)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
regulation of posttranscriptional gene silencing (GO:0060147)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
primary amino compound metabolic process (GO:1901160)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	154	2	3.00	-	.67	7.73E-01	1.00E00
cell adhesion (GO:0007155)	449	6	8.74	-	.69	4.86E-01	1.00E00
cell communication (GO:0007154)	3640	65	70.82	-	.92	5.13E-01	1.00E00
regulation of endopeptidase activity (GO:0052548)	92	3	1.79	+	1.68	4.32E-01	1.00E00
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of peptidase activity (GO:0052547)	96	3	1.87	+	1.61	4.41E-01	1.00E00
regulation of syncytium formation by plasma membrane fusion (GO:0060142)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
macrophage migration (GO:1905517)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of fertilization (GO:1905516)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
non-motile cilium assembly (GO:1905515)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
eye pigmentation (GO:0048069)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA damage response, detection of DNA damage (GO:0042769)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein folding (GO:1903334)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of protein folding (GO:1903332)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid biosynthetic process (GO:0042761)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid catabolic process (GO:0042760)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribonucleoprotein complex disassembly (GO:0032988)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process by virus (GO:0060139)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
female meiosis II (GO:0007147)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phagolysosome assembly (GO:0001845)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
female meiosis I (GO:0007144)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
female meiotic nuclear division (GO:0007143)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex I assembly (GO:0032981)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
neural tube closure (GO:0001843)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
male meiosis I (GO:0007141)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
male meiotic nuclear division (GO:0007140)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule organizing center (GO:1905508)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of motile cilium assembly (GO:1905505)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of motile cilium assembly (GO:1905503)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid biosynthetic process (GO:0042759)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid catabolic process (GO:0042758)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
drinking behavior (GO:0042756)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
eating behavior (GO:0042755)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian rhythm (GO:0042754)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of circadian rhythm (GO:0042753)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of inner ear receptor cell differentiation (GO:2000980)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of circadian rhythm (GO:0042752)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
post-embryonic eye morphogenesis (GO:0048050)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
response to radiation (GO:0009314)	161	3	3.13	-	.96	1.00E00	1.00E00
protein insertion into mitochondrial inner membrane from matrix (GO:0032979)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
oligosaccharide catabolic process (GO:0009313)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
protein insertion into membrane from inner side (GO:0032978)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
oligosaccharide biosynthetic process (GO:0009312)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
oligosaccharide metabolic process (GO:0009311)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
amine catabolic process (GO:0009310)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
release of cytochrome c from mitochondria (GO:0001836)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
female germ-line stem cell population maintenance (GO:0036099)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth hormone secretion (GO:0060124)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of growth hormone secretion (GO:0060123)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament-based process (GO:0032970)	194	3	3.77	-	.79	1.00E00	1.00E00
inner ear receptor cell stereocilium organization (GO:0060122)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell stereocilium organization (GO:0060121)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptonemal complex assembly (GO:0007130)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
germ cell proliferation (GO:0036093)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)	10	1	.19	+	5.14	1.91E-01	1.00E00
regulation of circadian sleep/wake cycle (GO:0042749)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein maturation (GO:1903319)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of pro-B cell differentiation (GO:2000975)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein maturation (GO:1903318)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of protein maturation (GO:1903317)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle, wakefulness (GO:0042746)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pro-B cell differentiation (GO:2000973)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle (GO:0042745)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide catabolic process (GO:0042744)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide metabolic process (GO:0042743)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
amine biosynthetic process (GO:0009309)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
defense response to bacterium (GO:0042742)	110	2	2.14	-	.93	1.00E00	1.00E00
negative regulation of mRNA metabolic process (GO:1903312)	20	1	.39	+	2.57	3.33E-01	1.00E00
amine metabolic process (GO:0009308)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
carbohydrate derivative biosynthetic process (GO:1901137)	403	6	7.84	-	.77	7.13E-01	1.00E00
protein secretion (GO:0009306)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
carbohydrate derivative catabolic process (GO:1901136)	80	0	1.56	-	 < 0.01	4.10E-01	1.00E00
carbohydrate derivative metabolic process (GO:1901135)	626	7	12.18	-	.57	1.82E-01	1.00E00
tRNA transcription (GO:0009304)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
rRNA transcription (GO:0009303)	9	1	.18	+	5.71	1.75E-01	1.00E00
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968)	13	1	.25	+	3.95	2.36E-01	1.00E00
synapsis (GO:0007129)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
snRNA transcription (GO:0009301)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell development (GO:0060118)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
meiosis I (GO:0007127)	47	2	.91	+	2.19	2.40E-01	1.00E00
regulation of collagen biosynthetic process (GO:0032965)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell development (GO:0060117)	9	1	.18	+	5.71	1.75E-01	1.00E00
collagen biosynthetic process (GO:0032964)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell morphogenesis (GO:0060116)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
collagen metabolic process (GO:0032963)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
D-serine catabolic process (GO:0036088)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell differentiation (GO:0060114)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mesonephros development (GO:0001823)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GDP-fucose import into Golgi lumen (GO:0036085)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
exogenous drug catabolic process (GO:0042738)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
drug catabolic process (GO:0042737)	95	0	1.85	-	 < 0.01	2.68E-01	1.00E00
positive regulation of regulated secretory pathway (GO:1903307)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of regulated secretory pathway (GO:1903306)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
heme O biosynthetic process (GO:0048034)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of regulated secretory pathway (GO:1903305)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
heme o metabolic process (GO:0048033)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
olfactory placode development (GO:0071698)	11	1	.21	+	4.67	2.06E-01	1.00E00
D-xylose metabolic process (GO:0042732)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fibrinolysis (GO:0042730)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in extracellular region (GO:0071694)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of hexokinase activity (GO:1903300)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to extracellular region (GO:0071692)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
inositol trisphosphate biosynthetic process (GO:0032959)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
cardiac muscle thin filament assembly (GO:0071691)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
inositol phosphate biosynthetic process (GO:0032958)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
cardiac muscle myosin thick filament assembly (GO:0071690)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inositol trisphosphate metabolic process (GO:0032957)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytokine production (GO:0001819)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
regulation of actin cytoskeleton organization (GO:0032956)	191	3	3.72	-	.81	1.00E00	1.00E00
negative regulation of cytokine production (GO:0001818)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
regulation of cytokine production (GO:0001817)	88	0	1.71	-	 < 0.01	4.19E-01	1.00E00
cytokine production (GO:0001816)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
ligamentous ossification (GO:0036076)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
replacement ossification (GO:0036075)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of phagocytosis, engulfment (GO:0060100)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
perichondral ossification (GO:0036073)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
direct ossification (GO:0036072)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
N-glycan fucosylation (GO:0036071)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
flavin-containing compound biosynthetic process (GO:0042727)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA splicing, via spliceosome (GO:0048026)	10	1	.19	+	5.14	1.91E-01	1.00E00
flavin-containing compound metabolic process (GO:0042726)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA splicing, via spliceosome (GO:0048025)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
striated muscle myosin thick filament assembly (GO:0071688)	11	1	.21	+	4.67	2.06E-01	1.00E00
thiamine-containing compound metabolic process (GO:0042723)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of mononuclear cell proliferation (GO:0032946)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of mononuclear cell proliferation (GO:0032945)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of mononuclear cell proliferation (GO:0032944)	34	1	.66	+	1.51	4.91E-01	1.00E00
mononuclear cell proliferation (GO:0032943)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
secretion by tissue (GO:0032941)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
fucosylation (GO:0036065)	23	1	.45	+	2.23	3.70E-01	1.00E00
slit diaphragm assembly (GO:0036060)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
inositol lipid-mediated signaling (GO:0048017)	37	1	.72	+	1.39	5.19E-01	1.00E00
inositol phosphate-mediated signaling (GO:0048016)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol-mediated signaling (GO:0048015)	34	1	.66	+	1.51	4.91E-01	1.00E00
Tie signaling pathway (GO:0048014)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ephrin receptor signaling pathway (GO:0048013)	16	1	.31	+	3.21	2.79E-01	1.00E00
neurotrophin TRK receptor signaling pathway (GO:0048011)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
mononuclear cell migration (GO:0071674)	37	0	.72	-	 < 0.01	1.00E00	1.00E00
SREBP signaling pathway (GO:0032933)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
filtration diaphragm assembly (GO:0036058)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
insulin-like growth factor receptor signaling pathway (GO:0048009)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
platelet-derived growth factor receptor signaling pathway (GO:0048008)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
eye photoreceptor cell fate commitment (GO:0042706)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen (GO:0048002)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
luteinizing hormone signaling pathway (GO:0042700)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of activin receptor signaling pathway (GO:0032926)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of activin receptor signaling pathway (GO:0032925)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
circadian regulation of gene expression (GO:0032922)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
spermidine acetylation (GO:0032918)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptide hormone processing (GO:0016486)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
polyamine acetylation (GO:0032917)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein processing (GO:0016485)	60	1	1.17	-	.86	1.00E00	1.00E00
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytosolic transport (GO:0016482)	53	0	1.03	-	 < 0.01	6.28E-01	1.00E00
negative regulation of transcription by RNA polymerase III (GO:0016480)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell activation (GO:0036037)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to oxidative stress (GO:1902883)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta1 production (GO:0032905)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of response to oxidative stress (GO:1902882)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
TORC2 signaling (GO:0038203)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
TORC1 signaling (GO:0038202)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ovulation (GO:0030728)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
bile acid biosynthetic process (GO:0006699)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ergosterol biosynthetic process (GO:0006696)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process (GO:0006695)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
steroid biosynthetic process (GO:0006694)	54	1	1.05	-	.95	1.00E00	1.00E00
prostaglandin metabolic process (GO:0006693)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
prostanoid metabolic process (GO:0006692)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
leukotriene metabolic process (GO:0006691)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
icosanoid metabolic process (GO:0006690)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
optomotor response (GO:0071632)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of amacrine cell differentiation (GO:1902871)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
P granule organization (GO:0030719)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
germ-line stem cell population maintenance (GO:0030718)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ganglioside catabolic process (GO:0006689)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
glycosphingolipid biosynthetic process (GO:0006688)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
glycosphingolipid metabolic process (GO:0006687)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
sphingomyelin biosynthetic process (GO:0006686)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
sphingomyelin catabolic process (GO:0006685)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein localization to endosome (GO:0036010)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
sphingomyelin metabolic process (GO:0006684)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
galactosylceramide catabolic process (GO:0006683)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
galactosylceramide metabolic process (GO:0006681)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
glucosylceramide catabolic process (GO:0006680)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte chemotaxis (GO:0071624)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of amacrine cell differentiation (GO:1902869)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of retina development in camera-type eye (GO:1902868)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
granulocyte chemotaxis (GO:0071621)	73	0	1.42	-	 < 0.01	6.52E-01	1.00E00
regulation of retina development in camera-type eye (GO:1902866)	10	1	.19	+	5.14	1.91E-01	1.00E00
ovarian follicle cell development (GO:0030707)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
glucosylceramide biosynthetic process (GO:0006679)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytoskeleton-dependent intracellular transport (GO:0030705)	82	3	1.60	+	1.88	2.21E-01	1.00E00
microtubule organizing center localization (GO:0061842)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
glucosylceramide metabolic process (GO:0006678)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
glycosylceramide metabolic process (GO:0006677)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
eggshell formation (GO:0030703)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ceramide metabolic process (GO:0006672)	47	0	.91	-	 < 0.01	1.00E00	1.00E00
phytosphingosine metabolic process (GO:0006671)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sphingosine metabolic process (GO:0006670)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
acyl-CoA biosynthetic process (GO:0071616)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
somatic recombination of immunoglobulin gene segments (GO:0016447)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of non-motile cilium assembly (GO:1902855)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
somatic hypermutation of immunoglobulin genes (GO:0016446)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immunoglobulins (GO:0016445)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
somatic cell DNA recombination (GO:0016444)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
3-keto-sphinganine metabolic process (GO:0006666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sphingolipid metabolic process (GO:0006665)	82	0	1.60	-	 < 0.01	4.12E-01	1.00E00
glycolipid metabolic process (GO:0006664)	59	1	1.15	-	.87	1.00E00	1.00E00
glycerol ether metabolic process (GO:0006662)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol biosynthetic process (GO:0006661)	38	2	.74	+	2.71	1.77E-01	1.00E00
phosphatidylserine catabolic process (GO:0006660)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta production (GO:0071604)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endothelial cell-cell adhesion (GO:0071603)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phytosphingosine biosynthetic process (GO:0071602)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcium-dependent self proteolysis (GO:1990092)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to nerve growth factor stimulus (GO:1990090)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine biosynthetic process (GO:0006659)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine metabolic process (GO:0006658)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
telomeric D-loop disassembly (GO:0061820)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phosphatidylcholine biosynthetic process (GO:0006656)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol biosynthetic process (GO:0006655)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphatidic acid biosynthetic process (GO:0006654)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
glycerophospholipid metabolic process (GO:0006650)	154	3	3.00	+	1.00	1.00E00	1.00E00
T-helper cell lineage commitment (GO:0002295)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell differentiation involved in immune response (GO:0002293)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to nerve growth factor (GO:1990089)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
T cell differentiation involved in immune response (GO:0002292)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum-plasma membrane tethering (GO:0061817)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine biosynthetic process (GO:0006646)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
phospholipid metabolic process (GO:0006644)	209	3	4.07	-	.74	8.02E-01	1.00E00
membrane lipid metabolic process (GO:0006643)	116	1	2.26	-	.44	7.30E-01	1.00E00
triglyceride mobilization (GO:0006642)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
triglyceride metabolic process (GO:0006641)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell activation involved in immune response (GO:0002287)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
T cell activation involved in immune response (GO:0002286)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
lymphocyte activation involved in immune response (GO:0002285)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
neutrophil activation involved in immune response (GO:0002283)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
macrophage activation involved in immune response (GO:0002281)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
monocyte activation involved in immune response (GO:0002280)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acylglycerol metabolic process (GO:0006639)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
neutral lipid metabolic process (GO:0006638)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
acyl-CoA metabolic process (GO:0006637)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
unsaturated fatty acid biosynthetic process (GO:0006636)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
fatty acid beta-oxidation (GO:0006635)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
fatty acid biosynthetic process (GO:0006633)	45	0	.88	-	 < 0.01	1.00E00	1.00E00
fatty acid metabolic process (GO:0006631)	115	0	2.24	-	 < 0.01	2.86E-01	1.00E00
establishment of protein localization to extracellular region (GO:0035592)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
basophil activation involved in immune response (GO:0002276)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myeloid cell activation involved in immune response (GO:0002275)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
myeloid leukocyte activation (GO:0002274)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid catabolic process (GO:0000098)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid biosynthetic process (GO:0000097)	12	1	.23	+	4.28	2.22E-01	1.00E00
sulfur amino acid metabolic process (GO:0000096)	20	1	.39	+	2.57	3.33E-01	1.00E00
positive regulation of skeletal muscle fiber differentiation (GO:1902811)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-13 biosynthetic process (GO:0045366)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein processing involved in protein targeting to mitochondrion (GO:0006627)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
protein targeting to mitochondrion (GO:0006626)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
protein targeting to peroxisome (GO:0006625)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
vacuolar protein processing (GO:0006624)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
G protein-coupled purinergic receptor signaling pathway (GO:0035588)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein targeting to vacuole (GO:0006623)	25	1	.49	+	2.06	3.94E-01	1.00E00
purinergic receptor signaling pathway (GO:0035587)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein retention in ER lumen (GO:0006621)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
calcium-mediated signaling using intracellular calcium source (GO:0035584)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sequestering of TGFbeta in extracellular matrix (GO:0035583)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sequestering of extracellular ligand from receptor (GO:0035581)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukocyte activation involved in inflammatory response (GO:0002269)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle fiber differentiation (GO:1902809)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell cycle G1/S phase transition (GO:1902808)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
endothelial cell activation involved in immune response (GO:0002264)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cell activation involved in immune response (GO:0002263)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
D-alanine catabolic process (GO:0055130)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of cell cycle G1/S phase transition (GO:1902806)	21	1	.41	+	2.45	3.46E-01	1.00E00
positive regulation of synaptic vesicle transport (GO:1902805)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lymphocyte homeostasis (GO:0002260)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-beta biosynthetic process (GO:0045359)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle transport (GO:1902803)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
G2/M transition of mitotic cell cycle (GO:0000086)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-beta biosynthetic process (GO:0045357)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitotic G1 phase (GO:0000080)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acetate ester biosynthetic process (GO:1900620)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
nucleoside salvage (GO:0043174)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
nucleotide salvage (GO:0043173)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
cotranslational protein targeting to membrane (GO:0006613)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
protein targeting to membrane (GO:0006612)	56	0	1.09	-	 < 0.01	6.29E-01	1.00E00
peptide catabolic process (GO:0043171)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
L-proline biosynthetic process (GO:0055129)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
immune effector process (GO:0002252)	122	0	2.37	-	 < 0.01	1.79E-01	1.00E00
adaptive immune response (GO:0002250)	61	0	1.19	-	 < 0.01	6.33E-01	1.00E00
positive regulation of MHC class II biosynthetic process (GO:0045348)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acetate ester metabolic process (GO:1900619)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of MHC class II biosynthetic process (GO:0045346)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of MHC class I biosynthetic process (GO:0045345)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of MHC class I biosynthetic process (GO:0045343)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomere trimming (GO:0090737)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA repair complex assembly (GO:0090735)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
NLS-bearing protein import into nucleus (GO:0006607)	9	1	.18	+	5.71	1.75E-01	1.00E00
protein targeting (GO:0006605)	132	1	2.57	-	.39	5.25E-01	1.00E00
phosphocreatine metabolic process (GO:0006603)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	208	5	4.05	+	1.24	6.09E-01	1.00E00
creatine biosynthetic process (GO:0006601)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
creatine metabolic process (GO:0006600)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
relaxation of cardiac muscle (GO:0055119)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from arginine (GO:0033388)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from ornithine (GO:0033387)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle contraction (GO:0055117)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
geranyl diphosphate biosynthetic process (GO:0033384)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
geranyl diphosphate metabolic process (GO:0033383)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
epiboly involved in gastrulation with mouth forming second (GO:0055113)	41	0	.80	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate metabolic process (GO:0045338)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate biosynthetic process (GO:0045337)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular respiration (GO:0045333)	78	0	1.52	-	 < 0.01	4.09E-01	1.00E00
phospholipid translocation (GO:0045332)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
entrainment of circadian clock by photoperiod (GO:0043153)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
induction of bacterial agglutination (GO:0043152)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
intracellular signal transduction (GO:0035556)	1251	20	24.34	-	.82	4.60E-01	1.00E00
oxidative single-stranded RNA demethylation (GO:0035553)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
oxidative single-stranded DNA demethylation (GO:0035552)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
invagination involved in gastrulation with mouth forming second (GO:0055109)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Golgi to secretory granule transport (GO:0055107)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
response to molecule of bacterial origin (GO:0002237)	61	1	1.19	-	.84	1.00E00	1.00E00
leukocyte chemotaxis involved in immune response (GO:0002233)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukocyte chemotaxis involved in inflammatory response (GO:0002232)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of defense response to virus by host (GO:0002230)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
carnitine biosynthetic process (GO:0045329)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
ribosomal subunit export from nucleus (GO:0000054)	9	1	.18	+	5.71	1.75E-01	1.00E00
citrulline metabolic process (GO:0000052)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
late endosome to vacuole transport (GO:0045324)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
urea cycle (GO:0000050)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
stress fiber assembly (GO:0043149)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
leukocyte activation (GO:0045321)	77	1	1.50	-	.67	1.00E00	1.00E00
snoRNA processing (GO:0043144)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
electron transport coupled proton transport (GO:0015990)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
determination of left/right asymmetry in nervous system (GO:0035545)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of SNARE complex assembly (GO:0035542)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
toll-like receptor signaling pathway (GO:0002224)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
pattern recognition receptor signaling pathway (GO:0002221)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
transition metal ion transport (GO:0000041)	68	0	1.32	-	 < 0.01	6.43E-01	1.00E00
energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ATP synthesis coupled proton transport (GO:0015986)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
energy coupled proton transport, down electrochemical gradient (GO:0015985)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
DNA replication, removal of RNA primer (GO:0043137)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
anterior/posterior pattern specification involved in kidney development (GO:0072098)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
energy derivation by oxidation of organic compounds (GO:0015980)	107	1	2.08	-	.48	7.26E-01	1.00E00
activation of innate immune response (GO:0002218)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethionine cycle (GO:0033353)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
peptide modification (GO:0031179)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
retinal cell apoptotic process (GO:1990009)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid metabolic process (GO:0000038)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
lifelong otolith mineralization (GO:0031174)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell wall mannoprotein biosynthetic process (GO:0000032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
surfactant homeostasis (GO:0043129)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
stem cell proliferation (GO:0072089)	15	1	.29	+	3.43	2.65E-01	1.00E00
reproductive behavior (GO:0019098)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
nephron epithelium morphogenesis (GO:0072088)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)	30	1	.58	+	1.71	4.50E-01	1.00E00
renal vesicle development (GO:0072087)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)	46	1	.89	+	1.12	5.96E-01	1.00E00
monoubiquitinated histone H2A deubiquitination (GO:0035522)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
monoubiquitinated histone deubiquitination (GO:0035521)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nephron tubule development (GO:0072080)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
monoubiquitinated protein deubiquitination (GO:0035520)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immunoglobulins involved in immune response (GO:0002208)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
asparagine catabolic process via L-aspartate (GO:0033345)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cholesterol efflux (GO:0033344)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
rRNA methylation (GO:0031167)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
pelvic fin development (GO:0033340)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ribosomal small subunit assembly (GO:0000028)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
ribosomal large subunit assembly (GO:0000027)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immune receptors (GO:0002200)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
metallo-sulfur cluster assembly (GO:0031163)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
diadenosine tetraphosphate biosynthetic process (GO:0015966)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diadenosine tetraphosphate metabolic process (GO:0015965)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular permeability (GO:0043116)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vascular permeability (GO:0043114)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
nephron tubule morphogenesis (GO:0072078)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate catabolic process (GO:0015961)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H2A monoubiquitination (GO:0035518)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
receptor clustering (GO:0043113)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
renal vesicle morphogenesis (GO:0072077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate biosynthetic process (GO:0015960)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
receptor metabolic process (GO:0043112)	37	1	.72	+	1.39	5.19E-01	1.00E00
replication fork arrest (GO:0043111)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
oxidative RNA demethylation (GO:0035513)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
medial fin development (GO:0033338)	11	1	.21	+	4.67	2.06E-01	1.00E00
oxidative DNA demethylation (GO:0035511)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
DNA dealkylation (GO:0035510)	9	1	.18	+	5.71	1.75E-01	1.00E00
anal fin development (GO:0033335)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate metabolic process (GO:0015959)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
viral genome replication (GO:0019079)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of GTP cyclohydrolase I activity (GO:0043105)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
late distal convoluted tubule development (GO:0072068)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
purine ribonucleotide interconversion (GO:0015951)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
purine nucleotide interconversion (GO:0015950)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
amino acid salvage (GO:0043102)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
virus maturation (GO:0019075)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
purine-containing compound salvage (GO:0043101)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of motor neuron migration (GO:1905483)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate-ammonia ligase activity (GO:1905480)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mRNA transcription (GO:0009299)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GDP-mannose biosynthetic process (GO:0009298)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
UDP-D-xylose biosynthetic process (GO:0033320)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	51	1	.99	+	1.01	1.00E00	1.00E00
anaphase-promoting complex-dependent catabolic process (GO:0031145)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
mitochondrial genome maintenance (GO:0000002)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nucleobase-containing small molecule interconversion (GO:0015949)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate-ammonia ligase activity (GO:1905478)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to membrane (GO:1905477)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
formate metabolic process (GO:0015942)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
virion assembly (GO:0019068)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to membrane (GO:1905476)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to membrane (GO:1905475)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of hexokinase activity (GO:1903299)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
virion attachment to host cell (GO:0019062)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
UDP-D-xylose metabolic process (GO:0033319)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
S-shaped body morphogenesis (GO:0072050)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to Golgi membrane (GO:1903292)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle checkpoint (GO:0033313)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phagocytosis, engulfment (GO:0060099)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytoskeletal rearrangement involved in phagocytosis, engulfment (GO:0060097)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
coenzyme A catabolic process (GO:0015938)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic transmission, glycinergic (GO:0060092)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
coenzyme A biosynthetic process (GO:0015937)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
coenzyme A metabolic process (GO:0015936)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
comma-shaped body morphogenesis (GO:0072049)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
viral life cycle (GO:0019058)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
renal system pattern specification (GO:0072048)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
proximal/distal pattern formation involved in nephron development (GO:0072047)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity involved in nephron morphogenesis (GO:0072046)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in nephron morphogenesis (GO:0072045)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA duplex unwinding (GO:1905463)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modulation by virus of host cellular process (GO:0019054)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA duplex unwinding (GO:1905462)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion import across plasma membrane (GO:1903288)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
induction by virus of host apoptotic process (GO:0019051)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of potassium ion import (GO:1903286)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
phytol metabolic process (GO:0033306)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
developmental induction (GO:0031128)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cell cycle comprising mitosis without cytokinesis (GO:0033301)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
snoRNA 3'-end processing (GO:0031126)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
rRNA 3'-end processing (GO:0031125)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
mRNA 3'-end processing (GO:0031124)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell stereocilium organization (GO:0060088)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
nuclear migration (GO:0007097)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
RNA 3'-end processing (GO:0031123)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
regulation of exit from mitosis (GO:0007096)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
mitotic spindle assembly checkpoint (GO:0007094)	9	1	.18	+	5.71	1.75E-01	1.00E00
snRNA pseudouridine synthesis (GO:0031120)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
inhibitory postsynaptic potential (GO:0060080)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel diameter (GO:0097756)	23	1	.45	+	2.23	3.70E-01	1.00E00
positive regulation of blood vessel diameter (GO:0097755)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphoid progenitor cell differentiation (GO:1905458)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphoid progenitor cell differentiation (GO:1905457)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modulation by virus of host morphology or physiology (GO:0019048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lymphoid progenitor cell differentiation (GO:1905456)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of DNA stability (GO:0097752)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid progenitor cell differentiation (GO:1905455)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endosome membrane tubulation (GO:0097750)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid progenitor cell differentiation (GO:1905453)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to pH (GO:0009268)	9	1	.18	+	5.71	1.75E-01	1.00E00
positive regulation of autophagosome maturation (GO:1901098)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to starvation (GO:0009267)	39	1	.76	+	1.32	5.38E-01	1.00E00
negative regulation of autophagosome maturation (GO:1901097)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
response to temperature stimulus (GO:0009266)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
tRNA pseudouridine synthesis (GO:0031119)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of autophagosome maturation (GO:1901096)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
2'-deoxyribonucleotide biosynthetic process (GO:0009265)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
rRNA pseudouridine synthesis (GO:0031118)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide catabolic process (GO:0009264)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule depolymerization (GO:0031117)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide biosynthetic process (GO:0009263)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule polymerization (GO:0031116)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide metabolic process (GO:0009262)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
excitatory postsynaptic potential (GO:0060079)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
ribonucleotide catabolic process (GO:0009261)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule depolymerization (GO:0031114)	14	1	.27	+	3.67	2.51E-01	1.00E00
regulation of postsynaptic membrane potential (GO:0060078)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
ribonucleotide biosynthetic process (GO:0009260)	127	3	2.47	+	1.21	7.40E-01	1.00E00
regulation of microtubule polymerization (GO:0031113)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule polymerization or depolymerization (GO:0031112)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mitotic nuclear envelope reassembly (GO:0007084)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
synapse maturation (GO:0060074)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peroxisomal membrane transport (GO:0015919)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
sterol transport (GO:0015918)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
membrane tubulation (GO:0097749)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitotic metaphase plate congression (GO:0007080)	9	1	.18	+	5.71	1.75E-01	1.00E00
canonical Wnt signaling pathway (GO:0060070)	47	2	.91	+	2.19	2.40E-01	1.00E00
neutrophil homeostasis (GO:0001780)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel diameter (GO:0097746)	57	1	1.11	-	.90	1.00E00	1.00E00
phospholipid transport (GO:0015914)	64	0	1.25	-	 < 0.01	6.37E-01	1.00E00
mitotic cytokinesis checkpoint (GO:0044878)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nephron morphogenesis (GO:0072028)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid import into peroxisome (GO:0015910)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
distal convoluted tubule development (GO:0072025)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
lipoprotein localization (GO:0044872)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
proximal straight tubule development (GO:0072020)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribonucleotide metabolic process (GO:0009259)	199	3	3.87	-	.77	1.00E00	1.00E00
10-formyltetrahydrofolate catabolic process (GO:0009258)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
10-formyltetrahydrofolate biosynthetic process (GO:0009257)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
10-formyltetrahydrofolate metabolic process (GO:0009256)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidoglycan catabolic process (GO:0009253)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
natural killer cell differentiation (GO:0001779)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glucan catabolic process (GO:0009251)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
plasma membrane repair (GO:0001778)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glucan biosynthetic process (GO:0009250)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
leukocyte homeostasis (GO:0001776)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
fin regeneration (GO:0031101)	65	2	1.26	+	1.58	3.67E-01	1.00E00
cell activation (GO:0001775)	95	1	1.85	-	.54	1.00E00	1.00E00
animal organ regeneration (GO:0031100)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
microglial cell activation (GO:0001774)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid transport (GO:0015909)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
Spemann organizer formation at the embryonic shield (GO:0060063)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myeloid dendritic cell activation (GO:0001773)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid transport (GO:0015908)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
Spemann organizer formation (GO:0060061)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
proximal convoluted tubule development (GO:0072019)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K4 trimethylation (GO:1905437)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
distal tubule development (GO:0072017)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K4 trimethylation (GO:1905435)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proximal tubule development (GO:0072014)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
exon-exon junction complex disassembly (GO:1903259)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
microcystin transport (GO:1905431)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
glomerulus vasculature development (GO:0072012)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
glomerular endothelium development (GO:0072011)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein lipoylation (GO:0009249)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycolipid biosynthetic process (GO:0009247)	40	1	.78	+	1.28	5.46E-01	1.00E00
glucosamine-containing compound biosynthetic process (GO:1901073)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
embryonic retina morphogenesis in camera-type eye (GO:0060059)	27	1	.53	+	1.90	4.17E-01	1.00E00
glucosamine-containing compound catabolic process (GO:1901072)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
glucosamine-containing compound metabolic process (GO:1901071)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate biosynthetic process (GO:0009240)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
guanosine-containing compound biosynthetic process (GO:1901070)	17	1	.33	+	3.02	2.93E-01	1.00E00
angiogenesis involved in wound healing (GO:0060055)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane raft assembly (GO:0001765)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
morphogenesis of a branching structure (GO:0001763)	18	1	.35	+	2.86	3.07E-01	1.00E00
neurofilament cytoskeleton organization (GO:0060052)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
male meiosis chromosome segregation (GO:0007060)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
plasma membrane raft organization (GO:0044857)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
sperm motility (GO:0097722)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
plasma membrane raft assembly (GO:0044854)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
calcineurin-mediated signaling (GO:0097720)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
kidney rudiment formation (GO:0072003)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retinal cone cell fate determination (GO:0042671)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
guanosine-containing compound metabolic process (GO:1901068)	21	1	.41	+	2.45	3.46E-01	1.00E00
siderophore metabolic process (GO:0009237)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retinal cone cell differentiation (GO:0042670)	12	1	.23	+	4.28	2.22E-01	1.00E00
cobalamin biosynthetic process (GO:0009236)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cobalamin metabolic process (GO:0009235)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
menaquinone biosynthetic process (GO:0009234)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
menaquinone metabolic process (GO:0009233)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein glycosylation (GO:0060049)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
organ induction (GO:0001759)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spindle assembly involved in female meiosis II (GO:0007058)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
riboflavin biosynthetic process (GO:0009231)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac muscle contraction (GO:0060048)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
heart contraction (GO:0060047)	86	0	1.67	-	 < 0.01	4.16E-01	1.00E00
somite specification (GO:0001757)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
spindle assembly involved in female meiosis (GO:0007056)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of acrosome reaction (GO:0060046)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell proliferation (GO:0060043)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
compound eye photoreceptor cell differentiation (GO:0001751)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
biological phase (GO:0044848)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ciliary basal body-plasma membrane docking (GO:0097711)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell fate specification (GO:0042667)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ectodermal cell fate specification (GO:0042665)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of endodermal cell fate specification (GO:0042663)	14	1	.27	+	3.67	2.51E-01	1.00E00
thiamine diphosphate biosynthetic process (GO:0009229)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesodermal cell fate specification (GO:0042662)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of mesodermal cell fate specification (GO:0042661)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar biosynthetic process (GO:0009226)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar metabolic process (GO:0009225)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
neuropilin signaling pathway (GO:0038189)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of vacuole fusion, non-autophagic (GO:0032889)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleotide catabolic process (GO:0009223)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
sarcosine catabolic process (GO:1901053)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pericardium development (GO:0060039)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
sarcosine metabolic process (GO:1901052)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell proliferation (GO:0060038)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide biosynthetic process (GO:0009220)	20	1	.39	+	2.57	3.33E-01	1.00E00
notochord cell vacuolation (GO:0060036)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
notochord cell development (GO:0060035)	11	1	.21	+	4.67	2.06E-01	1.00E00
compound eye morphogenesis (GO:0001745)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cell-substrate junction assembly (GO:0007044)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cell-cell junction assembly (GO:0007043)	56	1	1.09	-	.92	1.00E00	1.00E00
nerve growth factor signaling pathway (GO:0038180)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
optic placode formation (GO:0001743)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization (GO:0032880)	111	4	2.16	+	1.85	1.78E-01	1.00E00
lysosomal transport (GO:0007041)	30	1	.58	+	1.71	4.50E-01	1.00E00
mediolateral intercalation (GO:0060031)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lysosome organization (GO:0007040)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
cell cycle G2/M phase transition (GO:0044839)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
modulation by organism of apoptotic process in other organism involved in symbiotic interaction (GO:0052433)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to oscillatory fluid shear stress (GO:0097704)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to oscillatory fluid shear stress (GO:0097702)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of cell fate specification (GO:0042659)	18	1	.35	+	2.86	3.07E-01	1.00E00
regulation of endodermal cell differentiation (GO:1903224)	15	1	.29	+	3.43	2.65E-01	1.00E00
pyrimidine deoxyribonucleotide metabolic process (GO:0009219)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide metabolic process (GO:0009218)	20	1	.39	+	2.57	3.33E-01	1.00E00
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
neurotrophin signaling pathway (GO:0038179)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cyclic nucleotide catabolic process (GO:0009214)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of localization (GO:0032879)	740	16	14.40	+	1.11	6.84E-01	1.00E00
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of establishment or maintenance of cell polarity (GO:0032878)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein catabolic process in the vacuole (GO:0007039)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA endoreduplication (GO:0032877)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in organogenesis (GO:0060029)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
morphogenesis of a polarized epithelium (GO:0001738)	12	1	.23	+	4.28	2.22E-01	1.00E00
regulation of DNA endoreduplication (GO:0032875)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of stress-activated MAPK cascade (GO:0032874)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
vacuolar acidification (GO:0007035)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of stress-activated MAPK cascade (GO:0032873)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic activity (GO:0060025)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vacuolar transport (GO:0007034)	70	1	1.36	-	.73	1.00E00	1.00E00
regulation of stress-activated MAPK cascade (GO:0032872)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
cannabinoid signaling pathway (GO:0038171)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vacuole organization (GO:0007033)	74	3	1.44	+	2.08	1.82E-01	1.00E00
soft palate development (GO:0060023)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endosome organization (GO:0007032)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
cellular response to hormone stimulus (GO:0032870)	160	1	3.11	-	.32	3.80E-01	1.00E00
hard palate development (GO:0060022)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
formation of cytoplasmic translation initiation complex (GO:0001732)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
peroxisome organization (GO:0007031)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
roof of mouth development (GO:0060021)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
formation of translation preinitiation complex (GO:0001731)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
Golgi organization (GO:0007030)	52	0	1.01	-	 < 0.01	6.28E-01	1.00E00
meiotic telomere tethering at nuclear periphery (GO:0044821)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209)	16	1	.31	+	3.21	2.79E-01	1.00E00
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208)	16	1	.31	+	3.21	2.79E-01	1.00E00
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	34	1	.66	+	1.51	4.91E-01	1.00E00
purine ribonucleoside triphosphate metabolic process (GO:0009205)	38	1	.74	+	1.35	5.29E-01	1.00E00
deoxyribonucleoside triphosphate catabolic process (GO:0009204)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to insulin stimulus (GO:0032869)	46	1	.89	+	1.12	5.96E-01	1.00E00
response to insulin (GO:0032868)	51	1	.99	+	1.01	1.00E00	1.00E00
endoplasmic reticulum organization (GO:0007029)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
radial glial cell differentiation (GO:0060019)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cytoplasm organization (GO:0007028)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ribonucleoside triphosphate biosynthetic process (GO:0009201)	41	1	.80	+	1.25	5.55E-01	1.00E00
regulation of response to reactive oxygen species (GO:1901031)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside triphosphate metabolic process (GO:0009200)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
parathyroid gland development (GO:0060017)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
granulosa cell development (GO:0060016)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prolactin signaling pathway (GO:0038161)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
granulosa cell differentiation (GO:0060014)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
post-chaperonin tubulin folding pathway (GO:0007023)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, glycinergic (GO:0060012)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
tubulin complex assembly (GO:0007021)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
microtubule nucleation (GO:0007020)	12	1	.23	+	4.28	2.22E-01	1.00E00
mitotic G1/S transition checkpoint (GO:0044819)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced neuron death (GO:1903204)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acetylcholine receptor signaling pathway (GO:0095500)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative stress-induced neuron death (GO:1903203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cholesterol homeostasis (GO:0042632)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced cell death (GO:1903202)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative stress-induced cell death (GO:1903201)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
granulocyte colony-stimulating factor signaling pathway (GO:0038158)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transmembrane transporter activity (GO:1901021)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transmembrane transporter activity (GO:1901020)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cytoskeletal anchoring at plasma membrane (GO:0007016)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
vestibular reflex (GO:0060005)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
reflex (GO:0060004)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate specification (GO:0001714)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
copper ion export (GO:0060003)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate commitment (GO:0001711)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
late nucleophagy (GO:0044805)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
autophagy of nucleus (GO:0044804)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
CAAX-box protein processing (GO:0071586)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transmembrane transporter activity (GO:1901019)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
detoxification of cadmium ion (GO:0071585)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of potassium ion transmembrane transporter activity (GO:1901017)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of potassium ion transmembrane transporter activity (GO:1901016)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
plasma membrane organization (GO:0007009)	65	1	1.26	-	.79	1.00E00	1.00E00
cell fate determination (GO:0001709)	10	1	.19	+	5.14	1.91E-01	1.00E00
outer mitochondrial membrane organization (GO:0007008)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inner mitochondrial membrane organization (GO:0007007)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
mesoderm formation (GO:0001707)	34	1	.66	+	1.51	4.91E-01	1.00E00
mitochondrial membrane organization (GO:0007006)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
endoderm formation (GO:0001706)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
mitochondrion organization (GO:0007005)	183	1	3.56	-	.28	2.72E-01	1.00E00
ectoderm formation (GO:0001705)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomerase (GO:0007004)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
formation of primary germ layer (GO:0001704)	49	1	.95	+	1.05	6.19E-01	1.00E00
gastrulation with mouth forming second (GO:0001702)	50	0	.97	-	 < 0.01	1.00E00	1.00E00
zinc ion import across plasma membrane (GO:0071578)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
zinc ion transmembrane transport (GO:0071577)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
ubiquinone-6 biosynthetic process (GO:1901006)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ubiquinone-6 metabolic process (GO:1901004)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glomerular basement membrane development (GO:0032836)	11	1	.21	+	4.67	2.06E-01	1.00E00
negative regulation of androgen secretion (GO:2000835)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of androgen secretion (GO:2000834)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of steroid hormone secretion (GO:2000832)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein ufmylation (GO:0071569)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of steroid hormone secretion (GO:2000831)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of quinolinate biosynthetic process (GO:1904985)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of quinolinate biosynthetic process (GO:1904984)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycine import into mitochondrion (GO:1904983)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ERBB2 signaling pathway (GO:0038128)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ERBB signaling pathway (GO:0038127)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
cellular response to transforming growth factor beta stimulus (GO:0071560)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
dense core granule priming (GO:0061789)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular phosphate ion homeostasis (GO:0030643)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of cellular pH (GO:0030641)	45	1	.88	+	1.14	5.88E-01	1.00E00
mitochondrial RNA surveillance (GO:2000827)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to transforming growth factor beta (GO:0071559)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
cell wall organization or biogenesis (GO:0071554)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
brush border assembly (GO:1904970)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of epinephrine secretion (GO:0032812)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of myoblast proliferation (GO:2000818)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic sister chromatid separation (GO:2000816)	10	1	.19	+	5.14	1.91E-01	1.00E00
regulation of mRNA stability involved in response to oxidative stress (GO:2000815)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of barbed-end actin filament capping (GO:2000813)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of barbed-end actin filament capping (GO:2000812)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to dexamethasone stimulus (GO:0071549)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of anoikis (GO:2000811)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to dexamethasone (GO:0071548)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
inositol phosphate catabolic process (GO:0071545)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
diphosphoinositol polyphosphate metabolic process (GO:0071543)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
Kit signaling pathway (GO:0038109)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dopaminergic neuron differentiation (GO:0071542)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
phosphagen metabolic process (GO:0006599)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
spermine biosynthetic process (GO:0006597)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
polyamine biosynthetic process (GO:0006596)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
polyamine metabolic process (GO:0006595)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
regulation of attachment of spindle microtubules to kinetochore (GO:0051988)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ornithine metabolic process (GO:0006591)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
thyroid hormone generation (GO:0006590)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromosome segregation (GO:0051985)	11	1	.21	+	4.67	2.06E-01	1.00E00
protein localization to centrosome (GO:0071539)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of protein localization (GO:1904951)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of protein localization (GO:1904950)	12	1	.23	+	4.28	2.22E-01	1.00E00
mitochondrial large ribosomal subunit assembly (GO:1902775)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
octopamine biosynthetic process (GO:0006589)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
indolalkylamine metabolic process (GO:0006586)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
dopamine biosynthetic process from tyrosine (GO:0006585)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
catecholamine metabolic process (GO:0006584)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
melanin biosynthetic process from tyrosine (GO:0006583)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
melanin metabolic process (GO:0006582)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
lysophospholipid transport (GO:0051977)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acetylcholine catabolic process (GO:0006581)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomerase activity (GO:0051974)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase activity (GO:0051973)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase activity (GO:0051972)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of transmission of nerve impulse (GO:0051971)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrion transport along microtubule (GO:0047497)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
sterol homeostasis (GO:0055092)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
vesicle transport along microtubule (GO:0047496)	19	1	.37	+	2.71	3.20E-01	1.00E00
phospholipid homeostasis (GO:0055091)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
isoprenoid biosynthetic process via mevalonate (GO:1902767)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dendrite development (GO:0016358)	33	1	.64	+	1.56	4.81E-01	1.00E00
acylglycerol homeostasis (GO:0055090)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell migration (GO:1902766)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
motor behavior (GO:0061744)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine biosynthetic process (GO:0006578)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine metabolic process (GO:0006577)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
protein targeting to lysosome involved in chaperone-mediated autophagy (GO:0061740)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular biogenic amine metabolic process (GO:0006576)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
cellular modified amino acid metabolic process (GO:0006575)	113	0	2.20	-	 < 0.01	2.83E-01	1.00E00
valine catabolic process (GO:0006574)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of transmission of nerve impulse (GO:0051969)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
valine metabolic process (GO:0006573)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
tyrosine catabolic process (GO:0006572)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission, glutamatergic (GO:0051967)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
tyrosine biosynthetic process (GO:0006571)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic transmission, glutamatergic (GO:0051966)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
tyrosine metabolic process (GO:0006570)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of synapse assembly (GO:0051963)	15	1	.29	+	3.43	2.65E-01	1.00E00
lipid homeostasis (GO:0055088)	44	0	.86	-	 < 0.01	1.00E00	1.00E00
nucleobase-containing small molecule metabolic process (GO:0055086)	312	3	6.07	-	.49	2.96E-01	1.00E00
establishment of imprinting at mating-type locus (GO:0071516)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
genetic imprinting at mating-type locus (GO:0071515)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
monovalent inorganic anion homeostasis (GO:0055083)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
genetic imprinting (GO:0071514)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular chemical homeostasis (GO:0055082)	339	7	6.60	+	1.06	8.42E-01	1.00E00
anion homeostasis (GO:0055081)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
cation homeostasis (GO:0055080)	367	8	7.14	+	1.12	7.02E-01	1.00E00
regulation of response to osmotic stress (GO:0047484)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell cycle G2/M phase transition (GO:1902751)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process (GO:0006569)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tryptophan metabolic process (GO:0006568)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
threonine catabolic process (GO:0006567)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
threonine metabolic process (GO:0006566)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
L-serine catabolic process (GO:0006565)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
L-serine biosynthetic process (GO:0006564)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
L-serine metabolic process (GO:0006563)	11	1	.21	+	4.67	2.06E-01	1.00E00
methotrexate transport (GO:0051958)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proline catabolic process (GO:0006562)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
proline biosynthetic process (GO:0006561)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
proline metabolic process (GO:0006560)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of amine transport (GO:0051954)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of amine transport (GO:0051953)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of amine transport (GO:0051952)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
sodium ion homeostasis (GO:0055078)	24	1	.47	+	2.14	3.82E-01	1.00E00
transition metal ion homeostasis (GO:0055076)	55	1	1.07	-	.93	1.00E00	1.00E00
potassium ion homeostasis (GO:0055075)	29	1	.56	+	1.77	4.39E-01	1.00E00
calcium ion homeostasis (GO:0055074)	230	6	4.47	+	1.34	4.66E-01	1.00E00
iron ion homeostasis (GO:0055072)	36	1	.70	+	1.43	5.10E-01	1.00E00
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
manganese ion homeostasis (GO:0055071)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular response to temperature stimulus (GO:0071502)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of lens fiber cell differentiation (GO:1902747)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
copper ion homeostasis (GO:0055070)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to sterol depletion (GO:0071501)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lens fiber cell differentiation (GO:1902746)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of lamellipodium organization (GO:1902745)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
otolith mineralization (GO:0045299)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lamellipodium organization (GO:1902743)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in development (GO:1902742)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
morphogenesis of follicular epithelium (GO:0016333)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-alpha secretion (GO:1902741)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of polarity of embryonic epithelium (GO:0016332)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process to lactate (GO:0061727)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrion disassembly (GO:0061726)	30	1	.58	+	1.71	4.50E-01	1.00E00
glycophagy (GO:0061723)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-phenylalanine catabolic process (GO:0006559)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
L-phenylalanine metabolic process (GO:0006558)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethioninamine biosynthetic process (GO:0006557)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethionine biosynthetic process (GO:0006556)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
methionine metabolic process (GO:0006555)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
lysine catabolic process (GO:0006554)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lysine metabolic process (GO:0006553)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
leucine catabolic process (GO:0006552)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
leucine metabolic process (GO:0006551)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
zinc ion homeostasis (GO:0055069)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
monovalent inorganic cation homeostasis (GO:0055067)	80	2	1.56	+	1.28	6.71E-01	1.00E00
metal ion homeostasis (GO:0055065)	321	8	6.25	+	1.28	4.17E-01	1.00E00
chloride ion homeostasis (GO:0055064)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-alpha secretion (GO:1902739)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
phosphate ion homeostasis (GO:0055062)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cap-dependent translational initiation (GO:0002191)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glucose catabolic process to pyruvate (GO:0061718)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum membrane fusion (GO:0016320)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histidine catabolic process (GO:0006548)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
histidine metabolic process (GO:0006547)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
glycine catabolic process (GO:0006546)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
glycine biosynthetic process (GO:0006545)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
glycine metabolic process (GO:0006544)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
glutamine catabolic process (GO:0006543)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
catecholamine transport (GO:0051937)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamine biosynthetic process (GO:0006542)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamine metabolic process (GO:0006541)	15	1	.29	+	3.43	2.65E-01	1.00E00
catecholamine uptake involved in synaptic transmission (GO:0051934)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
asymmetric neuroblast division (GO:0055059)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, GABAergic (GO:0051932)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of sensory perception (GO:0051931)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
neuroblast division (GO:0055057)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of sensory perception of pain (GO:0051930)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
translation reinitiation (GO:0002188)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational termination (GO:0002184)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational initiation (GO:0002183)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translation (GO:0002181)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
reticulophagy (GO:0061709)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
dephosphorylation (GO:0016311)	209	4	4.07	-	.98	1.00E00	1.00E00
phosphorylation (GO:0016310)	1111	27	21.62	+	1.25	2.23E-01	1.00E00
positive regulation of purine nucleotide metabolic process (GO:1900544)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of purine nucleotide metabolic process (GO:1900543)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of purine nucleotide metabolic process (GO:1900542)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
glutamate catabolic process (GO:0006538)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
purine nucleobase salvage (GO:0043096)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
glutamate biosynthetic process (GO:0006537)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of GTP cyclohydrolase I activity (GO:0043095)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutamate metabolic process (GO:0006536)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
carnosine biosynthetic process (GO:0035499)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular metabolic compound salvage (GO:0043094)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
carnosine metabolic process (GO:0035498)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transport (GO:0051928)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
cerebrospinal fluid circulation (GO:0090660)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
aspartate catabolic process (GO:0006533)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
aspartate biosynthetic process (GO:0006532)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
amino acid import (GO:0043090)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transport (GO:0051926)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
aspartate metabolic process (GO:0006531)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
SNARE complex disassembly (GO:0035494)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
asparagine catabolic process (GO:0006530)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
SNARE complex assembly (GO:0035493)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transport (GO:0051924)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
sulfation (GO:0051923)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
male germ cell proliferation (GO:0002176)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
palmitic acid biosynthetic process (GO:1900535)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
telomeric loop disassembly (GO:0090657)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
palmitic acid metabolic process (GO:1900533)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
t-circle formation (GO:0090656)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
asparagine biosynthetic process (GO:0006529)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
asparagine metabolic process (GO:0006528)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of catalytic activity (GO:0043086)	141	3	2.74	+	1.09	7.57E-01	1.00E00
arginine catabolic process (GO:0006527)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
arginine biosynthetic process (GO:0006526)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
arginine metabolic process (GO:0006525)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
alanine catabolic process (GO:0006524)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
alanine metabolic process (GO:0006522)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular amino acid metabolic process (GO:0006520)	194	2	3.77	-	.53	5.95E-01	1.00E00
mitochondrial tRNA processing (GO:0090646)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein deglycosylation (GO:0006517)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
glycoprotein catabolic process (GO:0006516)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
angioblast cell migration from lateral mesoderm to midline (GO:0035479)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of angioblast cell migration involved in selective angioblast sprouting (GO:0035477)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
angioblast cell migration (GO:0035476)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
angioblast cell migration involved in selective angioblast sprouting (GO:0035475)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process (GO:0006511)	353	9	6.87	+	1.31	4.33E-01	1.00E00
selective angioblast sprouting (GO:0035474)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pigment granule transport (GO:0051904)	25	1	.49	+	2.06	3.94E-01	1.00E00
negative regulation of cardiac muscle tissue development (GO:0055026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
desmosome assembly (GO:0002159)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle tissue development (GO:0055025)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle tissue development (GO:0055024)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
T-tubule organization (GO:0033292)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle tissue growth (GO:0055021)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
thyroid hormone mediated signaling pathway (GO:0002154)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of programmed cell death (GO:0043069)	336	3	6.54	-	.46	2.26E-01	1.00E00
membrane protein ectodomain proteolysis (GO:0006509)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of programmed cell death (GO:0043067)	506	14	9.84	+	1.42	1.92E-01	1.00E00
malonyl-CoA catabolic process (GO:2001294)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proteolysis (GO:0006508)	889	17	17.30	-	.98	1.00E00	1.00E00
negative regulation of apoptotic process (GO:0043066)	333	3	6.48	-	.46	2.26E-01	1.00E00
malonyl-CoA metabolic process (GO:2001293)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GPI anchor release (GO:0006507)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GPI anchor biosynthetic process (GO:0006506)	23	1	.45	+	2.23	3.70E-01	1.00E00
determination of pancreatic left/right asymmetry (GO:0035469)	12	1	.23	+	4.28	2.22E-01	1.00E00
GPI anchor metabolic process (GO:0006505)	25	1	.49	+	2.06	3.94E-01	1.00E00
extracellular structure organization (GO:0043062)	137	2	2.67	-	.75	1.00E00	1.00E00
activation of GTPase activity (GO:0090630)	48	2	.93	+	2.14	2.47E-01	1.00E00
meiotic metaphase I plate congression (GO:0043060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
C-terminal protein lipidation (GO:0006501)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
determination of left/right asymmetry in diencephalon (GO:0035462)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
vitamin transmembrane transport (GO:0035461)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cardiac muscle tissue growth (GO:0055017)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac muscle cell development (GO:0055015)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell development (GO:0055014)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to vitamin D (GO:0033280)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac muscle tissue morphogenesis (GO:0055010)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
tRNA wobble position uridine thiolation (GO:0002143)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein palmitoleylation (GO:0045234)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of caveolin-mediated endocytosis (GO:2001287)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of caveolin-mediated endocytosis (GO:2001286)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
vesicle cargo loading (GO:0035459)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac muscle tissue morphogenesis (GO:0055008)	19	1	.37	+	2.71	3.20E-01	1.00E00
retinoic acid biosynthetic process (GO:0002138)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to vitamin (GO:0033273)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
cardiac myofibril assembly (GO:0055003)	12	1	.23	+	4.28	2.22E-01	1.00E00
stress-activated protein kinase signaling cascade (GO:0031098)	72	3	1.40	+	2.14	1.73E-01	1.00E00
extracellular polysaccharide biosynthetic process (GO:0045226)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of unsaturated fatty acid biosynthetic process (GO:2001279)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
otic placode formation (GO:0043049)	17	1	.33	+	3.02	2.93E-01	1.00E00
dolichyl monophosphate biosynthetic process (GO:0043048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA methylation involved in gamete generation (GO:0043046)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
DNA methylation involved in embryo development (GO:0043045)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
drug transport (GO:0015893)	56	0	1.09	-	 < 0.01	6.29E-01	1.00E00
lipid import into cell (GO:0140354)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
export from cell (GO:0140352)	188	1	3.66	-	.27	2.76E-01	1.00E00
tRNA nucleoside ribose methylation (GO:0002128)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nuclear DNA replication (GO:0033260)	16	1	.31	+	3.21	2.79E-01	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell-cell junction maintenance (GO:0045217)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear pore distribution (GO:0031081)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell-cell junction organization (GO:0045216)	63	1	1.23	-	.82	1.00E00	1.00E00
sarcomere organization (GO:0045214)	31	1	.60	+	1.66	4.60E-01	1.00E00
cobalamin transport (GO:0015889)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thiamine transport (GO:0015888)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation (GO:0043039)	40	0	.78	-	 < 0.01	1.00E00	1.00E00
pantothenate transmembrane transport (GO:0015887)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
amino acid activation (GO:0043038)	40	0	.78	-	 < 0.01	1.00E00	1.00E00
heme transport (GO:0015886)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
folic acid transport (GO:0015884)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
L-ascorbic acid transmembrane transport (GO:0015882)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
maintenance of protein localization in endoplasmic reticulum (GO:0035437)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage activation (GO:0043032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phosphate ion transmembrane transport (GO:0035435)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage activation (GO:0043030)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
copper ion transmembrane transport (GO:0035434)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
store-operated calcium entry (GO:0002115)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of cation channel activity (GO:2001259)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cation channel activity (GO:2001258)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
carnitine transport (GO:0015879)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cation channel activity (GO:2001257)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
biotin transport (GO:0015878)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
T cell homeostasis (GO:0043029)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of store-operated calcium entry (GO:2001256)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K36 trimethylation (GO:2001255)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K36 trimethylation (GO:2001253)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
norepinephrine transport (GO:0015874)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dopamine transport (GO:0015872)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
choline transport (GO:0015871)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone deacetylation (GO:0031065)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA wobble adenosine to inosine editing (GO:0002100)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of histone deacetylation (GO:0031063)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone methylation (GO:0031062)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone methylation (GO:0031061)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
receptor signaling pathway via STAT (GO:0097696)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
transport across blood-brain barrier (GO:0150104)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	17	1	.33	+	3.02	2.93E-01	1.00E00
pyrimidine nucleoside transport (GO:0015864)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
uridine transport (GO:0015862)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 monomethylation (GO:0097692)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to synapse (GO:0035418)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
myeloid dendritic cell differentiation (GO:0043011)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor signaling pathway involved in heart process (GO:0086103)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone modification (GO:0031058)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone modification (GO:0031057)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
chromatin remodeling at centromere (GO:0031055)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
primary miRNA processing (GO:0031053)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	9	1	.18	+	5.71	1.75E-01	1.00E00
nucleoside transport (GO:0015858)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	13	1	.25	+	3.95	2.36E-01	1.00E00
positive regulation of apoptotic signaling pathway (GO:2001235)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase transport (GO:0015855)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
maintenance of rDNA (GO:0043007)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanine transport (GO:0015854)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
adenine transport (GO:0015853)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of CFTR protein (GO:0043004)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleobase transport (GO:0015851)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via alternative nonhomologous end joining (GO:0097681)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
organic hydroxy compound transport (GO:0015850)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
negative regulation of Golgi to plasma membrane CFTR protein transport (GO:0043002)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane protein transport (GO:0043001)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of snRNA transcription by RNA polymerase II (GO:1905382)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of snRNA transcription by RNA polymerase II (GO:1905380)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dsRNA transport (GO:0033227)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribonucleoside triphosphate metabolic process (GO:0009199)	45	1	.88	+	1.14	5.88E-01	1.00E00
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
chromatin silencing by small RNA (GO:0031048)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cyclic nucleotide biosynthetic process (GO:0009190)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
organic acid transport (GO:0015849)	127	0	2.47	-	 < 0.01	1.82E-01	1.00E00
regulation of hemoglobin biosynthetic process (GO:0046984)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron migration (GO:2001224)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 dimethylation (GO:0097676)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron migration (GO:2001223)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
monoamine transport (GO:0015844)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of neuron migration (GO:2001222)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
aminergic neurotransmitter loading into synaptic vesicle (GO:0015842)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
urea transport (GO:0015840)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ribonucleoside diphosphate biosynthetic process (GO:0009188)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cyclic nucleotide metabolic process (GO:0009187)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate metabolic process (GO:0009186)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
iron import into cell (GO:0033212)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribonucleoside diphosphate metabolic process (GO:0009185)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
adiponectin-activated signaling pathway (GO:0033211)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
leptin-mediated signaling pathway (GO:0033210)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myosin filament assembly (GO:0031034)	11	1	.21	+	4.67	2.06E-01	1.00E00
purine ribonucleoside diphosphate biosynthetic process (GO:0009180)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
myosin filament organization (GO:0031033)	11	1	.21	+	4.67	2.06E-01	1.00E00
amino-acid betaine transport (GO:0015838)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
amine transport (GO:0015837)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
peptide transport (GO:0015833)	730	10	14.20	-	.70	3.37E-01	1.00E00
trans-Golgi network to recycling endosome transport (GO:0044795)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glyoxal metabolic process (GO:1903189)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tumor necrosis factor-mediated signaling pathway (GO:0033209)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside diphosphate metabolic process (GO:0009179)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
nucleic acid-templated transcription (GO:0097659)	181	5	3.52	+	1.42	4.10E-01	1.00E00
proline transport (GO:0015824)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ornithine transport (GO:0015822)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication (GO:0044786)	16	1	.31	+	3.21	2.79E-01	1.00E00
leucine transport (GO:0015820)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of cell cycle (GO:0044784)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
G1 DNA damage checkpoint (GO:0044783)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cilium organization (GO:0044782)	213	6	4.14	+	1.45	3.18E-01	1.00E00
fatty alcohol metabolic process (GO:1903173)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside monophosphate catabolic process (GO:0009169)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transmembrane transport (GO:1903170)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
nucleotide catabolic process (GO:0009166)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
nucleotide biosynthetic process (GO:0009165)	162	3	3.15	-	.95	1.00E00	1.00E00
endocrine pancreas development (GO:0031018)	66	2	1.28	+	1.56	3.74E-01	1.00E00
nucleoside catabolic process (GO:0009164)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleoside biosynthetic process (GO:0009163)	22	1	.43	+	2.34	3.58E-01	1.00E00
pancreas development (GO:0031016)	137	5	2.67	+	1.88	2.00E-01	1.00E00
deoxyribonucleoside monophosphate metabolic process (GO:0009162)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ribonucleoside monophosphate metabolic process (GO:0009161)	39	2	.76	+	2.64	1.84E-01	1.00E00
habituation (GO:0046959)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
nonassociative learning (GO:0046958)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
tRNA 5'-leader removal (GO:0001682)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
glycine transport (GO:0015816)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ketone body catabolic process (GO:0046952)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
meiotic DNA integrity checkpoint (GO:0044778)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ketone body biosynthetic process (GO:0046951)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
L-glutamate transmembrane transport (GO:0015813)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular ketone body metabolic process (GO:0046950)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
L-cystine transport (GO:0015811)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aspartate transmembrane transport (GO:0015810)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transmembrane transport (GO:1903169)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
response to starvation (GO:0042594)	48	1	.93	+	1.07	6.11E-01	1.00E00
glucose homeostasis (GO:0042593)	47	1	.91	+	1.09	6.04E-01	1.00E00
deoxyribonucleoside monophosphate catabolic process (GO:0009159)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
homeostatic process (GO:0042592)	734	19	14.28	+	1.33	2.21E-01	1.00E00
detection of stimulus involved in sensory perception of pain (GO:0062149)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribonucleoside monophosphate catabolic process (GO:0009158)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide catabolic process (GO:0009155)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
purine ribonucleotide catabolic process (GO:0009154)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
purine ribonucleotide biosynthetic process (GO:0009152)	115	3	2.24	+	1.34	4.94E-01	1.00E00
purine deoxyribonucleotide metabolic process (GO:0009151)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular glucose homeostasis (GO:0001678)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
purine ribonucleotide metabolic process (GO:0009150)	186	3	3.62	-	.83	1.00E00	1.00E00
fatty-acyl-CoA biosynthetic process (GO:0046949)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid metabolic process (GO:0001676)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
arginine transport (GO:0015809)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
L-arginine import across plasma membrane (GO:0097638)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin assembly or disassembly (GO:0001672)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
L-amino acid transport (GO:0015807)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
carboxylic acid transport (GO:0046942)	123	0	2.39	-	 < 0.01	1.80E-01	1.00E00
neutral amino acid transport (GO:0015804)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid transport (GO:0015803)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
basic amino acid transport (GO:0015802)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
acidic amino acid transport (GO:0015800)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
multi-organism cellular process (GO:0044764)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of morphogenesis of an epithelium (GO:1905332)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of morphogenesis of an epithelium (GO:1905331)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside triphosphate catabolic process (GO:0009149)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)	18	1	.35	+	2.86	3.07E-01	1.00E00
pyrimidine nucleoside triphosphate metabolic process (GO:0009147)	21	1	.41	+	2.45	3.46E-01	1.00E00
purine nucleoside triphosphate catabolic process (GO:0009146)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
purine nucleoside triphosphate biosynthetic process (GO:0009145)	34	1	.66	+	1.51	4.91E-01	1.00E00
purine nucleoside triphosphate metabolic process (GO:0009144)	42	1	.82	+	1.22	5.64E-01	1.00E00
mitochondrial protein processing (GO:0034982)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
nucleoside triphosphate catabolic process (GO:0009143)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
nucleoside triphosphate biosynthetic process (GO:0009142)	45	1	.88	+	1.14	5.88E-01	1.00E00
nucleoside triphosphate metabolic process (GO:0009141)	58	1	1.13	-	.89	1.00E00	1.00E00
nucleotide phosphorylation (GO:0046939)	37	1	.72	+	1.39	5.19E-01	1.00E00
response to hypoxia (GO:0001666)	57	1	1.11	-	.90	1.00E00	1.00E00
pore complex assembly (GO:0046931)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
potassium ion export across plasma membrane (GO:0097623)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of autophagy of mitochondrion (GO:1903146)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
retinal metabolic process (GO:0042574)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
retinoic acid metabolic process (GO:0042573)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of endothelial barrier (GO:1903142)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
retinol metabolic process (GO:0042572)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside diphosphate metabolic process (GO:0009138)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to endoplasmic reticulum stress (GO:0034976)	105	2	2.04	-	.98	1.00E00	1.00E00
regulation of establishment of endothelial barrier (GO:1903140)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein folding in endoplasmic reticulum (GO:0034975)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
purine nucleoside diphosphate biosynthetic process (GO:0009136)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
purine nucleoside diphosphate metabolic process (GO:0009135)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial gene expression (GO:0062125)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H3-R26 methylation (GO:0034972)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate biosynthetic process (GO:0009133)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate metabolic process (GO:0009132)	42	1	.82	+	1.22	5.64E-01	1.00E00
temperature homeostasis (GO:0001659)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
ureteric bud development (GO:0001657)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Fc receptor signaling pathway (GO:0038093)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotransmitter secretion (GO:0046929)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of CREB transcription factor activity (GO:0032793)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
nodal signaling pathway (GO:0038092)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter secretion (GO:0046928)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
negative regulation of CREB transcription factor activity (GO:0032792)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribosome disassembly (GO:0032790)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein transmembrane import into intracellular organelle (GO:0044743)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
histone arginine methylation (GO:0034969)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate metabolic process (GO:0009129)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
mononuclear cell differentiation (GO:1903131)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
purine nucleoside monophosphate catabolic process (GO:0009128)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound catabolic process (GO:0042560)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
box H/ACA snoRNA processing (GO:0034964)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate catabolic process (GO:0009125)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
box C/D snoRNA processing (GO:0034963)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate biosynthetic process (GO:0009124)	38	2	.74	+	2.71	1.77E-01	1.00E00
nucleoside monophosphate metabolic process (GO:0009123)	44	2	.86	+	2.34	2.19E-01	1.00E00
osteoblast differentiation (GO:0001649)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-templated transcription, elongation (GO:0032786)	18	1	.35	+	2.86	3.07E-01	1.00E00
deoxyribonucleoside metabolic process (GO:0009120)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-templated transcription, elongation (GO:0032785)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
vascular endothelial growth factor signaling pathway (GO:0038084)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated transcription, elongation (GO:0032784)	25	1	.49	+	2.06	3.94E-01	1.00E00
peptidyl-tyrosine autophosphorylation (GO:0038083)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
bile acid secretion (GO:0032782)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATPase activity (GO:0032781)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
cellular transition metal ion homeostasis (GO:0046916)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATPase activity (GO:0032780)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
hemolysis in other organism involved in symbiotic interaction (GO:0052331)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction (GO:0052330)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound biosynthetic process (GO:0042559)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound metabolic process (GO:0042558)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
regulation of autophagosome assembly (GO:2000785)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
superoxide anion generation (GO:0042554)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of double-strand break repair (GO:2000781)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-strand break repair (GO:2000780)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
ribonucleoside metabolic process (GO:0009119)	34	1	.66	+	1.51	4.91E-01	1.00E00
myelination (GO:0042552)	49	2	.95	+	2.10	2.54E-01	1.00E00
neuron maturation (GO:0042551)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
nucleotide metabolic process (GO:0009117)	252	3	4.90	-	.61	6.40E-01	1.00E00
nucleoside metabolic process (GO:0009116)	54	1	1.05	-	.95	1.00E00	1.00E00
xanthine catabolic process (GO:0009115)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
vitamin catabolic process (GO:0009111)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vitamin biosynthetic process (GO:0009110)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
RNA biosynthetic process (GO:0032774)	184	5	3.58	+	1.40	4.15E-01	1.00E00
intracellular transport (GO:0046907)	762	13	14.83	-	.88	7.89E-01	1.00E00
leukocyte chemotaxis (GO:0030595)	81	0	1.58	-	 < 0.01	4.11E-01	1.00E00
regulation of mitochondrial membrane permeability (GO:0046902)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
neutrophil chemotaxis (GO:0030593)	69	0	1.34	-	 < 0.01	6.44E-01	1.00E00
tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolylpolyglutamate metabolic process (GO:0046900)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of double-strand break repair (GO:2000779)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-6 secretion (GO:2000778)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament-based movement (GO:1903116)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell wall biogenesis (GO:0042546)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular senescence (GO:2000773)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament-based movement (GO:1903115)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of cellular senescence (GO:2000772)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein N-linked glycosylation via arginine (GO:0042543)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
coenzyme catabolic process (GO:0009109)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to hydrogen peroxide (GO:0042542)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
coenzyme biosynthetic process (GO:0009108)	81	0	1.58	-	 < 0.01	4.11E-01	1.00E00
hemoglobin biosynthetic process (GO:0042541)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
p38MAPK cascade (GO:0038066)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycoprotein biosynthetic process (GO:0009101)	210	2	4.09	-	.49	4.47E-01	1.00E00
collagen-activated signaling pathway (GO:0038065)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
glycoprotein metabolic process (GO:0009100)	250	3	4.86	-	.62	6.39E-01	1.00E00
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
NIK/NF-kappaB signaling (GO:0038061)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of tumor necrosis factor production (GO:0032760)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of nephron tubule epithelial cell differentiation (GO:2000768)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic translation (GO:2000767)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
hypotonic salinity response (GO:0042539)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic translation (GO:2000766)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translation (GO:2000765)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
benzene-containing compound metabolic process (GO:0042537)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to fluid shear stress (GO:0071498)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular response to external stimulus (GO:0071496)	48	1	.93	+	1.07	6.11E-01	1.00E00
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to endogenous stimulus (GO:0071495)	334	6	6.50	-	.92	1.00E00	1.00E00
cellular response to UV-C (GO:0071494)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to UV-B (GO:0071493)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-8 production (GO:0032757)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-6 production (GO:0032755)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent SMAD protein catabolic process (GO:0030579)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
Cajal body organization (GO:0030576)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nuclear body organization (GO:0030575)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
collagen catabolic process (GO:0030574)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-lysine acetylation (GO:2000758)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
multi-organism reproductive process (GO:0044703)	138	3	2.68	+	1.12	7.53E-01	1.00E00
negative regulation of peptidyl-lysine acetylation (GO:2000757)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-lysine acetylation (GO:2000756)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to light stimulus (GO:0071482)	53	0	1.03	-	 < 0.01	6.28E-01	1.00E00
cellular response to X-ray (GO:0071481)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to gamma radiation (GO:0071480)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-2 production (GO:0032743)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterior head development (GO:2000744)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of anterior head development (GO:2000742)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to ionizing radiation (GO:0071479)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to radiation (GO:0071478)	63	0	1.23	-	 < 0.01	6.36E-01	1.00E00
cellular hypotonic salinity response (GO:0071477)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor signaling pathway via STAT (GO:1904894)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
cellular hypotonic response (GO:0071476)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor signaling pathway via STAT (GO:1904893)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of receptor signaling pathway via STAT (GO:1904892)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
cellular response to salt stress (GO:0071472)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to osmotic stress (GO:0071470)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
signal transduction in absence of ligand (GO:0038034)	15	1	.29	+	3.43	2.65E-01	1.00E00
positive regulation of interleukin-10 production (GO:0032733)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1 production (GO:0032732)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1 beta production (GO:0032731)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of stem cell differentiation (GO:2000738)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of stem cell differentiation (GO:2000737)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of tyrosine phosphorylation of STAT protein (GO:0042509)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of stem cell differentiation (GO:2000736)	22	1	.43	+	2.34	3.58E-01	1.00E00
regulation of excitatory synapse assembly (GO:1904889)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular response to acidic pH (GO:0071468)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to pH (GO:0071467)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to xenobiotic stimulus (GO:0071466)	81	1	1.58	-	.63	1.00E00	1.00E00
positive regulation of interferon-gamma production (GO:0032729)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-beta production (GO:0032728)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-alpha production (GO:0032727)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
reelin-mediated signaling pathway (GO:0038026)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to auditory stimulus (GO:0010996)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
free ubiquitin chain polymerization (GO:0010994)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detoxification of inorganic compound (GO:0061687)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ubiquitin recycling (GO:0010992)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine production (GO:0032722)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of SMAD protein complex assembly (GO:0010991)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of SMAD protein complex assembly (GO:0010990)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of tumor necrosis factor production (GO:0032720)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated autophagy (GO:0061684)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell differentiation (GO:2000727)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell differentiation (GO:2000726)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell differentiation (GO:2000725)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein localization to chromosome, centromeric region (GO:0071459)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to hypoxia (GO:0071456)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to oxygen levels (GO:0071453)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to superoxide (GO:0071451)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to oxygen radical (GO:0071450)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-8 production (GO:0032717)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of neuroblast proliferation (GO:1902692)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-5 production (GO:0032714)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
larval behavior (GO:0030537)	13	1	.25	+	3.95	2.36E-01	1.00E00
adult behavior (GO:0030534)	16	1	.31	+	3.21	2.79E-01	1.00E00
membrane depolarization (GO:0051899)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein kinase B signaling (GO:0051897)	10	1	.19	+	5.14	1.91E-01	1.00E00
positive regulation of focal adhesion assembly (GO:0051894)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardioblast differentiation (GO:0051890)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inhibitory synapse assembly (GO:1904862)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
excitatory synapse assembly (GO:1904861)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
netrin-activated signaling pathway (GO:0038007)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of receptor localization to synapse (GO:1902683)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
opioid receptor signaling pathway (GO:0038003)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial ribosome assembly (GO:0061668)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
paracrine signaling (GO:0038001)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
transport along microtubule (GO:0010970)	64	2	1.25	+	1.61	3.60E-01	1.00E00
N-terminal protein myristoylation (GO:0006499)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
N-terminal protein lipidation (GO:0006498)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein lipidation (GO:0006497)	66	1	1.28	-	.78	1.00E00	1.00E00
intracellular receptor signaling pathway (GO:0030522)	21	1	.41	+	2.45	3.46E-01	1.00E00
intracellular estrogen receptor signaling pathway (GO:0030520)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein O-linked glycosylation (GO:0006493)	47	1	.91	+	1.09	6.04E-01	1.00E00
N-glycan processing (GO:0006491)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
killing of cells in other organism involved in symbiotic interaction (GO:0051883)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial membrane potential (GO:0051881)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
O-glycan processing, core 1 (GO:0016267)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
O-glycan processing (GO:0016266)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
gap junction assembly (GO:0016264)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular magnesium ion homeostasis (GO:0010961)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
selenocysteine biosynthetic process (GO:0016260)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
intracellular steroid hormone receptor signaling pathway (GO:0030518)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
magnesium ion homeostasis (GO:0010960)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
dolichyl diphosphate biosynthetic process (GO:0006489)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of BMP signaling pathway (GO:0030514)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
protein N-linked glycosylation (GO:0006487)	52	0	1.01	-	 < 0.01	6.28E-01	1.00E00
positive regulation of BMP signaling pathway (GO:0030513)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
protein glycosylation (GO:0006486)	175	2	3.40	-	.59	7.78E-01	1.00E00
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pigment granule aggregation in cell center (GO:0051877)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
C-terminal protein methylation (GO:0006481)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pigment granule dispersal (GO:0051876)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
killing by host of symbiont cells (GO:0051873)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428)	9	1	.18	+	5.71	1.75E-01	1.00E00
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	21	1	.41	+	2.45	3.46E-01	1.00E00
hematopoietic stem cell proliferation (GO:0071425)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon guidance (GO:1902669)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
malate transmembrane transport (GO:0071423)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of axon guidance (GO:1902667)	43	2	.84	+	2.39	2.12E-01	1.00E00
selenocysteine metabolic process (GO:0016259)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
succinate transmembrane transport (GO:0071422)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of metal ion transport (GO:0010959)	74	0	1.44	-	 < 0.01	4.08E-01	1.00E00
manganese ion transmembrane transport (GO:0071421)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
N-glycan processing to lysosome (GO:0016256)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
attachment of GPI anchor to protein (GO:0016255)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein processing (GO:0010955)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein processing (GO:0010954)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 modification (GO:0061647)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway (GO:0030509)	55	2	1.07	+	1.87	2.97E-01	1.00E00
pyrimidine-containing compound salvage (GO:0008655)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of endopeptidase activity (GO:0010951)	51	0	.99	-	 < 0.01	1.00E00	1.00E00
phospholipid biosynthetic process (GO:0008654)	80	2	1.56	+	1.28	6.71E-01	1.00E00
response to amine (GO:0014075)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular amino acid biosynthetic process (GO:0008652)	52	1	1.01	-	.99	1.00E00	1.00E00
response to purine-containing compound (GO:0014074)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
inorganic diphosphate transport (GO:0030505)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine sulfation (GO:0006478)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
CENP-A containing chromatin organization (GO:0061641)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein sulfation (GO:0006477)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein deacetylation (GO:0006476)	25	1	.49	+	2.06	3.94E-01	1.00E00
negative regulation of bone mineralization (GO:0030502)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
response to organic cyclic compound (GO:0014070)	114	0	2.22	-	 < 0.01	2.85E-01	1.00E00
positive regulation of bone mineralization (GO:0030501)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
N-terminal protein amino acid acetylation (GO:0006474)	9	1	.18	+	5.71	1.75E-01	1.00E00
regulation of bone mineralization (GO:0030500)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
respiratory electron transport chain (GO:0022904)	53	0	1.03	-	 < 0.01	6.28E-01	1.00E00
protein dephosphorylation (GO:0006470)	146	4	2.84	+	1.41	5.38E-01	1.00E00
protein autoubiquitination (GO:0051865)	9	1	.18	+	5.71	1.75E-01	1.00E00
electron transport chain (GO:0022900)	57	0	1.11	-	 < 0.01	6.30E-01	1.00E00
cellular response to organonitrogen compound (GO:0071417)	111	1	2.16	-	.46	7.28E-01	1.00E00
calcium ion import into cytosol (GO:1902656)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
secondary alcohol biosynthetic process (GO:1902653)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
secondary alcohol metabolic process (GO:1902652)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
negative regulation of macroautophagy (GO:0016242)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	19	1	.37	+	2.71	3.20E-01	1.00E00
regulation of macroautophagy (GO:0016241)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
hexose transmembrane transport (GO:0008645)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cell death (GO:0010941)	529	14	10.29	+	1.36	2.63E-01	1.00E00
regulation of protein complex stability (GO:0061635)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	20	1	.39	+	2.57	3.33E-01	1.00E00
carbohydrate transport (GO:0008643)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol 3-kinase signaling (GO:0014065)	14	1	.27	+	3.67	2.51E-01	1.00E00
negative regulation of protein kinase activity (GO:0006469)	44	0	.86	-	 < 0.01	1.00E00	1.00E00
inflammatory response to wounding (GO:0090594)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
signal peptide processing (GO:0006465)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of epinephrine secretion (GO:0014060)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
disruption by host of symbiont cells (GO:0051852)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modification by host of symbiont morphology or physiology (GO:0051851)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule plus-end (GO:1904825)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to organic cyclic compound (GO:0071407)	58	0	1.13	-	 < 0.01	6.31E-01	1.00E00
cellular response to methanol (GO:0071405)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of macroautophagy (GO:0016239)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of necrotic cell death (GO:0010939)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tertiary alcohol biosynthetic process (GO:1902645)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lysosomal microautophagy (GO:0016237)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
C-terminal protein amino acid modification (GO:0018410)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
tertiary alcohol metabolic process (GO:1902644)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
maintenance of epithelial cell apical/basal polarity (GO:0045199)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage cytokine production (GO:0010935)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of epithelial cell apical/basal polarity (GO:0045198)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
telomere capping (GO:0016233)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
apoptotic mitochondrial changes (GO:0008637)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine secretion (GO:0014059)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of neuroblast polarity (GO:0045196)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of isotype switching (GO:0045191)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
'de novo' protein folding (GO:0006458)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
isotype switching (GO:0045190)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
canonical glycolysis (GO:0061621)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
protein folding (GO:0006457)	116	2	2.26	-	.89	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	30	1	.58	+	1.71	4.50E-01	1.00E00
glycolytic process through glucose-6-phosphate (GO:0061620)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
translational frameshifting (GO:0006452)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
translational readthrough (GO:0006451)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of translational fidelity (GO:0006450)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
tRNA wobble uridine modification (GO:0002098)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tRNA wobble base modification (GO:0002097)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell morphogenesis (GO:0002093)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor internalization (GO:0002092)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline hydroxylation to 3-hydroxy-L-proline (GO:0018400)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular component assembly involved in morphogenesis (GO:0010927)	80	2	1.56	+	1.28	6.71E-01	1.00E00
iron-sulfur cluster assembly (GO:0016226)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of circadian sleep/wake cycle, sleep (GO:0045187)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatase activity (GO:0010922)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location (GO:0045185)	36	1	.70	+	1.43	5.10E-01	1.00E00
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization (GO:0045184)	734	12	14.28	-	.84	6.82E-01	1.00E00
glycolytic process through fructose-6-phosphate (GO:0061615)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
establishment of endothelial blood-brain barrier (GO:0014045)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of translational termination (GO:0006449)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of translational elongation (GO:0006448)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation (GO:0006446)	23	1	.45	+	2.23	3.70E-01	1.00E00
lens morphogenesis in camera-type eye (GO:0002089)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
lens development in camera-type eye (GO:0002088)	89	0	1.73	-	 < 0.01	4.21E-01	1.00E00
regulation of heart rate by cardiac conduction (GO:0086091)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein depalmitoylation (GO:0002084)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
assembly of large subunit precursor of preribosome (GO:1902626)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of inositol phosphate biosynthetic process (GO:0010919)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative phosphorylation (GO:0002082)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil migration (GO:1902624)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate receptor signaling pathway (GO:1900449)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil migration (GO:1902622)	21	1	.41	+	2.45	3.46E-01	1.00E00
pyridoxine biosynthetic process (GO:0008615)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyridoxine metabolic process (GO:0008614)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
valyl-tRNA aminoacylation (GO:0006438)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ether lipid biosynthetic process (GO:0008611)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tyrosyl-tRNA aminoacylation (GO:0006437)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipid biosynthetic process (GO:0008610)	238	3	4.63	-	.65	6.35E-01	1.00E00
tryptophanyl-tRNA aminoacylation (GO:0006436)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
threonyl-tRNA aminoacylation (GO:0006435)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
seryl-tRNA aminoacylation (GO:0006434)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
prolyl-tRNA aminoacylation (GO:0006433)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
phenylalanyl-tRNA aminoacylation (GO:0006432)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
methionyl-tRNA aminoacylation (GO:0006431)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lysyl-tRNA aminoacylation (GO:0006430)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synapse structural plasticity (GO:0051823)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
osteoblast development (GO:0002076)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
extraocular skeletal muscle development (GO:0002074)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
non-replicative transposition, DNA-mediated (GO:0098038)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose metabolic process (GO:0010907)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
epithelial cell maturation (GO:0002070)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in cell fate commitment (GO:0045168)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
attachment of spindle microtubules to kinetochore (GO:0008608)	10	1	.19	+	5.14	1.91E-01	1.00E00
muscle attachment (GO:0016203)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of striated muscle tissue development (GO:0016202)	17	1	.33	+	3.02	2.93E-01	1.00E00
regulation of membrane permeability (GO:0090559)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of neuroinflammatory response (GO:0150077)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neuroinflammatory response (GO:0150076)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neural keel formation (GO:0014025)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
clustering of voltage-gated sodium channels (GO:0045162)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of endothelial intestinal barrier (GO:0090557)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
leucyl-tRNA aminoacylation (GO:0006429)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
neuronal ion channel clustering (GO:0045161)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
isoleucyl-tRNA aminoacylation (GO:0006428)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neural rod formation (GO:0014023)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histidyl-tRNA aminoacylation (GO:0006427)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycyl-tRNA aminoacylation (GO:0006426)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
secondary neural tube formation (GO:0014021)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutaminyl-tRNA aminoacylation (GO:0006425)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
primary neural tube formation (GO:0014020)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
glutamyl-tRNA aminoacylation (GO:0006424)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cysteinyl-tRNA aminoacylation (GO:0006423)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
disruption of cells of other organism involved in symbiotic interaction (GO:0051818)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
aspartyl-tRNA aminoacylation (GO:0006422)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modification of morphology or physiology of other organism involved in symbiotic interaction (GO:0051817)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
asparaginyl-tRNA aminoacylation (GO:0006421)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
Roundabout signaling pathway (GO:0035385)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endocytic iron import into cell (GO:0140298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
arginyl-tRNA aminoacylation (GO:0006420)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
thioester biosynthetic process (GO:0035384)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
thioester metabolic process (GO:0035383)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
glandular epithelial cell development (GO:0002068)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamate ADP-deribosylation (GO:0140291)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glandular epithelial cell differentiation (GO:0002067)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine ADP-deribosylation (GO:0140290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
columnar/cuboidal epithelial cell development (GO:0002066)	28	1	.54	+	1.84	4.28E-01	1.00E00
chondrocyte development (GO:0002063)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
chondrocyte differentiation (GO:0002062)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
neuron death (GO:0070997)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
proton transmembrane transport (GO:1902600)	62	0	1.21	-	 < 0.01	6.34E-01	1.00E00
neuroblast fate commitment (GO:0014017)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuroblast differentiation (GO:0014016)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of gliogenesis (GO:0014015)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
alanyl-tRNA aminoacylation (GO:0006419)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of gliogenesis (GO:0014014)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation for protein translation (GO:0006418)	37	0	.72	-	 < 0.01	1.00E00	1.00E00
translational termination (GO:0006415)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
translational elongation (GO:0006414)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
carbon dioxide transmembrane transport (GO:0035378)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
translational initiation (GO:0006413)	49	1	.95	+	1.05	6.19E-01	1.00E00
transepithelial water transport (GO:0035377)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule (GO:0035372)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell to AV node cell communication (GO:0086066)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endosome fission (GO:0140285)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to ATP (GO:0033198)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cell communication involved in cardiac conduction (GO:0086065)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cytolysis in other organism involved in symbiotic interaction (GO:0051801)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuroblast proliferation (GO:0002052)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
error-free translesion synthesis (GO:0070987)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
left/right axis specification (GO:0070986)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
dendrite guidance (GO:0070983)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-asparagine metabolic process (GO:0070982)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
homologous chromosome segregation (GO:0045143)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
L-asparagine biosynthetic process (GO:0070981)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
microglia development (GO:0014005)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tRNA export from nucleus (GO:0006409)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
microglia differentiation (GO:0014004)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
meiotic telomere clustering (GO:0045141)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
snRNA export from nucleus (GO:0006408)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte development (GO:0014003)	21	1	.41	+	2.45	3.46E-01	1.00E00
astrocyte development (GO:0014002)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of postsynapse assembly (GO:0150052)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mRNA export from nucleus (GO:0006406)	21	1	.41	+	2.45	3.46E-01	1.00E00
RNA import into nucleus (GO:0006404)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mRNA catabolic process (GO:0006402)	65	2	1.26	+	1.58	3.67E-01	1.00E00
RNA catabolic process (GO:0006401)	80	2	1.56	+	1.28	6.71E-01	1.00E00
tRNA modification (GO:0006400)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
thymine transport (GO:0035364)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone ubiquitination (GO:0033183)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of histone ubiquitination (GO:0033182)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cell migration involved in sprouting angiogenesis (GO:0002042)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
protein K11-linked ubiquitination (GO:0070979)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
voltage-gated calcium channel complex assembly (GO:0070978)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sprouting angiogenesis (GO:0002040)	83	1	1.61	-	.62	1.00E00	1.00E00
negative regulation of cellular response to oxidative stress (GO:1900408)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
development of primary sexual characteristics (GO:0045137)	14	1	.27	+	3.67	2.51E-01	1.00E00
regulation of cellular response to oxidative stress (GO:1900407)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein localization to endoplasmic reticulum exit site (GO:0070973)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein localization to endoplasmic reticulum (GO:0070972)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-10 secretion (GO:2001181)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
vesicle tethering involved in exocytosis (GO:0090522)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-10 secretion (GO:2001180)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sphingolipid mediated signaling pathway (GO:0090520)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
heme transmembrane transport (GO:0035351)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcineurin-NFAT signaling cascade (GO:0033173)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-10 secretion (GO:2001179)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
myo-inositol transport (GO:0015798)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular extravasation (GO:0045123)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to lysosome (GO:0150032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to lysosome (GO:0150031)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polyol transport (GO:0015791)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hypoxanthine transport (GO:0035344)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 demethylation (GO:0033169)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell-cell fusion (GO:0140253)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of sodium ion transport (GO:0002028)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
regulation of heart rate (GO:0002027)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation (GO:0086030)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
azole transport (GO:0045117)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein neddylation (GO:0045116)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
intermediate filament bundle assembly (GO:0045110)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
epiboly involved in wound healing (GO:0090505)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
epiboly (GO:0090504)	61	0	1.19	-	 < 0.01	6.33E-01	1.00E00
GDP-fucose transmembrane transport (GO:0015783)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
RNA phosphodiester bond hydrolysis (GO:0090501)	36	1	.70	+	1.43	5.10E-01	1.00E00
nucleotide-sugar transmembrane transport (GO:0015780)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
fatty-acyl-CoA metabolic process (GO:0035337)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
long-chain fatty-acyl-CoA metabolic process (GO:0035336)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell to AV node cell signaling (GO:0086026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of hippo signaling (GO:0035331)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of hippo signaling (GO:0035330)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0086023)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell receptor V(D)J recombination (GO:0033153)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
immunoglobulin V(D)J recombination (GO:0033152)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
V(D)J recombination (GO:0033151)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an epithelial sheet (GO:0002011)	79	2	1.54	+	1.30	6.69E-01	1.00E00
intermediate filament organization (GO:0045109)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of intermediate filament polymerization or depolymerization (GO:0045108)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neutrophil mediated killing of bacterium (GO:0070944)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neutrophil mediated killing of symbiont cell (GO:0070943)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intermediate filament cytoskeleton organization (GO:0045104)	23	1	.45	+	2.23	3.70E-01	1.00E00
neutrophil mediated cytotoxicity (GO:0070942)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intermediate filament-based process (GO:0045103)	23	1	.45	+	2.23	3.70E-01	1.00E00
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
hippo signaling (GO:0035329)	15	1	.29	+	3.43	2.65E-01	1.00E00
postsynaptic endocytosis (GO:0140239)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in cardiac conduction (GO:0086019)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
presynaptic endocytosis (GO:0140238)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
xylulose metabolic process (GO:0005997)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
monosaccharide metabolic process (GO:0005996)	60	0	1.17	-	 < 0.01	6.32E-01	1.00E00
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell action potential (GO:0086014)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during cardiac muscle cell action potential (GO:0086013)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during action potential (GO:0086011)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
trehalose metabolic process (GO:0005991)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during action potential (GO:0086010)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
protein K48-linked ubiquitination (GO:0070936)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
3'-UTR-mediated mRNA stabilization (GO:0070935)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histone H4 deacetylation (GO:0070933)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone H3 deacetylation (GO:0070932)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane repolarization (GO:0086009)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
sucrose biosynthetic process (GO:0005986)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-serine phosphorylation (GO:0033138)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac muscle cell action potential (GO:0086005)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sucrose metabolic process (GO:0005985)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-serine phosphorylation (GO:0033137)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell contraction (GO:0086004)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
disaccharide metabolic process (GO:0005984)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell contraction (GO:0086003)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-serine phosphorylation (GO:0033135)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell action potential involved in contraction (GO:0086002)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of programmed necrotic cell death (GO:0062098)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell action potential (GO:0086001)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
glycogen catabolic process (GO:0005980)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucokinase activity (GO:0033132)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glucokinase activity (GO:0033131)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
small RNA loading onto RISC (GO:0070922)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endocytic recycling (GO:2001135)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lipid biosynthetic process (GO:0046890)	31	1	.60	+	1.66	4.60E-01	1.00E00
negative regulation of protein dephosphorylation (GO:0035308)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
lamellipodium organization (GO:0097581)	9	1	.18	+	5.71	1.75E-01	1.00E00
regulation of protein dephosphorylation (GO:0035304)	21	1	.41	+	2.45	3.46E-01	1.00E00
glycogen biosynthetic process (GO:0005978)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
glycogen metabolic process (GO:0005977)	26	1	.51	+	1.98	4.06E-01	1.00E00
polysaccharide metabolic process (GO:0005976)	49	1	.95	+	1.05	6.19E-01	1.00E00
valine biosynthetic process (GO:0009099)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
leucine biosynthetic process (GO:0009098)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cysteine catabolic process (GO:0009093)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid biosynthetic process (GO:0046889)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of hormone secretion (GO:0046888)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
UV-damage excision repair (GO:0070914)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of hormone secretion (GO:0046887)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
monosaccharide transmembrane transport (GO:0015749)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
organophosphate ester transport (GO:0015748)	68	0	1.32	-	 < 0.01	6.43E-01	1.00E00
citrate transport (GO:0015746)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of hormone secretion (GO:0046883)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
sequestering of iron ion (GO:0097577)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
vacuole fusion (GO:0097576)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
succinate transport (GO:0015744)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
malate transport (GO:0015743)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial tube formation (GO:1905276)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
C4-dicarboxylate transport (GO:0015740)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
methionine biosynthetic process (GO:0009086)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
lysine biosynthetic process (GO:0009085)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glutamine family amino acid biosynthetic process (GO:0009084)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid catabolic process (GO:0009083)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid biosynthetic process (GO:0009082)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid metabolic process (GO:0009081)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
pyruvate family amino acid catabolic process (GO:0009080)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
hormone secretion (GO:0046879)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
sialic acid transport (GO:0015739)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA methylation (GO:0070901)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
quinolinate metabolic process (GO:0046874)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA modification (GO:0070900)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin organization (GO:1905269)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
taurine transport (GO:0015734)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage involved in tRNA processing (GO:1905267)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex assembly (GO:0033108)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
pyruvate family amino acid metabolic process (GO:0009078)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family catabolic process (GO:0009074)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family biosynthetic process (GO:0009073)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family metabolic process (GO:0009072)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
serine family amino acid catabolic process (GO:0009071)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
serine family amino acid biosynthetic process (GO:0009070)	14	1	.27	+	3.67	2.51E-01	1.00E00
oxaloacetate transport (GO:0015729)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
terpenoid transport (GO:0046865)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
isoprenoid transport (GO:0046864)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
calcium ion transmembrane import into cytosol (GO:0097553)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
bile acid and bile salt transport (GO:0015721)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mitochondrial double-strand break repair via homologous recombination (GO:0097552)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial double-strand break repair (GO:0097551)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to plasma membrane (GO:1903078)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to plasma membrane (GO:1903077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to plasma membrane (GO:1903076)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
serine family amino acid metabolic process (GO:0009069)	29	1	.56	+	1.77	4.39E-01	1.00E00
aspartate family amino acid catabolic process (GO:0009068)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid biosynthetic process (GO:0009067)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid metabolic process (GO:0009066)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
glutamine family amino acid catabolic process (GO:0009065)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
glutamine family amino acid metabolic process (GO:0009064)	49	1	.95	+	1.05	6.19E-01	1.00E00
cellular amino acid catabolic process (GO:0009063)	78	0	1.52	-	 < 0.01	4.09E-01	1.00E00
fatty acid catabolic process (GO:0009062)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
aerobic respiration (GO:0009060)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol dephosphorylation (GO:0046856)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
monocarboxylic acid transport (GO:0015718)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
inositol phosphate dephosphorylation (GO:0046855)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol phosphorylation (GO:0046854)	42	2	.82	+	2.45	2.05E-01	1.00E00
regulation of modification of synaptic structure (GO:1905244)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to drug (GO:0042493)	211	1	4.11	-	.24	1.98E-01	1.00E00
macromolecule biosynthetic process (GO:0009059)	837	16	16.28	-	.98	1.00E00	1.00E00
biosynthetic process (GO:0009058)	1494	22	29.07	-	.76	2.07E-01	1.00E00
negative regulation of protein lipidation (GO:1903060)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
macromolecule catabolic process (GO:0009057)	551	14	10.72	+	1.31	3.47E-01	1.00E00
catabolic process (GO:0009056)	1100	20	21.40	-	.93	9.11E-01	1.00E00
pentose-phosphate shunt, non-oxidative branch (GO:0009052)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid transport (GO:0001579)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt, oxidative branch (GO:0009051)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
microtubule bundle formation (GO:0001578)	43	1	.84	+	1.20	5.72E-01	1.00E00
ganglioside biosynthetic process (GO:0001574)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
thiosulfate transport (GO:0015709)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ganglioside metabolic process (GO:0001573)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
chorion micropyle formation (GO:0046844)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vasculogenesis (GO:0001570)	47	1	.91	+	1.09	6.04E-01	1.00E00
thymus epithelium morphogenesis (GO:0097536)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lymphoid lineage cell migration into thymus (GO:0097535)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
lymphoid lineage cell migration (GO:0097534)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
bicarbonate transport (GO:0015701)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
granulocyte migration (GO:0097530)	79	0	1.54	-	 < 0.01	4.09E-01	1.00E00
regulation of protein lipidation (GO:1903059)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular matrix organization (GO:1903055)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix organization (GO:1903053)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
dosage compensation by inactivation of X chromosome (GO:0009048)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)	43	1	.84	+	1.20	5.72E-01	1.00E00
branching involved in blood vessel morphogenesis (GO:0001569)	13	1	.25	+	3.95	2.36E-01	1.00E00
blood vessel development (GO:0001568)	325	8	6.32	+	1.27	4.23E-01	1.00E00
negative regulation of stress granule assembly (GO:0062030)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phospholipid dephosphorylation (GO:0046839)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
phosphorylated carbohydrate dephosphorylation (GO:0046838)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
glycolipid transport (GO:0046836)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
carbohydrate phosphorylation (GO:0046835)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
myeloid leukocyte migration (GO:0097529)	84	0	1.63	-	 < 0.01	4.14E-01	1.00E00
response to protozoan (GO:0001562)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lipid phosphorylation (GO:0046834)	52	2	1.01	+	1.98	2.76E-01	1.00E00
fatty acid alpha-oxidation (GO:0001561)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
modulation of signal transduction in other organism involved in symbiotic interaction (GO:0052250)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
epicardium morphogenesis (GO:1905223)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
atrioventricular canal morphogenesis (GO:1905222)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of eye photoreceptor cell development (GO:0042478)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adhesion of symbiont to host cell (GO:0044650)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neural crest cell migration involved in sympathetic nervous system development (GO:1903045)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
odontogenesis of dentin-containing tooth (GO:0042475)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte hypertrophy (GO:1903041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of stress granule assembly (GO:0062028)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-13 production (GO:0032696)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-12 production (GO:0032695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oocyte maturation (GO:0001556)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-10 production (GO:0032693)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oocyte growth (GO:0001555)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modulation of programmed cell death in other organism involved in symbiotic interaction (GO:0052248)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleocytoplasmic transport (GO:0046823)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 dimethylation (GO:0044648)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
base-excision repair, AP site formation via deaminated base removal (GO:0097510)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell differentiation involved in kidney development (GO:2000696)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte cell-cell adhesion (GO:1903037)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to wounding (GO:1903036)	10	1	.19	+	5.14	1.91E-01	1.00E00
negative regulation of response to wounding (GO:1903035)	9	1	.18	+	5.71	1.75E-01	1.00E00
regulation of cardiac muscle cell myoblast differentiation (GO:2000690)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-gamma production (GO:0032689)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of small molecule metabolic process (GO:0062014)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of small molecule metabolic process (GO:0062013)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of tumor necrosis factor production (GO:0032680)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ovarian follicle development (GO:0001541)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiocyte differentiation (GO:1905209)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiocyte differentiation (GO:1905208)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiocyte differentiation (GO:1905207)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
sialylation (GO:0097503)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mannosylation (GO:0097502)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
stress response to metal ion (GO:0097501)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
receptor localization to non-motile cilium (GO:0097500)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ribonucleoside biosynthetic process (GO:0042455)	22	1	.43	+	2.34	3.58E-01	1.00E00
ribonucleoside catabolic process (GO:0042454)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
secondary palate development (GO:0062009)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
purine nucleoside biosynthetic process (GO:0042451)	22	1	.43	+	2.34	3.58E-01	1.00E00
arginine biosynthetic process via ornithine (GO:0042450)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-8 production (GO:0032677)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cilium or flagellum-dependent cell motility (GO:0001539)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-6 production (GO:0032675)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-5 production (GO:0032674)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation (GO:0030497)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of transmembrane transporter activity (GO:0022898)	74	0	1.44	-	 < 0.01	4.08E-01	1.00E00
maturation of SSU-rRNA (GO:0030490)	33	1	.64	+	1.56	4.81E-01	1.00E00
regulation of transcription regulatory region DNA binding (GO:2000677)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycoprotein metabolic process (GO:1903019)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glycoprotein metabolic process (GO:1903018)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
progesterone metabolic process (GO:0042448)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hormone catabolic process (GO:0042447)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
hormone biosynthetic process (GO:0042446)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
hormone metabolic process (GO:0042445)	54	0	1.05	-	 < 0.01	6.28E-01	1.00E00
positive regulation of bone development (GO:1903012)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone development (GO:1903011)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
eye pigment metabolic process (GO:0042441)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of bone development (GO:1903010)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-2 production (GO:0032663)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
angiogenesis (GO:0001525)	211	5	4.11	+	1.22	6.12E-01	1.00E00
tRNA methylation (GO:0030488)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
retinoid metabolic process (GO:0001523)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
pseudouridine synthesis (GO:0001522)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
ethanolamine-containing compound metabolic process (GO:0042439)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-13 secretion (GO:2000666)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
organelle disassembly (GO:1903008)	41	1	.80	+	1.25	5.55E-01	1.00E00
melanin biosynthetic process (GO:0042438)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-13 secretion (GO:2000665)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
indole-containing compound catabolic process (GO:0042436)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-5 secretion (GO:2000663)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
indole-containing compound biosynthetic process (GO:0042435)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-5 secretion (GO:2000662)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to fatty acid (GO:0071398)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein deubiquitination (GO:1903003)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1-mediated signaling pathway (GO:2000660)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to lipid (GO:0071396)	69	0	1.34	-	 < 0.01	6.44E-01	1.00E00
indole-containing compound metabolic process (GO:0042430)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
cellular response to estradiol stimulus (GO:0071392)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to estrogen stimulus (GO:0071391)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-13 production (GO:0032656)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-12 production (GO:0032655)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
prostaglandin biosynthetic process (GO:0001516)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-10 production (GO:0032653)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1 production (GO:0032652)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
selenocysteine incorporation (GO:0001514)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1 beta production (GO:0032651)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
RNA methylation (GO:0001510)	41	0	.80	-	 < 0.01	1.00E00	1.00E00
spindle pole body duplication (GO:0030474)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear migration along microtubule (GO:0030473)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1-mediated signaling pathway (GO:2000659)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
serotonin metabolic process (GO:0042428)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
serotonin biosynthetic process (GO:0042427)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
catecholamine catabolic process (GO:0042424)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium ion transmembrane transporter activity (GO:2000651)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
catecholamine biosynthetic process (GO:0042423)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium ion transmembrane transporter activity (GO:2000650)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
norepinephrine biosynthetic process (GO:0042421)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to glucocorticoid stimulus (GO:0071385)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
dopamine catabolic process (GO:0042420)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to corticosteroid stimulus (GO:0071384)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to steroid hormone stimulus (GO:0071383)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-gamma production (GO:0032649)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-beta production (GO:0032648)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to prostaglandin E stimulus (GO:0071380)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-alpha production (GO:0032647)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
action potential (GO:0001508)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter levels (GO:0001505)	122	0	2.37	-	 < 0.01	1.79E-01	1.00E00
regulation of chemokine production (GO:0032642)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurotransmitter uptake (GO:0001504)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
tumor necrosis factor production (GO:0032640)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of sodium ion transmembrane transporter activity (GO:2000649)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
positive regulation of stem cell proliferation (GO:2000648)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dopamine metabolic process (GO:0042417)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
dopamine biosynthetic process (GO:0042416)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
norepinephrine metabolic process (GO:0042415)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to prostaglandin stimulus (GO:0071379)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of early endosome to late endosome transport (GO:2000641)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to growth hormone stimulus (GO:0071378)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
taurine biosynthetic process (GO:0042412)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to corticotropin-releasing hormone stimulus (GO:0071376)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to peptide hormone stimulus (GO:0071375)	57	1	1.11	-	.90	1.00E00	1.00E00
positive regulation of gene silencing by miRNA (GO:2000637)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cristae formation (GO:0042407)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
protein myristoylation (GO:0018377)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
thyroid hormone metabolic process (GO:0042403)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular biogenic amine catabolic process (GO:0042402)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular biogenic amine biosynthetic process (GO:0042401)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to epidermal growth factor stimulus (GO:0071364)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axon midline choice point recognition (GO:0016199)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
axon choice point recognition (GO:0016198)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to ethanol (GO:0071361)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride catabolic process (GO:0010898)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endosomal transport (GO:0016197)	104	1	2.02	-	.49	7.26E-01	1.00E00
cellular response to exogenous dsRNA (GO:0071360)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride catabolic process (GO:0010896)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
calcium activated phospholipid scrambling (GO:0061588)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid biosynthetic process (GO:0010893)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of complement activation (GO:0030449)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anterior/posterior axis specification, embryo (GO:0008595)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell morphogenesis (GO:0008594)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Notch signaling pathway (GO:0008593)	50	2	.97	+	2.06	2.61E-01	1.00E00
regulation of Toll signaling pathway (GO:0008592)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to dsRNA (GO:0071359)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to type I interferon (GO:0071357)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular response to tumor necrosis factor (GO:0071356)	48	0	.93	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamine methylation (GO:0018364)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle maturation (GO:0016188)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid storage (GO:0010888)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-15 (GO:0071350)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol storage (GO:0010887)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol storage (GO:0010885)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of lipid storage (GO:0010883)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding from endosome (GO:0016182)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
snRNA processing (GO:0016180)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
male gonad development (GO:0008584)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament bundle retrograde transport (GO:0061573)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
actin filament bundle organization (GO:0061572)	54	1	1.05	-	.95	1.00E00	1.00E00
ubiquitin-dependent ERAD pathway (GO:0030433)	51	2	.99	+	2.02	2.68E-01	1.00E00
peristalsis (GO:0030432)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sleep (GO:0030431)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid catabolic process (GO:0051793)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid metabolic process (GO:0051791)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-1 (GO:0071347)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
cellular response to interferon-gamma (GO:0071346)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
cellular response to cytokine stimulus (GO:0071345)	131	0	2.55	-	 < 0.01	1.86E-01	1.00E00
skeletal muscle acetylcholine-gated channel clustering (GO:0071340)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
type I interferon production (GO:0032606)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol efflux (GO:0010874)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol esterification (GO:0010873)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol esterification (GO:0010872)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
chemokine production (GO:0032602)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA metabolic process (GO:0006399)	122	0	2.37	-	 < 0.01	1.79E-01	1.00E00
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
termination of mitochondrial transcription (GO:0006393)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to misfolded protein (GO:0051788)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
transcription elongation from mitochondrial promoter (GO:0006392)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transcription initiation from mitochondrial promoter (GO:0006391)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial transcription (GO:0006390)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear division (GO:0051784)	15	1	.29	+	3.43	2.65E-01	1.00E00
negative regulation of cell division (GO:0051782)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell division (GO:0051781)	18	1	.35	+	2.86	3.07E-01	1.00E00
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein palmitoylation (GO:0018345)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
protein geranylgeranylation (GO:0018344)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein farnesylation (GO:0018343)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to glucose stimulus (GO:0071333)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
protein prenylation (GO:0018342)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular response to hexose stimulus (GO:0071331)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride biosynthetic process (GO:0010867)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride biosynthetic process (GO:0010866)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of serine-type peptidase activity (GO:1902572)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of serine-type peptidase activity (GO:1902571)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase C activity (GO:0010863)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
termination of RNA polymerase III transcription (GO:0006386)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transcription initiation from RNA polymerase III promoter (GO:0006384)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
transcription by RNA polymerase III (GO:0006383)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
adenosine to inosine editing (GO:0006382)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to monosaccharide stimulus (GO:0071326)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
protein succinylation (GO:0018335)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to carbohydrate stimulus (GO:0071322)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to cAMP (GO:0071320)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
sympathetic ganglion development (GO:0061549)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ganglion development (GO:0061548)	9	1	.18	+	5.71	1.75E-01	1.00E00
viral RNA genome replication (GO:0039694)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic plasticity by receptor localization to synapse (GO:1900383)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mRNA cleavage (GO:0006379)	10	1	.19	+	5.14	1.91E-01	1.00E00
mRNA polyadenylation (GO:0006378)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
mRNA splice site selection (GO:0006376)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
7-methylguanosine mRNA capping (GO:0006370)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
actin crosslink formation (GO:0051764)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to cocaine (GO:0071314)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to alkaloid (GO:0071312)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative stranded viral RNA replication (GO:0039689)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular response to organic substance (GO:0071310)	592	9	11.52	-	.78	5.47E-01	1.00E00
retina layer formation (GO:0010842)	41	2	.80	+	2.51	1.98E-01	1.00E00
epidermis development (GO:0008544)	77	3	1.50	+	2.00	1.97E-01	1.00E00
regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of purine nucleotide biosynthetic process (GO:1900373)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell migration (GO:0090497)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
termination of RNA polymerase II transcription (GO:0006369)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of purine nucleotide biosynthetic process (GO:1900371)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
transcription elongation from RNA polymerase II promoter (GO:0006368)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
transcription initiation from RNA polymerase II promoter (GO:0006367)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
dopamine uptake (GO:0090494)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
transcription by RNA polymerase II (GO:0006366)	72	1	1.40	-	.71	1.00E00	1.00E00
catecholamine uptake (GO:0090493)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
rRNA processing (GO:0006364)	114	1	2.22	-	.45	7.29E-01	1.00E00
termination of RNA polymerase I transcription (GO:0006363)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
transcription elongation from RNA polymerase I promoter (GO:0006362)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
transcription initiation from RNA polymerase I promoter (GO:0006361)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
transcription by RNA polymerase I (GO:0006360)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal lipid absorption (GO:1904729)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein C-linked glycosylation via tryptophan (GO:0018317)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin D (GO:0071305)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
glycoside catabolic process (GO:0016139)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
glycoside metabolic process (GO:0016137)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to retinoic acid (GO:0071300)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomere lengthening (GO:0010833)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA polyadenylation (GO:1900365)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex IV assembly (GO:0008535)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of myotube differentiation (GO:0010831)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA polyadenylation (GO:1900364)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of myotube differentiation (GO:0010830)	10	1	.19	+	5.14	1.91E-01	1.00E00
regulation of transcription by RNA polymerase III (GO:0006359)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription, elongation (GO:0006354)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription, termination (GO:0006353)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
purine nucleotide-sugar transmembrane transport (GO:0090480)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription, initiation (GO:0006352)	45	2	.88	+	2.28	2.26E-01	1.00E00
transcription, DNA-templated (GO:0006351)	181	5	3.52	+	1.42	4.10E-01	1.00E00
phytosteroid biosynthetic process (GO:0016129)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucose transmembrane transport (GO:0010829)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phytosteroid metabolic process (GO:0016128)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose transmembrane transport (GO:0010828)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sterol catabolic process (GO:0016127)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of glucose transmembrane transport (GO:0010827)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
sterol biosynthetic process (GO:0016126)	27	1	.53	+	1.90	4.17E-01	1.00E00
positive regulation of intracellular signal transduction (GO:1902533)	264	8	5.14	+	1.56	1.84E-01	1.00E00
sterol metabolic process (GO:0016125)	48	1	.93	+	1.07	6.11E-01	1.00E00
positive regulation of innate immune response (GO:0045089)	40	1	.78	+	1.28	5.46E-01	1.00E00
negative regulation of intracellular signal transduction (GO:1902532)	114	3	2.22	+	1.35	4.91E-01	1.00E00
positive regulation of centrosome duplication (GO:0010825)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of innate immune response (GO:0045088)	55	1	1.07	-	.93	1.00E00	1.00E00
xanthophyll biosynthetic process (GO:0016123)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
innate immune response (GO:0045087)	136	2	2.65	-	.76	1.00E00	1.00E00
negative regulation of mitochondrion organization (GO:0010823)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xanthophyll metabolic process (GO:0016122)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrion organization (GO:0010822)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
carotene catabolic process (GO:0016121)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrion organization (GO:0010821)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
myeloid cell development (GO:0061515)	54	1	1.05	-	.95	1.00E00	1.00E00
regulation of gene expression by genetic imprinting (GO:0006349)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to cilium (GO:0061512)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
chromatin silencing at telomere (GO:0006348)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
centriole elongation (GO:0061511)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein monoubiquitination (GO:1902527)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
carotene metabolic process (GO:0016119)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of protein monoubiquitination (GO:1902525)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
carotenoid biosynthetic process (GO:0016117)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of hormone levels (GO:0010817)	96	1	1.87	-	.54	1.00E00	1.00E00
carotenoid metabolic process (GO:0016116)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
terpenoid catabolic process (GO:0016115)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
terpenoid biosynthetic process (GO:0016114)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-gamma biosynthetic process (GO:0045078)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-substrate adhesion (GO:0010812)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-12 biosynthetic process (GO:0045075)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell-substrate adhesion (GO:0010811)	10	1	.19	+	5.14	1.91E-01	1.00E00
regulation of interferon-gamma biosynthetic process (GO:0045072)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral genome replication (GO:0045070)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA replication-dependent nucleosome assembly (GO:0006335)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of tube diameter (GO:0035296)	57	1	1.11	-	.90	1.00E00	1.00E00
tetraterpenoid biosynthetic process (GO:0016109)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tetraterpenoid metabolic process (GO:0016108)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle priming (GO:0010807)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of organelle transport along microtubule (GO:1902513)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of viral genome replication (GO:0045069)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
triterpenoid biosynthetic process (GO:0016104)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
diterpenoid catabolic process (GO:0016103)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
diterpenoid biosynthetic process (GO:0016102)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
diterpenoid metabolic process (GO:0016101)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-threonine phosphorylation (GO:0010801)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
T-helper 2 cell differentiation (GO:0045064)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thymic T cell selection (GO:0045061)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative thymic T cell selection (GO:0045060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to stimulus (GO:0051716)	4068	82	79.15	+	1.04	7.08E-01	1.00E00
brain segmentation (GO:0035284)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cytolysis in other organism (GO:0051715)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
central nervous system segmentation (GO:0035283)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of killing of cells of other organism (GO:0051712)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA wobble uridine modification (GO:0070899)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint (GO:1902504)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA polymerase III preinitiation complex assembly (GO:0070898)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
transcription preinitiation complex assembly (GO:0070897)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
T cell selection (GO:0045058)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
transcytosis (GO:0045056)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulated exocytosis (GO:0045055)	69	0	1.34	-	 < 0.01	6.44E-01	1.00E00
miRNA mediated inhibition of translation (GO:0035278)	10	1	.19	+	5.14	1.91E-01	1.00E00
regulation of killing of cells of other organism (GO:0051709)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transposition, DNA-mediated (GO:0006313)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mitotic recombination (GO:0006312)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
response to other organism (GO:0051707)	327	4	6.36	-	.63	5.39E-01	1.00E00
multi-organism behavior (GO:0051705)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
multi-organism process (GO:0051704)	474	6	9.22	-	.65	3.96E-01	1.00E00
intraspecies interaction between organisms (GO:0051703)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
interaction with symbiont (GO:0051702)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interaction with host (GO:0051701)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to chemical stimulus (GO:0070887)	825	11	16.05	-	.69	2.46E-01	1.00E00
protein insertion into ER membrane (GO:0045048)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein targeting to ER (GO:0045047)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome membrane (GO:0045046)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of calcineurin-NFAT signaling cascade (GO:0070884)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein import into mitochondrial intermembrane space (GO:0045041)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
DNA catabolic process (GO:0006308)	14	1	.27	+	3.67	2.51E-01	1.00E00
DNA dealkylation involved in DNA repair (GO:0006307)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
DNA methylation (GO:0006306)	13	1	.25	+	3.95	2.36E-01	1.00E00
DNA alkylation (GO:0006305)	13	1	.25	+	3.95	2.36E-01	1.00E00
protein O-linked mannosylation (GO:0035269)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
protein mannosylation (GO:0035268)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via nonhomologous end joining (GO:0006303)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
postreplication repair (GO:0006301)	17	1	.33	+	3.02	2.93E-01	1.00E00
organ growth (GO:0035265)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
multicellular organism growth (GO:0035264)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
gonad morphogenesis (GO:0035262)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial inner membrane (GO:0045039)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
T cell differentiation in thymus (GO:0033077)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
heterochromatin assembly involved in chromatin silencing (GO:0070869)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heterochromatin organization involved in chromatin silencing (GO:0070868)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
plasma membrane fusion (GO:0045026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein exit from endoplasmic reticulum (GO:0070863)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
inorganic anion transport (GO:0015698)	89	0	1.73	-	 < 0.01	4.21E-01	1.00E00
regulation of protein exit from endoplasmic reticulum (GO:0070861)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
quaternary ammonium group transport (GO:0015697)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
early endosome to late endosome transport (GO:0045022)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
ammonium transport (GO:0015696)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
organic cation transport (GO:0015695)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
magnesium ion transport (GO:0015693)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, glutamatergic (GO:0035249)	40	0	.78	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine N-methylation (GO:0035246)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycerolipid biosynthetic process (GO:0045017)	71	2	1.38	+	1.45	4.07E-01	1.00E00
mitochondrial magnesium ion transmembrane transport (GO:0045016)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
molybdate ion transport (GO:0015689)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
organophosphate biosynthetic process (GO:0090407)	284	5	5.53	-	.90	1.00E00	1.00E00
actin nucleation (GO:0045010)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
vitamin A biosynthetic process (GO:0035238)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ionotropic glutamate receptor signaling pathway (GO:0035235)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular pigmentation (GO:0033059)	48	2	.93	+	2.14	2.47E-01	1.00E00
directional locomotion (GO:0033058)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to epidermal growth factor (GO:0070849)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA-dependent DNA replication maintenance of fidelity (GO:0045005)	17	1	.33	+	3.02	2.93E-01	1.00E00
double-strand break repair via synthesis-dependent strand annealing (GO:0045003)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
reactive nitrogen species metabolic process (GO:2001057)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
copper ion import (GO:0015677)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via single-strand annealing (GO:0045002)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
monovalent inorganic cation transport (GO:0015672)	260	2	5.06	-	.40	2.51E-01	1.00E00
positive regulation of glutamate-cysteine ligase activity (GO:0035229)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oxygen transport (GO:0015671)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
carbon dioxide transport (GO:0015670)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate-cysteine ligase activity (GO:0035227)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic sister chromatid segregation (GO:0033048)	10	1	.19	+	5.14	1.91E-01	1.00E00
negative regulation of sister chromatid segregation (GO:0033046)	10	1	.19	+	5.14	1.91E-01	1.00E00
divalent metal ion transport (GO:0070838)	167	1	3.25	-	.31	3.85E-01	1.00E00
caveola assembly (GO:0070836)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
gas transport (GO:0015669)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
basement membrane assembly (GO:0070831)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
protein localization to non-motile cilium (GO:0097499)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin-mediated signaling pathway (GO:2001046)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
bicellular tight junction assembly (GO:0070830)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
endothelial tube lumen extension (GO:0097498)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin-mediated signaling pathway (GO:2001045)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell delamination (GO:0097497)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of integrin-mediated signaling pathway (GO:2001044)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
blood vessel lumen ensheathment (GO:0097496)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
macromolecule localization (GO:0033036)	1127	16	21.93	-	.73	2.23E-01	1.00E00
positive regulation of myeloid cell apoptotic process (GO:0033034)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid cell apoptotic process (GO:0033032)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil apoptotic process (GO:0033031)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
chromatin maintenance (GO:0070827)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to drug (GO:2001038)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of double-strand break repair via nonhomologous end joining (GO:2001032)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
dendrite extension (GO:0097484)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil apoptotic process (GO:0033029)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
export across plasma membrane (GO:0140115)	17	1	.33	+	3.02	2.93E-01	1.00E00
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle localization (GO:0097479)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
lateral motor column neuron migration (GO:0097477)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle tissue regeneration (GO:1905179)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spinal cord motor neuron migration (GO:0097476)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of response to drug (GO:2001023)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to DNA damage stimulus (GO:2001022)	26	1	.51	+	1.98	4.06E-01	1.00E00
negative regulation of response to DNA damage stimulus (GO:2001021)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole biosynthetic process (GO:0033014)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole metabolic process (GO:0033013)	29	1	.56	+	1.77	4.39E-01	1.00E00
neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
protein autophosphorylation (GO:0046777)	273	2	5.31	-	.38	1.84E-01	1.00E00
signal release from synapse (GO:0099643)	61	0	1.19	-	 < 0.01	6.33E-01	1.00E00
positive regulation of skeletal muscle cell differentiation (GO:2001016)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axo-dendritic protein transport (GO:0099640)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle cell differentiation (GO:2001014)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of double-strand break repair via homologous recombination (GO:1905168)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell activation involved in immune response (GO:0033006)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell activation (GO:0033005)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell activation (GO:0033003)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
muscle cell proliferation (GO:0033002)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
endosome to plasma membrane protein transport (GO:0099638)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport (GO:0099637)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
anterior lateral line nerve glial cell morphogenesis involved in differentiation (GO:0048940)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein localization to postsynaptic specialization membrane (GO:0099633)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane invagination (GO:1905155)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of membrane invagination (GO:1905153)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anterior lateral line nerve glial cell development (GO:0048939)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system neuron axonogenesis (GO:0048936)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system neuron development (GO:0048935)	18	1	.35	+	2.86	3.07E-01	1.00E00
peripheral nervous system neuron differentiation (GO:0048934)	18	1	.35	+	2.86	3.07E-01	1.00E00
neurotransmitter receptor diffusion trapping (GO:0099628)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
afferent axon development in posterior lateral line nerve (GO:0048933)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell membrane repolarization (GO:0099623)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
viral budding (GO:0046755)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell membrane repolarization (GO:0099622)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to acetylcholine (GO:1905145)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
response to acetylcholine (GO:1905144)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
cellular modified amino acid biosynthetic process (GO:0042398)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
[2Fe-2S] cluster assembly (GO:0044571)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
phosphagen biosynthetic process (GO:0042396)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of membrane potential (GO:0042391)	166	2	3.23	-	.62	7.75E-01	1.00E00
efferent axon development in posterior lateral line nerve (GO:0048929)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
posterior lateral line neuromast mantle cell differentiation (GO:0048924)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
posterior lateral line neuromast deposition (GO:0048922)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
protein localization to axon (GO:0099612)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
chondrocyte activation (GO:0044566)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic chromosome separation (GO:1905133)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic chromosome separation (GO:1905132)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
posterior lateral line nerve development (GO:0048918)	9	1	.18	+	5.71	1.75E-01	1.00E00
posterior lateral line ganglion development (GO:0048917)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myelination of anterior lateral line nerve axons (GO:0048914)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
anterior lateral line nerve glial cell differentiation (GO:0048913)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein maturation by iron-sulfur cluster transfer (GO:0097428)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter receptor activity (GO:0099601)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
positive regulation by symbiont of host apoptotic process (GO:0052151)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host apoptotic process (GO:0052150)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vitamin K metabolic process (GO:0042373)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
vitamin K biosynthetic process (GO:0042371)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anterior lateral line nerve development (GO:0048909)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H4-K20 trimethylation (GO:0034773)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histone H4-K20 methylation (GO:0034770)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
anterior lateral line neuromast hair cell differentiation (GO:0048903)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein transport within lipid bilayer (GO:0032594)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anterior lateral line neuromast development (GO:0048901)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
basement membrane disassembly (GO:0034769)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
water-soluble vitamin biosynthetic process (GO:0042364)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin catabolic process (GO:0042363)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of ion transmembrane transport (GO:0034767)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin biosynthetic process (GO:0042362)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of ion transmembrane transport (GO:0034766)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
vitamin E metabolic process (GO:0042360)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transmembrane transport (GO:0034764)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of transmembrane transport (GO:0034763)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
viral entry into host cell (GO:0046718)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
acid secretion (GO:0046717)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
muscle cell cellular homeostasis (GO:0046716)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid import into cell (GO:0044539)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
vitamin D metabolic process (GO:0042359)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modulation of apoptotic process in other organism (GO:0044532)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modulation of programmed cell death in other organism (GO:0044531)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
thiamine diphosphate metabolic process (GO:0042357)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000582)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000580)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose salvage (GO:0042352)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
'de novo' GDP-L-fucose biosynthetic process (GO:0042351)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
iron ion transmembrane transport (GO:0034755)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose biosynthetic process (GO:0042350)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular hormone metabolic process (GO:0034754)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
response to vitamin K (GO:0032571)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to progesterone (GO:0032570)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
heterocycle catabolic process (GO:0046700)	158	5	3.07	+	1.63	2.44E-01	1.00E00
positive regulation of microtubule motor activity (GO:2000576)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule motor activity (GO:2000574)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
fructose 1,6-bisphosphate metabolic process (GO:0030388)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin (GO:0071295)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to zinc ion (GO:0071294)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
modulation of signal transduction in other organism (GO:0044501)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphorylation (GO:0042327)	351	8	6.83	+	1.17	5.61E-01	1.00E00
negative regulation of phosphorylation (GO:0042326)	61	0	1.19	-	 < 0.01	6.33E-01	1.00E00
regulation of phosphorylation (GO:0042325)	495	11	9.63	+	1.14	6.21E-01	1.00E00
protein-chromophore linkage (GO:0018298)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
histone H3-K79 methylation (GO:0034729)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
piecemeal microautophagy of the nucleus (GO:0034727)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein-FAD linkage (GO:0018293)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA replication-dependent nucleosome organization (GO:0034723)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to iron ion (GO:0071281)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 demethylation (GO:0034720)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial translation (GO:0032543)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastrulation (GO:2000543)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastrulation (GO:2000542)	11	1	.21	+	4.67	2.06E-01	1.00E00
cellular response to calcium ion (GO:0071277)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
cellular response to cadmium ion (GO:0071276)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vasodilation (GO:0042311)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vasoconstriction (GO:0042310)	23	1	.45	+	2.23	3.70E-01	1.00E00
iron incorporation into metallo-sulfur cluster (GO:0018283)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic translational initiation (GO:1904690)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
metal incorporation into metallo-sulfur cluster (GO:0018282)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell projection size (GO:0032536)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cellular component size (GO:0032535)	210	7	4.09	+	1.71	2.02E-01	1.00E00
regulation of microvillus assembly (GO:0032534)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of microvillus organization (GO:0032530)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to environmental stimulus (GO:0104004)	73	0	1.42	-	 < 0.01	6.52E-01	1.00E00
negative regulation of protein import into nucleus (GO:0042308)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational initiation (GO:1904688)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein import into nucleus (GO:0042306)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein N-linked glycosylation via asparagine (GO:0018279)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid biosynthetic process (GO:0042304)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
L-methionine salvage (GO:0071267)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
L-methionine biosynthetic process (GO:0071265)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation in response to starvation (GO:0071264)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation in response to starvation (GO:0071262)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-threonine phosphorylation (GO:0010799)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
microvillus organization (GO:0032528)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to mechanical stimulus (GO:0071260)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein exit from endoplasmic reticulum (GO:0032527)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
polyprenol catabolic process (GO:0016095)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to retinoic acid (GO:0032526)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
polyprenol biosynthetic process (GO:0016094)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
somite rostral/caudal axis specification (GO:0032525)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
polyprenol metabolic process (GO:0016093)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA export from nucleus (GO:0010793)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell homeostasis (GO:0061484)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphoprotein phosphatase activity (GO:0032516)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphoprotein phosphatase activity (GO:0032515)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to platelet aggregation inhibitor (GO:0061478)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle priming (GO:0016082)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle docking (GO:0016081)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell migration (GO:0030336)	38	2	.74	+	2.71	1.77E-01	1.00E00
positive regulation of cell migration (GO:0030335)	79	3	1.54	+	1.95	2.06E-01	1.00E00
karyomere membrane fusion (GO:0061472)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction by p53 class mediator (GO:0030330)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament uncapping (GO:0051695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
actin filament capping (GO:0051693)	25	1	.49	+	2.06	3.94E-01	1.00E00
negative regulation of ubiquitin protein ligase activity (GO:1904667)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to metal ion (GO:0071248)	40	0	.78	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle exocytosis (GO:0016079)	52	0	1.01	-	 < 0.01	6.28E-01	1.00E00
cellular response to ammonium ion (GO:0071242)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
tRNA catabolic process (GO:0016078)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
endosome transport via multivesicular body sorting pathway (GO:0032509)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
cellular response to inorganic substance (GO:0071241)	41	0	.80	-	 < 0.01	1.00E00	1.00E00
snoRNA catabolic process (GO:0016077)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
snRNA catabolic process (GO:0016076)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in cell (GO:0032507)	33	1	.64	+	1.56	4.81E-01	1.00E00
rRNA catabolic process (GO:0016075)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
snoRNA metabolic process (GO:0016074)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of type B pancreatic cell proliferation (GO:0061469)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
snRNA metabolic process (GO:0016073)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
multicellular organism reproduction (GO:0032504)	119	3	2.32	+	1.30	5.07E-01	1.00E00
rRNA metabolic process (GO:0016072)	120	1	2.33	-	.43	7.32E-01	1.00E00
prenylcysteine metabolic process (GO:0030329)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
prenylcysteine catabolic process (GO:0030328)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
prenylated protein catabolic process (GO:0030327)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
adrenal gland development (GO:0030325)	13	1	.25	+	3.95	2.36E-01	1.00E00
protein localization to lysosome (GO:0061462)	17	1	.33	+	3.02	2.93E-01	1.00E00
mismatch repair (GO:0006298)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
lung development (GO:0030324)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
respiratory tube development (GO:0030323)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
ATP generation from poly-ADP-D-ribose (GO:1990966)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
stabilization of membrane potential (GO:0030322)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, preincision complex assembly (GO:0006294)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular monovalent inorganic anion homeostasis (GO:0030320)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
pyrimidine dimer repair (GO:0006290)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glucose transmembrane transport (GO:1904659)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to antibiotic (GO:0071236)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
cellular response to leucine (GO:0071233)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
chloride transmembrane transport (GO:1902476)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
L-alpha-amino acid transmembrane transport (GO:1902475)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
cellular response to amino acid stimulus (GO:0071230)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to synapse (GO:1902473)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium ion transport (GO:0010766)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium ion transport (GO:0010765)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
immunoglobulin mediated immune response (GO:0016064)	47	0	.91	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast migration (GO:0010764)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
reproductive system development (GO:0061458)	19	1	.37	+	2.71	3.20E-01	1.00E00
regulation of fibroblast migration (GO:0010762)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage chemotaxis (GO:0010760)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
flagellated sperm motility (GO:0030317)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
osteoclast differentiation (GO:0030316)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair (GO:0006289)	38	1	.74	+	1.35	5.29E-01	1.00E00
base-excision repair, DNA ligation (GO:0006288)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
base-excision repair, AP site formation (GO:0006285)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
poly-N-acetyllactosamine biosynthetic process (GO:0030311)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
transcription-coupled nucleotide-excision repair (GO:0006283)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to acid chemical (GO:0071229)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
cellular response to lipopolysaccharide (GO:0071222)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage chemotaxis (GO:0010758)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-L-cysteine S-palmitoylation (GO:0018230)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasminogen activation (GO:0010757)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rhodopsin mediated signaling pathway (GO:0016056)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein localization to cell leading edge (GO:1902463)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of plasminogen activation (GO:0010756)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of plasminogen activation (GO:0010755)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
organic acid catabolic process (GO:0016054)	125	0	2.43	-	 < 0.01	1.81E-01	1.00E00
negative regulation of cGMP-mediated signaling (GO:0010754)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
organic acid biosynthetic process (GO:0016053)	131	1	2.55	-	.39	5.25E-01	1.00E00
connective tissue development (GO:0061448)	137	5	2.67	+	1.88	2.00E-01	1.00E00
positive regulation of cGMP-mediated signaling (GO:0010753)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
carbohydrate catabolic process (GO:0016052)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
regulation of cGMP-mediated signaling (GO:0010752)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
carbohydrate biosynthetic process (GO:0016051)	79	0	1.54	-	 < 0.01	4.09E-01	1.00E00
poly-N-acetyllactosamine metabolic process (GO:0030309)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
vesicle organization (GO:0016050)	129	0	2.51	-	 < 0.01	1.84E-01	1.00E00
positive regulation of cell growth (GO:0030307)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
endocardial cushion cell development (GO:0061444)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endocardial cushion cell differentiation (GO:0061443)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA-dependent DNA biosynthetic process (GO:0006278)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
kidney vasculature development (GO:0061440)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cholesterol transport (GO:0030301)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
DNA replication termination (GO:0006274)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lagging strand elongation (GO:0006273)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
localization within membrane (GO:0051668)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
actin cortical patch localization (GO:0051666)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate (GO:0000971)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane raft localization (GO:0051665)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear pore localization (GO:0051664)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to molecule of bacterial origin (GO:0071219)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
maintenance of centrosome location (GO:0051661)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to misfolded protein (GO:0071218)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
establishment of centrosome localization (GO:0051660)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to biotic stimulus (GO:0071216)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
cellular response to abiotic stimulus (GO:0071214)	73	0	1.42	-	 < 0.01	6.52E-01	1.00E00
cell growth (GO:0016049)	51	2	.99	+	2.02	2.68E-01	1.00E00
detection of temperature stimulus (GO:0016048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein targeting to vacuole involved in autophagy (GO:0071211)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of stem cell population maintenance (GO:1902455)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
detection of bacterium (GO:0016045)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
kidney vasculature morphogenesis (GO:0061439)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
renal system vasculature morphogenesis (GO:0061438)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lipid catabolic process (GO:0016042)	134	0	2.61	-	 < 0.01	1.89E-01	1.00E00
renal system vasculature development (GO:0061437)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
establishment of skin barrier (GO:0061436)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase C activity (GO:1900274)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular senescence (GO:0090398)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA replication, synthesis of RNA primer (GO:0006269)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of long-term synaptic potentiation (GO:1900271)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
tRNA exon ligation (GO:0000968)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267)	9	1	.18	+	5.71	1.75E-01	1.00E00
rRNA 5'-end processing (GO:0000967)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA ligation (GO:0006266)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
RNA 5'-end processing (GO:0000966)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA 3'-end processing (GO:0000965)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA replication (GO:0006264)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA processing (GO:0000963)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
maintenance of organelle location (GO:0051657)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial RNA catabolic process (GO:0000962)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial RNA catabolic process (GO:0000961)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial RNA catabolic process (GO:0000960)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
establishment of mitochondrion localization (GO:0051654)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
spindle localization (GO:0051653)	21	1	.41	+	2.45	3.46E-01	1.00E00
maintenance of location in cell (GO:0051651)	43	1	.84	+	1.20	5.72E-01	1.00E00
establishment of vesicle localization (GO:0051650)	87	3	1.69	+	1.77	2.47E-01	1.00E00
peptidyl-arginine methylation (GO:0018216)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to juxtaparanode region of axon (GO:0071205)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein carboxylation (GO:0018214)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
absorption of UV light (GO:0016039)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine modification (GO:0018212)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein kinase A signaling (GO:0010739)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
absorption of visible light (GO:0016038)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
peptidyl-tryptophan modification (GO:0018211)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of protein kinase A signaling (GO:0010738)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
light absorption (GO:0016037)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-threonine modification (GO:0018210)	29	1	.56	+	1.77	4.39E-01	1.00E00
protein kinase A signaling (GO:0010737)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to phosphate starvation (GO:0016036)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription via serum response element binding (GO:0010735)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
viral process (GO:0016032)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
tRNA import into mitochondrion (GO:0016031)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phagolysosome assembly involved in apoptotic cell clearance (GO:0090387)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
phagosome maturation involved in apoptotic cell clearance (GO:0090386)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to amino acid starvation (GO:1990928)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA metabolic process (GO:0000959)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
phagosome-lysosome fusion (GO:0090385)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA catabolic process (GO:0000958)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA catabolic process (GO:0000957)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process (GO:0000956)	58	2	1.13	+	1.77	3.18E-01	1.00E00
phagosome maturation (GO:0090382)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
establishment of localization in cell (GO:0051649)	158	5	3.07	+	1.63	2.44E-01	1.00E00
dCTP catabolic process (GO:0006253)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle localization (GO:0051648)	90	3	1.75	+	1.71	2.62E-01	1.00E00
nucleus localization (GO:0051647)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
mitochondrion localization (GO:0051646)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
Golgi localization (GO:0051645)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum localization (GO:0051643)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine modification (GO:0018209)	87	3	1.69	+	1.77	2.47E-01	1.00E00
centrosome localization (GO:0051642)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular localization (GO:0051641)	1109	21	21.58	-	.97	1.00E00	1.00E00
organelle localization (GO:0051640)	223	7	4.34	+	1.61	2.16E-01	1.00E00
peptidyl-methionine modification (GO:0018206)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine modification (GO:0018202)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
peptidyl-glycine modification (GO:0018201)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamic acid modification (GO:0018200)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of primitive erythrocyte differentiation (GO:0010725)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CDP-diacylglycerol biosynthetic process (GO:0016024)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to iron (GO:0010723)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0061417)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
double-strand break repair involved in meiotic recombination (GO:1990918)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide catabolic process (GO:0006244)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
actin filament network formation (GO:0051639)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
barbed-end actin filament uncapping (GO:0051638)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CTP biosynthetic process (GO:0006241)	15	1	.29	+	3.43	2.65E-01	1.00E00
negative regulation of epithelial to mesenchymal transition (GO:0010719)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial to mesenchymal transition (GO:0010718)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial to mesenchymal transition (GO:0010717)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational elongation (GO:1900247)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of collagen metabolic process (GO:0010712)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA modification (GO:0090365)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dTTP biosynthetic process (GO:0006235)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dTDP biosynthetic process (GO:0006233)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dTMP biosynthetic process (GO:0006231)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein localization to cell junction (GO:1902414)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ganglioside biosynthetic process via lactosylceramide (GO:0010706)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cytokinesis (GO:1902412)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic cytokinetic process (GO:1902410)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
gonad development (GO:0008406)	13	1	.25	+	3.95	2.36E-01	1.00E00
UTP biosynthetic process (GO:0006228)	10	1	.19	+	5.14	1.91E-01	1.00E00
dUDP biosynthetic process (GO:0006227)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dUMP biosynthetic process (GO:0006226)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
hatching behavior (GO:0035187)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
UMP biosynthetic process (GO:0006222)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide biosynthetic process (GO:0006221)	32	1	.62	+	1.61	4.71E-01	1.00E00
pyrimidine nucleotide metabolic process (GO:0006220)	34	1	.66	+	1.51	4.91E-01	1.00E00
serotonin uptake (GO:0051610)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
charged-tRNA amino acid modification (GO:0019988)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
translesion synthesis (GO:0019985)	11	1	.21	+	4.67	2.06E-01	1.00E00
negative regulation of RIG-I signaling pathway (GO:0039536)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of RIG-I signaling pathway (GO:0039535)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell aging (GO:0090344)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cytidine catabolic process (GO:0006216)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of cell aging (GO:0090342)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside metabolic process (GO:0006213)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
uracil catabolic process (GO:0006212)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
social behavior (GO:0035176)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
defense response to virus (GO:0051607)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
detection of stimulus (GO:0051606)	88	2	1.71	+	1.17	6.91E-01	1.00E00
thymine catabolic process (GO:0006210)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein maturation (GO:0051604)	89	2	1.73	+	1.16	6.93E-01	1.00E00
proteolysis involved in cellular protein catabolic process (GO:0051603)	409	11	7.96	+	1.38	2.76E-01	1.00E00
exocyst localization (GO:0051601)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
modulation by virus of host apoptotic process (GO:0039526)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine exposure on apoptotic cell surface (GO:0070782)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of brown fat cell differentiation (GO:0090336)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase catabolic process (GO:0006208)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of brown fat cell differentiation (GO:0090335)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase metabolic process (GO:0006206)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
dGTP catabolic process (GO:0006203)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic spine development (GO:0060999)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic spine development (GO:0060998)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
dendritic spine morphogenesis (GO:0060997)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
dendritic spine development (GO:0060996)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
kidney morphogenesis (GO:0060993)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
response to fungicide (GO:0060992)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of tube size (GO:0035150)	57	1	1.11	-	.90	1.00E00	1.00E00
axon arborization (GO:0140060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sexual reproduction (GO:0019953)	138	3	2.68	+	1.12	7.53E-01	1.00E00
positive regulation of intracellular protein transport (GO:0090316)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein targeting to membrane (GO:0090314)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein targeting to membrane (GO:0090313)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein deacetylation (GO:0090312)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein deacetylation (GO:0090311)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
dendrite arborization (GO:0140059)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anal fin morphogenesis (GO:0035144)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuron projection arborization (GO:0140058)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
organelle localization by membrane tethering (GO:0140056)	62	0	1.21	-	 < 0.01	6.34E-01	1.00E00
medial fin morphogenesis (GO:0035141)	9	1	.18	+	5.71	1.75E-01	1.00E00
mitochondrial gene expression (GO:0140053)	44	0	.86	-	 < 0.01	1.00E00	1.00E00
modification-dependent protein catabolic process (GO:0019941)	363	9	7.06	+	1.27	4.41E-01	1.00E00
homogentisate metabolic process (GO:1901999)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
toxin transport (GO:1901998)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of methylation-dependent chromatin silencing (GO:0090309)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of methylation-dependent chromatin silencing (GO:0090308)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic cell cycle phase transition (GO:1901995)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle phase transition (GO:1901994)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spindle assembly involved in meiosis (GO:0090306)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor internalization (GO:0099590)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle phase transition (GO:1901993)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	67	1	1.30	-	.77	1.00E00	1.00E00
positive regulation of mitotic cell cycle phase transition (GO:1901992)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
angiogenesis involved in coronary vascular morphogenesis (GO:0060978)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of wound healing (GO:0090303)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
pelvic fin morphogenesis (GO:0035139)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
coronary vasculature morphogenesis (GO:0060977)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
coronary vasculature development (GO:0060976)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of neural crest formation (GO:0090301)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hindlimb morphogenesis (GO:0035137)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardioblast migration to the midline involved in heart field formation (GO:0060975)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
forelimb morphogenesis (GO:0035136)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cell migration involved in heart formation (GO:0060974)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
cell migration involved in heart development (GO:0060973)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
left/right pattern formation (GO:0060972)	20	1	.39	+	2.57	3.33E-01	1.00E00
embryonic heart tube left/right pattern formation (GO:0060971)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of methylglyoxal (GO:0140041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cyclic-nucleotide-mediated signaling (GO:0019935)	129	2	2.51	-	.80	1.00E00	1.00E00
cGMP-mediated signaling (GO:0019934)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
anterior lateral line system development (GO:0048898)	12	1	.23	+	4.28	2.22E-01	1.00E00
cAMP-mediated signaling (GO:0019933)	116	2	2.26	-	.89	1.00E00	1.00E00
second-messenger-mediated signaling (GO:0019932)	199	3	3.87	-	.77	1.00E00	1.00E00
efferent axon development in a lateral line nerve (GO:0048894)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
afferent axon development in lateral line nerve (GO:0048893)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inorganic ion import across plasma membrane (GO:0099587)	77	1	1.50	-	.67	1.00E00	1.00E00
positive regulation of cell cycle phase transition (GO:1901989)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
lateral line ganglion development (GO:0048890)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein acetylation (GO:1901985)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein acetylation (GO:1901984)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein acetylation (GO:1901983)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of gene silencing by RNA (GO:0060967)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of gene silencing by RNA (GO:0060966)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of gene silencing by miRNA (GO:0060965)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of gene silencing by miRNA (GO:0060964)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
embryonic anal fin morphogenesis (GO:0035125)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
embryonic caudal fin morphogenesis (GO:0035124)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
embryonic medial fin morphogenesis (GO:0035122)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
neuromast mantle cell differentiation (GO:0048888)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuromast deposition (GO:0048885)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
neuromast development (GO:0048884)	66	2	1.28	+	1.56	3.74E-01	1.00E00
histone H3-K27 methylation (GO:0070734)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac neuron development (GO:0060959)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of guanyl-nucleotide exchange factor activity (GO:1905097)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
endocardial cell development (GO:0060958)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic sister chromatid separation (GO:1901970)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
embryonic pelvic fin morphogenesis (GO:0035119)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
embryonic hindlimb morphogenesis (GO:0035116)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
embryonic forelimb morphogenesis (GO:0035115)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
exocytic process (GO:0140029)	47	0	.91	-	 < 0.01	1.00E00	1.00E00
lipid storage (GO:0019915)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
chemical homeostasis (GO:0048878)	483	9	9.40	-	.96	1.00E00	1.00E00
chemical homeostasis within a tissue (GO:0048875)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular macromolecule localization (GO:0070727)	772	14	15.02	-	.93	8.95E-01	1.00E00
homeostasis of number of cells within a tissue (GO:0048873)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
homeostasis of number of cells (GO:0048872)	110	4	2.14	+	1.87	1.74E-01	1.00E00
chemical synaptic transmission, postsynaptic (GO:0099565)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
synaptic membrane adhesion (GO:0099560)	11	1	.21	+	4.67	2.06E-01	1.00E00
cellular lipid biosynthetic process (GO:0097384)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cardiac neuron differentiation (GO:0060945)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dorsal spinal cord interneuron anterior axon guidance (GO:0097380)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
stem cell fate determination (GO:0048867)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to mercury ion (GO:0046689)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to copper ion (GO:0046688)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to cadmium ion (GO:0046686)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
response to arsenic-containing substance (GO:0046685)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
dorsal spinal cord interneuron posterior axon guidance (GO:0097379)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dorsal spinal cord interneuron axon guidance (GO:0097378)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to organophosphorus (GO:0046683)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
spinal cord interneuron axon guidance (GO:0097377)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling, modulating synaptic transmission (GO:0099550)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interneuron axon guidance (GO:0097376)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sensory neuron axon guidance (GO:0097374)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac jelly development (GO:1905072)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by nitric oxide (GO:0099548)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to antibiotic (GO:0046677)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
negative regulation of insulin secretion (GO:0046676)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by soluble gas (GO:0099543)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by endocannabinoid (GO:0099542)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by lipid (GO:0099541)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to bronchodilator (GO:0097366)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinal cell programmed cell death (GO:0046671)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neurohypophysis morphogenesis (GO:0048848)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
venous blood vessel morphogenesis (GO:0048845)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
artery morphogenesis (GO:0048844)	16	1	.31	+	3.21	2.79E-01	1.00E00
positive regulation of axon extension involved in axon guidance (GO:0048842)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of retinal cell programmed cell death (GO:0046668)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle endosomal processing (GO:0099532)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
male sex differentiation (GO:0046661)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
female sex differentiation (GO:0046660)	12	1	.23	+	4.28	2.22E-01	1.00E00
prenylation (GO:0097354)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
autophagosome maturation (GO:0097352)	19	1	.37	+	2.71	3.20E-01	1.00E00
positive regulation of base-excision repair (GO:1905053)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heart formation (GO:0060914)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
neutrophil clearance (GO:0097350)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of base-excision repair (GO:1905051)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac cell fate specification (GO:0060912)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cardiac cell fate commitment (GO:0060911)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
presynaptic dense core vesicle exocytosis (GO:0099525)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
folic acid metabolic process (GO:0046655)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate biosynthetic process (GO:0046654)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate metabolic process (GO:0046653)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
lymphocyte proliferation (GO:0046651)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial outer membrane permeabilization (GO:0097345)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage cytokine production (GO:0060907)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
zymogen inhibition (GO:0097341)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
inhibition of cysteine-type endopeptidase activity (GO:0097340)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
otic placode development (GO:1905040)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to prostaglandin E (GO:0034695)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to prostaglandin (GO:0034694)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
vesicle cytoskeletal trafficking (GO:0099518)	20	1	.39	+	2.57	3.33E-01	1.00E00
nucleate erythrocyte development (GO:0048823)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle transport along microtubule (GO:0099517)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
lymphocyte activation (GO:0046649)	59	1	1.15	-	.87	1.00E00	1.00E00
erythrocyte development (GO:0048821)	37	0	.72	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle cytoskeletal transport (GO:0099514)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
carboxylic acid transmembrane transport (GO:1905039)	61	0	1.19	-	 < 0.01	6.33E-01	1.00E00
negative regulation of alpha-beta T cell proliferation (GO:0046642)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of membrane lipid metabolic process (GO:1905038)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of alpha-beta T cell proliferation (GO:0046640)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of presynaptic cytosolic calcium ion concentration (GO:0099509)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of dendrite morphogenesis (GO:0048814)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
dendrite morphogenesis (GO:0048813)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of alpha-beta T cell differentiation (GO:0046639)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
diadenosine hexaphosphate catabolic process (GO:1901909)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of alpha-beta T cell differentiation (GO:0046638)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
diadenosine hexaphosphate metabolic process (GO:1901908)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of alpha-beta T cell differentiation (GO:0046637)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle cycle (GO:0099504)	92	0	1.79	-	 < 0.01	4.26E-01	1.00E00
diadenosine pentaphosphate catabolic process (GO:1901907)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of alpha-beta T cell activation (GO:0046636)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
diadenosine pentaphosphate metabolic process (GO:1901906)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of alpha-beta T cell activation (GO:0046635)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to antimetabolite (GO:0097329)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of alpha-beta T cell activation (GO:0046634)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
response to antineoplastic agent (GO:0097327)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
vesicle fusion to plasma membrane (GO:0099500)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell differentiation (GO:0046632)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
motile cilium assembly (GO:0044458)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell activation (GO:0046631)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
melanocyte proliferation (GO:0097325)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
melanocyte migration (GO:0097324)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
plasma membrane tubulation (GO:0097320)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
purine nucleoside metabolic process (GO:0042278)	31	1	.60	+	1.66	4.60E-01	1.00E00
error-prone translesion synthesis (GO:0042276)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ribosomal small subunit biogenesis (GO:0042274)	41	1	.80	+	1.25	5.55E-01	1.00E00
ribosomal large subunit biogenesis (GO:0042273)	47	0	.91	-	 < 0.01	1.00E00	1.00E00
anterior/posterior pattern specification involved in pronephros development (GO:0034672)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to lipopolysaccharide (GO:0032496)	58	1	1.13	-	.89	1.00E00	1.00E00
response to peptidoglycan (GO:0032494)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of insulin receptor signaling pathway (GO:0046627)	9	1	.18	+	5.71	1.75E-01	1.00E00
regulation of insulin receptor signaling pathway (GO:0046626)	10	1	.19	+	5.14	1.91E-01	1.00E00
regulation of organ growth (GO:0046620)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation by symbiont of host programmed cell death (GO:0052042)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
amino acid import across plasma membrane (GO:0089718)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host programmed cell death (GO:0052040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in compound eye morphogenesis (GO:2000495)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-asparagine hydroxylation (GO:0042265)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid hydroxylation (GO:0042264)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
DNA protection (GO:0042262)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Cdc42 protein signal transduction (GO:0032488)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
ncRNA catabolic process (GO:0034661)	16	1	.31	+	3.21	2.79E-01	1.00E00
ncRNA metabolic process (GO:0034660)	265	3	5.16	-	.58	4.98E-01	1.00E00
Rap protein signal transduction (GO:0032486)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of Ral protein signal transduction (GO:0032485)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
optic placode formation involved in camera-type eye formation (GO:0046619)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of Rab protein signal transduction (GO:0032483)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Rab protein signal transduction (GO:0032482)	85	0	1.65	-	 < 0.01	4.15E-01	1.00E00
positive regulation of type I interferon production (GO:0032481)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of type I interferon production (GO:0032480)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell contraction (GO:0106134)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to alcohol (GO:0097306)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
response to alcohol (GO:0097305)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
programmed necrotic cell death (GO:0097300)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mature ribosome assembly (GO:0042256)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-8 secretion (GO:2000483)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
ribosome assembly (GO:0042255)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-8 secretion (GO:2000482)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein kinase D signaling (GO:0089700)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ribosome biogenesis (GO:0042254)	167	2	3.25	-	.62	7.75E-01	1.00E00
negative regulation of cAMP-dependent protein kinase activity (GO:2000480)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nucleobase-containing small molecule catabolic process (GO:0034656)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleobase-containing compound catabolic process (GO:0034655)	125	3	2.43	+	1.23	7.38E-01	1.00E00
nucleobase-containing compound biosynthetic process (GO:0034654)	415	9	8.07	+	1.11	7.18E-01	1.00E00
retinoic acid catabolic process (GO:0034653)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of type I interferon production (GO:0032479)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cortisol biosynthetic process (GO:0034651)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cortisol metabolic process (GO:0034650)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
otolith formation (GO:0032475)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
otolith morphogenesis (GO:0032474)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
intestinal cholesterol absorption (GO:0030299)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
Golgi calcium ion transport (GO:0032472)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of centrosome cycle (GO:0046607)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host signal transduction pathway (GO:0052027)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic centrosome separation (GO:0046604)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic centrosome separation (GO:0046602)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of centriole replication (GO:0046600)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of cAMP-dependent protein kinase activity (GO:2000479)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
RNA repair (GO:0042245)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of hematopoietic stem cell migration (GO:2000472)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell migration (GO:2000471)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular macromolecule biosynthetic process (GO:0034645)	835	16	16.25	-	.98	1.00E00	1.00E00
cellular response to UV (GO:0034644)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
establishment of mitochondrion localization, microtubule-mediated (GO:0034643)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum calcium ion homeostasis (GO:0032469)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
Golgi calcium ion homeostasis (GO:0032468)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytokinesis (GO:0032467)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokinesis (GO:0032466)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
formation of extrachromosomal circular DNA (GO:0001325)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
bone mineralization (GO:0030282)	14	1	.27	+	3.67	2.51E-01	1.00E00
positive regulation of excitatory postsynaptic potential (GO:2000463)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphatidylcholine catabolic process (GO:0034638)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular carbohydrate biosynthetic process (GO:0034637)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
retinol transport (GO:0034633)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endocytic recycling (GO:0032456)	26	1	.51	+	1.98	4.06E-01	1.00E00
negative regulation of ossification (GO:0030279)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ossification (GO:0030278)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
maintenance of gastrointestinal epithelium (GO:0030277)	10	1	.19	+	5.14	1.91E-01	1.00E00
entry into host (GO:0044409)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
adhesion of symbiont to host (GO:0044406)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
symbiotic process (GO:0044403)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamine modification (GO:0018199)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine modification (GO:0018198)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
cellular protein-containing complex localization (GO:0034629)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid modification (GO:0018197)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
peptidyl-asparagine modification (GO:0018196)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
'de novo' NAD biosynthetic process (GO:0034627)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine modification (GO:0018195)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, polyunsaturated fatty acid (GO:0034626)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
response to chemical (GO:0042221)	1333	29	25.93	+	1.12	5.40E-01	1.00E00
fatty acid elongation, monounsaturated fatty acid (GO:0034625)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
response to cocaine (GO:0042220)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
protein urmylation (GO:0032447)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular response to unfolded protein (GO:0034620)	47	1	.91	+	1.09	6.04E-01	1.00E00
thermosensory behavior (GO:0040040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
replicative cell aging (GO:0001302)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
entry into host cell (GO:0030260)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular modified amino acid catabolic process (GO:0042219)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
terpene metabolic process (GO:0042214)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mitotic spindle checkpoint (GO:0071174)	9	1	.18	+	5.71	1.75E-01	1.00E00
cellular response to reactive oxygen species (GO:0034614)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
spindle assembly checkpoint (GO:0071173)	9	1	.18	+	5.71	1.75E-01	1.00E00
negative regulation of protein import (GO:1904590)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular protein localization (GO:0034613)	768	14	14.94	-	.94	1.00E00	1.00E00
response to tumor necrosis factor (GO:0034612)	57	0	1.11	-	 < 0.01	6.30E-01	1.00E00
site-specific DNA replication termination at RTS1 barrier (GO:0071171)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
melanosome organization (GO:0032438)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation, ncRNA-mediated (GO:0040033)	10	1	.19	+	5.14	1.91E-01	1.00E00
site-specific DNA replication termination (GO:0071170)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
snRNA modification (GO:0040031)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	37	1	.72	+	1.39	5.19E-01	1.00E00
lipid glycosylation (GO:0030259)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
lipid modification (GO:0030258)	132	2	2.57	-	.78	1.00E00	1.00E00
growth hormone secretion (GO:0030252)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein neddylation (GO:2000435)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein import (GO:1904589)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein neddylation (GO:2000434)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to glycoprotein (GO:1904587)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to heat (GO:0034605)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
DNA replication preinitiation complex assembly (GO:0071163)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine oxidation (GO:0018171)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase A2 activity (GO:0032429)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic nuclear division (GO:0040020)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
autophagy of peroxisome (GO:0030242)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
skeletal muscle myosin thick filament assembly (GO:0030241)	10	1	.19	+	5.14	1.91E-01	1.00E00
RNA acetylation (GO:1990884)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
skeletal muscle thin filament assembly (GO:0030240)	11	1	.21	+	4.67	2.06E-01	1.00E00
rRNA acetylation (GO:1990882)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic cell clearance (GO:2000425)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell cycle arrest (GO:0071157)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of embryonic development (GO:0040019)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of cell cycle arrest (GO:0071156)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of multicellular organism growth (GO:0040018)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of multicellular organism growth (GO:0040015)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of multicellular organism growth (GO:0040014)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
peptidyl-pyrromethane cofactor linkage (GO:0018160)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lysosome localization (GO:0032418)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of ion transmembrane transporter activity (GO:0032414)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of ion transmembrane transporter activity (GO:0032413)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
myofibril assembly (GO:0030239)	77	2	1.50	+	1.34	6.64E-01	1.00E00
regulation of ion transmembrane transporter activity (GO:0032412)	72	0	1.40	-	 < 0.01	6.50E-01	1.00E00
male sex determination (GO:0030238)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of transporter activity (GO:0032411)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
female sex determination (GO:0030237)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of transporter activity (GO:0032410)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
activin receptor signaling pathway involved in heart jogging (GO:0061372)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to methylmercury (GO:0051597)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process (GO:0051596)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to methylglyoxal (GO:0051595)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to calcium ion (GO:0051592)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
protein oxidation (GO:0018158)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
response to cAMP (GO:0051591)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of thymocyte migration (GO:2000410)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of growth rate (GO:0040009)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of transporter activity (GO:0032409)	74	0	1.44	-	 < 0.01	4.08E-01	1.00E00
resolution of mitotic recombination intermediates (GO:0071140)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular carbohydrate metabolic process (GO:0010677)	9	1	.18	+	5.71	1.75E-01	1.00E00
positive regulation of cellular carbohydrate metabolic process (GO:0010676)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
establishment of mitotic spindle localization (GO:0040001)	18	1	.35	+	2.86	3.07E-01	1.00E00
light-induced release of internally sequestered calcium ion (GO:0008377)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
melanosome transport (GO:0032402)	25	1	.49	+	2.06	3.94E-01	1.00E00
cellular response to chemokine (GO:1990869)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
macrophage differentiation (GO:0030225)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
response to chemokine (GO:1990868)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
monocyte differentiation (GO:0030224)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
neutrophil differentiation (GO:0030223)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
AMP catabolic process (GO:0006196)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine nucleotide catabolic process (GO:0006195)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotransmitter transport (GO:0051589)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter transport (GO:0051588)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell migration (GO:2000406)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell migration (GO:2000405)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of T cell migration (GO:2000404)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
dopamine uptake involved in synaptic transmission (GO:0051583)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte migration (GO:2000403)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
peptide cross-linking (GO:0018149)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte migration (GO:2000402)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
resolution of recombination intermediates (GO:0071139)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte migration (GO:2000401)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
histone H4-R3 methylation (GO:0043985)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone H4-K16 acetylation (GO:0043984)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H4-K12 acetylation (GO:0043983)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone H4-K8 acetylation (GO:0043982)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histone H4-K5 acetylation (GO:0043981)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
epithelial structure maintenance (GO:0010669)	13	1	.25	+	3.95	2.36E-01	1.00E00
negative regulation of cardiac muscle cell apoptotic process (GO:0010667)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA catabolic process (GO:1902373)	14	1	.27	+	3.67	2.51E-01	1.00E00
regulation of cardiac muscle cell apoptotic process (GO:0010665)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle cell apoptotic process (GO:0010664)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axon ensheathment (GO:0008366)	51	2	.99	+	2.02	2.68E-01	1.00E00
regulation of striated muscle cell apoptotic process (GO:0010662)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
megakaryocyte differentiation (GO:0030219)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Wnt protein secretion (GO:0061355)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of oocyte maturation (GO:1900194)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of muscle cell apoptotic process (GO:0010660)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell differentiation (GO:0030217)	25	1	.49	+	2.06	3.94E-01	1.00E00
regulation of oocyte maturation (GO:1900193)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
keratinocyte differentiation (GO:0030216)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
hyaluronan catabolic process (GO:0030214)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ribonucleoprotein complex assembly (GO:0022618)	103	3	2.00	+	1.50	4.59E-01	1.00E00
hyaluronan biosynthetic process (GO:0030213)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
hyaluronan metabolic process (GO:0030212)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
extracellular matrix disassembly (GO:0022617)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heparin biosynthetic process (GO:0030210)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GTP biosynthetic process (GO:0006183)	12	1	.23	+	4.28	2.22E-01	1.00E00
ribonucleoprotein complex biogenesis (GO:0022613)	239	5	4.65	+	1.08	8.12E-01	1.00E00
cGMP biosynthetic process (GO:0006182)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
gland morphogenesis (GO:0022612)	12	1	.23	+	4.28	2.22E-01	1.00E00
biological adhesion (GO:0022610)	449	6	8.74	-	.69	4.86E-01	1.00E00
positive regulation of histone H3-K9 methylation (GO:0051574)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K4 methylation (GO:0051571)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA catabolic process (GO:1902369)	15	1	.29	+	3.43	2.65E-01	1.00E00
regulation of Notch signaling pathway involved in somitogenesis (GO:1902366)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heterocycle biosynthetic process (GO:0018130)	473	9	9.20	-	.98	1.00E00	1.00E00
negative regulation of muscle cell apoptotic process (GO:0010656)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
melanocyte apoptotic process (GO:1902362)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
maternal determination of anterior/posterior axis, embryo (GO:0008358)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of clathrin-dependent endocytosis (GO:1900186)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
germ cell migration (GO:0008354)	14	1	.27	+	3.67	2.51E-01	1.00E00
chondroitin sulfate biosynthetic process (GO:0030206)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate metabolic process (GO:0030205)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
guanine salvage (GO:0006178)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
non-canonical Wnt signaling pathway involved in heart development (GO:0061341)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to nucleus (GO:1900181)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate metabolic process (GO:0030204)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan metabolic process (GO:0030203)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
GMP biosynthetic process (GO:0006177)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to nucleus (GO:1900180)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heparin metabolic process (GO:0030202)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan metabolic process (GO:0030201)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
adaptive thermogenesis (GO:1990845)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K4 methylation (GO:0051569)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan catabolic process (GO:0030200)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 methylation (GO:0051568)	15	1	.29	+	3.43	2.65E-01	1.00E00
histone H3-K9 methylation (GO:0051567)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ADP biosynthetic process (GO:0006172)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cAMP biosynthetic process (GO:0006171)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
histone H2A acetylation (GO:0043968)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
histone H4 acetylation (GO:0043967)	15	1	.29	+	3.43	2.65E-01	1.00E00
histone H3 acetylation (GO:0043966)	9	1	.18	+	5.71	1.75E-01	1.00E00
positive regulation of mitochondrial calcium ion concentration (GO:0051561)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial calcium ion homeostasis (GO:0051560)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
protein hydroxylation (GO:0018126)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric loop disassembly (GO:1904534)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric loop disassembly (GO:1904533)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sulfate transmembrane transport (GO:1902358)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine ADP-ribosylation (GO:0018120)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
endothelial tube lumen extension involved in blood vessel lumen ensheathment (GO:1902355)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell delamination involved in blood vessel lumen ensheathment (GO:1902354)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of monopolar cell polarity (GO:0061339)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell communication by electrical coupling (GO:0010644)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cardiac conduction (GO:0061337)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
glial cell migration (GO:0008347)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900176)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of neural crest formation (GO:0090299)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
larval locomotory behavior (GO:0008345)	13	1	.25	+	3.95	2.36E-01	1.00E00
regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900175)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
adult locomotory behavior (GO:0008344)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
adult feeding behavior (GO:0008343)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
renal tubule morphogenesis (GO:0061333)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adenine salvage (GO:0006168)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
AMP biosynthetic process (GO:0006167)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
determination of adult lifespan (GO:0008340)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside salvage (GO:0006166)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate phosphorylation (GO:0006165)	36	1	.70	+	1.43	5.10E-01	1.00E00
purine nucleotide biosynthetic process (GO:0006164)	119	3	2.32	+	1.30	5.07E-01	1.00E00
response to odorant (GO:1990834)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine nucleotide metabolic process (GO:0006163)	197	3	3.83	-	.78	1.00E00	1.00E00
protein K48-linked deubiquitination (GO:0071108)	13	1	.25	+	3.95	2.36E-01	1.00E00
cellular component maintenance (GO:0043954)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of cAMP-mediated signaling (GO:0043951)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of organelle organization (GO:0010638)	136	3	2.65	+	1.13	7.50E-01	1.00E00
positive regulation of epithelial cell migration (GO:0010634)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell migration (GO:0010633)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal tubule development (GO:0061326)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell migration (GO:0010632)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
epithelial cell migration (GO:0010631)	33	1	.64	+	1.56	4.81E-01	1.00E00
negative regulation of cellular response to growth factor stimulus (GO:0090288)	47	1	.91	+	1.09	6.04E-01	1.00E00
histone mRNA metabolic process (GO:0008334)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
endosome to lysosome transport (GO:0008333)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid beta-oxidation (GO:0031998)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cytoskeletal anchoring at nuclear membrane (GO:0090286)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion import (GO:0090281)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
adenosine catabolic process (GO:0006154)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion import (GO:0090280)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
basic amino acid transmembrane transport (GO:1990822)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mRNA export from nucleus in response to heat stress (GO:0031990)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine nucleoside catabolic process (GO:0006152)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cAMP-mediated signaling (GO:0043949)	14	1	.27	+	3.67	2.51E-01	1.00E00
peptidyl-tyrosine phosphorylation (GO:0018108)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
peptidyl-threonine phosphorylation (GO:0018107)	29	1	.56	+	1.77	4.39E-01	1.00E00
peptidyl-serine phosphorylation (GO:0018105)	85	3	1.65	+	1.81	2.36E-01	1.00E00
protein C-linked glycosylation (GO:0018103)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein citrullination (GO:0018101)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone mineralization involved in bone maturation (GO:1900158)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of bone mineralization involved in bone maturation (GO:1900157)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in heart development (GO:0061316)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion import (GO:0090279)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptide hormone secretion (GO:0090278)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptide hormone secretion (GO:0090277)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of peptide hormone secretion (GO:0090276)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in heart development (GO:0061312)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell surface receptor signaling pathway involved in heart development (GO:0061311)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
guanine catabolic process (GO:0006147)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine nucleobase catabolic process (GO:0006145)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide metabolic process (GO:0006140)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell development involved in heart development (GO:0061308)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell differentiation involved in heart development (GO:0061307)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900146)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
retinal blood vessel morphogenesis (GO:0061304)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA stability involved in response to stress (GO:0010610)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cornea development in camera-type eye (GO:0061303)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cerebellum vasculature development (GO:0061300)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
response to nicotine (GO:0035094)	21	1	.41	+	2.45	3.46E-01	1.00E00
spermatogenesis, exchange of chromosomal proteins (GO:0035093)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
exonucleolytic catabolism of deadenylated mRNA (GO:0043928)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
sperm chromatin condensation (GO:0035092)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of apical/basal cell polarity (GO:0035090)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
axonal transport of mitochondrion (GO:0019896)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear DNA replication termination (GO:1902317)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear cell cycle DNA replication initiation (GO:1902315)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase A2 activity (GO:1900138)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic mRNA processing body assembly (GO:0010603)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of retinal ganglion cell axon guidance (GO:0090259)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of muscle system process (GO:0090257)	35	1	.68	+	1.47	5.01E-01	1.00E00
isoprenoid catabolic process (GO:0008300)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
establishment of apical/basal cell polarity (GO:0035089)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of apical/basal cell polarity (GO:0035088)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
siRNA loading onto RISC involved in RNA interference (GO:0035087)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to corticosteroid (GO:0031960)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
axoneme assembly (GO:0035082)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium ion transmembrane transport (GO:1902307)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous antigen (GO:0019884)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium ion transmembrane transport (GO:1902306)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous antigen (GO:0019883)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation (GO:0019882)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
regulation of sodium ion transmembrane transport (GO:1902305)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of hyaluronan biosynthetic process (GO:1900125)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oxidative phosphorylation (GO:0006119)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
axis elongation involved in somitogenesis (GO:0090245)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein autophosphorylation (GO:0031954)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
NADH oxidation (GO:0006116)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein autophosphorylation (GO:0031953)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein autophosphorylation (GO:0031952)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
glycerol biosynthetic process (GO:0006114)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
energy reserve metabolic process (GO:0006112)	29	1	.56	+	1.77	4.39E-01	1.00E00
regulation of gluconeogenesis (GO:0006111)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of glycolytic process (GO:0006110)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lysine biosynthetic process via aminoadipic acid (GO:0019878)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of symbiosis, encompassing mutualism through parasitism (GO:0043903)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of multi-organism process (GO:0043902)	62	1	1.21	-	.83	1.00E00	1.00E00
negative regulation of multi-organism process (GO:0043901)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of multi-organism process (GO:0043900)	86	1	1.67	-	.60	1.00E00	1.00E00
extracellular negative regulation of signal transduction (GO:1900116)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proteasome regulatory particle assembly (GO:0070682)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extracellular regulation of signal transduction (GO:1900115)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
malate metabolic process (GO:0006108)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K9 dimethylation (GO:1900111)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase plate congression (GO:0090235)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of kinetochore assembly (GO:0090234)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
oxaloacetate metabolic process (GO:0006107)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fumarate metabolic process (GO:0006106)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid metabolic process (GO:0031943)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
succinate metabolic process (GO:0006105)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
succinyl-CoA metabolic process (GO:0006104)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of centromere complex assembly (GO:0090230)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
2-oxoglutarate metabolic process (GO:0006103)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone acetylation (GO:0035067)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
isocitrate metabolic process (GO:0006102)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone acetylation (GO:0035066)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
citrate metabolic process (GO:0006101)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of histone acetylation (GO:0035065)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
uracil metabolic process (GO:0019860)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K9 dimethylation (GO:1900109)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway (GO:1900108)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of nodal signaling pathway (GO:1900107)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
response to interleukin-15 (GO:0070672)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin silencing at telomere (GO:0031938)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin silencing (GO:0031937)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum unfolded protein response (GO:1900101)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of spindle organization (GO:0090224)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
eye field cell fate commitment involved in camera-type eye formation (GO:0060898)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
centrosome-templated microtubule nucleation (GO:0090222)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
thymine metabolic process (GO:0019859)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase biosynthetic process (GO:0019856)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
L-ascorbic acid biosynthetic process (GO:0019853)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-ascorbic acid metabolic process (GO:0019852)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte proliferation (GO:0070665)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte proliferation (GO:0070664)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte proliferation (GO:0070663)	34	1	.66	+	1.51	4.91E-01	1.00E00
negative regulation of lipid kinase activity (GO:0090219)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukocyte proliferation (GO:0070661)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
TOR signaling (GO:0031929)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid kinase activity (GO:0090218)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pronuclear migration (GO:0035046)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuromast hair cell differentiation involved in neuromast regeneration (GO:0070658)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neuromast regeneration (GO:0070657)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mechanoreceptor differentiation involved in mechanosensory epithelium regeneration (GO:0070656)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mechanosensory epithelium regeneration (GO:0070655)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sensory epithelium regeneration (GO:0070654)	15	1	.29	+	3.43	2.65E-01	1.00E00
positive regulation of triglyceride metabolic process (GO:0090208)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
nonfunctional rRNA decay (GO:0070651)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride metabolic process (GO:0090207)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament bundle distribution (GO:0070650)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell junction assembly (GO:1901890)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
male pronucleus assembly (GO:0035039)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
semicircular canal formation (GO:0060876)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
female pronucleus assembly (GO:0035038)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of release of cytochrome c from mitochondria (GO:0090200)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
sperm-egg recognition (GO:0035036)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
semicircular canal development (GO:0060872)	21	1	.41	+	2.45	3.46E-01	1.00E00
cytolysis (GO:0019835)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
swim bladder formation (GO:0048797)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
formin-nucleated actin cable assembly (GO:0070649)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein modification by small protein removal (GO:0070646)	97	3	1.89	+	1.59	4.43E-01	1.00E00
calcium ion-regulated exocytosis of neurotransmitter (GO:0048791)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
regulation of cell junction assembly (GO:1901888)	9	1	.18	+	5.71	1.75E-01	1.00E00
vitamin D3 metabolic process (GO:0070640)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein depolymerization (GO:1901881)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rho protein signal transduction (GO:0035024)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
stem cell population maintenance (GO:0019827)	12	1	.23	+	4.28	2.22E-01	1.00E00
hatching gland development (GO:0048785)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of protein depolymerization (GO:1901879)	43	2	.84	+	2.39	2.12E-01	1.00E00
transepithelial transport (GO:0070633)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
signal release (GO:0023061)	78	0	1.52	-	 < 0.01	4.09E-01	1.00E00
somatic stem cell population maintenance (GO:0035019)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of blood-brain barrier (GO:0060856)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
venous endothelial cell migration involved in lymph vessel development (GO:0060855)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
branching involved in lymph vessel morphogenesis (GO:0060854)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of centriole replication (GO:0046599)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
tissue remodeling (GO:0048771)	12	1	.23	+	4.28	2.22E-01	1.00E00
signaling (GO:0023052)	3577	62	69.59	-	.89	3.57E-01	1.00E00
positive regulation of muscle tissue development (GO:1901863)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle tissue development (GO:1901862)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of muscle tissue development (GO:1901861)	18	1	.35	+	2.86	3.07E-01	1.00E00
endothelial cell fate specification (GO:0060847)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
arterial endothelial cell fate commitment (GO:0060844)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
arterial endothelial cell differentiation (GO:0060842)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
venous blood vessel development (GO:0060841)	13	1	.25	+	3.95	2.36E-01	1.00E00
artery development (GO:0060840)	30	1	.58	+	1.71	4.50E-01	1.00E00
sarcomerogenesis (GO:0048769)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
quinolinate biosynthetic process (GO:0019805)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium-dependent cell-cell adhesion (GO:0046588)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein processing (GO:0070613)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of calcium-dependent cell-cell adhesion (GO:0046586)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of Ras protein signal transduction (GO:0046580)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell differentiation (GO:0060837)	10	1	.19	+	5.14	1.91E-01	1.00E00
ammonia homeostasis (GO:0097272)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
oocyte animal/vegetal axis specification (GO:0060832)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pigment granule maturation (GO:0048757)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
branching morphogenesis of a nerve (GO:0048755)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
branching morphogenesis of an epithelial tube (GO:0048754)	13	1	.25	+	3.95	2.36E-01	1.00E00
pigment granule organization (GO:0048753)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
semicircular canal morphogenesis (GO:0048752)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
cellular response to ceramide (GO:0106097)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of high voltage-gated calcium channel activity (GO:1901842)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
self proteolysis (GO:0097264)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of high voltage-gated calcium channel activity (GO:1901841)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
actin cortical patch organization (GO:0044396)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
compound eye development (GO:0048749)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle fiber development (GO:0048743)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
skeletal muscle fiber development (GO:0048741)	46	2	.89	+	2.23	2.33E-01	1.00E00
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inactivation of X chromosome by genetic imprinting (GO:0060819)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte apoptotic process (GO:0097252)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial respirasome assembly (GO:0097250)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
glucose import in response to insulin stimulus (GO:0044381)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoskeleton (GO:0044380)	15	1	.29	+	3.43	2.65E-01	1.00E00
histone succinylation (GO:0106077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
epidermis morphogenesis (GO:0048730)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
signal transduction by protein phosphorylation (GO:0023014)	78	3	1.52	+	1.98	2.01E-01	1.00E00
zeaxanthin biosynthetic process (GO:1901827)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
zeaxanthin metabolic process (GO:1901825)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106072)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell fate commitment (GO:0046552)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mesodermal to mesenchymal transition involved in gastrulation (GO:0060809)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retinal cone cell fate commitment (GO:0046551)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of peroxisome size (GO:0044375)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell migration to bone marrow (GO:0097241)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
chromosome attachment to the nuclear envelope (GO:0097240)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in mesodermal cell fate specification (GO:0060803)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to oxidative stress (GO:0034599)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
retinal rod cell development (GO:0046548)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
development of primary male sexual characteristics (GO:0046546)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
development of primary female sexual characteristics (GO:0046545)	9	1	.18	+	5.71	1.75E-01	1.00E00
regulation of cobalamin metabolic process (GO:0106064)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to methylglyoxal (GO:0097238)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to toxic substance (GO:0097237)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
saliva secretion (GO:0046541)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
disruption of cells of other organism (GO:0044364)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
piRNA metabolic process (GO:0034587)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
ketone catabolic process (GO:0042182)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
ketone biosynthetic process (GO:0042181)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
cellular ketone metabolic process (GO:0042180)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
negative regulation of oligodendrocyte differentiation (GO:0048715)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of oligodendrocyte differentiation (GO:0048714)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of oligodendrocyte differentiation (GO:0048713)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of calcineurin-mediated signaling (GO:0106056)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of photoreceptor cell differentiation (GO:0046533)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of photoreceptor cell differentiation (GO:0046532)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteasomal protein catabolic process (GO:1901800)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
xenobiotic catabolic process (GO:0042178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein catabolic process (GO:0042177)	10	1	.19	+	5.14	1.91E-01	1.00E00
regulation of protein catabolic process (GO:0042176)	76	1	1.48	-	.68	1.00E00	1.00E00
astrocyte differentiation (GO:0048708)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
chondrocyte development involved in endochondral bone morphogenesis (GO:0003433)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
spermidine deacetylation (GO:0106048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polyamine deacetylation (GO:0106047)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanine deglycation, glyoxal removal (GO:0106046)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanine deglycation, methylglyoxal removal (GO:0106045)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
guanine deglycation (GO:0106044)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sphingoid biosynthetic process (GO:0046520)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell proliferation (GO:0044342)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heme metabolic process (GO:0042168)	26	1	.51	+	1.98	4.06E-01	1.00E00
sodium-dependent phosphate transport (GO:0044341)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil extravasation (GO:2000391)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte morphogenesis (GO:0003429)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
chondrocyte intercalation involved in growth plate cartilage morphogenesis (GO:0003428)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage morphogenesis (GO:0003422)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular cholesterol transport (GO:0032385)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sphingoid metabolic process (GO:0046519)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular cholesterol transport (GO:0032383)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular sterol transport (GO:0032382)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein maturation by [4Fe-4S] cluster transfer (GO:0106035)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular sterol transport (GO:0032380)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ceramide catabolic process (GO:0046514)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
ceramide biosynthetic process (GO:0046513)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
sphingosine biosynthetic process (GO:0046512)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuron projection fasciculation (GO:0106030)	10	1	.19	+	5.14	1.91E-01	1.00E00
renal filtration (GO:0097205)	24	1	.47	+	2.14	3.82E-01	1.00E00
regulation of neutrophil extravasation (GO:2000389)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
lipoprotein catabolic process (GO:0042159)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion mediated by cadherin (GO:0044331)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
lipoprotein biosynthetic process (GO:0042158)	68	1	1.32	-	.76	1.00E00	1.00E00
lipoprotein metabolic process (GO:0042157)	95	1	1.85	-	.54	1.00E00	1.00E00
regulation of ectoderm development (GO:2000383)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesoderm development (GO:2000381)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mesoderm development (GO:2000380)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte proliferation (GO:0003419)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte differentiation (GO:0003418)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage development (GO:0003417)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
endochondral bone growth (GO:0003416)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex II assembly (GO:0034553)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular lipid transport (GO:0032379)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex II assembly (GO:0034552)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex III assembly (GO:0034551)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
chondrocyte morphogenesis involved in endochondral bone morphogenesis (GO:0003414)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular lipid transport (GO:0032377)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol transport (GO:0032376)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis (GO:0003412)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol transport (GO:0032374)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
neuron projection organization (GO:0106027)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of sterol transport (GO:0032373)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
collagen fibril organization (GO:0030199)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of sterol transport (GO:0032371)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
extracellular matrix organization (GO:0030198)	137	2	2.67	-	.75	1.00E00	1.00E00
positive regulation of lipid transport (GO:0032370)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glycerol ether biosynthetic process (GO:0046504)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
glycerolipid catabolic process (GO:0046503)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood coagulation (GO:0030195)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
uroporphyrinogen III metabolic process (GO:0046502)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood coagulation (GO:0030194)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protoporphyrinogen IX metabolic process (GO:0046501)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of blood coagulation (GO:0030193)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethionine metabolic process (GO:0046500)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of reactive oxygen species metabolic process (GO:2000379)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of reactive oxygen species metabolic process (GO:2000378)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of reactive oxygen species metabolic process (GO:2000377)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular response to glucose starvation (GO:0042149)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
strand invasion (GO:0042148)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to leptin (GO:0044321)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retrograde transport, endosome to Golgi (GO:0042147)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
cellular response to leptin stimulus (GO:0044320)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vacuole fusion, non-autophagic (GO:0042144)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retinal pigment epithelium development (GO:0003406)	13	1	.25	+	3.95	2.36E-01	1.00E00
negative regulation of lipid transport (GO:0032369)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of lipid transport (GO:0032368)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
optic vesicle morphogenesis (GO:0003404)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
intracellular cholesterol transport (GO:0032367)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
optic vesicle formation (GO:0003403)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
intracellular sterol transport (GO:0032366)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in axis elongation (GO:0003402)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intracellular lipid transport (GO:0032365)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of COPII vesicle coating (GO:0003400)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
melatonin biosynthetic process (GO:0030187)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
melatonin metabolic process (GO:0030186)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
wound healing, spreading of cells (GO:0044319)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
B cell differentiation (GO:0030183)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of clathrin-dependent endocytosis (GO:2000369)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
protein K6-linked deubiquitination (GO:0044313)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break formation (GO:0042138)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
AMPA selective glutamate receptor signaling pathway (GO:0098990)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurotransmitter biosynthetic process (GO:0042136)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
neurotransmitter catabolic process (GO:0042135)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
neurotransmitter metabolic process (GO:0042133)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell proliferation (GO:0042130)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
response to estradiol (GO:0032355)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-dependent DNA replication initiation (GO:0030174)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of T cell proliferation (GO:0042129)	34	1	.66	+	1.51	4.91E-01	1.00E00
nitrate assimilation (GO:0042128)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nitrate metabolic process (GO:0042126)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein polyglutamylation (GO:0018095)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
platelet activation (GO:0030168)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
proteoglycan catabolic process (GO:0030167)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proteoglycan biosynthetic process (GO:0030166)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
protein catabolic process (GO:0030163)	434	11	8.44	+	1.30	3.78E-01	1.00E00
regulation of proteolysis (GO:0030162)	145	4	2.82	+	1.42	3.73E-01	1.00E00
postsynaptic actin cytoskeleton organization (GO:0098974)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
neutrophil activation (GO:0042119)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
endothelial cell activation (GO:0042118)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of acrosome reaction (GO:2000344)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
monocyte activation (GO:0042117)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
macrophage activation (GO:0042116)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
B cell activation (GO:0042113)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
RNA 3' uridylation (GO:0071076)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell activation (GO:0042110)	44	1	.86	+	1.17	5.80E-01	1.00E00
protein localization to ciliary transition zone (GO:1904491)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid biosynthetic process (GO:0071072)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid biosynthetic process (GO:0071071)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
retina vasculature morphogenesis in camera-type eye (GO:0061299)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
retina vasculature development in camera-type eye (GO:0061298)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of chondrocyte differentiation (GO:0032332)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte differentiation (GO:0032331)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte differentiation (GO:0032330)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pancreas regeneration (GO:1990798)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
protein import into mitochondrial matrix (GO:0030150)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dorsal root ganglion development (GO:1990791)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytokine biosynthetic process (GO:0042108)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
centromere complex assembly (GO:0034508)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell proliferation (GO:0042102)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
cellular response to tetrahydrofolate (GO:1904482)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tooth mineralization (GO:0034505)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
response to tetrahydrofolate (GO:1904481)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
alanine transport (GO:0032328)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to kinetochore (GO:0034501)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell migration (GO:0010596)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
isoprenoid biosynthetic process (GO:0008299)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell migration (GO:0010595)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell migration (GO:0010594)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
intracellular mRNA localization (GO:0008298)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
molybdopterin cofactor biosynthetic process (GO:0032324)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sphingolipid catabolic process (GO:0030149)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
sphingolipid biosynthetic process (GO:0030148)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
regulation of lamellipodium assembly (GO:0010591)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
spermidine biosynthetic process (GO:0008295)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
acetylcholine biosynthetic process (GO:0008292)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
acetylcholine metabolic process (GO:0008291)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
retrograde axonal transport of mitochondrion (GO:0098958)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anterograde axonal transport of mitochondrion (GO:0098957)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of hh target transcription factor activity (GO:1990787)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 17 cell lineage commitment (GO:2000329)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
receptor diffusion trapping (GO:0098953)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 17 cell lineage commitment (GO:2000328)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear receptor transcription coactivator activity (GO:2000327)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear receptor transcription coactivator activity (GO:2000325)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal absorption (GO:1904478)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of Ras GTPase binding (GO:1904476)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 17 cell differentiation (GO:2000320)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of Ras GTPase binding (GO:1904475)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein-cofactor linkage (GO:0018065)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299)	9	1	.18	+	5.71	1.75E-01	1.00E00
cytochrome c-heme linkage (GO:0018063)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication maintenance of fidelity (GO:1902298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in cell cycle DNA replication (GO:1902296)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
snoRNA polyadenylation (GO:0071050)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication termination (GO:1902294)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication initiation (GO:1902292)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
insulin receptor signaling pathway (GO:0008286)	28	1	.54	+	1.84	4.28E-01	1.00E00
positive regulation of cell population proliferation (GO:0008284)	95	1	1.85	-	.54	1.00E00	1.00E00
protein localization to cell periphery (GO:1990778)	81	1	1.58	-	.63	1.00E00	1.00E00
regulation of T-helper 17 cell differentiation (GO:2000319)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 17 type immune response (GO:2000317)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of stress fiber assembly (GO:0051496)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 17 type immune response (GO:2000316)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoskeleton organization (GO:0051495)	81	0	1.58	-	 < 0.01	4.11E-01	1.00E00
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription (GO:0071049)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of stress fiber assembly (GO:0051492)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of kainate selective glutamate receptor activity (GO:2000312)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of AMPA receptor activity (GO:2000311)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
positive regulation of filopodium assembly (GO:0051491)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine oxidation (GO:0018057)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent mRNA catabolic process (GO:0071047)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of NMDA receptor activity (GO:2000310)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of filopodium assembly (GO:0051490)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
histone mRNA catabolic process (GO:0071044)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
CUT metabolic process (GO:0071043)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)	11	1	.21	+	4.67	2.06E-01	1.00E00
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
antisense RNA transcript catabolic process (GO:0071041)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
icosanoid secretion (GO:0032309)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)	11	1	.21	+	4.67	2.06E-01	1.00E00
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular endothelial growth factor production (GO:0010575)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of vascular endothelial growth factor production (GO:0010574)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
sulfate transport (GO:0008272)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid cycle (GO:0006099)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt (GO:0006098)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
anterograde dendritic transport (GO:0098937)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
glyoxylate cycle (GO:0006097)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycolytic process (GO:0006096)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
dendritic transport (GO:0098935)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
gluconeogenesis (GO:0006094)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of filopodium assembly (GO:0051489)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
generation of precursor metabolites and energy (GO:0006091)	153	1	2.98	-	.34	3.77E-01	1.00E00
axonal transport (GO:0098930)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
pyruvate metabolic process (GO:0006090)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
regulation of ceramide biosynthetic process (GO:2000303)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle exocytosis (GO:2000301)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytosolic calcium ion concentration (GO:0051481)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle exocytosis (GO:2000300)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of cytosolic calcium ion concentration (GO:0051480)	178	4	3.46	+	1.16	7.81E-01	1.00E00
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
CUT catabolic process (GO:0071034)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nuclear retention of pre-mRNA at the site of transcription (GO:0071033)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of double-strand break repair via homologous recombination (GO:0010569)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing (GO:0071030)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ketone biosynthetic process (GO:0010566)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphorus metabolic process (GO:0010563)	78	2	1.52	+	1.32	6.67E-01	1.00E00
positive regulation of phosphorus metabolic process (GO:0010562)	361	9	7.02	+	1.28	4.39E-01	1.00E00
negative regulation of glycoprotein biosynthetic process (GO:0010561)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry (GO:1900094)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lactate metabolic process (GO:0006089)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated transport between endosomal compartments (GO:0098927)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
postsynaptic signal transduction (GO:0098926)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process from pyruvate (GO:0006086)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process (GO:0006085)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA metabolic process (GO:0006084)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
acetate metabolic process (GO:0006083)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by endocannabinoid (GO:0098921)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular aldehyde metabolic process (GO:0006081)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by lipid (GO:0098920)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nuclear ncRNA surveillance (GO:0071029)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
folate import across plasma membrane (GO:1904447)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear mRNA surveillance (GO:0071028)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
nuclear RNA surveillance (GO:0071027)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell migration (GO:0014911)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell migration (GO:0014910)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cytoplasmic RNA surveillance (GO:0071026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
RNA surveillance (GO:0071025)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of glycoprotein biosynthetic process (GO:0010559)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in blood vessel morphogenesis (GO:1902262)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of delayed rectifier potassium channel activity (GO:1902260)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of bipolar cell polarity (GO:0061245)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
water homeostasis (GO:0030104)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular detoxification (GO:1990748)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling (GO:0098917)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
natural killer cell activation (GO:0030101)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endocytosis (GO:0030100)	37	1	.72	+	1.39	5.19E-01	1.00E00
primary miRNA methylation (GO:1990744)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular glucan metabolic process (GO:0006073)	26	1	.51	+	1.98	4.06E-01	1.00E00
smooth muscle cell migration (GO:0014909)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate metabolic process (GO:0006072)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of ventricular cardiac muscle cell action potential (GO:0098911)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycerol metabolic process (GO:0006071)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of atrial cardiac muscle cell action potential (GO:0098910)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
octanol metabolic process (GO:0006070)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myotube cell development (GO:0014904)	46	2	.89	+	2.23	2.33E-01	1.00E00
myotube differentiation (GO:0014902)	59	2	1.15	+	1.74	3.25E-01	1.00E00
peptidyl-lysine dimethylation (GO:0018027)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of corticotropin secretion (GO:0051460)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine monomethylation (GO:0018026)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of delayed rectifier potassium channel activity (GO:1902259)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine trimethylation (GO:0018023)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
tRNA threonylcarbamoyladenosine modification (GO:0002949)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to insulin stimulus (GO:1900077)	9	1	.18	+	5.71	1.75E-01	1.00E00
regulation of cellular response to insulin stimulus (GO:1900076)	11	1	.21	+	4.67	2.06E-01	1.00E00
regulation of release of cytochrome c from mitochondria (GO:0090199)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ethanol oxidation (GO:0006069)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of neuronal action potential (GO:0098908)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
syncytium formation by plasma membrane fusion (GO:0000768)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
ethanol metabolic process (GO:0006067)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tRNA N2-guanine methylation (GO:0002940)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of corticotropin secretion (GO:0051459)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during action potential (GO:0098903)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell action potential (GO:0098901)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation (GO:0051455)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intracellular pH elevation (GO:0051454)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular pH (GO:0051453)	41	1	.80	+	1.25	5.55E-01	1.00E00
positive regulation of calcium ion transmembrane transport (GO:1904427)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
intracellular pH reduction (GO:0051452)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
myoblast migration (GO:0051451)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
myoblast proliferation (GO:0051450)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of GTP binding (GO:1904424)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
tRNA N1-guanine methylation (GO:0002939)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in ureteric bud morphogenesis (GO:0090189)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
desmosome organization (GO:0002934)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
primary miRNA modification (GO:1990729)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mannoprotein biosynthetic process (GO:0006057)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of kidney development (GO:0090184)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to ischemia (GO:0002931)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ceramide biosynthetic process (GO:1900060)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mannoprotein metabolic process (GO:0006056)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of kidney development (GO:0090183)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate metabolic process (GO:0006054)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle (GO:0051447)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic cell cycle (GO:0051446)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
N-acetylmannosamine metabolic process (GO:0006051)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle (GO:0051445)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
mannosamine metabolic process (GO:0006050)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin-protein transferase activity (GO:0051444)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-glycine N-myristoylation (GO:0018008)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-glutamic acid acetylation (GO:0018002)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of transposition (GO:0010529)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of transposition (GO:0010528)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transposition, RNA-mediated (GO:0010526)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of transposition, RNA-mediated (GO:0010525)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transport into cytosol (GO:0010524)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of mesonephros development (GO:0061217)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transport into cytosol (GO:0010522)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in neural tube closure (GO:0090179)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of planar polarity involved in neural tube closure (GO:0090178)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesonephros development (GO:0061213)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of planar polarity (GO:0090175)	9	1	.18	+	5.71	1.75E-01	1.00E00
UDP-N-acetylglucosamine biosynthetic process (GO:0006048)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
organelle membrane fusion (GO:0090174)	62	0	1.21	-	 < 0.01	6.34E-01	1.00E00
UDP-N-acetylglucosamine metabolic process (GO:0006047)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of humoral immune response (GO:0002921)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-acetylglucosamine catabolic process (GO:0006046)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of humoral immune response (GO:0002920)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chondrocyte morphogenesis (GO:0090171)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
N-acetylglucosamine metabolic process (GO:0006044)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
glucosamine catabolic process (GO:0006043)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glucosamine metabolic process (GO:0006041)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
amino sugar metabolic process (GO:0006040)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
karyogamy (GO:0000741)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitric oxide metabolic process (GO:1904407)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase activity (GO:0010519)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase activity (GO:0010518)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ketone body metabolic process (GO:1902224)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase activity (GO:0010517)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cell death (GO:0008219)	226	5	4.40	+	1.14	6.32E-01	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of hemostasis (GO:1900048)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of blood pressure (GO:0008217)	42	1	.82	+	1.22	5.64E-01	1.00E00
negative regulation of hemostasis (GO:1900047)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
spermidine metabolic process (GO:0008216)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of hemostasis (GO:1900046)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein K63-linked ubiquitination (GO:1900045)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of spindle assembly (GO:0090169)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
spermine metabolic process (GO:0008215)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
paramesonephric duct development (GO:0061205)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein K63-linked ubiquitination (GO:1900044)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
Golgi reassembly (GO:0090168)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
Golgi disassembly (GO:0090166)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glucocorticoid metabolic process (GO:0008211)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
estrogen metabolic process (GO:0008210)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
DNA catabolic process, exonucleolytic (GO:0000738)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
DNA catabolic process, endonucleolytic (GO:0000737)	13	1	.25	+	3.95	2.36E-01	1.00E00
establishment of epithelial cell polarity (GO:0090162)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
removal of nonhomologous ends (GO:0000735)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chitin catabolic process (GO:0006032)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
chitin biosynthetic process (GO:0006031)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chitin metabolic process (GO:0006030)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
DNA synthesis involved in DNA repair (GO:0000731)	14	1	.27	+	3.67	2.51E-01	1.00E00
nucleolar chromatin organization (GO:1990700)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA recombinase assembly (GO:0000730)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagy (GO:0010508)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagy (GO:0010507)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of autophagy (GO:0010506)	73	2	1.42	+	1.41	6.56E-01	1.00E00
androgen metabolic process (GO:0008209)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
C21-steroid hormone metabolic process (GO:0008207)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
bile acid metabolic process (GO:0008206)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ergosterol metabolic process (GO:0008204)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum membrane organization (GO:0090158)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cholesterol metabolic process (GO:0008203)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
steroid metabolic process (GO:0008202)	75	1	1.46	-	.69	1.00E00	1.00E00
proteoglycan metabolic process (GO:0006029)	51	0	.99	-	 < 0.01	1.00E00	1.00E00
cellular sphingolipid homeostasis (GO:0090156)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
DNA double-strand break processing (GO:0000729)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of sphingolipid biosynthetic process (GO:0090155)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan catabolic process (GO:0006027)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
aminoglycan catabolic process (GO:0006026)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of sphingolipid biosynthetic process (GO:0090153)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
non-recombinational repair (GO:0000726)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrial membrane (GO:0090151)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan biosynthetic process (GO:0006024)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to membrane (GO:0090150)	87	0	1.69	-	 < 0.01	4.18E-01	1.00E00
microtubule nucleation by microtubule organizing center (GO:0051418)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
aminoglycan biosynthetic process (GO:0006023)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
aminoglycan metabolic process (GO:0006022)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
telomere maintenance (GO:0000723)	35	1	.68	+	1.47	5.01E-01	1.00E00
telomeric 3' overhang formation (GO:0031860)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via recombination (GO:0000722)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
inositol biosynthetic process (GO:0006021)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
microtubule nucleation by interphase microtubule organizing center (GO:0051415)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
inositol metabolic process (GO:0006020)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
response to cortisol (GO:0051414)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ruffle assembly (GO:1900029)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of ruffle assembly (GO:1900027)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
dendrite self-avoidance (GO:0070593)	15	1	.29	+	3.43	2.65E-01	1.00E00
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial membrane fission (GO:0090149)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane fission (GO:0090148)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of substrate adhesion-dependent cell spreading (GO:1900024)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
photoreactive repair (GO:0000719)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA damage recognition (GO:0000715)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-ribose metabolic process (GO:0006014)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial fission (GO:0090141)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mannose metabolic process (GO:0006013)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial fission (GO:0090140)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
galactose metabolic process (GO:0006012)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
resolution of meiotic recombination intermediates (GO:0000712)	12	1	.23	+	4.28	2.22E-01	1.00E00
UDP-glucose metabolic process (GO:0006011)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
meiotic DNA repair synthesis (GO:0000711)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic mismatch repair (GO:0000710)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
stress-activated MAPK cascade (GO:0051403)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
neuron apoptotic process (GO:0051402)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cellular component macromolecule biosynthetic process (GO:0070589)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
calcium ion transmembrane transport (GO:0070588)	118	1	2.30	-	.44	7.31E-01	1.00E00
cell-cell adhesion involved in gastrulation (GO:0070586)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein localization to mitochondrion (GO:0070585)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
mitochondrion morphogenesis (GO:0070584)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokine production involved in inflammatory response (GO:1900016)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cytokine production involved in inflammatory response (GO:1900015)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell fate specification (GO:0009996)	9	1	.18	+	5.71	1.75E-01	1.00E00
protection from non-homologous end joining at telomere (GO:0031848)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
soluble molecule recognition (GO:0009995)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oocyte differentiation (GO:0009994)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
epithelial cell-cell adhesion (GO:0090136)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of corticotropin-releasing hormone receptor activity (GO:1900011)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell migration involved in mesendoderm migration (GO:0090134)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
glucose catabolic process (GO:0006007)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of corticotropin-releasing hormone receptor activity (GO:1900010)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to extracellular stimulus (GO:0009991)	91	1	1.77	-	.56	1.00E00	1.00E00
glucose metabolic process (GO:0006006)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
mesendoderm migration (GO:0090133)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
epithelium migration (GO:0090132)	37	1	.72	+	1.39	5.19E-01	1.00E00
meiotic DNA double-strand break processing (GO:0000706)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
fucose metabolic process (GO:0006004)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
tissue migration (GO:0090130)	41	2	.80	+	2.51	1.98E-01	1.00E00
fructose 2,6-bisphosphate metabolic process (GO:0006003)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
fructose 6-phosphate metabolic process (GO:0006002)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
fructose metabolic process (GO:0006000)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
cellular response to benomyl (GO:0072755)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of eating behavior (GO:1903999)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of eating behavior (GO:1903998)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendrite development (GO:1900006)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
cell-cell recognition (GO:0009988)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of serine-type endopeptidase activity (GO:1900003)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of transcription involved in primary germ layer cell fate commitment (GO:0060796)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cell fate commitment involved in formation of primary germ layer (GO:0060795)	9	1	.18	+	5.71	1.75E-01	1.00E00
one-carbon compound transport (GO:0019755)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
polyol metabolic process (GO:0019751)	72	0	1.40	-	 < 0.01	6.50E-01	1.00E00
receptor-mediated endocytosis involved in cholesterol transport (GO:0090118)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
C-5 methylation of cytosine (GO:0090116)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
COPII-coated vesicle budding (GO:0090114)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cytidine deamination (GO:0009972)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ectodermal placode formation (GO:0060788)	20	1	.39	+	2.57	3.33E-01	1.00E00
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
COPII-coated vesicle cargo loading (GO:0090110)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of apoptosis involved in tissue homeostasis (GO:0060785)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in tissue homeostasis (GO:0060784)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
secondary metabolic process (GO:0019748)	13	1	.25	+	3.95	2.36E-01	1.00E00
regulation of microglial cell activation (GO:1903978)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to interleukin-1 (GO:0070555)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
positive regulation of signal transduction by p53 class mediator (GO:1901798)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pancreatic epsilon cell differentiation (GO:0090104)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	56	0	1.09	-	 < 0.01	6.29E-01	1.00E00
planar cell polarity pathway involved in gastrula mediolateral intercalation (GO:0060775)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid catabolic process (GO:0050996)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of lipid catabolic process (GO:0050994)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of collateral sprouting in absence of injury (GO:0048696)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
antibacterial humoral response (GO:0019731)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
antimicrobial humoral response (GO:0019730)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
arachidonate transport (GO:1903963)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
response to fatty acid (GO:0070542)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
epidermal cell fate specification (GO:0009957)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
proximal/distal pattern formation (GO:0009954)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral axis specification (GO:0009950)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to cytokine stimulus (GO:0060761)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to cytokine stimulus (GO:0060760)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular homeostasis (GO:0019725)	431	10	8.39	+	1.19	5.95E-01	1.00E00
regulation of anion transmembrane transport (GO:1903959)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
B cell mediated immunity (GO:0019724)	47	0	.91	-	 < 0.01	1.00E00	1.00E00
calcium-mediated signaling (GO:0019722)	66	1	1.28	-	.78	1.00E00	1.00E00
cellular response to hydroxyurea (GO:0072711)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of collateral sprouting of intact axon in response to injury (GO:0048685)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histone H2A K63-linked deubiquitination (GO:0070537)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
Mo-molybdopterin cofactor metabolic process (GO:0019720)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to hydroxyurea (GO:0072710)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903954)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein K63-linked deubiquitination (GO:0070536)	23	1	.45	+	2.23	3.70E-01	1.00E00
regulation of collateral sprouting of intact axon in response to injury (GO:0048683)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sprouting of injured axon (GO:0048682)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903952)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein K63-linked ubiquitination (GO:0070534)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
anterior/posterior axis specification (GO:0009948)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 trimethylation (GO:0097198)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of response to cytokine stimulus (GO:0060759)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
execution phase of apoptosis (GO:0097194)	18	1	.35	+	2.86	3.07E-01	1.00E00
intrinsic apoptotic signaling pathway (GO:0097193)	41	1	.80	+	1.25	5.55E-01	1.00E00
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	15	1	.29	+	3.43	2.65E-01	1.00E00
extrinsic apoptotic signaling pathway (GO:0097191)	23	1	.45	+	2.23	3.70E-01	1.00E00
apoptotic signaling pathway (GO:0097190)	77	2	1.50	+	1.34	6.64E-01	1.00E00
positive regulation of mast cell chemotaxis (GO:0060754)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell chemotaxis (GO:0060753)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception of touch (GO:0050976)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sensory perception of touch (GO:0050975)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of atrial cardiac muscle cell action potential (GO:1903949)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception (GO:0050974)	15	1	.29	+	3.43	2.65E-01	1.00E00
axon extension involved in regeneration (GO:0048677)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ventricular cardiac muscle cell action potential (GO:1903947)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axon extension (GO:0048675)	38	2	.74	+	2.71	1.77E-01	1.00E00
platelet aggregation (GO:0070527)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethioninamine metabolic process (GO:0046499)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
S-adenosylhomocysteine metabolic process (GO:0046498)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of collateral sprouting (GO:0048671)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of collateral sprouting (GO:0048670)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
nicotinamide nucleotide metabolic process (GO:0046496)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
dentinogenesis (GO:0097187)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
amelogenesis (GO:0097186)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
L-methylmalonyl-CoA metabolic process (GO:0046491)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate metabolic process (GO:0046490)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in prostate gland development (GO:0060742)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of pain (GO:0050968)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
collateral sprouting (GO:0048668)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
detection of light stimulus involved in sensory perception (GO:0050962)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell proliferation (GO:0048662)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol metabolic process (GO:0046488)	113	3	2.20	+	1.36	4.88E-01	1.00E00
regulation of smooth muscle cell proliferation (GO:0048660)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
glyoxylate metabolic process (GO:0046487)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
glycerolipid metabolic process (GO:0046486)	186	3	3.62	-	.83	1.00E00	1.00E00
ether lipid metabolic process (GO:0046485)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ruffle assembly (GO:0097178)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
leukotriene D4 biosynthetic process (GO:1901750)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
prostate gland growth (GO:0060736)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of eIF2 alpha phosphorylation by amino acid starvation (GO:0060733)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol phosphate biosynthetic process (GO:0060732)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
equilibrioception (GO:0050957)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell proliferation (GO:0048659)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sensory perception of mechanical stimulus (GO:0050954)	53	1	1.03	-	.97	1.00E00	1.00E00
sensory perception of light stimulus (GO:0050953)	157	3	3.05	-	.98	1.00E00	1.00E00
calcium ion import (GO:0070509)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
sensory perception of temperature stimulus (GO:0050951)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
epithelial cell morphogenesis involved in gastrulation (GO:0003381)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycosphingolipid catabolic process (GO:0046479)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
glycosylceramide catabolic process (GO:0046477)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
leukotriene D4 metabolic process (GO:1901748)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glycosylceramide biosynthetic process (GO:0046476)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycerophospholipid catabolic process (GO:0046475)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
glycerophospholipid biosynthetic process (GO:0046474)	60	2	1.17	+	1.71	3.32E-01	1.00E00
hormone transport (GO:0009914)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
phosphatidic acid metabolic process (GO:0046473)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial structure maintenance (GO:0060729)	9	1	.18	+	5.71	1.75E-01	1.00E00
phosphatidylglycerol metabolic process (GO:0046471)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of myoblast fusion (GO:1901741)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
ammonium ion metabolic process (GO:0097164)	68	0	1.32	-	 < 0.01	6.43E-01	1.00E00
phosphatidylcholine metabolic process (GO:0046470)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
establishment of cell polarity involved in gastrulation cell migration (GO:0003379)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sphingosine-1-phosphate receptor signaling pathway (GO:0003376)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
animal organ formation (GO:0048645)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
dynamin family protein polymerization involved in membrane fission (GO:0003373)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
muscle organ morphogenesis (GO:0048644)	24	1	.47	+	2.14	3.82E-01	1.00E00
positive regulation of skeletal muscle tissue development (GO:0048643)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle tissue development (GO:0048642)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion involved in mesendodermal cell migration (GO:0003370)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of myoblast fusion (GO:1901739)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle tissue development (GO:0048641)	12	1	.23	+	4.28	2.22E-01	1.00E00
membrane lipid biosynthetic process (GO:0046467)	78	1	1.52	-	.66	1.00E00	1.00E00
positive regulation of receptor clustering (GO:1903911)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
membrane lipid catabolic process (GO:0046466)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
dolichyl diphosphate metabolic process (GO:0046465)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter (GO:0001193)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acylglycerol catabolic process (GO:0046464)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
maintenance of transcriptional fidelity during DNA-templated transcription elongation (GO:0001192)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acylglycerol biosynthetic process (GO:0046463)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
monoacylglycerol metabolic process (GO:0046462)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neutral lipid catabolic process (GO:0046461)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
fasciculation of sensory neuron axon (GO:0097155)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GABAergic neuron differentiation (GO:0097154)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
neutral lipid biosynthetic process (GO:0046460)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
chorionic trophoblast cell differentiation (GO:0060718)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
chorion development (GO:0060717)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
small molecule biosynthetic process (GO:0044283)	275	2	5.35	-	.37	1.84E-01	1.00E00
neuronal stem cell population maintenance (GO:0097150)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of cell polarity involved in mesendodermal cell migration (GO:0003369)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
iridophore differentiation (GO:0050935)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of developmental growth (GO:0048639)	18	1	.35	+	2.86	3.07E-01	1.00E00
cell-cell adhesion involved in ameboidal cell migration (GO:0003367)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of receptor clustering (GO:1903909)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
late stripe melanocyte differentiation (GO:0050934)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
establishment of cell polarity involved in ameboidal cell migration (GO:0003365)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle organ development (GO:0048635)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
induction of positive chemotaxis (GO:0050930)	13	1	.25	+	3.95	2.36E-01	1.00E00
RNA polymerase I preinitiation complex assembly (GO:0001188)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of T cell polarity (GO:1903904)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid metabolic process (GO:0046459)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of T cell polarity (GO:1903903)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral life cycle (GO:1903902)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prostanoid biosynthetic process (GO:0046457)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
icosanoid biosynthetic process (GO:0046456)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of viral life cycle (GO:1903900)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dihydrofolate metabolic process (GO:0046452)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular carbohydrate catabolic process (GO:0044275)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
sulfur compound catabolic process (GO:0044273)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
sulfur compound biosynthetic process (GO:0044272)	51	1	.99	+	1.01	1.00E00	1.00E00
cellular nitrogen compound biosynthetic process (GO:0044271)	758	10	14.75	-	.68	2.81E-01	1.00E00
T cell proliferation (GO:0042098)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular nitrogen compound catabolic process (GO:0044270)	153	5	2.98	+	1.68	2.32E-01	1.00E00
late endosome to Golgi transport (GO:0034499)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
T-helper cell differentiation (GO:0042093)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
early endosome to Golgi transport (GO:0034498)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to phagophore assembly site (GO:0034497)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
type 2 immune response (GO:0042092)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of positive chemotaxis (GO:0050927)	13	1	.25	+	3.95	2.36E-01	1.00E00
regulation of positive chemotaxis (GO:0050926)	13	1	.25	+	3.95	2.36E-01	1.00E00
noradrenergic neuron development (GO:0003358)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
noradrenergic neuron differentiation (GO:0003357)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cilium beat frequency (GO:0003356)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cilium movement involved in otolith formation (GO:0003355)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemotaxis (GO:0050921)	14	1	.27	+	3.67	2.51E-01	1.00E00
myoblast fate commitment (GO:0048625)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cilium movement (GO:0003352)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	24	1	.47	+	2.14	3.82E-01	1.00E00
transcriptional start site selection at RNA polymerase II promoter (GO:0001174)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcriptional start site selection (GO:0001173)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
FMN metabolic process (GO:0046444)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
FAD metabolic process (GO:0046443)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
L-lysine metabolic process (GO:0046440)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular macromolecule catabolic process (GO:0044265)	510	14	9.92	+	1.41	1.94E-01	1.00E00
cellular polysaccharide metabolic process (GO:0044264)	49	1	.95	+	1.05	6.19E-01	1.00E00
cellular carbohydrate metabolic process (GO:0044262)	91	1	1.77	-	.56	1.00E00	1.00E00
negative chemotaxis (GO:0050919)	39	2	.76	+	2.64	1.84E-01	1.00E00
epicardial cell to mesenchymal cell transition (GO:0003347)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
embryonic foregut morphogenesis (GO:0048617)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pericardium morphogenesis (GO:0003344)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
septum transversum development (GO:0003343)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proepicardium development (GO:0003342)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cilium movement (GO:0003341)	57	2	1.11	+	1.80	3.11E-01	1.00E00
L-cysteine metabolic process (GO:0046439)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-alanine metabolic process (GO:0046436)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
organophosphate catabolic process (GO:0046434)	62	0	1.21	-	 < 0.01	6.34E-01	1.00E00
cellular response to oxygen-containing compound (GO:1901701)	209	1	4.07	-	.25	1.96E-01	1.00E00
cellular protein catabolic process (GO:0044257)	411	11	8.00	+	1.38	2.78E-01	1.00E00
receptor localization to synapse (GO:0097120)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
germ-line stem cell division (GO:0042078)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sensory perception of taste (GO:0050909)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
intraciliary transport (GO:0042073)	20	1	.39	+	2.57	3.33E-01	1.00E00
detection of light stimulus involved in visual perception (GO:0050908)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
detection of calcium ion (GO:0005513)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
U6 snRNA 3'-end processing (GO:0034477)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
U5 snRNA 3'-end processing (GO:0034476)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception (GO:0050907)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
detection of stimulus involved in sensory perception (GO:0050906)	24	1	.47	+	2.14	3.82E-01	1.00E00
U4 snRNA 3'-end processing (GO:0034475)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
neuromuscular process (GO:0050905)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
multicellular organismal reproductive process (GO:0048609)	118	3	2.30	+	1.31	5.04E-01	1.00E00
U2 snRNA 3'-end processing (GO:0034474)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
reproductive structure development (GO:0048608)	19	1	.37	+	2.71	3.20E-01	1.00E00
U1 snRNA 3'-end processing (GO:0034473)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
snRNA 3'-end processing (GO:0034472)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
ncRNA 5'-end processing (GO:0034471)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
keratinocyte development (GO:0003334)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ncRNA processing (GO:0034470)	211	2	4.11	-	.49	4.48E-01	1.00E00
amino acid transmembrane transport (GO:0003333)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
leukocyte migration (GO:0050900)	91	0	1.77	-	 < 0.01	4.24E-01	1.00E00
regulation of extracellular matrix constituent secretion (GO:0003330)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
axon ensheathment in central nervous system (GO:0032291)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
cellular biosynthetic process (GO:0044249)	1372	21	26.69	-	.79	3.12E-01	1.00E00
cellular catabolic process (GO:0044248)	938	19	18.25	+	1.04	8.09E-01	1.00E00
cellular polysaccharide catabolic process (GO:0044247)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid receptor clustering (GO:0097112)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular lipid catabolic process (GO:0044242)	83	0	1.61	-	 < 0.01	4.13E-01	1.00E00
lipid digestion (GO:0044241)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of pteridine metabolic process (GO:0042068)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of myoblast proliferation (GO:2000291)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of myotome development (GO:2000290)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
small-subunit processome assembly (GO:0034462)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
central nervous system myelin formation (GO:0032289)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myelin assembly (GO:0032288)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pancreatic D cell development (GO:0003324)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell development (GO:0003323)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
pancreatic A cell development (GO:0003322)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
non-myelinated axon ensheathment (GO:0032285)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-amino acid metabolic process (GO:0046416)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
urate metabolic process (GO:0046415)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
postsynaptic density assembly (GO:0097107)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
postsynaptic density organization (GO:0097106)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
presynaptic membrane assembly (GO:0097105)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
postsynaptic membrane assembly (GO:0097104)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell fate specification (GO:0097101)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
compound eye photoreceptor development (GO:0042051)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cardioblast migration to the midline involved in heart rudiment formation (GO:0003319)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cell migration to the midline involved in heart development (GO:0003318)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
microtubule anchoring (GO:0034453)	15	1	.29	+	3.43	2.65E-01	1.00E00
heart rudiment formation (GO:0003315)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
heart rudiment morphogenesis (GO:0003314)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of gonadotropin secretion (GO:0032277)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heart rudiment development (GO:0003313)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of gonadotropin secretion (GO:0032276)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pancreatic D cell differentiation (GO:0003311)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pancreatic A cell differentiation (GO:0003310)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein polymerization (GO:0032273)	62	0	1.21	-	 < 0.01	6.34E-01	1.00E00
negative regulation of protein polymerization (GO:0032272)	42	1	.82	+	1.22	5.64E-01	1.00E00
myeloid cell differentiation (GO:0030099)	149	5	2.90	+	1.72	2.23E-01	1.00E00
regulation of protein polymerization (GO:0032271)	123	1	2.39	-	.42	7.35E-01	1.00E00
lymphocyte differentiation (GO:0030098)	38	1	.74	+	1.35	5.29E-01	1.00E00
protein repair (GO:0030091)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA biosynthetic process (GO:2000279)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of DNA biosynthetic process (GO:2000278)	15	1	.29	+	3.43	2.65E-01	1.00E00
positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
striated muscle hypertrophy (GO:0014897)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
muscle hypertrophy (GO:0014896)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative phosphorylation uncoupler activity (GO:2000275)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
epithelial fluid transport (GO:0042045)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of signaling receptor activity (GO:2000272)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
fluid transport (GO:0042044)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
very-low-density lipoprotein particle clearance (GO:0034447)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell differentiation (GO:0003309)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
substrate adhesion-dependent cell spreading (GO:0034446)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
metal incorporation into metallo-molybdopterin complex (GO:0042040)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in heart development (GO:0003306)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular protein metabolic process (GO:0032269)	186	3	3.62	-	.83	1.00E00	1.00E00
lipid oxidation (GO:0034440)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in heart jogging (GO:0003303)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
physiological cardiac muscle hypertrophy (GO:0003301)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
IMP salvage (GO:0032264)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cardiac muscle hypertrophy (GO:0003300)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
GMP salvage (GO:0032263)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide salvage (GO:0032262)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
purine nucleotide salvage (GO:0032261)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
protein-DNA complex remodeling (GO:0001120)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of blood coagulation, intrinsic pathway (GO:2000266)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CTP salvage (GO:0044211)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
'de novo' CTP biosynthetic process (GO:0044210)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cytokine biosynthetic process (GO:0042035)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of myofibril size (GO:0014881)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycoprotein transport (GO:0034436)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cholesterol esterification (GO:0034435)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
sterol esterification (GO:0034434)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
steroid esterification (GO:0034433)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
methylation (GO:0032259)	138	5	2.68	+	1.86	2.02E-01	1.00E00
cytoplasm to vacuole transport by the Cvt pathway (GO:0032258)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
transcriptional open complex formation at RNA polymerase II promoter (GO:0001113)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcriptional open complex formation (GO:0001112)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
AMP salvage (GO:0044209)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
insulin secretion (GO:0030073)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
'de novo' AMP biosynthetic process (GO:0044208)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
peptide hormone secretion (GO:0030072)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
UMP salvage (GO:0044206)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
postsynaptic neurotransmitter receptor internalization (GO:0098884)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
'de novo' UMP biosynthetic process (GO:0044205)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of protein activation cascade (GO:2000257)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein refolding (GO:0042026)	22	1	.43	+	2.34	3.58E-01	1.00E00
positive regulation of feeding behavior (GO:2000253)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of feeding behavior (GO:2000252)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin cytoskeleton reorganization (GO:2000251)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)	10	1	.19	+	5.14	1.91E-01	1.00E00
response to acid chemical (GO:0001101)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
neurotransmitter receptor transport to plasma membrane (GO:0098877)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated transport to the plasma membrane (GO:0098876)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
regulation of actin cytoskeleton reorganization (GO:2000249)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
skeletal myofibril assembly (GO:0014866)	21	1	.41	+	2.45	3.46E-01	1.00E00
positive regulation of reproductive process (GO:2000243)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
negative regulation of reproductive process (GO:2000242)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of reproductive process (GO:2000241)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
activation of store-operated calcium channel activity (GO:0032237)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament bundle assembly (GO:0032233)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament bundle assembly (GO:0032231)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
cellular oxidant detoxification (GO:0098869)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
bone growth (GO:0098868)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
protein depalmitoleylation (GO:1990697)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle cell proliferation (GO:0014857)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of embryonic development (GO:0045992)	13	1	.25	+	3.95	2.36E-01	1.00E00
striated muscle cell proliferation (GO:0014855)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of rRNA processing (GO:2000233)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of rRNA processing (GO:2000232)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to muscle activity (GO:0014850)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to fluid shear stress (GO:0034405)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleobase-containing small molecule biosynthetic process (GO:0034404)	49	1	.95	+	1.05	6.19E-01	1.00E00
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic transmission, GABAergic (GO:0032228)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
proteasomal protein catabolic process (GO:0010498)	217	5	4.22	+	1.18	6.19E-01	1.00E00
regulation of synaptic transmission, cholinergic (GO:0032222)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
actin filament-based movement (GO:0030048)	18	1	.35	+	2.86	3.07E-01	1.00E00
parallel actin filament bundle assembly (GO:0030046)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte development (GO:0061182)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte development (GO:0061181)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of immunoglobulin mediated immune response (GO:0002891)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
intestinal lipid absorption (GO:0098856)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of striated muscle contraction (GO:0045989)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
actin filament depolymerization (GO:0030042)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
actin filament polymerization (GO:0030041)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle contraction (GO:0045988)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of pancreatic A cell differentiation (GO:2000228)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic A cell differentiation (GO:2000227)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic A cell differentiation (GO:2000226)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
esophagus smooth muscle contraction (GO:0014846)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
myoblast proliferation involved in skeletal muscle regeneration (GO:0014844)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide metabolic process (GO:0045981)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide metabolic process (GO:0045980)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cell periphery (GO:1904377)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell periphery (GO:1904376)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell periphery (GO:1904375)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
riboflavin transport (GO:0032218)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of immunoglobulin mediated immune response (GO:0002889)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal cell division (GO:0010482)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
contractile actin filament bundle assembly (GO:0030038)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid leukocyte mediated immunity (GO:0002886)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via telomerase (GO:0032211)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
epidermal cell division (GO:0010481)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via telomerase (GO:0032210)	14	1	.27	+	3.67	2.51E-01	1.00E00
actin cytoskeleton organization (GO:0030036)	414	11	8.05	+	1.37	2.81E-01	1.00E00
microvillus assembly (GO:0030033)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell projection assembly (GO:0030031)	244	7	4.75	+	1.47	3.45E-01	1.00E00
myoblast migration involved in skeletal muscle regeneration (GO:0014839)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of translation, ncRNA-mediated (GO:0045974)	10	1	.19	+	5.14	1.91E-01	1.00E00
protein transport along microtubule (GO:0098840)	25	1	.49	+	2.06	3.94E-01	1.00E00
myoblast differentiation involved in skeletal muscle regeneration (GO:0014835)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA acetylation (GO:0051391)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
gastro-intestinal system smooth muscle contraction (GO:0014831)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of anoikis (GO:2000210)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via recombination (GO:0032208)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via recombination (GO:0032207)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance (GO:0032205)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance (GO:0032204)	18	1	.35	+	2.86	3.07E-01	1.00E00
actin filament-based process (GO:0030029)	426	12	8.29	+	1.45	2.12E-01	1.00E00
telomere organization (GO:0032200)	35	1	.68	+	1.47	5.01E-01	1.00E00
endoplasmic reticulum polarization (GO:0061163)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of monopolar cell polarity (GO:0061162)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
folate transmembrane transport (GO:0098838)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth rate (GO:0045967)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of anoikis (GO:2000209)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
intestine smooth muscle contraction (GO:0014827)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to glucocorticoid (GO:0051384)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
kinetochore organization (GO:0051383)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
kinetochore assembly (GO:0051382)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
response to activity (GO:0014823)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via telomere lengthening (GO:1904357)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via telomere lengthening (GO:1904356)	16	1	.31	+	3.21	2.79E-01	1.00E00
phasic smooth muscle contraction (GO:0014821)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of signaling receptor activity (GO:0010469)	39	1	.76	+	1.32	5.38E-01	1.00E00
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidase activity (GO:0010466)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
3'-UTR-mediated mRNA destabilization (GO:0061158)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mRNA destabilization (GO:0061157)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
endothelial tube morphogenesis (GO:0061154)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein maturation by protein folding (GO:0022417)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of cell polarity (GO:0030011)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
establishment of cell polarity (GO:0030010)	39	1	.76	+	1.32	5.38E-01	1.00E00
positive regulation of calcium ion-dependent exocytosis (GO:0045956)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction (GO:0014819)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion-dependent exocytosis (GO:0045955)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular process involved in reproduction in multicellular organism (GO:0022412)	76	1	1.48	-	.68	1.00E00	1.00E00
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell differentiation (GO:0014816)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle process (GO:0022410)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic recombination (GO:0045951)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
muscle cell migration (GO:0014812)	9	1	.18	+	5.71	1.75E-01	1.00E00
positive regulation of dopaminergic neuron differentiation (GO:1904340)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart rate (GO:0010459)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
exit from mitosis (GO:0010458)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
centriole-centriole cohesion (GO:0010457)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell proliferation in dorsal spinal cord (GO:0010456)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell fate commitment (GO:0010454)	12	1	.23	+	4.28	2.22E-01	1.00E00
regulation of cell fate commitment (GO:0010453)	22	1	.43	+	2.34	3.58E-01	1.00E00
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 methylation (GO:0010452)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to lipid (GO:0033993)	140	1	2.72	-	.37	5.29E-01	1.00E00
actin polymerization or depolymerization (GO:0008154)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
cellular potassium ion homeostasis (GO:0030007)	14	1	.27	+	3.67	2.51E-01	1.00E00
regulation of natural killer cell mediated immune response to tumor cell (GO:0002855)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular monovalent inorganic cation homeostasis (GO:0030004)	60	2	1.17	+	1.71	3.32E-01	1.00E00
positive regulation of cell-cell adhesion (GO:0022409)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
cellular cation homeostasis (GO:0030003)	318	7	6.19	+	1.13	6.81E-01	1.00E00
negative regulation of cell-cell adhesion (GO:0022408)	55	1	1.07	-	.93	1.00E00	1.00E00
regulation of cell-cell adhesion (GO:0022407)	69	2	1.34	+	1.49	3.94E-01	1.00E00
cellular anion homeostasis (GO:0030002)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
modulation of excitatory postsynaptic potential (GO:0098815)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation (GO:0045948)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
metal ion transport (GO:0030001)	418	4	8.13	-	.49	2.04E-01	1.00E00
membrane docking (GO:0022406)	62	0	1.21	-	 < 0.01	6.34E-01	1.00E00
negative regulation of translational initiation (GO:0045947)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cell cycle phase (GO:0022403)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by RNA polymerase III (GO:0045945)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of somitogenesis (GO:0014807)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neurotransmitter reuptake (GO:0098810)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of rhodopsin mediated signaling pathway (GO:0022400)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of dopaminergic neuron differentiation (GO:1904338)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid metabolic process (GO:0045940)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
morphogenesis of a branching epithelium (GO:0061138)	16	1	.31	+	3.21	2.79E-01	1.00E00
response to methanol (GO:0033986)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of proteasomal protein catabolic process (GO:0061136)	42	1	.82	+	1.22	5.64E-01	1.00E00
pancreas field specification (GO:0061131)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pancreatic bud formation (GO:0061130)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphate metabolic process (GO:0045937)	361	9	7.02	+	1.28	4.39E-01	1.00E00
negative regulation of phosphate metabolic process (GO:0045936)	78	2	1.52	+	1.32	6.67E-01	1.00E00
regulation of renal system process (GO:0098801)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle contraction (GO:0045933)	9	1	.18	+	5.71	1.75E-01	1.00E00
negative regulation of oxidoreductase activity (GO:0051354)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle contraction (GO:0045932)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidoreductase activity (GO:0051353)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of ligase activity (GO:0051351)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of lyase activity (GO:0051350)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904325)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904323)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to forskolin (GO:1904322)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to forskolin (GO:1904321)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
box H/ACA snoRNA metabolic process (GO:0033979)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of immune response to tumor cell (GO:0002839)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of immune response to tumor cell (GO:0002837)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to tumor cell (GO:0002836)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of peptide transport (GO:0090087)	82	2	1.60	+	1.25	6.76E-01	1.00E00
regulation of response to tumor cell (GO:0002834)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to biotic stimulus (GO:0002833)	40	1	.78	+	1.28	5.46E-01	1.00E00
negative regulation of response to biotic stimulus (GO:0002832)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of protein deubiquitination (GO:0090085)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of response to biotic stimulus (GO:0002831)	59	1	1.15	-	.87	1.00E00	1.00E00
positive regulation of growth (GO:0045927)	21	1	.41	+	2.45	3.46E-01	1.00E00
positive regulation of lyase activity (GO:0051349)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of transferase activity (GO:0051348)	48	0	.93	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrolase activity (GO:0051346)	75	2	1.46	+	1.37	6.60E-01	1.00E00
positive regulation of fatty acid metabolic process (GO:0045923)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid metabolic process (GO:0045922)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of exocytosis (GO:0045921)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of exocytosis (GO:0045920)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of oxidoreductase activity (GO:0051341)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of ligase activity (GO:0051340)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
box C/D snoRNA metabolic process (GO:0033967)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA methylation on cytosine within a CG sequence (GO:0010424)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of type 2 immune response (GO:0002829)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of type 2 immune response (GO:0002828)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 1 type immune response (GO:0002827)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
branching involved in pancreas morphogenesis (GO:0061114)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cytoplasmic mRNA processing body assembly (GO:0033962)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 type immune response (GO:0002825)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pancreas morphogenesis (GO:0061113)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
relaxation of skeletal muscle (GO:0090076)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
relaxation of muscle (GO:0090075)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of adaptive immune response (GO:0002821)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of adaptive immune response (GO:0002820)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of lyase activity (GO:0051339)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribosome biogenesis (GO:0090071)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement activation (GO:0045916)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of carbohydrate metabolic process (GO:0045913)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of carbohydrate metabolic process (GO:0045912)	9	1	.18	+	5.71	1.75E-01	1.00E00
positive regulation of DNA recombination (GO:0045911)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule cytoskeleton (GO:0072698)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of DNA recombination at telomere (GO:0072695)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of adaptive immune response (GO:0002819)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of ribosome biogenesis (GO:0090069)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of anatomical structure size (GO:0090066)	267	8	5.19	+	1.54	2.59E-01	1.00E00
positive regulation of vasoconstriction (GO:0045907)	15	1	.29	+	3.43	2.65E-01	1.00E00
mitotic interphase (GO:0051329)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational termination (GO:0045905)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational fidelity (GO:0045903)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interphase (GO:0051325)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational elongation (GO:0045901)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational elongation (GO:0045900)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
choline metabolic process (GO:0019695)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of organelle assembly (GO:1902117)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
alkanesulfonate metabolic process (GO:0019694)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neural plate formation (GO:0021990)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ribose phosphate metabolic process (GO:0019693)	205	3	3.99	-	.75	1.00E00	1.00E00
negative regulation of organelle assembly (GO:1902116)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
T cell extravasation (GO:0072683)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of organelle assembly (GO:1902115)	44	1	.86	+	1.17	5.80E-01	1.00E00
deoxyribose phosphate metabolic process (GO:0019692)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
protein localization (GO:0008104)	924	15	17.98	-	.83	5.44E-01	1.00E00
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
G1 phase (GO:0051318)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebral cortex development (GO:0021987)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
meiotic metaphase plate congression (GO:0051311)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
metaphase plate congression (GO:0051310)	10	1	.19	+	5.14	1.91E-01	1.00E00
neurohypophysis development (GO:0021985)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
thymocyte migration (GO:0072679)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
T cell migration (GO:0072678)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
eosinophil migration (GO:0072677)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lymphocyte migration (GO:0072676)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
osteoclast fusion (GO:0072675)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte differentiation (GO:1902107)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
multinuclear osteoclast differentiation (GO:0072674)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte differentiation (GO:1902106)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte differentiation (GO:1902105)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
glyceraldehyde-3-phosphate metabolic process (GO:0019682)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
interleukin-1-mediated signaling pathway (GO:0070498)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mitochondria-associated ubiquitin-dependent protein catabolic process (GO:0072671)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	10	1	.19	+	5.14	1.91E-01	1.00E00
thrombin-activated receptor signaling pathway (GO:0070493)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of cell migration involved in sprouting angiogenesis (GO:0090049)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
male meiosis chromosome separation (GO:0051308)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid separation (GO:0051306)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypothalamus cell differentiation (GO:0021979)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of chromosome localization (GO:0051303)	14	1	.27	+	3.67	2.51E-01	1.00E00
telencephalon regionalization (GO:0021978)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spindle pole body organization (GO:0051300)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell fate specification (GO:0043704)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell fate determination (GO:0043703)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
NAD catabolic process (GO:0019677)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to vacuole (GO:0072666)	35	1	.68	+	1.47	5.01E-01	1.00E00
protein localization to vacuole (GO:0072665)	38	1	.74	+	1.35	5.29E-01	1.00E00
NAD metabolic process (GO:0019674)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to peroxisome (GO:0072663)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
GDP-mannose metabolic process (GO:0019673)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
protein localization to peroxisome (GO:0072662)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
response to oxygen levels (GO:0070482)	58	1	1.13	-	.89	1.00E00	1.00E00
positive regulation of catabolic process (GO:0009896)	87	1	1.69	-	.59	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein kinase C signaling (GO:0090036)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein localization to plasma membrane (GO:0072659)	60	0	1.17	-	 < 0.01	6.32E-01	1.00E00
protein localization to membrane (GO:0072657)	173	1	3.37	-	.30	2.69E-01	1.00E00
establishment of protein localization to mitochondrion (GO:0072655)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
posterior commissure morphogenesis (GO:0021961)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rRNA (guanine-N7)-methylation (GO:0070476)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
rRNA base methylation (GO:0070475)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
tRNA-guanine transglycosylation (GO:0101030)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil chemotaxis (GO:0090023)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
central nervous system projection neuron axonogenesis (GO:0021952)	17	1	.33	+	3.02	2.93E-01	1.00E00
anterior neural plate formation (GO:0090017)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of morphogenesis of a branching structure (GO:0060688)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
formation of radial glial scaffolds (GO:0021943)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aerobic electron transport chain (GO:0019646)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of cerebellar granule cell precursor proliferation (GO:0021940)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prolactin secretion (GO:0070459)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrogen compound (GO:1901699)	125	1	2.43	-	.41	7.36E-01	1.00E00
response to nitrogen compound (GO:1901698)	233	3	4.53	-	.66	6.34E-01	1.00E00
primitive streak formation (GO:0090009)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypoblast development (GO:0090008)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tight junction organization (GO:0120193)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
tight junction assembly (GO:0120192)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cerebellar granule cell precursor proliferation (GO:0021936)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hindbrain tangential cell migration (GO:0021934)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
organophosphate metabolic process (GO:0019637)	531	6	10.33	-	.58	2.03E-01	1.00E00
response to stimulus (GO:0050896)	4952	98	96.35	+	1.02	8.62E-01	1.00E00
hindbrain radial glia guided cell migration (GO:0021932)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oocyte development (GO:0048599)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
intestinal absorption (GO:0050892)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
extraembryonic membrane development (GO:1903867)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
multicellular organismal water homeostasis (GO:0050891)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cognition (GO:0050890)	15	1	.29	+	3.43	2.65E-01	1.00E00
positive regulation of oxidative phosphorylation (GO:1903862)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
auxin catabolic process (GO:0009852)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
auxin metabolic process (GO:0009850)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
urate catabolic process (GO:0019628)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
urea metabolic process (GO:0019627)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cell proliferation in hindbrain ventricular zone (GO:0021923)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endocrine process (GO:0050886)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid catabolic process (GO:0019626)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
neuromuscular process controlling balance (GO:0050885)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
developmental cell growth (GO:0048588)	45	2	.88	+	2.28	2.26E-01	1.00E00
musculoskeletal movement (GO:0050881)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
nucleotide transmembrane transport (GO:1901679)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
iron coordination entity transport (GO:1901678)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle assembly (GO:1901673)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
steroid hormone biosynthetic process (GO:0120178)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
frontonasal suture morphogenesis (GO:0097095)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
craniofacial suture morphogenesis (GO:0097094)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
presynaptic membrane organization (GO:0097090)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
multicellular organismal movement (GO:0050879)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
regulation of body fluid levels (GO:0050878)	71	0	1.38	-	 < 0.01	6.48E-01	1.00E00
nervous system process (GO:0050877)	464	6	9.03	-	.66	3.94E-01	1.00E00
catechol-containing compound catabolic process (GO:0019614)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
brown fat cell differentiation (GO:0050873)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell activation (GO:0050871)	44	0	.86	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell activation (GO:0050870)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	19	1	.37	+	2.71	3.20E-01	1.00E00
abscission (GO:0009838)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
carboxylic acid catabolic process (GO:0046395)	125	0	2.43	-	 < 0.01	1.81E-01	1.00E00
carboxylic acid biosynthetic process (GO:0046394)	129	1	2.51	-	.40	5.24E-01	1.00E00
quinone biosynthetic process (GO:1901663)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
5-phosphoribose 1-diphosphate metabolic process (GO:0046391)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
quinone metabolic process (GO:1901661)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
ribose phosphate biosynthetic process (GO:0046390)	131	3	2.55	+	1.18	7.44E-01	1.00E00
vascular smooth muscle cell development (GO:0097084)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcium ion export (GO:1901660)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hindbrain-spinal cord boundary formation (GO:0021906)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell activation (GO:0050869)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
forebrain-midbrain boundary formation (GO:0021905)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell activation (GO:0050868)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell activation (GO:0050867)	66	0	1.28	-	 < 0.01	6.40E-01	1.00E00
negative regulation of cell activation (GO:0050866)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
physiological muscle hypertrophy (GO:0003298)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of cell activation (GO:0050865)	100	1	1.95	-	.51	1.00E00	1.00E00
post-embryonic animal organ development (GO:0048569)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
butyrate metabolic process (GO:0019605)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of B cell activation (GO:0050864)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
regulation of T cell activation (GO:0050863)	47	1	.91	+	1.09	6.04E-01	1.00E00
positive regulation of T cell receptor signaling pathway (GO:0050862)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
atrial ventricular junction remodeling (GO:0003294)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell receptor signaling pathway (GO:0050861)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to cold (GO:0070417)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
post-embryonic animal organ morphogenesis (GO:0048563)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycosyl compound biosynthetic process (GO:1901659)	24	1	.47	+	2.14	3.82E-01	1.00E00
signal transduction involved in cellular response to ammonium ion (GO:1903831)	41	0	.80	-	 < 0.01	1.00E00	1.00E00
glycosyl compound catabolic process (GO:1901658)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
glycosyl compound metabolic process (GO:1901657)	62	1	1.21	-	.83	1.00E00	1.00E00
deoxyribose phosphate catabolic process (GO:0046386)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
magnesium ion transmembrane transport (GO:1903830)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
deoxyribose phosphate biosynthetic process (GO:0046385)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
unidimensional cell growth (GO:0009826)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to ketone (GO:1901655)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
response to ketone (GO:1901654)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to peptide (GO:1901653)	57	1	1.11	-	.90	1.00E00	1.00E00
response to peptide (GO:1901652)	71	1	1.38	-	.72	1.00E00	1.00E00
regulation of microtubule-based movement (GO:0060632)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of meiosis I (GO:0060631)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell receptor signaling pathway (GO:0050859)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of T cell receptor signaling pathway (GO:0050856)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of B cell receptor signaling pathway (GO:0050855)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of antigen receptor-mediated signaling pathway (GO:0050854)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
B cell receptor signaling pathway (GO:0050853)	51	0	.99	-	 < 0.01	1.00E00	1.00E00
T cell receptor signaling pathway (GO:0050852)	40	0	.78	-	 < 0.01	1.00E00	1.00E00
arginine transmembrane transport (GO:1903826)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
antigen receptor-mediated signaling pathway (GO:0050851)	88	0	1.71	-	 < 0.01	4.19E-01	1.00E00
organic acid transmembrane transport (GO:1903825)	61	0	1.19	-	 < 0.01	6.33E-01	1.00E00
oxidation-dependent protein catabolic process (GO:0070407)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extracellular polysaccharide metabolic process (GO:0046379)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
L-arabinose metabolic process (GO:0046373)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to thyroid hormone (GO:0097066)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nucleoside transmembrane transport (GO:1901642)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
anterior head development (GO:0097065)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ncRNA export from nucleus (GO:0097064)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of ER to Golgi vesicle-mediated transport (GO:0060628)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle-mediated transport (GO:0060627)	143	1	2.78	-	.36	5.32E-01	1.00E00
dendritic spine maintenance (GO:0097062)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dendritic spine organization (GO:0097061)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
chemosensory behavior (GO:0007635)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
optokinetic behavior (GO:0007634)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
regulation of chromosome condensation (GO:0060623)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
visual behavior (GO:0007632)	24	1	.47	+	2.14	3.82E-01	1.00E00
feeding behavior (GO:0007631)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of calcium-mediated signaling (GO:0050848)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity (GO:1903818)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of voltage-gated potassium channel activity (GO:1903817)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to steroid hormone (GO:0048545)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
endocardial cushion formation (GO:0003272)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose metabolic process (GO:0046368)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
monosaccharide catabolic process (GO:0046365)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
monosaccharide biosynthetic process (GO:0046364)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
L-kynurenine catabolic process (GO:0097053)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
locomotory behavior (GO:0007626)	85	2	1.65	+	1.21	6.83E-01	1.00E00
L-kynurenine metabolic process (GO:0097052)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ultradian rhythm (GO:0007624)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
circadian rhythm (GO:0007623)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
rhythmic behavior (GO:0007622)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
adipose tissue development (GO:0060612)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of secondary heart field cardioblast proliferation (GO:0003266)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
defense response to fungus (GO:0050832)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of cardioblast proliferation (GO:0003264)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endocardial progenitor cell migration to the midline involved in heart field formation (GO:0003262)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cardiac muscle progenitor cell migration to the midline involved in heart field formation (GO:0003261)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glycine import across plasma membrane (GO:1903804)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardioblast migration (GO:0003260)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
butyrate catabolic process (GO:0046359)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of postsynaptic membrane organization (GO:1901628)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic membrane organization (GO:1901626)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hemolysis in other organism (GO:0044179)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
disaccharide biosynthetic process (GO:0046351)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
courtship behavior (GO:0007619)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mating (GO:0007618)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mating behavior (GO:0007617)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
long-term memory (GO:0007616)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tube closure (GO:0060606)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
short-term memory (GO:0007614)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
memory (GO:0007613)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
learning or memory (GO:0007611)	14	1	.27	+	3.67	2.51E-01	1.00E00
behavior (GO:0007610)	178	6	3.46	+	1.73	1.70E-01	1.00E00
defense response to Gram-negative bacterium (GO:0050829)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein localization to cell surface (GO:0034394)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
protein stabilization (GO:0050821)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of coagulation (GO:0050820)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral process (GO:0048524)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
amino sugar biosynthetic process (GO:0046349)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
amino sugar catabolic process (GO:0046348)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of behavior (GO:0048521)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of behavior (GO:0048520)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
organic hydroxy compound biosynthetic process (GO:1901617)	99	1	1.93	-	.52	1.00E00	1.00E00
organic hydroxy compound catabolic process (GO:1901616)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
protein linear polyubiquitination (GO:0097039)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
organic hydroxy compound metabolic process (GO:1901615)	188	1	3.66	-	.27	2.76E-01	1.00E00
heme export (GO:0097037)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane sterol distribution (GO:0097036)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of membrane lipid distribution (GO:0097035)	45	0	.88	-	 < 0.01	1.00E00	1.00E00
CDP-diacylglycerol metabolic process (GO:0046341)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
sensory perception of smell (GO:0007608)	115	0	2.24	-	 < 0.01	2.86E-01	1.00E00
diacylglycerol catabolic process (GO:0046340)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle transport along microtubule (GO:1901610)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sensory perception of chemical stimulus (GO:0007606)	128	0	2.49	-	 < 0.01	1.83E-01	1.00E00
sensory perception of sound (GO:0007605)	42	1	.82	+	1.22	5.64E-01	1.00E00
phototransduction, visible light (GO:0007603)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
phototransduction (GO:0007602)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
visual perception (GO:0007601)	150	2	2.92	-	.69	1.00E00	1.00E00
sensory perception (GO:0007600)	341	4	6.63	-	.60	4.25E-01	1.00E00
lipid droplet organization (GO:0034389)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of coagulation (GO:0050819)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of coagulation (GO:0050818)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
coagulation (GO:0050817)	54	0	1.05	-	 < 0.01	6.28E-01	1.00E00
chylomicron remnant clearance (GO:0034382)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle clearance (GO:0034381)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spermatid differentiation (GO:0048515)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle assembly (GO:0034380)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of steroid biosynthetic process (GO:0050810)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
blood vessel morphogenesis (GO:0048514)	273	6	5.31	+	1.13	6.60E-01	1.00E00
cardiac chamber ballooning (GO:0003242)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
growth involved in heart morphogenesis (GO:0003241)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
circadian behavior (GO:0048512)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
diacylglycerol metabolic process (GO:0046339)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
rhythmic process (GO:0048511)	70	1	1.36	-	.73	1.00E00	1.00E00
phosphatidylethanolamine metabolic process (GO:0046337)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle transport along microtubule (GO:1901608)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
alpha-amino acid biosynthetic process (GO:1901607)	48	1	.93	+	1.07	6.11E-01	1.00E00
alpha-amino acid catabolic process (GO:1901606)	70	0	1.36	-	 < 0.01	6.46E-01	1.00E00
alpha-amino acid metabolic process (GO:1901605)	133	2	2.59	-	.77	1.00E00	1.00E00
dendritic cell differentiation (GO:0097028)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
octopamine metabolic process (GO:0046333)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of JNK cascade (GO:0046330)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
histone H3-K14 acetylation (GO:0044154)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synapse organization (GO:0050808)	100	1	1.95	-	.51	1.00E00	1.00E00
plasma lipoprotein particle assembly (GO:0034377)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of synapse organization (GO:0050807)	28	1	.54	+	1.84	4.28E-01	1.00E00
positive regulation of synaptic transmission (GO:0050806)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle remodeling (GO:0034375)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission (GO:0050805)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle remodeling (GO:0034374)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modulation of chemical synaptic transmission (GO:0050804)	132	0	2.57	-	 < 0.01	1.87E-01	1.00E00
regulation of synapse structure or activity (GO:0050803)	46	1	.89	+	1.12	5.96E-01	1.00E00
very-low-density lipoprotein particle remodeling (GO:0034372)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
bulbus arteriosus formation (GO:0003234)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ion homeostasis (GO:0050801)	389	8	7.57	+	1.06	8.52E-01	1.00E00
bulbus arteriosus morphogenesis (GO:0003233)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
triglyceride-rich lipoprotein particle remodeling (GO:0034370)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
transposition (GO:0032196)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
bulbus arteriosus development (GO:0003232)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac ventricle development (GO:0003231)	19	1	.37	+	2.71	3.20E-01	1.00E00
negative regulation of JNK cascade (GO:0046329)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of JNK cascade (GO:0046328)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
glycerol biosynthetic process from pyruvate (GO:0046327)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose import (GO:0046326)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucose import (GO:0046325)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
antibiotic metabolic process (GO:0016999)	40	0	.78	-	 < 0.01	1.00E00	1.00E00
regulation of glucose import (GO:0046324)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cell wall macromolecule catabolic process (GO:0016998)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
glucose import (GO:0046323)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid oxidation (GO:0046321)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of fatty acid oxidation (GO:0046320)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of ribonucleoprotein complex localization (GO:2000197)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle remodeling (GO:0034369)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex remodeling (GO:0034368)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein-containing complex remodeling (GO:0034367)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac muscle tissue development (GO:0003229)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle tissue development (GO:0003228)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ventricular compact myocardium morphogenesis (GO:0003223)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ventricular trabecula myocardium morphogenesis (GO:0003222)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
energy homeostasis (GO:0097009)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
phosphocreatine biosynthetic process (GO:0046314)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of plasma lipoprotein particle levels (GO:0097006)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel morphogenesis (GO:2000181)	22	1	.43	+	2.34	3.58E-01	1.00E00
cardiac left ventricle formation (GO:0003218)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
'de novo' NAD biosynthetic process from tryptophan (GO:0034354)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cardiac left ventricle morphogenesis (GO:0003214)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cardiac ventricle formation (GO:0003211)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
alkanesulfonate biosynthetic process (GO:0046305)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
poly(A)+ mRNA export from nucleus (GO:0016973)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of neural precursor cell proliferation (GO:2000179)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein deglycation, glyoxal removal (GO:0036529)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of neural precursor cell proliferation (GO:2000178)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of neural precursor cell proliferation (GO:2000177)	9	1	.18	+	5.71	1.75E-01	1.00E00
protein deglycation (GO:0036525)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glial cell apoptotic process (GO:0034349)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiac ventricle morphogenesis (GO:0003208)	13	1	.25	+	3.95	2.36E-01	1.00E00
cardiac chamber formation (GO:0003207)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to interferon-gamma (GO:0034341)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
endocardial cushion morphogenesis (GO:0003203)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to type I interferon (GO:0034340)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085033)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085032)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extracellular matrix assembly (GO:0085029)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
adherens junction maintenance (GO:0034334)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
adherens junction assembly (GO:0034333)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
adherens junction organization (GO:0034332)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
cell junction maintenance (GO:0034331)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cell junction organization (GO:0034330)	79	1	1.54	-	.65	1.00E00	1.00E00
pre-mRNA cleavage required for polyadenylation (GO:0098789)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mRNA cleavage involved in mRNA processing (GO:0098787)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular alcohol biosynthetic process (GO:0044108)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular alcohol metabolic process (GO:0044107)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular amine metabolic process (GO:0044106)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
protein alpha-1,2-demannosylation (GO:0036508)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ncRNA transcription (GO:0098781)	16	1	.31	+	3.21	2.79E-01	1.00E00
regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein demannosylation (GO:0036507)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of cilium-dependent cell motility (GO:2000155)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
ERAD pathway (GO:0036503)	59	2	1.15	+	1.74	3.25E-01	1.00E00
cell junction assembly (GO:0034329)	64	1	1.25	-	.80	1.00E00	1.00E00
activation of protein kinase activity (GO:0032147)	97	3	1.89	+	1.59	4.43E-01	1.00E00
skin epidermis development (GO:0098773)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell motility (GO:2000147)	86	3	1.67	+	1.79	2.41E-01	1.00E00
inorganic ion homeostasis (GO:0098771)	374	8	7.28	+	1.10	7.06E-01	1.00E00
negative regulation of cell motility (GO:2000146)	40	2	.78	+	2.57	1.91E-01	1.00E00
positive regulation of DNA-templated transcription, initiation (GO:2000144)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated transcription, initiation (GO:2000142)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERAD pathway (GO:1904294)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of ERAD pathway (GO:1904292)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
Arp2/3 complex-mediated actin nucleation (GO:0034314)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
diol biosynthetic process (GO:0034312)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
diol metabolic process (GO:0034311)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein tyrosine kinase activity (GO:0061099)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein tyrosine kinase activity (GO:0061098)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein tyrosine kinase activity (GO:0061097)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045899)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
mitotic cell cycle phase (GO:0098763)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein K69-linked ufmylation (GO:1990592)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in heart morphogenesis (GO:2000136)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic DNA damage checkpoint (GO:1904289)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
primary alcohol biosynthetic process (GO:0034309)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
primary alcohol metabolic process (GO:0034308)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
regulation of sequestering of zinc ion (GO:0061088)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K27 methylation (GO:0061086)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K27 methylation (GO:0061085)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptide secretion (GO:0002793)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptide secretion (GO:0002792)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein desumoylation (GO:0016926)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
retrograde axonal transport (GO:0008090)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of peptide secretion (GO:0002791)	58	0	1.13	-	 < 0.01	6.31E-01	1.00E00
protein sumoylation (GO:0016925)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
peptide secretion (GO:0002790)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
detoxification (GO:0098754)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
bone cell development (GO:0098751)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle adaptation (GO:0014744)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of muscle hypertrophy (GO:0014743)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle hypertrophy (GO:0014742)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
COP9 signalosome assembly (GO:0010387)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of flagellated sperm motility (GO:1902093)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
anterograde axonal transport (GO:0008089)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
axo-dendritic transport (GO:0008088)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated protein folding (GO:0061077)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
positive regulation of neural retina development (GO:0061075)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of neural retina development (GO:0061074)	9	1	.18	+	5.71	1.75E-01	1.00E00
cerebellar neuron development (GO:0098749)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
iris morphogenesis (GO:0061072)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway (GO:0045879)	16	1	.31	+	3.21	2.79E-01	1.00E00
mitochondrial L-ornithine transmembrane transport (GO:1990575)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
potassium ion import across plasma membrane (GO:1990573)	60	1	1.17	-	.86	1.00E00	1.00E00
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	177	3	3.44	-	.87	1.00E00	1.00E00
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of muscle hyperplasia (GO:0014738)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of spindle orientation (GO:0051294)	17	1	.33	+	3.02	2.93E-01	1.00E00
regulation of establishment of cell polarity (GO:2000114)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
establishment of spindle localization (GO:0051293)	21	1	.41	+	2.45	3.46E-01	1.00E00
cell dedifferentiation (GO:0043697)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
nuclear pore complex assembly (GO:0051292)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle adaptation (GO:0014733)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dedifferentiation (GO:0043696)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of TORC1 signaling (GO:1904263)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of TORC1 signaling (GO:1904262)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
reverse cholesterol transport (GO:0043691)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to nutrient levels (GO:0032108)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of response to nutrient levels (GO:0032107)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to extracellular stimulus (GO:0032105)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of response to extracellular stimulus (GO:0032104)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
mesodermal cell migration (GO:0008078)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
import across plasma membrane (GO:0098739)	84	1	1.63	-	.61	1.00E00	1.00E00
protein homotetramerization (GO:0051289)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
macromolecule depalmitoylation (GO:0098734)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
protein polyufmylation (GO:1990564)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte apoptotic process (GO:2000108)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
macromolecule deacylation (GO:0098732)	32	1	.62	+	1.61	4.71E-01	1.00E00
regulation of leukocyte apoptotic process (GO:2000106)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteolysis (GO:0045862)	72	3	1.40	+	2.14	1.73E-01	1.00E00
negative regulation of DNA-dependent DNA replication (GO:2000104)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of sequestering of calcium ion (GO:0051284)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of sequestering of calcium ion (GO:0051283)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
negative regulation of proteolysis (GO:0045861)	59	1	1.15	-	.87	1.00E00	1.00E00
regulation of twitch skeletal muscle contraction (GO:0014724)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of sequestering of calcium ion (GO:0051282)	40	0	.78	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein kinase activity (GO:0045860)	128	4	2.49	+	1.61	3.23E-01	1.00E00
post-translational protein modification (GO:0043687)	9	1	.18	+	5.71	1.75E-01	1.00E00
regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
twitch skeletal muscle contraction (GO:0014721)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	113	0	2.20	-	 < 0.01	2.83E-01	1.00E00
sclerotome development (GO:0061056)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
myotome development (GO:0061055)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of actin polymerization or depolymerization (GO:0008064)	117	1	2.28	-	.44	7.30E-01	1.00E00
Toll signaling pathway (GO:0008063)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid leukocyte differentiation (GO:0002763)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid leukocyte differentiation (GO:0002762)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid leukocyte differentiation (GO:0002761)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
maintenance of cell number (GO:0098727)	14	1	.27	+	3.67	2.51E-01	1.00E00
regulation of protein kinase activity (GO:0045859)	212	6	4.12	+	1.45	3.16E-01	1.00E00
symmetric cell division (GO:0098725)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
asymmetric stem cell division (GO:0098722)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pH elevation (GO:0045852)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pH reduction (GO:0045851)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular component movement (GO:0051272)	88	3	1.71	+	1.75	2.52E-01	1.00E00
regulation of anion channel activity (GO:0010359)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
innate immune response-activating signal transduction (GO:0002758)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
eye pigment granule organization (GO:0008057)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
MyD88-independent toll-like receptor signaling pathway (GO:0002756)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of wound healing (GO:0061045)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
MyD88-dependent toll-like receptor signaling pathway (GO:0002755)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
mitochondrial fusion (GO:0008053)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
sodium ion import across plasma membrane (GO:0098719)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of wound healing (GO:0061041)	16	1	.31	+	3.21	2.79E-01	1.00E00
embryonic axis specification (GO:0000578)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
mitochondrial tricarboxylic acid transmembrane transport (GO:1990546)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mitochondrial transmembrane transport (GO:1990542)	53	0	1.03	-	 < 0.01	6.28E-01	1.00E00
positive regulation of striated muscle tissue development (GO:0045844)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
branchiomeric skeletal muscle development (GO:0014707)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle tissue development (GO:0045843)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic metaphase/anaphase transition (GO:0045842)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	9	1	.18	+	5.71	1.75E-01	1.00E00
pericyte cell differentiation (GO:1904238)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein tetramerization (GO:0051262)	36	1	.70	+	1.43	5.10E-01	1.00E00
regulation of phosphoprotein phosphatase activity (GO:0043666)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
protein homooligomerization (GO:0051260)	93	0	1.81	-	 < 0.01	4.28E-01	1.00E00
male courtship behavior (GO:0008049)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cartilage development (GO:0061037)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of cartilage development (GO:0061036)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of cartilage development (GO:0061035)	21	1	.41	+	2.45	3.46E-01	1.00E00
motor neuron axon guidance (GO:0008045)	50	1	.97	+	1.03	6.26E-01	1.00E00
visceral serous pericardium development (GO:0061032)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytokine secretion involved in immune response (GO:0002741)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic nuclear division (GO:0045839)	13	1	.25	+	3.95	2.36E-01	1.00E00
iron ion import across cell outer membrane (GO:0098706)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
neuron projection maintenance (GO:1990535)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein complex oligomerization (GO:0051259)	107	1	2.08	-	.48	7.26E-01	1.00E00
calcium ion import across plasma membrane (GO:0098703)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic nuclear division (GO:0045835)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid metabolic process (GO:0045834)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
neurotransmitter loading into synaptic vesicle (GO:0098700)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid metabolic process (GO:0045833)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of isotype switching (GO:0045830)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte activation (GO:0051251)	62	0	1.21	-	 < 0.01	6.34E-01	1.00E00
negative regulation of lymphocyte activation (GO:0051250)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
mitochondrial fragmentation involved in apoptotic process (GO:0043653)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
engulfment of apoptotic cell (GO:0043652)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
dicarboxylic acid biosynthetic process (GO:0043650)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of serine C-palmitoyltransferase activity (GO:1904220)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic target recognition (GO:0008039)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
establishment of endothelial barrier (GO:0061028)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of cytokine secretion involved in immune response (GO:0002739)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
ribonucleoside bisphosphate metabolic process (GO:0033875)	57	0	1.11	-	 < 0.01	6.30E-01	1.00E00
cell recognition (GO:0008037)	87	2	1.69	+	1.18	6.88E-01	1.00E00
response to gamma radiation (GO:0010332)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane fusion (GO:0061025)	80	0	1.56	-	 < 0.01	4.10E-01	1.00E00
tRNA processing (GO:0008033)	76	0	1.48	-	 < 0.01	4.08E-01	1.00E00
regulation of lymphocyte activation (GO:0051249)	93	1	1.81	-	.55	1.00E00	1.00E00
negative regulation of protein metabolic process (GO:0051248)	190	3	3.70	-	.81	1.00E00	1.00E00
positive regulation of protein metabolic process (GO:0051247)	465	13	9.05	+	1.44	1.77E-01	1.00E00
negative regulation of innate immune response (GO:0045824)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart contraction (GO:0045823)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart contraction (GO:0045822)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
dicarboxylic acid catabolic process (GO:0043649)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
dicarboxylic acid metabolic process (GO:0043648)	37	0	.72	-	 < 0.01	1.00E00	1.00E00
inositol phosphate metabolic process (GO:0043647)	49	0	.95	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycolytic process (GO:0045820)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of multicellular organismal process (GO:0051240)	260	6	5.06	+	1.19	6.48E-01	1.00E00
positive regulation of hematopoietic stem cell differentiation (GO:1902038)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of hematopoietic stem cell differentiation (GO:1902037)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell differentiation (GO:1902036)	19	1	.37	+	2.71	3.20E-01	1.00E00
programmed cell death (GO:0012501)	223	5	4.34	+	1.15	6.27E-01	1.00E00
nucleoside bisphosphate catabolic process (GO:0033869)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell proliferation (GO:1902033)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
nucleoside bisphosphate biosynthetic process (GO:0033866)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
membrane invagination (GO:0010324)	71	1	1.38	-	.72	1.00E00	1.00E00
positive regulation of natural killer cell cytokine production (GO:0002729)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of NADP metabolic process (GO:1902031)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleoside bisphosphate metabolic process (GO:0033865)	57	0	1.11	-	 < 0.01	6.30E-01	1.00E00
hepatoblast differentiation (GO:0061017)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell cytokine production (GO:0002727)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
snRNA import into nucleus (GO:0061015)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA catabolic process (GO:0061014)	13	1	.25	+	3.95	2.36E-01	1.00E00
regulation of T cell cytokine production (GO:0002724)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide import into mitochondrion (GO:1990519)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
hepatic duct development (GO:0061011)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
gall bladder development (GO:0061010)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytokine production involved in immune response (GO:0002720)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
sequestering of metal ion (GO:0051238)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
piRNA biosynthetic process (GO:1990511)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of location (GO:0051235)	52	1	1.01	-	.99	1.00E00	1.00E00
negative regulation of Wnt signaling pathway, calcium modulating pathway (GO:0045812)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle hypertrophy (GO:1904206)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to endoplasmic reticulum (GO:0072599)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
spindle disassembly (GO:0051230)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle hypertrophy (GO:1904204)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent RNA catabolic process (GO:0043633)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
modification-dependent macromolecule catabolic process (GO:0043632)	370	10	7.20	+	1.39	2.59E-01	1.00E00
RNA polyadenylation (GO:0043631)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
maintenance of protein localization in organelle (GO:0072595)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
reactive oxygen species metabolic process (GO:0072593)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
L-arginine transport (GO:1902023)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
common bile duct development (GO:0061009)	14	1	.27	+	3.67	2.51E-01	1.00E00
hepaticobiliary system development (GO:0061008)	124	3	2.41	+	1.24	5.24E-01	1.00E00
regulation of cytokine production involved in immune response (GO:0002718)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
hepaticobiliary system process (GO:0061007)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of heart contraction (GO:0008016)	53	1	1.03	-	.97	1.00E00	1.00E00
positive regulation of natural killer cell mediated immunity (GO:0002717)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
blood circulation (GO:0008015)	176	3	3.42	-	.88	1.00E00	1.00E00
regulation of natural killer cell mediated immunity (GO:0002715)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in kidney development (GO:0061004)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide metabolic process (GO:0010310)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell mediated immunity (GO:0002714)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic spine morphogenesis (GO:0061003)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of B cell mediated immunity (GO:0002712)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic spine morphogenesis (GO:0061001)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication maintenance of fidelity (GO:1990505)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dense core granule exocytosis (GO:1990504)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of endocytosis (GO:0045807)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
mitotic spindle disassembly (GO:0051228)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of endocytosis (GO:0045806)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cellular response to nutrient (GO:0031670)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein transport (GO:0051224)	12	1	.23	+	4.28	2.22E-01	1.00E00
ncRNA polyadenylation (GO:0043629)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment (GO:0021899)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein transport (GO:0051223)	79	2	1.54	+	1.30	6.69E-01	1.00E00
ncRNA 3'-end processing (GO:0043628)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
commitment of multipotent stem cells to neuronal lineage in forebrain (GO:0021898)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein transport (GO:0051222)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
response to estrogen (GO:0043627)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of protein (GO:0051220)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cerebral cortex neuron differentiation (GO:0021895)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular protein complex disassembly (GO:0043624)	39	2	.76	+	2.64	1.84E-01	1.00E00
histone H3-K4 trimethylation (GO:0080182)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of cilium-dependent cell motility (GO:1902019)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cortical microtubule organization (GO:0043622)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated transcription in response to stress (GO:0043620)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of cilium assembly (GO:1902017)	18	1	.35	+	2.86	3.07E-01	1.00E00
clathrin-dependent endocytosis (GO:0072583)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of T cell mediated immunity (GO:0002709)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte mediated immunity (GO:0002708)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte mediated immunity (GO:0002706)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to nutrient levels (GO:0031669)	44	1	.86	+	1.17	5.80E-01	1.00E00
positive regulation of leukocyte mediated immunity (GO:0002705)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to extracellular stimulus (GO:0031668)	45	1	.88	+	1.14	5.88E-01	1.00E00
response to nutrient levels (GO:0031667)	90	1	1.75	-	.57	1.00E00	1.00E00
regulation of leukocyte mediated immunity (GO:0002703)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of production of molecular mediator of immune response (GO:0002702)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of production of molecular mediator of immune response (GO:0002700)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
cartilage development (GO:0051216)	134	5	2.61	+	1.92	1.96E-01	1.00E00
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glycine receptor clustering (GO:0072579)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
forebrain neuron development (GO:0021884)	13	1	.25	+	3.95	2.36E-01	1.00E00
neurotransmitter-gated ion channel clustering (GO:0072578)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lytic vacuole organization (GO:0080171)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
liver morphogenesis (GO:0072576)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in liver morphogenesis (GO:0072575)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
hepatocyte proliferation (GO:0072574)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
fatty acid transmembrane transport (GO:1902001)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
homogentisate catabolic process (GO:1902000)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
release of sequestered calcium ion into cytosol (GO:0051209)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
positive regulation of heat generation (GO:0031652)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of heat generation (GO:0031650)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
protein insertion into membrane (GO:0051205)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial membrane (GO:0051204)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
forebrain neuron differentiation (GO:0021879)	21	1	.41	+	2.45	3.46E-01	1.00E00
forebrain neuron fate commitment (GO:0021877)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
formamide metabolic process (GO:0043606)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular amide catabolic process (GO:0043605)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of protein serine/threonine phosphatase activity (GO:0080163)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
forebrain neuroblast division (GO:0021873)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
forebrain generation of neurons (GO:0021872)	24	1	.47	+	2.14	3.82E-01	1.00E00
axis specification (GO:0009798)	48	0	.93	-	 < 0.01	1.00E00	1.00E00
protein destabilization (GO:0031648)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein stability (GO:0031647)	19	1	.37	+	2.71	3.20E-01	1.00E00
regulation of mitotic cell cycle, embryonic (GO:0009794)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of nervous system process (GO:0031646)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
negative regulation of nervous system process (GO:0031645)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of nervous system process (GO:0031644)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of myelination (GO:0031643)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of myelination (GO:0031642)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of myelination (GO:0031641)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
killing of cells of other organism (GO:0031640)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
forebrain ventricular zone progenitor cell division (GO:0021869)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of fertilization (GO:0080154)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
arabinose metabolic process (GO:0019566)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
early neuron differentiation in forebrain (GO:0021862)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
forebrain radial glial cell differentiation (GO:0021861)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
blood vessel lumenization (GO:0072554)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
glycerol catabolic process (GO:0019563)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERK5 cascade (GO:0070378)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of ERK5 cascade (GO:0070376)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	71	1	1.38	-	.72	1.00E00	1.00E00
negative regulation of ERK1 and ERK2 cascade (GO:0070373)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of ERK1 and ERK2 cascade (GO:0070372)	78	2	1.52	+	1.32	6.67E-01	1.00E00
plasminogen activation (GO:0031639)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
zymogen activation (GO:0031638)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular heat acclimation (GO:0070370)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hypothalamic tangential migration using cell-axon interactions (GO:0021856)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histidine catabolic process to glutamate and formate (GO:0019557)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
histidine catabolic process to glutamate and formamide (GO:0019556)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glutamatergic neuron differentiation (GO:1905962)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
T-helper 17 cell lineage commitment (GO:0072540)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hepatocyte differentiation (GO:0070365)	12	1	.23	+	4.28	2.22E-01	1.00E00
positive regulation of cardiac conduction (GO:1903781)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
telomeric loop formation (GO:0031627)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hemostasis (GO:0007599)	56	0	1.09	-	 < 0.01	6.29E-01	1.00E00
receptor internalization (GO:0031623)	32	1	.62	+	1.61	4.71E-01	1.00E00
blood coagulation (GO:0007596)	54	0	1.05	-	 < 0.01	6.28E-01	1.00E00
ventricular zone neuroblast division (GO:0021847)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell proliferation in forebrain (GO:0021846)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
T-helper 17 cell differentiation (GO:0072539)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
T-helper 17 type immune response (GO:0072538)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to ornithine (GO:0019547)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
substrate-independent telencephalic tangential interneuron migration (GO:0021843)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid localization (GO:1905954)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid localization (GO:1905953)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of lipid localization (GO:1905952)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac conduction (GO:1903779)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to glutamate (GO:0019544)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
propionate catabolic process (GO:0019543)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound transmembrane transport (GO:0072531)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
actin polymerization-dependent cell motility (GO:0070358)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
propionate metabolic process (GO:0019541)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
body fluid secretion (GO:0007589)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to nutrient (GO:0007584)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
proteasome core complex assembly (GO:0080129)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an epithelial fold (GO:0060571)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound catabolic process (GO:0072529)	12	1	.23	+	4.28	2.22E-01	1.00E00
pyrimidine-containing compound biosynthetic process (GO:0072528)	35	1	.68	+	1.47	5.01E-01	1.00E00
pyrimidine-containing compound metabolic process (GO:0072527)	49	2	.95	+	2.10	2.54E-01	1.00E00
regulation of insulin secretion (GO:0050796)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
pyridine-containing compound catabolic process (GO:0072526)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyridine-containing compound biosynthetic process (GO:0072525)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
regulation of behavior (GO:0050795)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle membrane organization (GO:0048499)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
CAAX-box protein maturation (GO:0080120)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pyridine-containing compound metabolic process (GO:0072524)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
interneuron migration from the subpallium to the cortex (GO:0021830)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine-containing compound catabolic process (GO:0072523)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
purine-containing compound biosynthetic process (GO:0072522)	127	3	2.47	+	1.21	7.40E-01	1.00E00
oxalate transport (GO:0019532)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of viral process (GO:0050792)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maintenance of animal organ identity (GO:0048496)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of gonad development (GO:1905940)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine-containing compound metabolic process (GO:0072521)	221	3	4.30	-	.70	8.04E-01	1.00E00
taurine metabolic process (GO:0019530)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
postsynaptic cytoskeleton organization (GO:0099188)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
anterograde synaptic vesicle transport (GO:0048490)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hormone-mediated signaling pathway (GO:0009755)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
response to fructose (GO:0009750)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in morphogenesis (GO:0060561)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
age-dependent general metabolic decline (GO:0007571)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of gonad development (GO:1905939)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
substrate-independent telencephalic tangential migration (GO:0021826)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cerebral cortex tangential migration (GO:0021825)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cerebral cortex tangential migration using cell-axon interactions (GO:0021824)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of germ cell proliferation (GO:1905936)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detoxification of mercury ion (GO:0050787)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
DNA demethylation (GO:0080111)	9	1	.18	+	5.71	1.75E-01	1.00E00
synaptic vesicle transport (GO:0048489)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle endocytosis (GO:0048488)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
positive regulation of secondary heart field cardioblast proliferation (GO:0072513)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
divalent inorganic cation transport (GO:0072511)	167	1	3.25	-	.31	3.85E-01	1.00E00
sympathetic nervous system development (GO:0048485)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic membrane adhesion (GO:0099179)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-gluconate metabolic process (GO:0019521)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aldonic acid metabolic process (GO:0019520)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of trans-synaptic signaling (GO:0099177)	132	0	2.57	-	 < 0.01	1.87E-01	1.00E00
response to glucose (GO:0009749)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of postsynapse organization (GO:0099175)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of presynapse organization (GO:0099174)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
postsynapse organization (GO:0099173)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
response to hexose (GO:0009746)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
organic substance biosynthetic process (GO:1901576)	1435	22	27.92	-	.79	2.78E-01	1.00E00
presynapse organization (GO:0099172)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
organic substance catabolic process (GO:1901575)	925	16	18.00	-	.89	7.16E-01	1.00E00
response to sucrose (GO:0009744)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to carbohydrate (GO:0009743)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
cell aging (GO:0007569)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cell adhesion involved in sprouting angiogenesis (GO:0120078)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
aging (GO:0007568)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative transport (GO:1901571)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
angiogenic sprout fusion (GO:0120077)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative biosynthetic process (GO:1901570)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
RNA destabilization (GO:0050779)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of immune response (GO:0050778)	187	1	3.64	-	.27	2.75E-01	1.00E00
divalent inorganic cation homeostasis (GO:0072507)	244	6	4.75	+	1.26	4.85E-01	1.00E00
negative regulation of immune response (GO:0050777)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
lactate oxidation (GO:0019516)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
trivalent inorganic anion homeostasis (GO:0072506)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendrite morphogenesis (GO:0050775)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
divalent inorganic anion homeostasis (GO:0072505)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
replication fork protection (GO:0048478)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cellular divalent inorganic cation homeostasis (GO:0072503)	231	6	4.49	+	1.34	4.67E-01	1.00E00
regulation of dendrite development (GO:0050773)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
oogenesis (GO:0048477)	37	0	.72	-	 < 0.01	1.00E00	1.00E00
cellular trivalent inorganic anion homeostasis (GO:0072502)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
triglyceride homeostasis (GO:0070328)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
peptidyl-proline hydroxylation (GO:0019511)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cellular divalent inorganic anion homeostasis (GO:0072501)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
thyroid hormone transport (GO:0070327)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterograde synaptic vesicle transport (GO:1903744)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative catabolic process (GO:1901569)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde synaptic vesicle transport (GO:1903742)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative metabolic process (GO:1901568)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
synaptic signaling by nitric oxide (GO:0099163)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycolate biosynthetic process (GO:0046295)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
organonitrogen compound catabolic process (GO:1901565)	625	13	12.16	+	1.07	7.68E-01	1.00E00
formaldehyde catabolic process (GO:0046294)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
organonitrogen compound metabolic process (GO:1901564)	3622	78	70.47	+	1.11	3.27E-01	1.00E00
formaldehyde metabolic process (GO:0046292)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell death (GO:0060548)	356	3	6.93	-	.43	1.71E-01	1.00E00
response to benomyl (GO:1901561)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of necroptotic process (GO:0060544)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
respiratory system development (GO:0060541)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
L-methionine salvage from methylthioadenosine (GO:0019509)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of phagocytosis (GO:0050766)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell maturation (GO:0048469)	40	1	.78	+	1.28	5.46E-01	1.00E00
endocardial cushion development (GO:0003197)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of phagocytosis (GO:0050765)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phagocytosis (GO:0050764)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebral cortex tangential migration (GO:0021800)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of recycling endosome localization within postsynapse (GO:0099158)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve formation (GO:0003190)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
G1 to G0 transition (GO:0070314)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0099152)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic density assembly (GO:0099151)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic specialization assembly (GO:0099150)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell development (GO:1901552)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dosage compensation (GO:0007549)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
skeletal muscle organ development (GO:0060538)	105	3	2.04	+	1.47	4.64E-01	1.00E00
sex differentiation (GO:0007548)	18	1	.35	+	2.86	3.07E-01	1.00E00
regulation of endothelial cell development (GO:1901550)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cartilage morphogenesis (GO:0060536)	47	0	.91	-	 < 0.01	1.00E00	1.00E00
heart valve formation (GO:0003188)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesoderm formation (GO:1905903)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of mesoderm formation (GO:1905902)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane organization (GO:1903729)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lens fiber cell morphogenesis (GO:0070309)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid metabolic process (GO:1903727)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid metabolic process (GO:1903726)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
lens fiber cell development (GO:0070307)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid metabolic process (GO:1903725)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
lens fiber cell differentiation (GO:0070306)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve morphogenesis (GO:0003181)	9	1	.18	+	5.71	1.75E-01	1.00E00
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	32	0	.62	-	 < 0.01	1.00E00	1.00E00
response to endogenous stimulus (GO:0009719)	394	6	7.67	-	.78	7.12E-01	1.00E00
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of stress-activated protein kinase signaling cascade (GO:0070302)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
cellular response to hydrogen peroxide (GO:0070301)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle lumen acidification (GO:1901546)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
catechol-containing compound biosynthetic process (GO:0009713)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
catechol-containing compound metabolic process (GO:0009712)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
IRE1-mediated unfolded protein response (GO:0036498)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of molecular function (GO:0044092)	172	3	3.35	-	.90	1.00E00	1.00E00
membrane biogenesis (GO:0044091)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein metabolic process (GO:0050748)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
heart valve morphogenesis (GO:0003179)	10	1	.19	+	5.14	1.91E-01	1.00E00
regulation of lipoprotein metabolic process (GO:0050746)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve development (GO:0003171)	15	1	.29	+	3.43	2.65E-01	1.00E00
changes to DNA methylation involved in embryo development (GO:1901538)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA demethylation (GO:1901537)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA demethylation (GO:1901535)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of hematopoietic progenitor cell differentiation (GO:1901534)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular component biogenesis (GO:0044089)	112	1	2.18	-	.46	7.28E-01	1.00E00
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of vacuole organization (GO:0044088)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic progenitor cell differentiation (GO:1901532)	24	1	.47	+	2.14	3.82E-01	1.00E00
establishment of synaptic specificity at neuromuscular junction (GO:0007529)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of cellular component biogenesis (GO:0044087)	251	5	4.88	+	1.02	8.19E-01	1.00E00
neuromuscular junction development (GO:0007528)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
somatic muscle development (GO:0007525)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	50	1	.97	+	1.03	6.26E-01	1.00E00
plasma membrane bounded cell projection assembly (GO:0120031)	217	7	4.22	+	1.66	2.09E-01	1.00E00
muscle cell fate determination (GO:0007521)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
myoblast fusion (GO:0007520)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of hemopoiesis (GO:1903708)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of hemopoiesis (GO:1903707)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
regulation of hemopoiesis (GO:1903706)	59	1	1.15	-	.87	1.00E00	1.00E00
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
cardiac conduction system development (GO:0003161)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proton export across plasma membrane (GO:0120029)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
skeletal muscle tissue development (GO:0007519)	95	3	1.85	+	1.62	4.39E-01	1.00E00
type I pneumocyte differentiation (GO:0060509)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
muscle organ development (GO:0007517)	144	5	2.80	+	1.78	2.13E-01	1.00E00
adult heart development (GO:0007512)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of anion transport (GO:0044070)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell death in response to oxidative stress (GO:0036473)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of inflammatory response (GO:0050729)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of inflammatory response (GO:0050728)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of inflammatory response (GO:0050727)	33	1	.64	+	1.56	4.81E-01	1.00E00
morphogenesis of an endothelium (GO:0003159)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of animal organ formation (GO:0003156)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in determination of left/right symmetry (GO:0003154)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
microtubule-based protein transport (GO:0099118)	25	1	.49	+	2.06	3.94E-01	1.00E00
outflow tract morphogenesis (GO:0003151)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tRNA 5'-end processing (GO:0099116)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
terpene catabolic process (GO:0046247)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
microtubule-based transport (GO:0099111)	86	2	1.67	+	1.20	6.86E-01	1.00E00
mesoderm migration involved in gastrulation (GO:0007509)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host cellular process (GO:0044068)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of excretion (GO:0044062)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle recycling via endosome (GO:0036466)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
digestive tract mesoderm development (GO:0007502)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endocrine process (GO:0044060)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle recycling (GO:0036465)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
TRAIL-activated apoptotic signaling pathway (GO:0036462)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1 beta secretion (GO:0050718)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1 secretion (GO:0050716)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
response to disaccharide (GO:0034285)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to monosaccharide (GO:0034284)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
neural crest cell migration involved in heart formation (GO:0003147)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytokine secretion (GO:0050715)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein secretion (GO:0050714)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokine secretion (GO:0050710)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
determination of left/right asymmetry in lateral mesoderm (GO:0003140)	20	1	.39	+	2.57	3.33E-01	1.00E00
ether biosynthetic process (GO:1901503)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
intermembrane lipid transfer (GO:0120009)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of digestive system process (GO:0044058)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of system process (GO:0044057)	118	2	2.30	-	.87	1.00E00	1.00E00
negative regulation of protein secretion (GO:0050709)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of protein secretion (GO:0050708)	55	0	1.07	-	 < 0.01	6.29E-01	1.00E00
regulation of cytokine secretion (GO:0050707)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
secondary heart field specification (GO:0003139)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1 beta secretion (GO:0050706)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1 secretion (GO:0050704)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of appetite (GO:0032099)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of appetite (GO:0032098)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to food (GO:0032096)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of response to food (GO:0032095)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
response to food (GO:0032094)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
aflatoxin metabolic process (GO:0046222)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glucan metabolic process (GO:0044042)	26	1	.51	+	1.98	4.06E-01	1.00E00
positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neuronal stem cell division (GO:0036445)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
calcium import into the mitochondrion (GO:0036444)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
heart field specification (GO:0003128)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of GTPase activity (GO:0034260)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
indolalkylamine catabolic process (GO:0046218)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell wall macromolecule biosynthetic process (GO:0044038)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell wall macromolecule metabolic process (GO:0044036)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular amide metabolic process (GO:0034250)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
positive regulation of deoxyribonuclease activity (GO:0032077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclease activity (GO:0032075)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclease activity (GO:0032074)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nitric oxide metabolic process (GO:0046209)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of deoxyribonuclease activity (GO:0032070)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypermethylation of CpG island (GO:0044027)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA hypermethylation (GO:0044026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of type B pancreatic cell development (GO:2000077)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of type B pancreatic cell development (GO:2000074)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular amide metabolic process (GO:0034249)	47	2	.91	+	2.19	2.40E-01	1.00E00
snoRNA splicing (GO:0034247)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)	18	1	.35	+	2.86	3.07E-01	1.00E00
regulation of nuclease activity (GO:0032069)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
postsynaptic specialization assembly (GO:0098698)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0098696)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle cycle (GO:0098693)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
histone citrullination (GO:0036414)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation in response to stress (GO:0032058)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation in response to stress (GO:0032056)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ciliary basal body organization (GO:0032053)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	38	1	.74	+	1.35	5.29E-01	1.00E00
disruption by symbiont of host cell (GO:0044004)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modification by symbiont of host morphology or physiology (GO:0044003)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000056)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000055)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000053)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-canonical Wnt signaling pathway (GO:2000051)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of non-canonical Wnt signaling pathway (GO:2000050)	9	1	.18	+	5.71	1.75E-01	1.00E00
tRNA thio-modification (GO:0034227)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cardiolipin biosynthetic process (GO:0032049)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiolipin metabolic process (GO:0032048)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA metabolic process (GO:0032042)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cell-cell adhesion mediated by cadherin (GO:2000047)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	20	1	.39	+	2.57	3.33E-01	1.00E00
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
carbohydrate transmembrane transport (GO:0034219)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of planar cell polarity pathway involved in axis elongation (GO:2000040)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein hexamerization (GO:0034214)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
G protein-coupled serotonin receptor signaling pathway (GO:0098664)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
inorganic cation transmembrane transport (GO:0098662)	360	3	7.00	-	.43	1.72E-01	1.00E00
inorganic anion transmembrane transport (GO:0098661)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
regulation of stem cell population maintenance (GO:2000036)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of pyruvate dehydrogenase activity (GO:1904184)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of pyruvate dehydrogenase activity (GO:1904183)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
regulation of pyruvate dehydrogenase activity (GO:1904182)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
amyloid-beta formation (GO:0034205)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
lipid translocation (GO:0034204)	44	0	.86	-	 < 0.01	1.00E00	1.00E00
glycolipid translocation (GO:0034203)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of insulin secretion (GO:0032024)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of immune effector process (GO:0002699)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
negative regulation of immune effector process (GO:0002698)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of immune effector process (GO:0002697)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte activation (GO:0002696)	65	0	1.26	-	 < 0.01	6.38E-01	1.00E00
negative regulation of leukocyte activation (GO:0002695)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte activation (GO:0002694)	99	1	1.93	-	.52	1.00E00	1.00E00
inorganic cation import across plasma membrane (GO:0098659)	77	1	1.50	-	.67	1.00E00	1.00E00
positive regulation of cellular extravasation (GO:0002693)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
import into cell (GO:0098657)	313	4	6.09	-	.66	5.35E-01	1.00E00
regulation of cellular extravasation (GO:0002691)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
anion transmembrane transport (GO:0098656)	116	0	2.26	-	 < 0.01	1.78E-01	1.00E00
positive regulation of leukocyte chemotaxis (GO:0002690)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell adhesion (GO:0045785)	29	1	.56	+	1.77	4.39E-01	1.00E00
mRNA pseudouridine synthesis (GO:1990481)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
heat acclimation (GO:0010286)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte chemotaxis (GO:0002688)	17	1	.33	+	3.02	2.93E-01	1.00E00
regulation of ARF protein signal transduction (GO:0032012)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte migration (GO:0002687)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte migration (GO:0002685)	46	1	.89	+	1.12	5.96E-01	1.00E00
negative regulation of immune system process (GO:0002683)	61	1	1.19	-	.84	1.00E00	1.00E00
regulation of immune system process (GO:0002682)	343	4	6.67	-	.60	4.26E-01	1.00E00
somatic recombination of T cell receptor gene segments (GO:0002681)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of ossification (GO:0045778)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood pressure (GO:0045777)	10	1	.19	+	5.14	1.91E-01	1.00E00
negative regulation of male gonad development (GO:2000019)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood pressure (GO:0045776)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of male gonad development (GO:2000018)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of determination of dorsal identity (GO:2000016)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon extension (GO:0045773)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
regulation of determination of dorsal identity (GO:2000015)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cofactor metabolic process (GO:0051193)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate interconversion (GO:0035999)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
DNA synthesis involved in UV-damage excision repair (GO:1904161)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of muscle stretch (GO:0035995)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to muscle stretch (GO:0035994)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of TOR signaling (GO:0032008)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of TOR signaling (GO:0032006)	50	2	.97	+	2.06	2.61E-01	1.00E00
respiratory burst involved in defense response (GO:0002679)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of chronic inflammatory response (GO:0002678)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of chronic inflammatory response (GO:0002676)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell surface (GO:2000009)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
box H/ACA snoRNA 3'-end processing (GO:0000495)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
prosthetic group metabolic process (GO:0051189)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell surface (GO:2000008)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cofactor biosynthetic process (GO:0051188)	118	0	2.30	-	 < 0.01	1.78E-01	1.00E00
positive regulation of angiogenesis (GO:0045766)	38	0	.74	-	 < 0.01	1.00E00	1.00E00
box C/D snoRNA 3'-end processing (GO:0000494)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cofactor catabolic process (GO:0051187)	36	1	.70	+	1.43	5.10E-01	1.00E00
regulation of angiogenesis (GO:0045765)	82	1	1.60	-	.63	1.00E00	1.00E00
box H/ACA snoRNP assembly (GO:0000493)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
box C/D snoRNP assembly (GO:0000492)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
small nucleolar ribonucleoprotein complex assembly (GO:0000491)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
skin morphogenesis (GO:0043589)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
skin development (GO:0043588)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase activity (GO:0045761)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
axonemal central apparatus assembly (GO:1904158)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of action potential (GO:0045760)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
coenzyme transport (GO:0051182)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of DNA damage checkpoint (GO:2000001)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cofactor transport (GO:0051181)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
vitamin transport (GO:0051180)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
nose development (GO:0043584)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tendon development (GO:0035989)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chondrocyte proliferation (GO:0035988)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
endodermal cell differentiation (GO:0035987)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
response to selenium ion (GO:0010269)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
SCF complex assembly (GO:0010265)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
maturation of 5S rRNA (GO:0000481)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phosphorus metabolic process (GO:0051174)	526	14	10.23	+	1.37	2.61E-01	1.00E00
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peroxisomal transport (GO:0043574)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
maintenance of DNA repeat elements (GO:0043570)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
multicellular organism aging (GO:0010259)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
aggrephagy (GO:0035973)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
NADH dehydrogenase complex assembly (GO:0010257)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
endomembrane system organization (GO:0010256)	164	1	3.19	-	.31	3.83E-01	1.00E00
peptidyl-histidine dephosphorylation (GO:0035971)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage involved in rRNA processing (GO:0000478)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of Notch signaling pathway (GO:0045747)	9	1	.18	+	5.71	1.75E-01	1.00E00
negative regulation of Notch signaling pathway (GO:0045746)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744)	11	1	.21	+	4.67	2.06E-01	1.00E00
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
hemoglobin metabolic process (GO:0020027)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
maturation of LSU-rRNA (GO:0000470)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrogen levels (GO:0043562)	12	1	.23	+	4.28	2.22E-01	1.00E00
cellular response to topologically incorrect protein (GO:0035967)	65	1	1.26	-	.79	1.00E00	1.00E00
response to topologically incorrect protein (GO:0035966)	69	1	1.34	-	.74	1.00E00	1.00E00
cardiolipin acyl-chain remodeling (GO:0035965)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
COPI-coated vesicle budding (GO:0035964)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to organonitrogen compound (GO:0010243)	212	3	4.12	-	.73	8.02E-01	1.00E00
cell-cell adhesion (GO:0098609)	235	4	4.57	-	.87	1.00E00	1.00E00
cleavage involved in rRNA processing (GO:0000469)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA repair (GO:0045739)	17	1	.33	+	3.02	2.93E-01	1.00E00
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA repair (GO:0045738)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
glucose 6-phosphate metabolic process (GO:0051156)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of striated muscle cell differentiation (GO:0051155)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle cell differentiation (GO:0051154)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein catabolic process (GO:0045732)	54	0	1.05	-	 < 0.01	6.28E-01	1.00E00
maturation of 5.8S rRNA (GO:0000460)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of striated muscle cell differentiation (GO:0051153)	14	1	.27	+	3.67	2.51E-01	1.00E00
regulation of translational initiation in response to stress (GO:0043558)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
respiratory burst (GO:0045730)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell differentiation (GO:0051151)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to stress (GO:0043555)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell differentiation (GO:0051150)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol 3-kinase activity (GO:0043551)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of lipid kinase activity (GO:0043550)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of immunoglobulin production (GO:0002639)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of immunoglobulin production (GO:0002637)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of granuloma formation (GO:0002633)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
exonucleolytic trimming involved in rRNA processing (GO:0000459)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
miRNA transport (GO:1990428)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of granuloma formation (GO:0002631)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mitotic recombination-dependent replication fork processing (GO:1990426)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
respiratory burst after phagocytosis (GO:0045728)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle cell differentiation (GO:0051149)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation (GO:0045727)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
enzyme-directed rRNA pseudouridine synthesis (GO:0000455)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle cell differentiation (GO:0051148)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
wybutosine biosynthetic process (GO:0031591)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of muscle cell differentiation (GO:0051147)	16	1	.31	+	3.21	2.79E-01	1.00E00
wybutosine metabolic process (GO:0031590)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
enzyme-directed rRNA 2'-O-methylation (GO:0000453)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cilium assembly (GO:0045724)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell differentiation (GO:0051145)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
rRNA 2'-O-methylation (GO:0000451)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid biosynthetic process (GO:0045723)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of gluconeogenesis (GO:0045722)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of gluconeogenesis (GO:0045721)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
molybdopterin cofactor metabolic process (GO:0043545)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
endothelial cell migration (GO:0043542)	24	1	.47	+	2.14	3.82E-01	1.00E00
mitochondrial mRNA surveillance (GO:0035946)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitochondrial ncRNA surveillance (GO:0035945)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to lithium ion (GO:0010226)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to UV-C (GO:0010225)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to UV-B (GO:0010224)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell-substrate adhesion (GO:0031589)	70	0	1.36	-	 < 0.01	6.46E-01	1.00E00
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
activation of phospholipase D activity (GO:0031584)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid biosynthetic process (GO:0045717)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hemidesmosome assembly (GO:0031581)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
membrane raft distribution (GO:0031580)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel endothelial cell migration (GO:0043537)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated protein complex assembly (GO:0051131)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood vessel endothelial cell migration (GO:0043536)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular component organization (GO:0051130)	245	7	4.77	+	1.47	3.46E-01	1.00E00
regulation of blood vessel endothelial cell migration (GO:0043535)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell migration (GO:0043534)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal joint development (GO:0072498)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of convergent extension involved in gastrulation (GO:1904104)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of convergent extension involved in gastrulation (GO:1904103)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
maintenance of DNA methylation (GO:0010216)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to ionizing radiation (GO:0010212)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
membrane raft organization (GO:0031579)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
intra-S DNA damage checkpoint (GO:0031573)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
mitotic G1 DNA damage checkpoint (GO:0031571)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
embryonic brain development (GO:1990403)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin nucleation (GO:0051127)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
embryonic liver development (GO:1990402)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin nucleation (GO:0051126)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of actin nucleation (GO:0051125)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
synaptic growth at neuromuscular junction (GO:0051124)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
RNA polymerase II preinitiation complex assembly (GO:0051123)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
forebrain dorsal/ventral pattern formation (GO:0021798)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebral cortex cell migration (GO:0021795)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron apoptotic process (GO:0043525)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron apoptotic process (GO:0043524)	19	1	.37	+	2.71	3.20E-01	1.00E00
ammonium transmembrane transport (GO:0072488)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
thalamus development (GO:0021794)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
RNA import into mitochondrion (GO:0035927)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to vascular endothelial growth factor stimulus (GO:0035924)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to proline (GO:0019493)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mitophagy (GO:0000423)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
autophagy of mitochondrion (GO:0000422)	30	1	.58	+	1.71	4.50E-01	1.00E00
negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle tissue development (GO:1905899)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to endoplasmic reticulum stress (GO:1905898)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of response to endoplasmic reticulum stress (GO:1905897)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
branchiomotor neuron axon guidance (GO:0021785)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glial cell development (GO:0021782)	44	2	.86	+	2.34	2.19E-01	1.00E00
glial cell fate commitment (GO:0021781)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
glial cell fate specification (GO:0021780)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
skeletal muscle cell differentiation (GO:0035914)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
beta-alanine biosynthetic process (GO:0019483)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
beta-alanine metabolic process (GO:0019482)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dorsal aorta morphogenesis (GO:0035912)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
renal water absorption (GO:0070295)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
renal sodium ion absorption (GO:0070294)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-acylphosphatidylethanolamine metabolic process (GO:0070292)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
N-acylethanolamine metabolic process (GO:0070291)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K36 methylation (GO:0000416)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K36 methylation (GO:0000414)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031550)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte cell fate commitment (GO:0021779)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte cell fate specification (GO:0021778)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of JUN kinase activity (GO:0043508)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
DNA ligation involved in DNA repair (GO:0051103)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of JUN kinase activity (GO:0043507)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of JUN kinase activity (GO:0043506)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA repair (GO:0043504)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
D-amino acid catabolic process (GO:0019478)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
aorta morphogenesis (GO:0035909)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process (GO:0019477)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dorsal aorta development (GO:0035907)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of muscle adaptation (GO:0043502)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
L-lysine catabolic process to acetyl-CoA (GO:0019474)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aorta development (GO:0035904)	16	1	.31	+	3.21	2.79E-01	1.00E00
positive regulation of oogenesis (GO:1905881)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of oogenesis (GO:1905880)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to immobilization stress (GO:0035902)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axonemal dynein complex assembly (GO:0070286)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
pigment cell development (GO:0070285)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pronephric duct morphogenesis (GO:0039023)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
pronephric duct development (GO:0039022)	18	1	.35	+	2.86	3.07E-01	1.00E00
pronephric glomerulus development (GO:0039021)	26	1	.51	+	1.98	4.06E-01	1.00E00
pronephric nephron tubule development (GO:0039020)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein deglutathionylation (GO:0080058)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of oogenesis (GO:1905879)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic density organization (GO:1905874)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glycine decarboxylation via glycine cleavage system (GO:0019464)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell leading edge (GO:1905872)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell leading edge (GO:1905871)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pronephric nephron development (GO:0039019)	36	1	.70	+	1.43	5.10E-01	1.00E00
positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
extracellular matrix constituent secretion (GO:0070278)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pattern specification involved in pronephros development (GO:0039017)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cell differentiation involved in pronephros development (GO:0039014)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of exit from mitosis (GO:0031536)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
actin cytoskeleton reorganization (GO:0031532)	23	1	.45	+	2.23	3.70E-01	1.00E00
regulation of cell projection assembly (GO:0060491)	51	1	.99	+	1.01	1.00E00	1.00E00
regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
eurydendroid cell differentiation (GO:0021755)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyroptosis (GO:0070269)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
necroptotic process (GO:0070266)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
necrotic cell death (GO:0070265)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine dephosphorylation (GO:0070262)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
ruffle organization (GO:0031529)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
phospholipid efflux (GO:0033700)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
mesoderm development (GO:0007498)	81	3	1.58	+	1.90	2.16E-01	1.00E00
lung epithelial cell differentiation (GO:0060487)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate determination (GO:0007493)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
endoderm development (GO:0007492)	43	1	.84	+	1.20	5.72E-01	1.00E00
dorsal motor nucleus of vagus nerve development (GO:0021744)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
L-cysteine catabolic process (GO:0019448)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cap-independent translational initiation (GO:1903679)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process to acetyl-CoA (GO:0019442)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cap-independent translational initiation (GO:1903677)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tryptophan catabolic process to kynurenine (GO:0019441)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of mucus secretion (GO:0070257)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mitotic cleavage furrow formation (GO:1903673)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mucus secretion (GO:0070255)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mucus secretion (GO:0070254)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of sprouting angiogenesis (GO:1903672)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
negative regulation of sprouting angiogenesis (GO:1903671)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
calcium export from the mitochondrion (GO:0099093)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of sprouting angiogenesis (GO:1903670)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
lung cell differentiation (GO:0060479)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphangiogenesis (GO:1901492)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of lymphangiogenesis (GO:1901490)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of cortical granule exocytosis by positive regulation of cytosolic calcium ion concentration (GO:0060472)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cortical granule exocytosis (GO:0060471)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytosolic calcium ion concentration involved in egg activation (GO:0060470)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
aromatic compound catabolic process (GO:0019439)	165	5	3.21	+	1.56	2.63E-01	1.00E00
aromatic compound biosynthetic process (GO:0019438)	468	9	9.11	-	.99	1.00E00	1.00E00
triglyceride catabolic process (GO:0019433)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
triglyceride biosynthetic process (GO:0019432)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of defense response to virus by host (GO:0050691)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
removal of superoxide radicals (GO:0019430)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
postsynaptic specialization organization (GO:0099084)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
heterochromatin assembly (GO:0031507)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell wall glycoprotein biosynthetic process (GO:0031506)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA integration (GO:0015074)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to salt stress (GO:0009651)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
prevention of polyspermy (GO:0060468)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein-containing complex localization (GO:0031503)	105	3	2.04	+	1.47	4.64E-01	1.00E00
negative regulation of fertilization (GO:0060467)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pharynx development (GO:0060465)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric D-loop disassembly (GO:1905839)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric D-loop disassembly (GO:1905838)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of defense response to virus (GO:0050688)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
allantoin biosynthetic process (GO:0019428)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of defense response to virus (GO:0050687)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process from acetate (GO:0019427)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA processing (GO:0050686)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA processing (GO:0050685)	12	1	.23	+	4.28	2.22E-01	1.00E00
intermediate mesoderm development (GO:0048389)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinoic acid receptor signaling pathway (GO:0048387)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
retinoic acid receptor signaling pathway (GO:0048384)	15	1	.29	+	3.43	2.65E-01	1.00E00
negative regulation of epithelial cell proliferation (GO:0050680)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mesendoderm development (GO:0048382)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
entrainment of circadian clock (GO:0009649)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
photoperiodism (GO:0009648)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
pyruvate transmembrane transport (GO:1901475)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of digestive system process (GO:0060457)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastric acid secretion (GO:0060455)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of gastric acid secretion (GO:0060453)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mRNA methylation (GO:0080009)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle contraction (GO:0060452)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell proliferation (GO:0050679)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell proliferation (GO:0050678)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
sulfide oxidation (GO:0019418)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sulfur oxidation (GO:0019417)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic transport (GO:1903649)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation (GO:0050673)	24	1	.47	+	2.14	3.82E-01	1.00E00
negative regulation of lymphocyte proliferation (GO:0050672)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromosome separation (GO:1905820)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte proliferation (GO:0050671)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of chaperone-mediated protein folding (GO:1903646)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
postsynapse assembly (GO:0099068)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte proliferation (GO:0050670)	34	1	.66	+	1.51	4.91E-01	1.00E00
regulation of chaperone-mediated protein folding (GO:1903644)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to toxic substance (GO:0009636)	74	1	1.44	-	.69	1.00E00	1.00E00
sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellar granule cell differentiation (GO:0021707)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromosome separation (GO:1905819)	11	1	.21	+	4.67	2.06E-01	1.00E00
dolichol biosynthetic process (GO:0019408)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell differentiation (GO:0021702)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
alditol catabolic process (GO:0019405)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
renal water transport (GO:0003097)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide biosynthetic process (GO:0050665)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lateral mesoderm development (GO:0048368)	22	1	.43	+	2.34	3.58E-01	1.00E00
renal sodium ion transport (GO:0003096)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of motor neuron axon guidance (GO:1905812)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glomerular filtration (GO:0003094)	19	1	.37	+	2.71	3.20E-01	1.00E00
alditol biosynthetic process (GO:0019401)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of glomerular filtration (GO:0003093)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
alditol metabolic process (GO:0019400)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
renal water homeostasis (GO:0003091)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phenol-containing compound biosynthetic process (GO:0046189)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
response to abiotic stimulus (GO:0009628)	327	8	6.36	+	1.26	5.41E-01	1.00E00
presynapse assembly (GO:0099054)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
aldehyde catabolic process (GO:0046185)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
aldehyde biosynthetic process (GO:0046184)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to fungus (GO:0009620)	28	1	.54	+	1.84	4.28E-01	1.00E00
dermatan sulfate proteoglycan metabolic process (GO:0050655)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
negative regulation of systemic arterial blood pressure (GO:0003085)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of systemic arterial blood pressure (GO:0003084)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein homotrimerization (GO:0070207)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
protein trimerization (GO:0070206)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle tethering to endoplasmic reticulum (GO:0099044)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
D-gluconate catabolic process (GO:0046177)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to bacterium (GO:0009617)	193	3	3.75	-	.80	1.00E00	1.00E00
aldonic acid catabolic process (GO:0046176)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of protein localization (GO:0070201)	79	2	1.54	+	1.30	6.69E-01	1.00E00
vesicle tethering to Golgi (GO:0099041)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
polyol catabolic process (GO:0046174)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
response to virus (GO:0009615)	65	0	1.26	-	 < 0.01	6.38E-01	1.00E00
polyol biosynthetic process (GO:0046173)	48	0	.93	-	 < 0.01	1.00E00	1.00E00
lung epithelium development (GO:0060428)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
protein transport (GO:0015031)	720	10	14.01	-	.71	3.36E-01	1.00E00
regulation of heart growth (GO:0060420)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure (GO:0003073)	21	1	.41	+	2.45	3.46E-01	1.00E00
renal system process involved in regulation of systemic arterial blood pressure (GO:0003071)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
paraxial mesodermal cell differentiation (GO:0048342)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm formation (GO:0048341)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate catabolic process (GO:0046168)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm morphogenesis (GO:0048340)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate biosynthetic process (GO:0046167)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to biotic stimulus (GO:0009607)	329	4	6.40	-	.62	5.40E-01	1.00E00
alcohol biosynthetic process (GO:0046165)	67	0	1.30	-	 < 0.01	6.41E-01	1.00E00
alcohol catabolic process (GO:0046164)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
heart growth (GO:0060419)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
heme a metabolic process (GO:0046160)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to growth hormone (GO:0060416)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
muscle tissue morphogenesis (GO:0060415)	23	1	.45	+	2.23	3.70E-01	1.00E00
methylguanosine-cap decapping (GO:0110156)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
RNA decapping (GO:0110154)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of biomineralization (GO:0110151)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of biomineralization (GO:0110150)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mesodermal cell differentiation (GO:0048333)	15	1	.29	+	3.43	2.65E-01	1.00E00
mesoderm morphogenesis (GO:0048332)	39	1	.76	+	1.32	5.38E-01	1.00E00
plasma membrane invagination (GO:0099024)	71	1	1.38	-	.72	1.00E00	1.00E00
vesicle tethering (GO:0099022)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
rhodopsin metabolic process (GO:0046154)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process (GO:0015012)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
positive regulation of penile erection (GO:0060406)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
synapse assembly (GO:0007416)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
regulation of penile erection (GO:0060405)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
axonal defasciculation (GO:0007414)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
axonal fasciculation (GO:0007413)	10	1	.19	+	5.14	1.91E-01	1.00E00
calcium ion transport into cytosol (GO:0060402)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
sodium ion export across plasma membrane (GO:0036376)	14	1	.27	+	3.67	2.51E-01	1.00E00
cytosolic calcium ion transport (GO:0060401)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
imidazole-containing compound catabolic process (GO:0052805)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of biomineralization (GO:0110149)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
imidazole-containing compound metabolic process (GO:0052803)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
opsin transport (GO:0036372)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
activation of protein kinase A activity (GO:0034199)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to amino acid starvation (GO:0034198)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
biomineralization (GO:0110148)	22	1	.43	+	2.34	3.58E-01	1.00E00
triglyceride transport (GO:0034197)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acylglycerol transport (GO:0034196)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
multivesicular body sorting pathway (GO:0071985)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
tetrahydrobiopterin metabolic process (GO:0046146)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
neuronal dense core vesicle exocytosis (GO:0099011)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
D-alanine family amino acid metabolic process (GO:0046144)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cone photoresponse recovery (GO:0036368)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
glial cell fate determination (GO:0007403)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
neuroblast fate determination (GO:0007400)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta1 activation (GO:0036364)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta activation (GO:0036363)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044)	15	1	.29	+	3.43	2.65E-01	1.00E00
Golgi inheritance (GO:0048313)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
intracellular distribution of mitochondria (GO:0048312)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrion distribution (GO:0048311)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated transport in synapse (GO:0099003)	92	0	1.79	-	 < 0.01	4.26E-01	1.00E00
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside catabolic process (GO:0046135)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside catabolic process (GO:0046133)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside metabolic process (GO:0046131)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of tetrapyrrole metabolic process (GO:1901401)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside catabolic process (GO:0046130)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone H2A-K119 monoubiquitination (GO:0036353)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
organelle inheritance (GO:0048308)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside biosynthetic process (GO:0046129)	22	1	.43	+	2.34	3.58E-01	1.00E00
purine ribonucleoside metabolic process (GO:0046128)	31	1	.60	+	1.66	4.60E-01	1.00E00
pyrimidine deoxyribonucleoside metabolic process (GO:0046125)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
post-anal tail morphogenesis (GO:0036342)	18	1	.35	+	2.86	3.07E-01	1.00E00
toll-like receptor 10 signaling pathway (GO:0034166)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 9 signaling pathway (GO:0034162)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of animal organ morphogenesis (GO:0110111)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of animal organ morphogenesis (GO:0110110)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
nucleobase catabolic process (GO:0046113)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
xanthine metabolic process (GO:0046110)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
Fas signaling pathway (GO:0036337)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dendritic cell migration (GO:0036336)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 8 signaling pathway (GO:0034158)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vascular process in circulatory system (GO:0003018)	63	1	1.23	-	.82	1.00E00	1.00E00
toll-like receptor 7 signaling pathway (GO:0034154)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
heart process (GO:0003015)	90	0	1.75	-	 < 0.01	4.23E-01	1.00E00
circulatory system process (GO:0003013)	180	3	3.50	-	.86	1.00E00	1.00E00
muscle system process (GO:0003012)	82	2	1.60	+	1.25	6.76E-01	1.00E00
phenol-containing compound metabolic process (GO:0018958)	22	0	.43	-	 < 0.01	1.00E00	1.00E00
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
voluntary skeletal muscle contraction (GO:0003010)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
thymidine metabolic process (GO:0046104)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nitrogen cycle metabolic process (GO:0071941)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
inosine biosynthetic process (GO:0046103)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
inosine metabolic process (GO:0046102)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hypoxanthine metabolic process (GO:0046100)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
nuclear pore organization (GO:0006999)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
nuclear envelope organization (GO:0006998)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
nucleus organization (GO:0006997)	29	0	.56	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrogen starvation (GO:0006995)	12	1	.23	+	4.28	2.22E-01	1.00E00
skeletal muscle contraction (GO:0003009)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 5 signaling pathway (GO:0034146)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
system process (GO:0003008)	731	15	14.22	+	1.05	7.85E-01	1.00E00
response to sterol depletion (GO:0006991)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
developmental process involved in reproduction (GO:0003006)	110	2	2.14	-	.93	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vitamin A import (GO:0071939)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vitamin A transport (GO:0071938)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
replication fork reversal (GO:0071932)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to unfolded protein (GO:0006986)	50	1	.97	+	1.03	6.26E-01	1.00E00
toll-like receptor 3 signaling pathway (GO:0034138)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
ER-nucleus signaling pathway (GO:0006984)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
ER overload response (GO:0006983)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 2 signaling pathway (GO:0034134)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
alpha-tubulin acetylation (GO:0071929)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
endocannabinoid signaling pathway (GO:0071926)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular response to virus (GO:0098586)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
detection of external biotic stimulus (GO:0098581)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube elongation (GO:0036306)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to oxidative stress (GO:0006979)	70	1	1.36	-	.73	1.00E00	1.00E00
lymph vessel morphogenesis (GO:0036303)	37	1	.72	+	1.39	5.19E-01	1.00E00
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
atrioventricular canal development (GO:0036302)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hyperosmotic response (GO:0006972)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
hypotonic response (GO:0006971)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
response to osmotic stress (GO:0006970)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor signaling pathway (GO:0034122)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor signaling pathway (GO:0034121)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
urea transmembrane transport (GO:0071918)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
asynchronous neurotransmitter secretion (GO:0071912)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of liver left/right asymmetry (GO:0071910)	11	1	.21	+	4.67	2.06E-01	1.00E00
negative regulation of homotypic cell-cell adhesion (GO:0034111)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of homotypic cell-cell adhesion (GO:0034110)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of intestine left/right asymmetry (GO:0071908)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of digestive tract left/right asymmetry (GO:0071907)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein serine/threonine kinase activity (GO:0071902)	77	1	1.50	-	.67	1.00E00	1.00E00
negative regulation of protein serine/threonine kinase activity (GO:0071901)	28	0	.54	-	 < 0.01	1.00E00	1.00E00
epithelium regeneration (GO:1990399)	15	1	.29	+	3.43	2.65E-01	1.00E00
regulation of protein serine/threonine kinase activity (GO:0071900)	140	3	2.72	+	1.10	7.55E-01	1.00E00
humoral immune response (GO:0006959)	85	0	1.65	-	 < 0.01	4.15E-01	1.00E00
positive regulation of epiboly involved in gastrulation with mouth forming second (GO:1904088)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
complement activation, classical pathway (GO:0006958)	45	0	.88	-	 < 0.01	1.00E00	1.00E00
negative regulation of epiboly involved in gastrulation with mouth forming second (GO:1904087)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
homotypic cell-cell adhesion (GO:0034109)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of epiboly involved in gastrulation with mouth forming second (GO:1904086)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
complement activation, alternative pathway (GO:0006957)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
complement activation (GO:0006956)	62	0	1.21	-	 < 0.01	6.34E-01	1.00E00
acute-phase response (GO:0006953)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ether metabolic process (GO:0018904)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell differentiation (GO:0045687)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell differentiation (GO:0045686)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of epidermis development (GO:0045682)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
syncytium formation (GO:0006949)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of striated muscle contraction (GO:0006942)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
striated muscle contraction (GO:0006941)	44	1	.86	+	1.17	5.80E-01	1.00E00
regulation of smooth muscle contraction (GO:0006940)	10	1	.19	+	5.14	1.91E-01	1.00E00
lipid transport across blood-brain barrier (GO:1990379)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of other organism (GO:0098543)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
defense response to other organism (GO:0098542)	218	2	4.24	-	.47	4.51E-01	1.00E00
negative regulation of helicase activity (GO:0051097)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of helicase activity (GO:0051096)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of helicase activity (GO:0051095)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of developmental process (GO:0051094)	209	6	4.07	+	1.48	3.10E-01	1.00E00
smooth muscle contraction (GO:0006939)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
regulation of osteoclast differentiation (GO:0045670)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-binding transcription factor activity (GO:0051091)	36	1	.70	+	1.43	5.10E-01	1.00E00
regulation of muscle contraction (GO:0006937)	31	1	.60	+	1.66	4.60E-01	1.00E00
regulation of DNA-binding transcription factor activity (GO:0051090)	51	2	.99	+	2.02	2.68E-01	1.00E00
muscle contraction (GO:0006936)	78	2	1.52	+	1.32	6.67E-01	1.00E00
positive regulation of cation transmembrane transport (GO:1904064)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
negative regulation of cation transmembrane transport (GO:1904063)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
regulation of cation transmembrane transport (GO:1904062)	80	0	1.56	-	 < 0.01	4.10E-01	1.00E00
protein kinase B signaling (GO:0043491)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
malate-aspartate shuttle (GO:0043490)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cell migration, cell extension (GO:0006930)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
body morphogenesis (GO:0010171)	13	1	.25	+	3.95	2.36E-01	1.00E00
thrombocyte differentiation (GO:0002574)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
myeloid leukocyte differentiation (GO:0002573)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoblast differentiation (GO:0045669)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoblast differentiation (GO:0045668)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of osteoblast differentiation (GO:0045667)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
mRNA 5'-splice site recognition (GO:0000395)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
PMA-inducible membrane protein ectodomain proteolysis (GO:0051088)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
spliceosomal conformational changes to generate catalytic conformation (GO:0000393)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
chaperone cofactor-dependent protein refolding (GO:0051085)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of myoblast differentiation (GO:0045663)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
'de novo' posttranslational protein folding (GO:0051084)	27	0	.53	-	 < 0.01	1.00E00	1.00E00
RNA stabilization (GO:0043489)	12	1	.23	+	4.28	2.22E-01	1.00E00
regulation of locomotor rhythm (GO:1904059)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
spliceosomal complex disassembly (GO:0000390)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of myoblast differentiation (GO:0045661)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cell migration (GO:0006929)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil differentiation (GO:0045660)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
histone exchange (GO:0043486)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
endosome to pigment granule transport (GO:0043485)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
otolith tethering (GO:0035889)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular pigment accumulation (GO:0043482)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vascular smooth muscle cell differentiation (GO:0035886)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
enteroendocrine cell differentiation (GO:0035883)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
amacrine cell differentiation (GO:0035881)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
response to X-ray (GO:0010165)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
somatic diversification of T cell receptor genes (GO:0002568)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immune receptors via somatic mutation (GO:0002566)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
neuromuscular junction development, skeletal muscle fiber (GO:0098529)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
skeletal muscle fiber differentiation (GO:0098528)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mRNA 3'-splice site recognition (GO:0000389)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil differentiation (GO:0045659)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
spliceosomal snRNP assembly (GO:0000387)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil differentiation (GO:0045658)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte differentiation (GO:0045657)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte differentiation (GO:0045655)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of megakaryocyte differentiation (GO:0045654)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of megakaryocyte differentiation (GO:0045652)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	22	1	.43	+	2.34	3.58E-01	1.00E00
positive regulation of macrophage differentiation (GO:0045651)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pigment accumulation (GO:0043476)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor production (GO:1904046)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
apoptotic process (GO:0006915)	218	5	4.24	+	1.18	6.21E-01	1.00E00
pigment metabolic process involved in pigmentation (GO:0043474)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
phagocytosis, engulfment (GO:0006911)	69	0	1.34	-	 < 0.01	6.44E-01	1.00E00
phagocytosis, recognition (GO:0006910)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
specification of animal organ position (GO:0010159)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of proton transport (GO:0010155)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
neurofilament bundle assembly (GO:0033693)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cellular polysaccharide biosynthetic process (GO:0033692)	37	0	.72	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoblast proliferation (GO:0033690)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
tRNA-type intron splice site recognition and cleavage (GO:0000379)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
RNA exon ligation (GO:0000378)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage differentiation (GO:0045649)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of erythrocyte differentiation (GO:0045648)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of erythrocyte differentiation (GO:0045647)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of erythrocyte differentiation (GO:0045646)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
phagocytosis (GO:0006909)	97	0	1.89	-	 < 0.01	2.68E-01	1.00E00
pinocytosis (GO:0006907)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle fusion (GO:0006906)	60	0	1.17	-	 < 0.01	6.32E-01	1.00E00
vesicle docking involved in exocytosis (GO:0006904)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of ATPase activity (GO:0043462)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
vesicle targeting (GO:0006903)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclin-dependent protein kinase activity (GO:1904031)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
proton-transporting ATP synthase complex assembly (GO:0043461)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vesicle coating (GO:0006901)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclin-dependent protein kinase activity (GO:1904030)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular response to potassium ion (GO:0035865)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle budding from membrane (GO:0006900)	31	0	.60	-	 < 0.01	1.00E00	1.00E00
response to potassium ion (GO:0035864)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoblast proliferation (GO:0033689)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of osteoblast proliferation (GO:0033688)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
osteoblast proliferation (GO:0033687)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of luteinizing hormone secretion (GO:0033685)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
monocyte chemotaxis (GO:0002548)	37	0	.72	-	 < 0.01	1.00E00	1.00E00
regulation of luteinizing hormone secretion (GO:0033684)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA incision (GO:0033683)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
endothelial to hematopoietic transition (GO:0098508)	12	1	.23	+	4.28	2.22E-01	1.00E00
positive regulation of myeloid cell differentiation (GO:0045639)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid cell differentiation (GO:0045638)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid cell differentiation (GO:0045637)	19	0	.37	-	 < 0.01	1.00E00	1.00E00
DNA 3' dephosphorylation involved in DNA repair (GO:0098504)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of small GTPase mediated signal transduction (GO:0051058)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
DNA 3' dephosphorylation (GO:0098503)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
DNA dephosphorylation (GO:0098502)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of melanocyte differentiation (GO:0045634)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid biosynthetic process (GO:0051055)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of mechanoreceptor differentiation (GO:0045631)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of collagen fibril organization (GO:1904028)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of transport (GO:0051051)	57	1	1.11	-	.90	1.00E00	1.00E00
regulation of pentose-phosphate shunt (GO:0043456)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of collagen fibril organization (GO:1904026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of transport (GO:0051050)	97	2	1.89	+	1.06	7.14E-01	1.00E00
regulation of secondary metabolic process (GO:0043455)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
megakaryocyte development (GO:0035855)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide salvage (GO:0010138)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
chromosome passenger complex localization to spindle midzone (GO:0035853)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
proline catabolic process to glutamate (GO:0010133)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of kinase activity (GO:0033673)	46	0	.89	-	 < 0.01	1.00E00	1.00E00
production of molecular mediator involved in inflammatory response (GO:0002532)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of mating type switching (GO:0031494)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 2 cell differentiation (GO:0045629)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 2 cell differentiation (GO:0045628)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transport (GO:0051049)	451	5	8.77	-	.57	2.95E-01	1.00E00
positive regulation of T-helper 1 cell differentiation (GO:0045627)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of secretion (GO:0051048)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of secretion (GO:0051047)	42	0	.82	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 cell differentiation (GO:0045625)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper cell differentiation (GO:0045624)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper cell differentiation (GO:0045623)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper cell differentiation (GO:0045622)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
generation of catalytic spliceosome for second transesterification step (GO:0000350)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of vasculature development (GO:1904018)	40	0	.78	-	 < 0.01	1.00E00	1.00E00
regulation of membrane protein ectodomain proteolysis (GO:0051043)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte differentiation (GO:0045621)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte differentiation (GO:0045620)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell outer segment organization (GO:0035845)	20	1	.39	+	2.57	3.33E-01	1.00E00
phenylacetate catabolic process (GO:0010124)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process to proline via ornithine (GO:0010121)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acute inflammatory response (GO:0002526)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukocyte migration involved in inflammatory response (GO:0002523)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
generation of catalytic spliceosome for first transesterification step (GO:0000349)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
leukocyte migration involved in immune response (GO:0002522)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
leukocyte differentiation (GO:0002521)	72	1	1.40	-	.71	1.00E00	1.00E00
regulation of lymphocyte differentiation (GO:0045619)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte differentiation (GO:0045616)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tRNA transport (GO:0051031)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
snRNA transport (GO:0051030)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to corticotropin-releasing hormone (GO:0043435)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to peptide hormone (GO:0043434)	71	1	1.38	-	.72	1.00E00	1.00E00
negative regulation of DNA-binding transcription factor activity (GO:0043433)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
T cell tolerance induction (GO:0002517)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tolerance induction to self antigen (GO:0002513)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
protein deneddylation (GO:0000338)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
chiasma assembly (GO:0051026)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal cell differentiation (GO:0045604)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell differentiation (GO:0045603)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex structural organization (GO:0021698)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell differentiation (GO:0045601)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex formation (GO:0021697)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex morphogenesis (GO:0021696)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex development (GO:0021695)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer formation (GO:0021694)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide biosynthetic process (GO:0072388)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer structural organization (GO:0021693)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide metabolic process (GO:0072387)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer morphogenesis (GO:0021692)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
minus-end-directed organelle transport along microtubule (GO:0072385)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
fatty acid oxidation (GO:0019395)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
organelle transport along microtubule (GO:0072384)	29	1	.56	+	1.77	4.39E-01	1.00E00
anthranilate metabolic process (GO:0043420)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
minus-end-directed vesicle transport along microtubule (GO:0072382)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glucuronoside catabolic process (GO:0019391)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
central tolerance induction to self antigen (GO:0002509)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
central tolerance induction (GO:0002508)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
tolerance induction (GO:0002507)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
nuclear envelope reassembly (GO:0031468)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
actin filament bundle assembly (GO:0051017)	49	1	.95	+	1.05	6.19E-01	1.00E00
barbed-end actin filament capping (GO:0051016)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
actin filament severing (GO:0051014)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
microtubule severing (GO:0051013)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
homocysteine catabolic process (GO:0043418)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
microtubule sliding (GO:0051012)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle tissue regeneration (GO:0043416)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
glucuronoside metabolic process (GO:0019389)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer formation (GO:0021684)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
blood coagulation, fibrin clot formation (GO:0072378)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
galactose catabolic process (GO:0019388)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
macromolecule glycosylation (GO:0043413)	175	2	3.40	-	.59	7.78E-01	1.00E00
cerebellar granular layer morphogenesis (GO:0021683)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
protein activation cascade (GO:0072376)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer development (GO:0021681)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of MAPK cascade (GO:0043410)	170	3	3.31	-	.91	1.00E00	1.00E00
cerebellar Purkinje cell layer development (GO:0021680)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of renal sodium excretion (GO:0035814)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of renal sodium excretion (GO:0035813)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
meiotic attachment of telomere to nuclear envelope (GO:0070197)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of urine volume (GO:0035810)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptonemal complex organization (GO:0070193)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of cell-cell adhesion mediated by integrin (GO:0033632)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell adhesion mediated by integrin (GO:0033630)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycine betaine biosynthetic process (GO:0031456)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
glycine betaine metabolic process (GO:0031455)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of MAPK cascade (GO:0043409)	25	0	.49	-	 < 0.01	1.00E00	1.00E00
regulation of MAPK cascade (GO:0043408)	210	4	4.09	-	.98	1.00E00	1.00E00
third ventricle development (GO:0021678)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of MAP kinase activity (GO:0043407)	20	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of MAP kinase activity (GO:0043406)	66	1	1.28	-	.78	1.00E00	1.00E00
regulation of MAP kinase activity (GO:0043405)	91	1	1.77	-	.56	1.00E00	1.00E00
regulation of urine volume (GO:0035809)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
skeletal muscle tissue regeneration (GO:0043403)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
glycolipid catabolic process (GO:0019377)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
galactolipid catabolic process (GO:0019376)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
steroid hormone mediated signaling pathway (GO:0043401)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
galactolipid metabolic process (GO:0019374)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
lateral ventricle development (GO:0021670)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
kynurenine metabolic process (GO:0070189)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
egg coat formation (GO:0035803)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
cyclooxygenase pathway (GO:0019371)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion mediated by integrin (GO:0033629)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine acetylation (GO:0017198)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
leukotriene biosynthetic process (GO:0019370)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of cell adhesion mediated by integrin (GO:0033628)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cell adhesion mediated by integrin (GO:0033627)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-methionine acetylation (GO:0017196)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
mitochondrial tryptophanyl-tRNA aminoacylation (GO:0070183)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of virus (GO:0009597)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of biotic stimulus (GO:0009595)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus (GO:0009593)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
slow-twitch skeletal muscle fiber contraction (GO:0031444)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
fast-twitch skeletal muscle fiber contraction (GO:0031443)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to oxygen radical (GO:0000305)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA 3'-end processing (GO:0031442)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA 3'-end processing (GO:0031441)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
response to superoxide (GO:0000303)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
response to reactive oxygen species (GO:0000302)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of exonuclease activity (GO:1905778)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
arachidonic acid metabolic process (GO:0019369)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of exonuclease activity (GO:1905777)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cardiovascular system development (GO:0072358)	400	10	7.78	+	1.28	3.65E-01	1.00E00
fatty acid elongation, unsaturated fatty acid (GO:0019368)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, saturated fatty acid (GO:0019367)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
rhombomere 4 formation (GO:0021663)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA helicase activity (GO:1905775)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of DNA helicase activity (GO:1905774)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
rhombomere 4 morphogenesis (GO:0021661)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide catabolic process (GO:0019364)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagy of mitochondrion (GO:1903599)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide biosynthetic process (GO:0019363)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesodermal cell differentiation (GO:1905771)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide metabolic process (GO:0019362)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of mesodermal cell differentiation (GO:1905770)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
D-serine metabolic process (GO:0070178)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane protein proteolysis (GO:0033619)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamic acid carboxylation (GO:0017187)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid metabolic process (GO:0072350)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex IV assembly (GO:0033617)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine hydroxylation (GO:0017185)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-diphthamide metabolic process (GO:0017182)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA cleavage (GO:0031439)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of visible light (GO:0009584)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA cleavage (GO:0031437)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
detection of light stimulus (GO:0009583)	51	0	.99	-	 < 0.01	1.00E00	1.00E00
detection of abiotic stimulus (GO:0009582)	78	2	1.52	+	1.32	6.67E-01	1.00E00
detection of external stimulus (GO:0009581)	78	2	1.52	+	1.32	6.67E-01	1.00E00
growth hormone receptor signaling pathway via JAK-STAT (GO:0060397)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
growth hormone receptor signaling pathway (GO:0060396)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
SMAD protein signal transduction (GO:0060395)	43	0	.84	-	 < 0.01	1.00E00	1.00E00
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	44	0	.86	-	 < 0.01	1.00E00	1.00E00
nicotinamide nucleotide biosynthetic process (GO:0019359)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
sulfur compound transport (GO:0072348)	24	0	.47	-	 < 0.01	1.00E00	1.00E00
response to anesthetic (GO:0072347)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
rescue of stalled ribosome (GO:0072344)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of biomineral tissue development (GO:0070169)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone deubiquitination (GO:1903586)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of biomineral tissue development (GO:0070168)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of biomineral tissue development (GO:0070167)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
regulation of histone deubiquitination (GO:1903584)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
enamel mineralization (GO:0070166)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of catecholamine secretion (GO:0033605)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of catecholamine secretion (GO:0033604)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATP metabolic process (GO:1903580)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pathway-restricted SMAD protein phosphorylation (GO:0060389)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
ectoderm development (GO:0007398)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
synapse assembly involved in innervation (GO:0060386)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
axonogenesis involved in innervation (GO:0060385)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
innervation (GO:0060384)	11	0	.21	-	 < 0.01	1.00E00	1.00E00
dolichol metabolic process (GO:0019348)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
vagus nerve morphogenesis (GO:0021644)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
modified amino acid transport (GO:0072337)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP metabolic process (GO:1903579)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
UDP-galactose transmembrane transport (GO:0072334)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of ATP metabolic process (GO:1903578)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
cellular response to L-arginine (GO:1903577)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
signal transduction by p53 class mediator (GO:0072331)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
response to L-arginine (GO:1903576)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial seryl-tRNA aminoacylation (GO:0070158)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
monocarboxylic acid biosynthetic process (GO:0072330)	60	0	1.17	-	 < 0.01	6.32E-01	1.00E00
negative regulation of response to endoplasmic reticulum stress (GO:1903573)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
fertilization (GO:0009566)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
mitochondrial glycyl-tRNA aminoacylation (GO:0070150)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of buoyancy (GO:0031413)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of endosome to plasma membrane protein transport (GO:1905749)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
trigeminal nerve morphogenesis (GO:0021636)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
monocarboxylic acid catabolic process (GO:0072329)	47	0	.91	-	 < 0.01	1.00E00	1.00E00
optic nerve formation (GO:0021634)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
phenol-containing compound catabolic process (GO:0019336)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
optic nerve morphogenesis (GO:0021631)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi to plasma membrane CFTR protein transport (GO:0042999)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of Golgi to plasma membrane protein transport (GO:0042998)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of Golgi to plasma membrane protein transport (GO:0042997)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi to plasma membrane protein transport (GO:0042996)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion-dependent exocytosis (GO:0017158)	30	0	.58	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated protein transport (GO:0072321)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cilium (GO:1903566)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of exocytosis (GO:0017157)	83	0	1.61	-	 < 0.01	4.13E-01	1.00E00
cytoplasmic sequestering of transcription factor (GO:0042994)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
calcium-ion regulated exocytosis (GO:0017156)	35	0	.68	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cilium (GO:1903564)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
mitochondrial alanyl-tRNA aminoacylation (GO:0070143)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding (GO:0070142)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated calcium channel activity (GO:1901387)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of voltage-gated calcium channel activity (GO:1901386)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated calcium channel activity (GO:1901385)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
segment specification (GO:0007379)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion transmembrane transport (GO:1901381)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of potassium ion transmembrane transport (GO:1901380)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein modification process (GO:0031401)	348	10	6.77	+	1.48	2.36E-01	1.00E00
negative regulation of protein modification process (GO:0031400)	83	0	1.61	-	 < 0.01	4.13E-01	1.00E00
cranial suture morphogenesis (GO:0060363)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
central nervous system maturation (GO:0021626)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle uncoating (GO:0072319)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
clathrin coat disassembly (GO:0072318)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
oculomotor nerve formation (GO:0021623)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
oculomotor nerve morphogenesis (GO:0021622)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
sequestering of actin monomers (GO:0042989)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
glomerular epithelial cell fate commitment (GO:0072314)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
pentose catabolic process (GO:0019323)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
amyloid precursor protein catabolic process (GO:0042987)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation (GO:0017148)	44	2	.86	+	2.34	2.19E-01	1.00E00
pentose metabolic process (GO:0019321)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
organelle fusion (GO:0048284)	75	0	1.46	-	 < 0.01	4.08E-01	1.00E00
hexose catabolic process (GO:0019320)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of amyloid precursor protein biosynthetic process (GO:0042984)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
stem cell division (GO:0017145)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of potassium ion transmembrane transport (GO:1901379)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
amyloid precursor protein metabolic process (GO:0042982)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
vesicle fusion with Golgi apparatus (GO:0048280)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process (GO:0042981)	502	14	9.77	+	1.43	1.89E-01	1.00E00
positive regulation of mitochondrial translation (GO:0070131)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
organic heteropentacyclic compound metabolic process (GO:1901376)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
response to ammonium ion (GO:0060359)	49	0	.95	-	 < 0.01	1.00E00	1.00E00
segment polarity determination (GO:0007367)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
periodic partitioning (GO:0007365)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cartilage development involved in endochondral bone morphogenesis (GO:0060351)	34	0	.66	-	 < 0.01	1.00E00	1.00E00
endochondral bone morphogenesis (GO:0060350)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
hexose biosynthetic process (GO:0019319)	14	0	.27	-	 < 0.01	1.00E00	1.00E00
glossopharyngeal nerve morphogenesis (GO:0021615)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
hexose metabolic process (GO:0019318)	52	0	1.01	-	 < 0.01	6.28E-01	1.00E00
cellular response to aldehyde (GO:0110096)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule end (GO:1905725)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of aldehyde (GO:0110095)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
facial nerve formation (GO:0021611)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
vesicle docking (GO:0048278)	54	0	1.05	-	 < 0.01	6.28E-01	1.00E00
facial nerve morphogenesis (GO:0021610)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial translation (GO:0070129)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation for mitochondrial protein translation (GO:0070127)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational termination (GO:0070126)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational elongation (GO:0070125)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
guanine biosynthetic process (GO:0046099)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational initiation (GO:0070124)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
guanine metabolic process (GO:0046098)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to postsynaptic membrane (GO:1903540)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
ciliary neurotrophic factor-mediated signaling pathway (GO:0070120)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
bone morphogenesis (GO:0060349)	52	0	1.01	-	 < 0.01	6.28E-01	1.00E00
organic cyclic compound biosynthetic process (GO:1901362)	534	10	10.39	-	.96	1.00E00	1.00E00
bone development (GO:0060348)	68	1	1.32	-	.76	1.00E00	1.00E00
organic cyclic compound catabolic process (GO:1901361)	180	5	3.50	+	1.43	4.08E-01	1.00E00
heart trabecula formation (GO:0060347)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
trabecula formation (GO:0060343)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
inositol phosphorylation (GO:0052746)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
tripartite regional subdivision (GO:0007351)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
blastoderm segmentation (GO:0007350)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
cranial nerve formation (GO:0021603)	13	1	.25	+	3.95	2.36E-01	1.00E00
clathrin coat assembly (GO:0048268)	15	0	.29	-	 < 0.01	1.00E00	1.00E00
protein localization to postsynaptic membrane (GO:1903539)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
D-ribose catabolic process (GO:0019303)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
behavioral response to pain (GO:0048266)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane permeability (GO:1905710)	7	0	.14	-	 < 0.01	1.00E00	1.00E00
response to pain (GO:0048265)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
determination of ventral identity (GO:0048264)	17	0	.33	-	 < 0.01	1.00E00	1.00E00
determination of dorsal identity (GO:0048263)	14	1	.27	+	3.67	2.51E-01	1.00E00
regulation of protein targeting (GO:1903533)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
determination of dorsal/ventral asymmetry (GO:0048262)	31	1	.60	+	1.66	4.60E-01	1.00E00
positive regulation of secretion by cell (GO:1903532)	39	0	.76	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor-mediated endocytosis (GO:0048261)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
cytidine metabolic process (GO:0046087)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of secretion by cell (GO:1903531)	18	0	.35	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor-mediated endocytosis (GO:0048260)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
adenosine metabolic process (GO:0046085)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
plasma membrane phospholipid scrambling (GO:0017121)	26	0	.51	-	 < 0.01	1.00E00	1.00E00
adenine biosynthetic process (GO:0046084)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
adenine metabolic process (GO:0046083)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of type I interferon-mediated signaling pathway (GO:0060339)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
dUTP catabolic process (GO:0046081)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of type I interferon-mediated signaling pathway (GO:0060338)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
dUTP metabolic process (GO:0046080)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
type I interferon signaling pathway (GO:0060337)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-gamma-mediated signaling pathway (GO:0060334)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
pronuclear fusion (GO:0007344)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
egg activation (GO:0007343)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to interferon-gamma (GO:0060331)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
acrosome reaction (GO:0007340)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
regulation of response to interferon-gamma (GO:0060330)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of receptor-mediated endocytosis (GO:0048259)	15	1	.29	+	3.43	2.65E-01	1.00E00
positive regulation of membrane tubulation (GO:1903527)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
mRNA stabilization (GO:0048255)	12	1	.23	+	4.28	2.22E-01	1.00E00
snoRNA localization (GO:0048254)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of membrane tubulation (GO:1903525)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood circulation (GO:1903524)	19	1	.37	+	2.71	3.20E-01	1.00E00
lipoprotein transport (GO:0042953)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood circulation (GO:1903523)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of blood circulation (GO:1903522)	73	2	1.42	+	1.41	6.56E-01	1.00E00
dUMP metabolic process (GO:0046078)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
elastic fiber assembly (GO:0048251)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
dUDP metabolic process (GO:0046077)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
iron import into the mitochondrion (GO:0048250)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dTTP metabolic process (GO:0046075)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
dTMP metabolic process (GO:0046073)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
negative regulation of vasculature development (GO:1901343)	23	1	.45	+	2.23	3.70E-01	1.00E00
dTDP metabolic process (GO:0046072)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
binding of sperm to zona pellucida (GO:0007339)	12	0	.23	-	 < 0.01	1.00E00	1.00E00
regulation of vasculature development (GO:1901342)	90	1	1.75	-	.57	1.00E00	1.00E00
single fertilization (GO:0007338)	33	0	.64	-	 < 0.01	1.00E00	1.00E00
positive regulation of store-operated calcium channel activity (GO:1901341)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
dGTP metabolic process (GO:0046070)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
cytoplasmic actin-based contraction involved in cell motility (GO:0060327)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cell chemotaxis (GO:0060326)	119	1	2.32	-	.43	7.32E-01	1.00E00
face morphogenesis (GO:0060325)	8	0	.16	-	 < 0.01	1.00E00	1.00E00
face development (GO:0060324)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
head morphogenesis (GO:0060323)	9	0	.18	-	 < 0.01	1.00E00	1.00E00
interstrand cross-link repair (GO:0036297)	21	0	.41	-	 < 0.01	1.00E00	1.00E00
response to increased oxygen levels (GO:0036296)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to increased oxygen levels (GO:0036295)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
cellular response to decreased oxygen levels (GO:0036294)	4	0	.08	-	 < 0.01	1.00E00	1.00E00
response to decreased oxygen levels (GO:0036293)	57	1	1.11	-	.90	1.00E00	1.00E00
DNA rewinding (GO:0036292)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
lymphocyte chemotaxis (GO:0048247)	36	0	.70	-	 < 0.01	1.00E00	1.00E00
macrophage chemotaxis (GO:0048246)	10	0	.19	-	 < 0.01	1.00E00	1.00E00
eosinophil chemotaxis (GO:0048245)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
epinephrine secretion (GO:0048242)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cGMP catabolic process (GO:0046069)	5	0	.10	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum to cytosol transport (GO:1903513)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
epinephrine transport (GO:0048241)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
cGMP metabolic process (GO:0046068)	23	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of store-operated calcium channel activity (GO:1901339)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
sperm capacitation (GO:0048240)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
mucopolysaccharide metabolic process (GO:1903510)	16	0	.31	-	 < 0.01	1.00E00	1.00E00
dCTP metabolic process (GO:0046065)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dATP catabolic process (GO:0046061)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
dATP metabolic process (GO:0046060)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA recombination at telomere (GO:0048239)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament organization (GO:0110053)	133	1	2.59	-	.39	5.25E-01	1.00E00
liposaccharide metabolic process (GO:1903509)	59	1	1.15	-	.87	1.00E00	1.00E00
DNA biosynthetic process (GO:0071897)	27	1	.53	+	1.90	4.17E-01	1.00E00
male gamete generation (GO:0048232)	59	1	1.15	-	.87	1.00E00	1.00E00
cAMP metabolic process (GO:0046058)	13	0	.25	-	 < 0.01	1.00E00	1.00E00
protein localization to adherens junction (GO:0071896)	2	0	.04	-	 < 0.01	1.00E00	1.00E00
UTP metabolic process (GO:0046051)	10	1	.19	+	5.14	1.91E-01	1.00E00
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization (GO:0060306)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
pole plasm assembly (GO:0007315)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
oocyte anterior/posterior axis specification (GO:0007314)	3	0	.06	-	 < 0.01	1.00E00	1.00E00
thiamine pyrophosphate transmembrane transport (GO:0030974)	1	0	.02	-	 < 0.01	1.00E00	1.00E00
retrograde protein transport, ER to cytosol (GO:0030970)	6	0	.12	-	 < 0.01	1.00E00	1.00E00
